GO.ID,Term,Annotated,Significant,Expected,classicFisher,bonferroni,bh,foldEnrichment,Ontology
GO:0071840,cellular component organization or bioge...,6181,241,137.36,3.5e-24,1.6842e-20,1.2270600000000001e-20,1.75,BP
GO:0006996,organelle organization,3599,170,79.98,5.1e-24,2.4541200000000002e-20,1.2270600000000001e-20,2.13,BP
GO:0016043,cellular component organization,6004,233,133.43,9.7e-23,4.66764e-19,1.55588e-19,1.75,BP
GO:0051128,regulation of cellular component organiz...,2590,126,57.56,4.0e-18,1.9248e-14,4.812e-15,2.19,BP
GO:0007010,cytoskeleton organization,1323,83,29.4,5.3e-18,2.55036e-14,5.10072e-15,2.82,BP
GO:0009987,cellular process,15679,418,348.44,8.8e-16,4.23456e-12,7.0576e-13,1.2,BP
GO:0044260,cellular macromolecule metabolic process,7120,239,158.23,6.9e-15,3.32028e-11,4.743257142857143e-12,1.51,BP
GO:0043170,macromolecule metabolic process,8366,268,185.92,8.7e-15,4.18644e-11,5.23305e-12,1.44,BP
GO:0006807,nitrogen compound metabolic process,8802,276,195.61,3.6e-14,1.73232e-10,1.9247999999999997e-11,1.41,BP
GO:0044237,cellular metabolic process,9392,289,208.72,4.3e-14,2.0691599999999999e-10,1.9685454545454542e-11,1.38,BP
GO:0044085,cellular component biogenesis,3057,130,67.94,4.5e-14,2.1653999999999998e-10,1.9685454545454542e-11,1.91,BP
GO:0007017,microtubule-based process,770,54,17.11,7.9e-14,3.80148e-10,3.1679e-11,3.16,BP
GO:0044238,primary metabolic process,9317,286,207.05,1.1e-13,5.2932e-10,4.0716923076923076e-11,1.38,BP
GO:0033043,regulation of organelle organization,1260,72,28,1.3e-13,6.2556e-10,4.4682857142857144e-11,2.57,BP
GO:0022607,cellular component assembly,2829,122,62.87,1.4e-13,6.7368e-10,4.491200000000001e-11,1.94,BP
GO:0031323,regulation of cellular metabolic process,5454,193,121.21,2.1e-13,1.01052e-9,6.31575e-11,1.59,BP
GO:0034641,cellular nitrogen compound metabolic pro...,5536,194,123.03,4.6e-13,2.2135199999999996e-9,1.302070588235294e-10,1.58,BP
GO:0051641,cellular localization,2629,114,58.42,8.3e-13,3.99396e-9,2.2188666666666665e-10,1.95,BP
GO:0044267,cellular protein metabolic process,4573,168,101.63,9.8e-13,4.71576e-9,2.481978947368421e-10,1.65,BP
GO:0010467,gene expression,4801,173,106.69,2.0e-12,9.623999999999999e-9,4.812e-10,1.62,BP
GO:0051171,regulation of nitrogen compound metaboli...,5150,182,114.45,2.1e-12,1.01052e-8,4.812e-10,1.59,BP
GO:0048522,positive regulation of cellular process,5410,188,120.23,3.3e-12,1.58796e-8,7.218e-10,1.56,BP
GO:0080090,regulation of primary metabolic process,5295,184,117.67,6.8e-12,3.27216e-8,1.4226782608695651e-9,1.56,BP
GO:0009059,macromolecule biosynthetic process,4105,152,91.23,1.3e-11,6.255600000000001e-8,2.50224e-9,1.67,BP
GO:0019222,regulation of metabolic process,6009,201,133.54,1.3e-11,6.255600000000001e-8,2.50224e-9,1.51,BP
GO:0090304,nucleic acid metabolic process,4304,157,95.65,1.6e-11,7.699199999999999e-8,2.961230769230769e-9,1.64,BP
GO:0051246,regulation of protein metabolic process,2720,113,60.45,1.7e-11,8.1804e-8,3.029777777777778e-9,1.87,BP
GO:0034613,cellular protein localization,1709,82,37.98,2.2e-11,1.0586400000000001e-7,3.780857142857143e-9,2.16,BP
GO:0060255,regulation of macromolecule metabolic pr...,5534,188,122.98,2.7e-11,1.29924e-7,4.4801379310344835e-9,1.53,BP
GO:0070727,cellular macromolecule localization,1719,82,38.2,2.9e-11,1.39548e-7,4.6516e-9,2.15,BP
GO:0034645,cellular macromolecule biosynthetic proc...,4006,148,89.03,3.3e-11,1.5879600000000001e-7,5.122451612903226e-9,1.66,BP
GO:0016070,RNA metabolic process,3787,142,84.16,3.5e-11,1.6842000000000002e-7,5.263125000000001e-9,1.69,BP
GO:0032268,regulation of cellular protein metabolic...,2529,106,56.2,5.3e-11,2.55036e-7,7.728363636363636e-9,1.89,BP
GO:0048518,positive regulation of biological proces...,6114,201,135.87,6.9e-11,3.32028e-7,9.624e-9,1.48,BP
GO:0033554,cellular response to stress,1781,83,39.58,7.0e-11,3.3684000000000004e-7,9.624e-9,2.1,BP
GO:0022402,cell cycle process,1128,61,25.07,1.2e-10,5.7744e-7,1.5606486486486488e-8,2.43,BP
GO:0071704,organic substance metabolic process,9887,288,219.72,1.2e-10,5.7744e-7,1.5606486486486488e-8,1.31,BP
GO:0030036,actin cytoskeleton organization,670,44,14.89,1.6e-10,7.6992e-7,2.0261052631578945e-8,2.96,BP
GO:0019538,protein metabolic process,5210,177,115.78,1.7e-10,8.1804e-7,2.0975384615384617e-8,1.53,BP
GO:0007049,cell cycle,1659,78,36.87,1.9e-10,9.1428e-7,2.2856999999999997e-8,2.12,BP
GO:0048519,negative regulation of biological proces...,5347,180,118.83,2.2e-10,1.05864e-6,2.5820487804878045e-8,1.51,BP
GO:0006139,nucleobase-containing compound metabolic...,4840,167,107.56,2.3e-10,1.10676e-6,2.6351428571428573e-8,1.55,BP
GO:0008152,metabolic process,10362,297,230.28,2.8e-10,1.3473600000000002e-6,3.1333953488372095e-8,1.29,BP
GO:0050794,regulation of cellular process,10724,304,238.32,4.7e-10,2.2616400000000003e-6,5.1400909090909094e-8,1.28,BP
GO:0010564,regulation of cell cycle process,598,40,13.29,6.6e-10,3.17592e-6,7.0576e-8,3.01,BP
GO:0048523,negative regulation of cellular process,4750,163,105.56,6.9e-10,3.32028e-6,7.218e-8,1.54,BP
GO:0051130,positive regulation of cellular componen...,1303,65,28.96,7.6e-10,3.65712e-6,7.781106382978722e-8,2.24,BP
GO:0031399,regulation of protein modification proce...,1783,80,39.62,9.9e-10,4.7638800000000005e-6,9.820408163265306e-8,2.02,BP
GO:0044271,cellular nitrogen compound biosynthetic ...,3970,142,88.23,1.0e-09,4.812000000000001e-6,9.820408163265306e-8,1.61,BP
GO:0008104,protein localization,2633,105,58.51,1.2e-09,5.7744e-6,1.15488e-7,1.79,BP
GO:0050789,regulation of biological process,11466,318,254.81,1.4e-09,6.7368e-6,1.3209411764705884e-7,1.25,BP
GO:0010556,regulation of macromolecule biosynthetic...,3333,124,74.07,1.8e-09,8.6616e-6,1.6656923076923075e-7,1.67,BP
GO:0046483,heterocycle metabolic process,4969,167,110.43,1.9e-09,9.1428e-6,1.6931111111111111e-7,1.51,BP
GO:0051726,regulation of cell cycle,976,53,21.69,1.9e-09,9.1428e-6,1.6931111111111111e-7,2.44,BP
GO:0051493,regulation of cytoskeleton organization,548,37,12.18,2.3e-09,1.1067599999999999e-5,2.0122909090909089e-7,3.04,BP
GO:0030029,actin filament-based process,758,45,16.85,2.4e-09,1.15488e-5,2.0622857142857143e-7,2.67,BP
GO:0044087,regulation of cellular component biogene...,957,52,21.27,2.7e-09,1.2992400000000001e-5,2.2793684210526316e-7,2.44,BP
GO:0006928,movement of cell or subcellular componen...,2039,86,45.31,4.1e-09,1.97292e-5,3.401586206896552e-7,1.9,BP
GO:2000112,regulation of cellular macromolecule bio...,3241,120,72.03,4.8e-09,2.30976e-5,3.914847457627119e-7,1.67,BP
GO:0006725,cellular aromatic compound metabolic pro...,5041,167,112.03,5.6e-09,2.69472e-5,4.4912e-7,1.49,BP
GO:0000278,mitotic cell cycle,813,46,18.07,6.9e-09,3.32028e-5,5.443081967213116e-7,2.55,BP
GO:0006412,translation,572,37,12.71,7.2e-09,3.46464e-5,5.588129032258064e-7,2.91,BP
GO:1901564,organonitrogen compound metabolic proces...,6107,193,135.72,7.6e-09,3.65712e-5,5.804952380952381e-7,1.42,BP
GO:0006464,cellular protein modification process,3496,126,77.69,8.8e-09,4.2345599999999997e-5,6.514707692307692e-7,1.62,BP
GO:0036211,protein modification process,3496,126,77.69,8.8e-09,4.2345599999999997e-5,6.514707692307692e-7,1.62,BP
GO:1901360,organic cyclic compound metabolic proces...,5235,171,116.34,9.5e-09,4.5714e-5,6.822985074626866e-7,1.47,BP
GO:0000226,microtubule cytoskeleton organization,578,37,12.85,9.5e-09,4.5714e-5,6.822985074626866e-7,2.88,BP
GO:0033036,macromolecule localization,2958,111,65.74,1.1e-08,5.2931999999999994e-5,7.671304347826087e-7,1.69,BP
GO:0097435,supramolecular fiber organization,687,41,15.27,1.1e-08,5.2931999999999994e-5,7.671304347826087e-7,2.69,BP
GO:0051179,localization,5896,187,131.03,1.2e-08,5.7744e-5,8.249142857142858e-7,1.43,BP
GO:0065007,biological regulation,12076,327,268.37,1.3e-08,6.2556e-5,8.688333333333334e-7,1.22,BP
GO:0051172,negative regulation of nitrogen compound...,2297,92,51.05,1.3e-08,6.2556e-5,8.688333333333334e-7,1.8,BP
GO:0008088,axo-dendritic transport,77,13,1.71,1.4e-08,6.7368e-5,9.228493150684931e-7,7.6,BP
GO:0031324,negative regulation of cellular metaboli...,2476,97,55.02,1.5e-08,7.217999999999999e-5,9.754054054054055e-7,1.76,BP
GO:0051301,cell division,590,37,13.11,1.6e-08,7.699200000000001e-5,1.0130526315789475e-6,2.82,BP
GO:0009889,regulation of biosynthetic process,3570,127,79.34,1.6e-08,7.699200000000001e-5,1.0130526315789475e-6,1.6,BP
GO:0007018,microtubule-based movement,278,24,6.18,1.7e-08,8.1804e-5,1.0623896103896104e-6,3.88,BP
GO:0010970,transport along microtubule,160,18,3.56,1.9e-08,9.1428e-5,1.1573164556962026e-6,5.06,BP
GO:0099111,microtubule-based transport,160,18,3.56,1.9e-08,9.1428e-5,1.1573164556962026e-6,5.06,BP
GO:0043043,peptide biosynthetic process,595,37,13.22,2.0e-08,9.624e-5,1.203e-6,2.8,BP
GO:0051252,regulation of RNA metabolic process,3073,113,68.29,2.3e-08,1.1067600000000001e-4,1.3663703703703703e-6,1.65,BP
GO:0030030,cell projection organization,1590,70,35.34,2.8e-08,1.34736e-4,1.643121951219512e-6,1.98,BP
GO:0010638,positive regulation of organelle organiz...,604,37,13.42,3.0e-08,1.4435999999999998e-4,1.7392771084337349e-6,2.76,BP
GO:1903827,regulation of cellular protein localizat...,526,34,11.69,3.1e-08,1.49172e-4,1.7549647058823529e-6,2.91,BP
GO:0031326,regulation of cellular biosynthetic proc...,3496,124,77.69,3.1e-08,1.49172e-4,1.7549647058823529e-6,1.6,BP
GO:0044249,cellular biosynthetic process,4923,161,109.41,3.2e-08,1.5398400000000002e-4,1.790511627906977e-6,1.47,BP
GO:0009892,negative regulation of metabolic process,2874,107,63.87,3.3e-08,1.58796e-4,1.8252413793103446e-6,1.68,BP
GO:1901576,organic substance biosynthetic process,5019,163,111.54,4.1e-08,1.97292e-4,2.2419545454545455e-6,1.46,BP
GO:0006518,peptide metabolic process,749,42,16.65,4.2e-08,2.02104e-4,2.2456e-6,2.52,BP
GO:0010468,regulation of gene expression,3892,134,86.49,4.2e-08,2.02104e-4,2.2456e-6,1.55,BP
GO:0120036,plasma membrane bounded cell projection ...,1544,68,34.31,4.5e-08,2.1653999999999998e-4,2.3795604395604396e-6,1.98,BP
GO:0012501,programmed cell death,1947,80,43.27,5.0e-08,2.406e-4,2.6152173913043475e-6,1.85,BP
GO:0009058,biosynthetic process,5115,165,113.67,5.2e-08,2.50224e-4,2.6905806451612904e-6,1.45,BP
GO:0010605,negative regulation of macromolecule met...,2612,99,58.05,5.3e-08,2.55036e-4,2.7131489361702125e-6,1.71,BP
GO:0019219,regulation of nucleobase-containing comp...,3382,120,75.16,5.6e-08,2.69472e-4,2.8365473684210526e-6,1.6,BP
GO:0016071,mRNA metabolic process,647,38,14.38,5.8e-08,2.79096e-4,2.90725e-6,2.64,BP
GO:0030705,cytoskeleton-dependent intracellular tra...,172,18,3.82,5.9e-08,2.83908e-4,2.9268865979381443e-6,4.71,BP
GO:0051649,establishment of localization in cell,1933,79,42.96,7.7e-08,3.70524e-4,3.780857142857143e-6,1.84,BP
GO:0060341,regulation of cellular localization,971,49,21.58,8.1e-08,3.89772e-4,3.937090909090909e-6,2.27,BP
GO:0006915,apoptotic process,1905,78,42.34,8.8e-08,4.2345599999999995e-4,4.23456e-6,1.84,BP
GO:0043412,macromolecule modification,3676,127,81.69,9.3e-08,4.47516e-4,4.430851485148515e-6,1.55,BP
GO:0007346,regulation of mitotic cell cycle,505,32,11.22,1.2e-07,5.774399999999999e-4,5.661176470588235e-6,2.85,BP
GO:0008219,cell death,2108,83,46.85,1.7e-07,8.180399999999999e-4,7.942135922330097e-6,1.77,BP
GO:0006351,"transcription, DNA-templated",2897,105,64.38,1.8e-07,8.661599999999999e-4,8.328461538461538e-6,1.63,BP
GO:0050793,regulation of developmental process,2753,101,61.18,1.9e-07,9.142800000000001e-4,8.707428571428573e-6,1.65,BP
GO:0009653,anatomical structure morphogenesis,2759,101,61.31,2.1e-07,0.00101052,9.44411214953271e-6,1.65,BP
GO:0097659,nucleic acid-templated transcription,2905,105,64.56,2.1e-07,0.00101052,9.44411214953271e-6,1.63,BP
GO:0006355,"regulation of transcription, DNA-templat...",2805,102,62.34,2.4e-07,0.0011548799999999998,1.0693333333333333e-5,1.64,BP
GO:0032774,RNA biosynthetic process,2918,105,64.85,2.6e-07,0.00125112,1.1271351351351351e-5,1.62,BP
GO:1903047,mitotic cell cycle process,658,37,14.62,2.6e-07,0.00125112,1.1271351351351351e-5,2.53,BP
GO:0070925,organelle assembly,801,42,17.8,2.6e-07,0.00125112,1.1271351351351351e-5,2.36,BP
GO:1903506,regulation of nucleic acid-templated tra...,2813,102,62.51,2.8e-07,0.0013473600000000001,1.192353982300885e-5,1.63,BP
GO:0051276,chromosome organization,1105,52,24.56,2.8e-07,0.0013473600000000001,1.192353982300885e-5,2.12,BP
GO:2001141,regulation of RNA biosynthetic process,2822,102,62.71,3.3e-07,0.00158796,1.3929473684210527e-5,1.63,BP
GO:0043933,protein-containing complex subunit organ...,1969,78,43.76,3.4e-07,0.0016360799999999998,1.4104137931034483e-5,1.78,BP
GO:0032502,developmental process,6278,190,139.52,3.4e-07,0.0016360799999999998,1.4104137931034483e-5,1.36,BP
GO:0006397,mRNA processing,453,29,10.07,4.0e-07,0.0019248,1.645128205128205e-5,2.88,BP
GO:0043604,amide biosynthetic process,701,38,15.58,4.4e-07,0.00211728,1.794305084745763e-5,2.44,BP
GO:0051129,negative regulation of cellular componen...,761,40,16.91,4.8e-07,0.0023097599999999997,1.940974789915966e-5,2.37,BP
GO:0000910,cytokinesis,158,16,3.51,5.0e-07,0.0024059999999999997,2.005e-5,4.56,BP
GO:0033044,regulation of chromosome organization,358,25,7.96,5.2e-07,0.00250224,2.0679669421487602e-5,3.14,BP
GO:0019220,regulation of phosphate metabolic proces...,1720,70,38.22,5.6e-07,0.0026947200000000003,2.1908292682926832e-5,1.83,BP
GO:0009893,positive regulation of metabolic process,3528,120,78.4,5.6e-07,0.0026947200000000003,2.1908292682926832e-5,1.53,BP
GO:0048699,generation of neurons,1687,69,37.49,5.7e-07,0.0027428400000000003,2.211967741935484e-5,1.84,BP
GO:0051174,regulation of phosphorus metabolic proce...,1721,70,38.25,5.8e-07,0.00279096,2.2327679999999998e-5,1.83,BP
GO:0046907,intracellular transport,1523,64,33.85,6.2e-07,0.00298344,2.3678095238095238e-5,1.89,BP
GO:0010604,positive regulation of macromolecule met...,3247,112,72.16,7.8e-07,0.0037533600000000003,2.9554015748031495e-5,1.55,BP
GO:0070507,regulation of microtubule cytoskeleton o...,205,18,4.56,8.2e-07,0.00394584,3.0826875e-5,3.95,BP
GO:0022603,regulation of anatomical structure morph...,1091,50,24.25,1.1e-06,0.0052932000000000005,4.071692307692308e-5,2.06,BP
GO:0034622,cellular protein-containing complex asse...,1000,47,22.22,1.1e-06,0.0052932000000000005,4.071692307692308e-5,2.12,BP
GO:0032270,positive regulation of cellular protein ...,1551,64,34.47,1.2e-06,0.0057744,4.3092537313432835e-5,1.86,BP
GO:0043603,cellular amide metabolic process,970,46,21.56,1.2e-06,0.0057744,4.3092537313432835e-5,2.13,BP
GO:0010948,negative regulation of cell cycle proces...,232,19,5.16,1.2e-06,0.0057744,4.3092537313432835e-5,3.68,BP
GO:0045595,regulation of cell differentiation,1930,75,42.89,1.2e-06,0.0057744,4.3092537313432835e-5,1.75,BP
GO:0022008,neurogenesis,1793,71,39.85,1.3e-06,0.0062556,4.53304347826087e-5,1.78,BP
GO:1902903,regulation of supramolecular fiber organ...,351,24,7.8,1.3e-06,0.0062556,4.53304347826087e-5,3.08,BP
GO:0032879,regulation of localization,2869,101,63.76,1.3e-06,0.0062556,4.53304347826087e-5,1.58,BP
GO:0009890,negative regulation of biosynthetic proc...,1524,63,33.87,1.3e-06,0.0062556,4.53304347826087e-5,1.86,BP
GO:0042325,regulation of phosphorylation,1559,64,34.65,1.4e-06,0.006736799999999999,4.812e-5,1.85,BP
GO:0050790,regulation of catalytic activity,1833,72,40.74,1.4e-06,0.006736799999999999,4.812e-5,1.77,BP
GO:0006357,regulation of transcription by RNA polym...,2012,77,44.71,1.5e-06,0.0072180000000000005,5.1191489361702126e-5,1.72,BP
GO:0048856,anatomical structure development,5881,177,130.7,1.8e-06,0.0086616,6.0570629370629375e-5,1.35,BP
GO:0016310,phosphorylation,2198,82,48.85,1.8e-06,0.0086616,6.0570629370629375e-5,1.68,BP
GO:0030182,neuron differentiation,1507,62,33.49,1.9e-06,0.0091428,6.349166666666666e-5,1.85,BP
GO:0001667,ameboidal-type cell migration,411,26,9.13,2.0e-06,0.009623999999999999,6.591780821917808e-5,2.85,BP
GO:0048869,cellular developmental process,4475,142,99.45,2.0e-06,0.009623999999999999,6.591780821917808e-5,1.43,BP
GO:0051173,positive regulation of nitrogen compound...,3096,106,68.8,2.4e-06,0.0115488,7.856326530612245e-5,1.54,BP
GO:0051247,positive regulation of protein metabolic...,1659,66,36.87,2.7e-06,0.0129924,8.778648648648649e-5,1.79,BP
GO:2000113,negative regulation of cellular macromol...,1391,58,30.91,2.8e-06,0.013473599999999999,9.042684563758389e-5,1.88,BP
GO:0065009,regulation of molecular function,2513,90,55.85,2.9e-06,0.013954800000000002,9.241589403973511e-5,1.61,BP
GO:0010629,negative regulation of gene expression,1800,70,40,2.9e-06,0.013954800000000002,9.241589403973511e-5,1.75,BP
GO:0010558,negative regulation of macromolecule bio...,1428,59,31.73,3.1e-06,0.0149172,9.813947368421053e-5,1.86,BP
GO:0006396,RNA processing,822,40,18.27,3.3e-06,0.0158796,1.0244903225806453e-4,2.19,BP
GO:0001932,regulation of protein phosphorylation,1431,59,31.8,3.3e-06,0.0158796,1.0244903225806453e-4,1.86,BP
GO:0006468,protein phosphorylation,1842,71,40.94,3.3e-06,0.0158796,1.0244903225806453e-4,1.73,BP
GO:0008090,retrograde axonal transport,20,6,0.44,3.5e-06,0.016842,1.0796153846153846e-4,13.64,BP
GO:0007399,nervous system development,2347,85,52.16,3.7e-06,0.0178044,1.1340382165605096e-4,1.63,BP
GO:0043067,regulation of programmed cell death,1573,63,34.96,3.8e-06,0.0182856,1.14285e-4,1.8,BP
GO:0031325,positive regulation of cellular metaboli...,3240,109,72,3.8e-06,0.0182856,1.14285e-4,1.51,BP
GO:2001252,positive regulation of chromosome organi...,184,16,4.09,3.8e-06,0.0182856,1.14285e-4,3.91,BP
GO:0006366,transcription by RNA polymerase II,2067,77,45.94,4.2e-06,0.020210399999999996,1.2553043478260868e-4,1.68,BP
GO:1901988,negative regulation of cell cycle phase ...,165,15,3.67,4.4e-06,0.021172800000000002,1.2989447852760735e-4,4.09,BP
GO:0034329,cell junction assembly,208,17,4.62,4.4e-06,0.021172800000000002,1.2989447852760735e-4,3.68,BP
GO:1903829,positive regulation of cellular protein ...,302,21,6.71,4.5e-06,0.021654,1.3203658536585364e-4,3.13,BP
GO:0042981,regulation of apoptotic process,1552,62,34.49,4.9e-06,0.023578799999999997,1.429018181818182e-4,1.8,BP
GO:0098930,axonal transport,58,9,1.29,5.0e-06,0.02406,1.449397590361446e-4,6.98,BP
GO:1901991,negative regulation of mitotic cell cycl...,147,14,3.27,5.3e-06,0.0255036,1.5002117647058824e-4,4.28,BP
GO:0006974,cellular response to DNA damage stimulus,748,37,16.62,5.3e-06,0.0255036,1.5002117647058824e-4,2.23,BP
GO:0070647,protein modification by small protein co...,748,37,16.62,5.3e-06,0.0255036,1.5002117647058824e-4,2.23,BP
GO:0034330,cell junction organization,257,19,5.71,5.3e-06,0.0255036,1.5002117647058824e-4,3.33,BP
GO:0120035,regulation of plasma membrane bounded ce...,784,38,17.42,6.3e-06,0.030315599999999998,1.772842105263158e-4,2.18,BP
GO:0010631,epithelial cell migration,285,20,6.33,6.6e-06,0.0317592,1.835791907514451e-4,3.16,BP
GO:0007275,multicellular organism development,5380,162,119.56,6.6e-06,0.0317592,1.835791907514451e-4,1.35,BP
GO:0045930,negative regulation of mitotic cell cycl...,238,18,5.29,6.9e-06,0.0332028,1.908206896551724e-4,3.4,BP
GO:0008283,cell proliferation,2027,75,45.05,7.3e-06,0.0351276,2.0072914285714289e-4,1.66,BP
GO:0090132,epithelium migration,287,20,6.38,7.4e-06,0.0356088,2.0232272727272726e-4,3.13,BP
GO:0042127,regulation of cell proliferation,1676,65,37.25,7.5e-06,0.036090000000000004,2.0389830508474576e-4,1.74,BP
GO:0034654,nucleobase-containing compound biosynthe...,3328,110,73.96,7.6e-06,0.0365712,2.0545617977528092e-4,1.49,BP
GO:0060284,regulation of cell development,1106,48,24.58,7.7e-06,0.037052400000000006,2.0699664804469276e-4,1.95,BP
GO:0090130,tissue migration,289,20,6.42,8.2e-06,0.0394584,2.168043956043956e-4,3.12,BP
GO:0032886,regulation of microtubule-based process,241,18,5.36,8.2e-06,0.0394584,2.168043956043956e-4,3.36,BP
GO:0031344,regulation of cell projection organizati...,793,38,17.62,8.2e-06,0.0394584,2.168043956043956e-4,2.16,BP
GO:0008380,RNA splicing,366,23,8.13,8.6e-06,0.0413832,2.2490869565217392e-4,2.83,BP
GO:1901653,cellular response to peptide,290,20,6.44,8.6e-06,0.0413832,2.2490869565217392e-4,3.11,BP
GO:0031056,regulation of histone modification,154,14,3.42,9.1e-06,0.04378919999999999,2.3669837837837836e-4,4.09,BP
GO:0000902,cell morphogenesis,1114,48,24.76,9.3e-06,0.0447516,2.406e-4,1.94,BP
GO:0010941,regulation of cell death,1723,66,38.29,9.4e-06,0.0452328,2.406e-4,1.72,BP
GO:0051960,regulation of nervous system development,1082,47,24.05,9.4e-06,0.0452328,2.406e-4,1.95,BP
GO:0031327,negative regulation of cellular biosynth...,1485,59,33,1.0e-05,0.04812,2.546031746031746e-4,1.79,BP
GO:0031401,positive regulation of protein modificat...,1219,51,27.09,1.1e-05,0.052932,2.7858947368421055e-4,1.88,BP
GO:1901987,regulation of cell cycle phase transitio...,297,20,6.6,1.2e-05,0.057744000000000004,2.976494845360825e-4,3.03,BP
GO:0001934,positive regulation of protein phosphory...,996,44,22.13,1.2e-05,0.057744000000000004,2.976494845360825e-4,1.99,BP
GO:0040017,positive regulation of locomotion,597,31,13.27,1.2e-05,0.057744000000000004,2.976494845360825e-4,2.34,BP
GO:0032989,cellular component morphogenesis,1225,51,27.22,1.2e-05,0.057744000000000004,2.976494845360825e-4,1.87,BP
GO:0050767,regulation of neurogenesis,967,43,21.49,1.3e-05,0.062556,3.191632653061224e-4,2,BP
GO:0031175,neuron projection development,1097,47,24.38,1.3e-05,0.062556,3.191632653061224e-4,1.93,BP
GO:0051338,regulation of transferase activity,843,39,18.73,1.4e-05,0.067368,3.419695431472081e-4,2.08,BP
GO:0007015,actin filament organization,405,24,9,1.5e-05,0.07218000000000001,3.62713567839196e-4,2.67,BP
GO:0030154,cell differentiation,4243,132,94.29,1.5e-05,0.07218000000000001,3.62713567839196e-4,1.4,BP
GO:0031032,actomyosin structure organization,206,16,4.58,1.6e-05,0.07699199999999999,3.8304477611940293e-4,3.49,BP
GO:0045786,negative regulation of cell cycle,462,26,10.27,1.6e-05,0.07699199999999999,3.8304477611940293e-4,2.53,BP
GO:1990778,protein localization to cell periphery,355,22,7.89,1.7e-05,0.081804,4.04970297029703e-4,2.79,BP
GO:0045934,negative regulation of nucleobase-contai...,1410,56,31.33,1.8e-05,0.086616,4.245882352941177e-4,1.79,BP
GO:0018130,heterocycle biosynthetic process,3392,110,75.38,1.8e-05,0.086616,4.245882352941177e-4,1.46,BP
GO:0051253,negative regulation of RNA metabolic pro...,1281,52,28.47,2.0e-05,0.09624,4.6718446601941755e-4,1.83,BP
GO:0010634,positive regulation of epithelial cell m...,144,13,3.2,2.0e-05,0.09624,4.6718446601941755e-4,4.06,BP
GO:1903311,regulation of mRNA metabolic process,258,18,5.73,2.1e-05,0.10105199999999999,4.7442253521126756e-4,3.14,BP
GO:0051272,positive regulation of cellular componen...,584,30,12.98,2.1e-05,0.10105199999999999,4.7442253521126756e-4,2.31,BP
GO:0019438,aromatic compound biosynthetic process,3405,110,75.67,2.1e-05,0.10105199999999999,4.7442253521126756e-4,1.45,BP
GO:0000281,mitotic cytokinesis,69,9,1.53,2.1e-05,0.10105199999999999,4.7442253521126756e-4,5.88,BP
GO:0080135,regulation of cellular response to stres...,674,33,14.98,2.1e-05,0.10105199999999999,4.7442253521126756e-4,2.2,BP
GO:1902531,regulation of intracellular signal trans...,1733,65,38.51,2.1e-05,0.10105199999999999,4.7442253521126756e-4,1.69,BP
GO:0006325,chromatin organization,735,35,16.33,2.1e-05,0.10105199999999999,4.7442253521126756e-4,2.14,BP
GO:0032269,negative regulation of cellular protein ...,1020,44,22.67,2.2e-05,0.105864,4.946915887850468e-4,1.94,BP
GO:2000026,regulation of multicellular organismal d...,2207,78,49.05,2.4e-05,0.11548800000000001,5.322027649769585e-4,1.59,BP
GO:0045892,"negative regulation of transcription, DN...",1189,49,26.42,2.4e-05,0.11548800000000001,5.322027649769585e-4,1.85,BP
GO:0065003,protein-containing complex assembly,1740,65,38.67,2.4e-05,0.11548800000000001,5.322027649769585e-4,1.68,BP
GO:1903507,negative regulation of nucleic acid-temp...,1193,49,26.51,2.6e-05,0.125112,5.73908256880734e-4,1.85,BP
GO:1902679,negative regulation of RNA biosynthetic ...,1194,49,26.53,2.7e-05,0.12992399999999998,5.878914027149321e-4,1.85,BP
GO:0071824,protein-DNA complex subunit organization,215,16,4.78,2.7e-05,0.12992399999999998,5.878914027149321e-4,3.35,BP
GO:0006796,phosphate-containing compound metabolic ...,2963,98,65.85,2.7e-05,0.12992399999999998,5.878914027149321e-4,1.49,BP
GO:2000147,positive regulation of cell motility,565,29,12.56,2.9e-05,0.139548,6.257757847533633e-4,2.31,BP
GO:1901990,regulation of mitotic cell cycle phase t...,265,18,5.89,2.9e-05,0.139548,6.257757847533633e-4,3.06,BP
GO:0044089,positive regulation of cellular componen...,538,28,11.96,3.1e-05,0.149172,6.659464285714286e-4,2.34,BP
GO:1902905,positive regulation of supramolecular fi...,195,15,4.33,3.3e-05,0.15879600000000002,7.02637168141593e-4,3.46,BP
GO:0048666,neuron development,1238,50,27.51,3.3e-05,0.15879600000000002,7.02637168141593e-4,1.82,BP
GO:0006793,phosphorus metabolic process,2985,98,66.34,3.6e-05,0.173232,7.63136563876652e-4,1.48,BP
GO:0030335,positive regulation of cell migration,543,28,12.07,3.7e-05,0.17804399999999998,7.808947368421052e-4,2.32,BP
GO:0035556,intracellular signal transduction,2646,89,58.8,3.8e-05,0.18285600000000002,7.915844155844156e-4,1.51,BP
GO:1901362,organic cyclic compound biosynthetic pro...,3529,112,78.43,3.8e-05,0.18285600000000002,7.915844155844156e-4,1.43,BP
GO:0044093,positive regulation of molecular functio...,1450,56,32.22,3.8e-05,0.18285600000000002,7.915844155844156e-4,1.74,BP
GO:0023014,signal transduction by protein phosphory...,819,37,18.2,3.9e-05,0.187668,8.054420600858369e-4,2.03,BP
GO:0016358,dendrite development,296,19,6.58,3.9e-05,0.187668,8.054420600858369e-4,2.89,BP
GO:0033365,protein localization to organelle,789,36,17.53,4.0e-05,0.19248,8.225641025641027e-4,2.05,BP
GO:0044770,cell cycle phase transition,404,23,8.98,4.1e-05,0.197292,8.359830508474577e-4,2.56,BP
GO:1902275,regulation of chromatin organization,199,15,4.42,4.1e-05,0.197292,8.359830508474577e-4,3.39,BP
GO:0042327,positive regulation of phosphorylation,1050,44,23.33,4.3e-05,0.20691600000000002,8.730632911392406e-4,1.89,BP
GO:0061640,cytoskeleton-dependent cytokinesis,94,10,2.09,4.6e-05,0.221352,9.261589958158995e-4,4.78,BP
GO:0120031,plasma membrane bounded cell projection ...,492,26,10.93,4.6e-05,0.221352,9.261589958158995e-4,2.38,BP
GO:0051248,negative regulation of protein metabolic...,1087,45,24.16,4.7e-05,0.22616399999999998,9.4235e-4,1.86,BP
GO:0051347,positive regulation of transferase activ...,552,28,12.27,4.9e-05,0.235788,9.783734439834024e-4,2.28,BP
GO:0044265,cellular macromolecule catabolic process,1024,43,22.76,5.1e-05,0.245412,0.0010057868852459018,1.89,BP
GO:0045787,positive regulation of cell cycle,355,21,7.89,5.1e-05,0.245412,0.0010057868852459018,2.66,BP
GO:0045860,positive regulation of protein kinase ac...,438,24,9.73,5.1e-05,0.245412,0.0010057868852459018,2.47,BP
GO:0043549,regulation of kinase activity,737,34,16.38,5.3e-05,0.255036,0.0010409632653061223,2.08,BP
GO:0034248,regulation of cellular amide metabolic p...,384,22,8.53,5.5e-05,0.26466,0.0010758536585365854,2.58,BP
GO:0048870,cell motility,1612,60,35.82,5.7e-05,0.27428400000000003,0.001105983870967742,1.68,BP
GO:0051674,localization of cell,1612,60,35.82,5.7e-05,0.27428400000000003,0.001105983870967742,1.68,BP
GO:0090068,positive regulation of cell cycle proces...,254,17,5.64,5.9e-05,0.283908,0.001135632,3.01,BP
GO:0042255,ribosome assembly,61,8,1.36,5.9e-05,0.283908,0.001135632,5.88,BP
GO:0043085,positive regulation of catalytic activit...,1065,44,23.67,6.0e-05,0.28872000000000003,0.0011502788844621515,1.86,BP
GO:0000122,negative regulation of transcription by ...,869,38,19.31,6.1e-05,0.293532,0.0011556377952755903,1.97,BP
GO:0031329,regulation of cellular catabolic process,711,33,15.8,6.1e-05,0.293532,0.0011556377952755903,2.09,BP
GO:0071826,ribonucleoprotein complex subunit organi...,230,16,5.11,6.1e-05,0.293532,0.0011556377952755903,3.13,BP
GO:0022604,regulation of cell morphogenesis,530,27,11.78,6.2e-05,0.298344,0.001156372093023256,2.29,BP
GO:0098840,protein transport along microtubule,20,5,0.44,6.2e-05,0.298344,0.001156372093023256,11.36,BP
GO:0099118,microtubule-based protein transport,20,5,0.44,6.2e-05,0.298344,0.001156372093023256,11.36,BP
GO:0009057,macromolecule catabolic process,1235,49,27.45,6.2e-05,0.298344,0.001156372093023256,1.79,BP
GO:0006417,regulation of translation,334,20,7.42,6.5e-05,0.31277999999999995,0.001203,2.7,BP
GO:0010595,positive regulation of endothelial cell ...,98,10,2.18,6.5e-05,0.31277999999999995,0.001203,4.59,BP
GO:0031346,positive regulation of cell projection o...,474,25,10.53,6.7e-05,0.322404,0.0012305496183206107,2.37,BP
GO:0043408,regulation of MAPK cascade,746,34,16.58,6.7e-05,0.322404,0.0012305496183206107,2.05,BP
GO:1902115,regulation of organelle assembly,208,15,4.62,6.8e-05,0.327216,0.001244167300380228,3.25,BP
GO:0071495,cellular response to endogenous stimulus,1241,49,27.58,7.0e-05,0.33684,0.0012759090909090908,1.78,BP
GO:0030031,cell projection assembly,505,26,11.22,7.1e-05,0.341652,0.001284406015037594,2.32,BP
GO:0033674,positive regulation of kinase activity,476,25,10.58,7.1e-05,0.341652,0.001284406015037594,2.36,BP
GO:0042274,ribosomal small subunit biogenesis,63,8,1.4,7.4e-05,0.35608799999999996,0.0013336629213483145,5.71,BP
GO:0044772,mitotic cell cycle phase transition,365,21,8.11,7.6e-05,0.36571200000000004,0.0013595241635687733,2.59,BP
GO:0032446,protein modification by small protein co...,627,30,13.93,7.6e-05,0.36571200000000004,0.0013595241635687733,2.15,BP
GO:0061564,axon development,509,26,11.31,8.1e-05,0.389772,0.0014436000000000002,2.3,BP
GO:0072659,protein localization to plasma membrane,287,18,6.38,8.3e-05,0.399396,0.0014737859778597784,2.82,BP
GO:0048731,system development,4759,141,105.76,8.4e-05,0.40420799999999996,0.0014860588235294117,1.33,BP
GO:0008089,anterograde axonal transport,48,7,1.07,8.6e-05,0.41383200000000003,0.0015103357664233575,6.54,BP
GO:0051093,negative regulation of developmental pro...,1082,44,24.05,8.6e-05,0.41383200000000003,0.0015103357664233575,1.83,BP
GO:1902533,positive regulation of intracellular sig...,1016,42,22.58,8.8e-05,0.423456,0.00153984,1.86,BP
GO:0008286,insulin receptor signaling pathway,122,11,2.71,8.9e-05,0.428268,0.001551695652173913,4.06,BP
GO:0048588,developmental cell growth,263,17,5.84,9.0e-05,0.43308,0.0015578417266187052,2.91,BP
GO:0010628,positive regulation of gene expression,2000,70,44.45,9.0e-05,0.43308,0.0015578417266187052,1.57,BP
GO:0050772,positive regulation of axonogenesis,102,10,2.27,9.2e-05,0.442704,0.0015754590747330962,4.41,BP
GO:0016477,cell migration,1463,55,32.51,9.2e-05,0.442704,0.0015754590747330962,1.69,BP
GO:0032970,regulation of actin filament-based proce...,398,22,8.84,9.2e-05,0.442704,0.0015754590747330962,2.49,BP
GO:0010562,positive regulation of phosphorus metabo...,1120,45,24.89,9.5e-05,0.45714000000000005,0.0016153356890459365,1.81,BP
GO:0045937,positive regulation of phosphate metabol...,1120,45,24.89,9.5e-05,0.45714000000000005,0.0016153356890459365,1.81,BP
GO:0009719,response to endogenous stimulus,1430,54,31.78,9.6e-05,0.46195200000000003,0.001620884210526316,1.7,BP
GO:0051239,regulation of multicellular organismal p...,3294,104,73.2,9.6e-05,0.46195200000000003,0.001620884210526316,1.42,BP
GO:0043069,negative regulation of programmed cell d...,955,40,21.22,9.8e-05,0.471576,0.0016431219512195122,1.89,BP
GO:0016567,protein ubiquitination,575,28,12.78,9.8e-05,0.471576,0.0016431219512195122,2.19,BP
GO:0045859,regulation of protein kinase activity,667,31,14.82,9.9e-05,0.476388,0.0016541249999999998,2.09,BP
GO:0032880,regulation of protein localization,1057,43,23.49,0.00010,0.4812,0.0016593103448275862,1.83,BP
GO:1901699,cellular response to nitrogen compound,638,30,14.18,0.00010,0.4812,0.0016593103448275862,2.12,BP
GO:0006950,response to stress,3538,110,78.63,0.00011,0.52932,0.0017882432432432434,1.4,BP
GO:0031400,negative regulation of protein modificat...,578,28,12.85,0.00011,0.52932,0.0017882432432432434,2.18,BP
GO:0030865,cortical cytoskeleton organization,50,7,1.11,0.00011,0.52932,0.0017882432432432434,6.31,BP
GO:0120193,tight junction organization,50,7,1.11,0.00011,0.52932,0.0017882432432432434,6.31,BP
GO:0016482,cytosolic transport,147,12,3.27,0.00011,0.52932,0.0017882432432432434,3.67,BP
GO:0032956,regulation of actin cytoskeleton organiz...,348,20,7.73,0.00011,0.52932,0.0017882432432432434,2.59,BP
GO:0016049,cell growth,521,26,11.58,0.00012,0.5774400000000001,0.0019312374581939799,2.25,BP
GO:0000165,MAPK cascade,802,35,17.82,0.00012,0.5774400000000001,0.0019312374581939799,1.96,BP
GO:0007044,cell-substrate junction assembly,86,9,1.91,0.00012,0.5774400000000001,0.0019312374581939799,4.71,BP
GO:0048646,anatomical structure formation involved ...,1168,46,25.96,0.00013,0.6255599999999999,0.002017935483870968,1.77,BP
GO:0051983,regulation of chromosome segregation,106,10,2.36,0.00013,0.6255599999999999,0.002017935483870968,4.24,BP
GO:0010639,negative regulation of organelle organiz...,407,22,9.04,0.00013,0.6255599999999999,0.002017935483870968,2.43,BP
GO:2000059,negative regulation of ubiquitin-depende...,51,7,1.13,0.00013,0.6255599999999999,0.002017935483870968,6.19,BP
GO:0009725,response to hormone,708,32,15.73,0.00013,0.6255599999999999,0.002017935483870968,2.03,BP
GO:0051495,positive regulation of cytoskeleton orga...,220,15,4.89,0.00013,0.6255599999999999,0.002017935483870968,3.07,BP
GO:0009894,regulation of catabolic process,837,36,18.6,0.00013,0.6255599999999999,0.002017935483870968,1.94,BP
GO:0051270,regulation of cellular component movemen...,1035,42,23,0.00013,0.6255599999999999,0.002017935483870968,1.83,BP
GO:0043065,positive regulation of apoptotic process,647,30,14.38,0.00013,0.6255599999999999,0.002017935483870968,2.09,BP
GO:0040007,growth,1103,44,24.51,0.00013,0.6255599999999999,0.002017935483870968,1.8,BP
GO:0071375,cellular response to peptide hormone sti...,246,16,5.47,0.00013,0.6255599999999999,0.002017935483870968,2.93,BP
GO:0009966,regulation of signal transduction,2819,91,62.65,0.00014,0.67368,0.002125173501577287,1.45,BP
GO:0043066,negative regulation of apoptotic process,937,39,20.82,0.00014,0.67368,0.002125173501577287,1.87,BP
GO:0032870,cellular response to hormone stimulus,526,26,11.69,0.00014,0.67368,0.002125173501577287,2.22,BP
GO:0007098,centrosome cycle,128,11,2.84,0.00014,0.67368,0.002125173501577287,3.87,BP
GO:0060560,developmental growth involved in morphog...,273,17,6.07,0.00014,0.67368,0.002125173501577287,2.8,BP
GO:0051240,positive regulation of multicellular org...,1957,68,43.49,0.00014,0.67368,0.002125173501577287,1.56,BP
GO:1904377,positive regulation of protein localizat...,69,8,1.53,0.00014,0.67368,0.002125173501577287,5.23,BP
GO:0009967,positive regulation of signal transducti...,1527,56,33.93,0.00015,0.7217999999999999,0.00226269592476489,1.65,BP
GO:0043068,positive regulation of programmed cell d...,652,30,14.49,0.00015,0.7217999999999999,0.00226269592476489,2.07,BP
GO:0008360,regulation of cell shape,153,12,3.4,0.00016,0.76992,0.002406,3.53,BP
GO:0008284,positive regulation of cell proliferatio...,979,40,21.76,0.00017,0.8180400000000001,0.0025326315789473684,1.84,BP
GO:0007409,axonogenesis,473,24,10.51,0.00017,0.8180400000000001,0.0025326315789473684,2.28,BP
GO:0042886,amide transport,1859,65,41.31,0.00017,0.8180400000000001,0.0025326315789473684,1.57,BP
GO:0045022,early endosome to late endosome transpor...,38,6,0.84,0.00018,0.86616,0.0026651076923076924,7.14,BP
GO:0045664,regulation of neuron differentiation,785,34,17.45,0.00018,0.86616,0.0026651076923076924,1.95,BP
GO:0043542,endothelial cell migration,203,14,4.51,0.00019,0.9142800000000001,0.0028045398773006137,3.1,BP
GO:0032515,negative regulation of phosphoprotein ph...,25,5,0.56,0.00020,0.9624,0.0029341463414634147,8.93,BP
GO:0032990,cell part morphogenesis,726,32,16.13,0.00020,0.9624,0.0029341463414634147,1.98,BP
GO:1903051,negative regulation of proteolysis invol...,73,8,1.62,0.00021,1,0.0030621818181818185,4.94,BP
GO:0040012,regulation of locomotion,1025,41,22.78,0.00021,1,0.0030621818181818185,1.8,BP
GO:0015833,peptide transport,1838,64,40.85,0.00022,1,0.0031695808383233534,1.57,BP
GO:0006986,response to unfolded protein,113,10,2.51,0.00022,1,0.0031695808383233534,3.98,BP
GO:0060249,anatomical structure homeostasis,394,21,8.76,0.00022,1,0.0031695808383233534,2.4,BP
GO:0050770,regulation of axonogenesis,206,14,4.58,0.00022,1,0.0031695808383233534,3.06,BP
GO:0001894,tissue homeostasis,232,15,5.16,0.00023,1,0.0032939285714285713,2.91,BP
GO:0031060,regulation of histone methylation,74,8,1.64,0.00023,1,0.0032939285714285713,4.88,BP
GO:0051302,regulation of cell division,159,12,3.53,0.00024,1,0.0034067256637168144,3.4,BP
GO:0098927,vesicle-mediated transport between endos...,40,6,0.89,0.00024,1,0.0034067256637168144,6.74,BP
GO:0065008,regulation of biological quality,4092,122,90.94,0.00024,1,0.0034067256637168144,1.34,BP
GO:0006511,ubiquitin-dependent protein catabolic pr...,577,27,12.82,0.00025,1,0.003507288629737609,2.11,BP
GO:0031023,microtubule organizing center organizati...,137,11,3.04,0.00025,1,0.003507288629737609,3.62,BP
GO:0060548,negative regulation of cell death,1067,42,23.71,0.00025,1,0.003507288629737609,1.77,BP
GO:0030334,regulation of cell migration,899,37,19.98,0.00025,1,0.003507288629737609,1.85,BP
GO:0016192,vesicle-mediated transport,1382,51,30.71,0.00026,1,0.0036369767441860462,1.66,BP
GO:1901342,regulation of vasculature development,343,19,7.62,0.00027,1,0.0037442074927953894,2.49,BP
GO:0032535,regulation of cellular component size,400,21,8.89,0.00027,1,0.0037442074927953894,2.36,BP
GO:0010033,response to organic substance,3108,97,69.07,0.00027,1,0.0037442074927953894,1.4,BP
GO:0010975,regulation of neuron projection developm...,612,28,13.6,0.00028,1,0.003871724137931034,2.06,BP
GO:0015031,protein transport,1784,62,39.65,0.00029,1,0.003987085714285714,1.56,BP
GO:0045596,negative regulation of cell differentiat...,806,34,17.91,0.00029,1,0.003987085714285714,1.9,BP
GO:0010942,positive regulation of cell death,710,31,15.78,0.00030,1,0.004112820512820512,1.96,BP
GO:0048468,cell development,2424,79,53.87,0.00031,1,0.004225835694050992,1.47,BP
GO:0030866,cortical actin cytoskeleton organization,42,6,0.93,0.00031,1,0.004225835694050992,6.45,BP
GO:0072657,protein localization to membrane,555,26,12.33,0.00032,1,0.0043498305084745765,2.11,BP
GO:0034976,response to endoplasmic reticulum stress,240,15,5.33,0.00033,1,0.0044731267605633805,2.81,BP
GO:2000145,regulation of cell motility,946,38,21.02,0.00034,1,0.004570055865921788,1.81,BP
GO:0000904,cell morphogenesis involved in different...,813,34,18.07,0.00034,1,0.004570055865921788,1.88,BP
GO:0019941,modification-dependent protein catabolic...,589,27,13.09,0.00034,1,0.004570055865921788,2.06,BP
GO:0007169,transmembrane receptor protein tyrosine ...,559,26,12.42,0.00035,1,0.004691364902506964,2.09,BP
GO:0031122,cytoplasmic microtubule organization,60,7,1.33,0.00036,1,0.004772231404958678,5.26,BP
GO:0044380,protein localization to cytoskeleton,60,7,1.33,0.00036,1,0.004772231404958678,5.26,BP
GO:0006338,chromatin remodeling,143,11,3.18,0.00036,1,0.004772231404958678,3.46,BP
GO:0040011,locomotion,1837,63,40.82,0.00036,1,0.004772231404958678,1.54,BP
GO:0007163,establishment or maintenance of cell pol...,217,14,4.82,0.00038,1,0.004996065573770492,2.9,BP
GO:0022618,ribonucleoprotein complex assembly,217,14,4.82,0.00038,1,0.004996065573770492,2.9,BP
GO:0006333,chromatin assembly or disassembly,144,11,3.2,0.00038,1,0.004996065573770492,3.44,BP
GO:1903078,positive regulation of protein localizat...,61,7,1.36,0.00040,1,0.005216260162601626,5.15,BP
GO:0010923,negative regulation of phosphatase activ...,80,8,1.78,0.00040,1,0.005216260162601626,4.49,BP
GO:0070830,bicellular tight junction assembly,44,6,0.98,0.00040,1,0.005216260162601626,6.12,BP
GO:0001944,vasculature development,756,32,16.8,0.00041,1,0.005332216216216216,1.9,BP
GO:0048589,developmental growth,790,33,17.56,0.00042,1,0.005432903225806452,1.88,BP
GO:0032869,cellular response to insulin stimulus,194,13,4.31,0.00042,1,0.005432903225806452,3.02,BP
GO:0010921,regulation of phosphatase activity,123,10,2.73,0.00043,1,0.005503085106382978,3.66,BP
GO:0000070,mitotic sister chromatid segregation,146,11,3.24,0.00043,1,0.005503085106382978,3.4,BP
GO:0035295,tube development,1130,43,25.11,0.00043,1,0.005503085106382978,1.71,BP
GO:0061572,actin filament bundle organization,170,12,3.78,0.00043,1,0.005503085106382978,3.17,BP
GO:0072384,organelle transport along microtubule,81,8,1.8,0.00044,1,0.005586490765171504,4.44,BP
GO:0032386,regulation of intracellular transport,445,22,9.89,0.00044,1,0.005586490765171504,2.22,BP
GO:0043632,modification-dependent macromolecule cat...,599,27,13.31,0.00044,1,0.005586490765171504,2.03,BP
GO:0032147,activation of protein kinase activity,247,15,5.49,0.00045,1,0.005698421052631579,2.73,BP
GO:0120192,tight junction assembly,45,6,1,0.00046,1,0.0057945549738219896,6,BP
GO:0034250,positive regulation of cellular amide me...,147,11,3.27,0.00046,1,0.0057945549738219896,3.36,BP
GO:1901698,response to nitrogen compound,997,39,22.16,0.00047,1,0.005905065274151436,1.76,BP
GO:0030856,regulation of epithelial cell differenti...,148,11,3.29,0.00048,1,0.006015,3.34,BP
GO:0032273,positive regulation of protein polymeriz...,125,10,2.78,0.00049,1,0.006124363636363636,3.6,BP
GO:0031331,positive regulation of cellular cataboli...,361,19,8.02,0.00050,1,0.006233160621761658,2.37,BP
GO:1902904,negative regulation of supramolecular fi...,149,11,3.31,0.00051,1,0.006292615384615385,3.32,BP
GO:0045010,actin nucleation,46,6,1.02,0.00051,1,0.006292615384615385,5.88,BP
GO:0002181,cytoplasmic translation,83,8,1.84,0.00051,1,0.006292615384615385,4.35,BP
GO:0033045,regulation of sister chromatid segregati...,83,8,1.84,0.00051,1,0.006292615384615385,4.35,BP
GO:0010720,positive regulation of cell development,669,29,14.87,0.00052,1,0.0063995907928388746,1.95,BP
GO:1901652,response to peptide,392,20,8.71,0.00053,1,0.006506020408163265,2.3,BP
GO:0071417,cellular response to organonitrogen comp...,575,26,12.78,0.00054,1,0.006611908396946566,2.03,BP
GO:0072358,cardiovascular system development,769,32,17.09,0.00055,1,0.006649748743718593,1.87,BP
GO:0071902,positive regulation of protein serine/th...,279,16,6.2,0.00055,1,0.006649748743718593,2.58,BP
GO:0031330,negative regulation of cellular cataboli...,252,15,5.6,0.00055,1,0.006649748743718593,2.68,BP
GO:0048858,cell projection morphogenesis,704,30,15.65,0.00055,1,0.006649748743718593,1.92,BP
GO:0022411,cellular component disassembly,364,19,8.09,0.00055,1,0.006649748743718593,2.35,BP
GO:0061387,regulation of extent of cell growth,128,10,2.84,0.00059,1,0.00708,3.52,BP
GO:0010632,regulation of epithelial cell migration,227,14,5.04,0.00059,1,0.00708,2.78,BP
GO:0044257,cellular protein catabolic process,740,31,16.45,0.00059,1,0.00708,1.88,BP
GO:0045765,regulation of angiogenesis,309,17,6.87,0.00060,1,0.007128888888888888,2.47,BP
GO:0001525,angiogenesis,517,24,11.49,0.00060,1,0.007128888888888888,2.09,BP
GO:0034333,adherens junction assembly,85,8,1.89,0.00060,1,0.007128888888888888,4.23,BP
GO:1903363,negative regulation of cellular protein ...,85,8,1.89,0.00060,1,0.007128888888888888,4.23,BP
GO:0022613,ribonucleoprotein complex biogenesis,427,21,9.49,0.00063,1,0.007466896551724138,2.21,BP
GO:0009896,positive regulation of catabolic process,428,21,9.51,0.00065,1,0.007591747572815534,2.21,BP
GO:0047496,vesicle transport along microtubule,48,6,1.07,0.00065,1,0.007591747572815534,5.61,BP
GO:0035329,hippo signaling,32,5,0.71,0.00065,1,0.007591747572815534,7.04,BP
GO:0048668,collateral sprouting,32,5,0.71,0.00065,1,0.007591747572815534,7.04,BP
GO:0010976,positive regulation of neuron projection...,369,19,8.2,0.00065,1,0.007591747572815534,2.32,BP
GO:0043410,positive regulation of MAPK cascade,520,24,11.56,0.00065,1,0.007591747572815534,2.08,BP
GO:0007160,cell-matrix adhesion,204,13,4.53,0.00068,1,0.007922905569007264,2.87,BP
GO:0110053,regulation of actin filament organizatio...,258,15,5.73,0.00070,1,0.008136231884057972,2.62,BP
GO:0048812,neuron projection morphogenesis,683,29,15.18,0.00072,1,0.008348530120481928,1.91,BP
GO:1903320,regulation of protein modification by sm...,232,14,5.16,0.00073,1,0.008444134615384614,2.71,BP
GO:0010557,positive regulation of macromolecule bio...,1813,61,40.29,0.00074,1,0.008539280575539567,1.51,BP
GO:0007026,negative regulation of microtubule depol...,33,5,0.73,0.00075,1,0.008613365155131265,6.85,BP
GO:0034314,Arp2/3 complex-mediated actin nucleation,33,5,0.73,0.00075,1,0.008613365155131265,6.85,BP
GO:0098813,nuclear chromosome segregation,260,15,5.78,0.00076,1,0.008686745843230405,2.6,BP
GO:0000819,sister chromatid segregation,181,12,4.02,0.00076,1,0.008686745843230405,2.99,BP
GO:0016055,Wnt signaling pathway,434,21,9.64,0.00077,1,0.008780189573459714,2.18,BP
GO:0051094,positive regulation of developmental pro...,1560,54,34.67,0.00079,1,0.008986950354609929,1.56,BP
GO:0061024,membrane organization,655,28,14.56,0.00080,1,0.009079245283018868,1.92,BP
GO:0198738,cell-cell signaling by wnt,436,21,9.69,0.00082,1,0.009262535211267605,2.17,BP
GO:0045184,establishment of protein localization,1896,63,42.14,0.00082,1,0.009262535211267605,1.5,BP
GO:0033047,regulation of mitotic sister chromatid s...,69,7,1.53,0.00084,1,0.00946622950819672,4.58,BP
GO:0071539,protein localization to centrosome,34,5,0.76,0.00087,1,0.009781401869158879,6.58,BP
GO:0010594,regulation of endothelial cell migration,159,11,3.53,0.00088,1,0.009870769230769232,3.12,BP
GO:0051962,positive regulation of nervous system de...,660,28,14.67,0.00089,1,0.009959720930232558,1.91,BP
GO:0032784,regulation of DNA-templated transcriptio...,51,6,1.13,0.00090,1,0.010048259860788864,5.31,BP
GO:0035966,response to topologically incorrect prot...,136,10,3.02,0.00094,1,0.010470555555555556,3.31,BP
GO:0030516,regulation of axon extension,113,9,2.51,0.00095,1,0.010508965517241379,3.59,BP
GO:1903076,regulation of protein localization to pl...,113,9,2.51,0.00095,1,0.010508965517241379,3.59,BP
GO:1905269,positive regulation of chromatin organiz...,113,9,2.51,0.00095,1,0.010508965517241379,3.59,BP
GO:0051603,proteolysis involved in cellular protein...,696,29,15.47,0.00096,1,0.010595229357798166,1.87,BP
GO:0048667,cell morphogenesis involved in neuron di...,632,27,14.05,0.00099,1,0.010802448979591837,1.92,BP
GO:0034728,nucleosome organization,137,10,3.04,0.00099,1,0.010802448979591837,3.29,BP
GO:0032435,negative regulation of proteasomal ubiqu...,35,5,0.78,0.00099,1,0.010802448979591837,6.41,BP
GO:0035308,negative regulation of protein dephospho...,35,5,0.78,0.00099,1,0.010802448979591837,6.41,BP
GO:1905508,protein localization to microtubule orga...,35,5,0.78,0.00099,1,0.010802448979591837,6.41,BP
GO:1902750,negative regulation of cell cycle G2/M p...,52,6,1.16,0.00100,1,0.010886877828054298,5.17,BP
GO:0071705,nitrogen compound transport,2178,70,48.4,0.00102,1,0.011079548532731376,1.45,BP
GO:0120039,plasma membrane bounded cell projection ...,699,29,15.53,0.00103,1,0.01111291479820628,1.87,BP
GO:0097193,intrinsic apoptotic signaling pathway,296,16,6.58,0.00103,1,0.01111291479820628,2.43,BP
GO:0006886,intracellular protein transport,901,35,20.02,0.00103,1,0.01111291479820628,1.75,BP
GO:0030010,establishment of cell polarity,138,10,3.07,0.00105,1,0.011253006681514476,3.26,BP
GO:0048675,axon extension,138,10,3.07,0.00105,1,0.011253006681514476,3.26,BP
GO:0030163,protein catabolic process,902,35,20.05,0.00105,1,0.011253006681514476,1.75,BP
GO:0051668,localization within membrane,188,12,4.18,0.00106,1,0.011334933333333333,2.87,BP
GO:0042063,gliogenesis,326,17,7.24,0.00108,1,0.01152319290465632,2.35,BP
GO:0035305,negative regulation of dephosphorylation,93,8,2.07,0.00110,1,0.011710619469026549,3.86,BP
GO:0043666,regulation of phosphoprotein phosphatase...,53,6,1.18,0.00111,1,0.011739164835164836,5.08,BP
GO:0099518,vesicle cytoskeletal trafficking,53,6,1.18,0.00111,1,0.011739164835164836,5.08,BP
GO:1904375,regulation of protein localization to ce...,139,10,3.09,0.00111,1,0.011739164835164836,3.24,BP
GO:0031114,regulation of microtubule depolymerizati...,36,5,0.8,0.00113,1,0.011924473684210525,6.25,BP
GO:0032984,protein-containing complex disassembly,216,13,4.8,0.00114,1,0.012003676148796499,2.71,BP
GO:0010608,posttranscriptional regulation of gene e...,510,23,11.33,0.00115,1,0.012082532751091704,2.03,BP
GO:0043534,blood vessel endothelial cell migration,117,9,2.6,0.00122,1,0.01273457700650759,3.46,BP
GO:0043297,apical junction assembly,54,6,1.2,0.00122,1,0.01273457700650759,5,BP
GO:0072698,protein localization to microtubule cyto...,54,6,1.2,0.00122,1,0.01273457700650759,5,BP
GO:0032271,regulation of protein polymerization,218,13,4.84,0.00124,1,0.012915324675324675,2.69,BP
GO:0035239,tube morphogenesis,911,35,20.25,0.00125,1,0.01299136069114471,1.73,BP
GO:1902749,regulation of cell cycle G2/M phase tran...,95,8,2.11,0.00126,1,0.013067068965517244,3.79,BP
GO:0034243,regulation of transcription elongation f...,37,5,0.82,0.00129,1,0.013320772532188841,6.1,BP
GO:0045601,regulation of endothelial cell different...,37,5,0.82,0.00129,1,0.013320772532188841,6.1,BP
GO:0043406,positive regulation of MAP kinase activi...,219,13,4.87,0.00130,1,0.013395289079229121,2.67,BP
GO:0035303,regulation of dephosphorylation,167,11,3.71,0.00131,1,0.013440767590618337,2.96,BP
GO:0051017,actin filament bundle assembly,167,11,3.71,0.00131,1,0.013440767590618337,2.96,BP
GO:0045773,positive regulation of axon extension,55,6,1.22,0.00135,1,0.01379235668789809,4.92,BP
GO:1901799,negative regulation of proteasomal prote...,55,6,1.22,0.00135,1,0.01379235668789809,4.92,BP
GO:0000209,protein polyubiquitination,194,12,4.31,0.00139,1,0.014170932203389832,2.78,BP
GO:0042254,ribosome biogenesis,278,15,6.18,0.00149,1,0.01515830866807611,2.43,BP
GO:0043254,regulation of protein complex assembly,458,21,10.18,0.00151,1,0.015329367088607597,2.06,BP
GO:0048583,regulation of response to stimulus,3798,110,84.4,0.00154,1,0.01560101052631579,1.3,BP
GO:0007249,I-kappaB kinase/NF-kappaB signaling,197,12,4.38,0.00158,1,0.015972605042016808,2.74,BP
GO:0050684,regulation of mRNA processing,146,10,3.24,0.00161,1,0.01624176100628931,3.09,BP
GO:0043536,positive regulation of blood vessel endo...,57,6,1.27,0.00162,1,0.016308451882845187,4.72,BP
GO:0050768,negative regulation of neurogenesis,339,17,7.53,0.00164,1,0.016441,2.26,BP
GO:0014002,astrocyte development,39,5,0.87,0.00164,1,0.016441,5.75,BP
GO:0050769,positive regulation of neurogenesis,589,25,13.09,0.00165,1,0.016506860706860707,1.91,BP
GO:0001568,blood vessel development,722,29,16.05,0.00167,1,0.016672282157676348,1.81,BP
GO:0045727,positive regulation of translation,123,9,2.73,0.00173,1,0.0171999173553719,3.3,BP
GO:0071900,regulation of protein serine/threonine k...,432,20,9.6,0.00173,1,0.0171999173553719,2.08,BP
GO:0048514,blood vessel morphogenesis,625,26,13.89,0.00177,1,0.017561319587628868,1.87,BP
GO:0032868,response to insulin,227,13,5.04,0.00178,1,0.01761447852760736,2.58,BP
GO:0031328,positive regulation of cellular biosynth...,1919,62,42.65,0.00179,1,0.01761447852760736,1.45,BP
GO:0051336,regulation of hydrolase activity,1001,37,22.25,0.00179,1,0.01761447852760736,1.66,BP
GO:1905114,cell surface receptor signaling pathway ...,528,23,11.73,0.00179,1,0.01761447852760736,1.96,BP
GO:2001242,regulation of intrinsic apoptotic signal...,174,11,3.87,0.00182,1,0.017873142857142855,2.84,BP
GO:0010243,response to organonitrogen compound,898,34,19.96,0.00185,1,0.018130753564154785,1.7,BP
GO:0010389,regulation of G2/M transition of mitotic...,79,7,1.76,0.00187,1,0.018252413793103446,3.98,BP
GO:0032465,regulation of cytokinesis,79,7,1.76,0.00187,1,0.018252413793103446,3.98,BP
GO:0000375,"RNA splicing, via transesterification re...",257,14,5.71,0.00193,1,0.018724112903225808,2.45,BP
GO:0000377,"RNA splicing, via transesterification re...",257,14,5.71,0.00193,1,0.018724112903225808,2.45,BP
GO:0000398,"mRNA splicing, via spliceosome",257,14,5.71,0.00193,1,0.018724112903225808,2.45,BP
GO:0090066,regulation of anatomical structure size,564,24,12.53,0.00196,1,0.01893879518072289,1.92,BP
GO:0045666,positive regulation of neuron differenti...,468,21,10.4,0.00196,1,0.01893879518072289,2.02,BP
GO:0051781,positive regulation of cell division,80,7,1.78,0.00201,1,0.01938300601202405,3.93,BP
GO:0007167,enzyme linked receptor protein signaling...,903,34,20.07,0.00203,1,0.019536720000000004,1.69,BP
GO:0018107,peptidyl-threonine phosphorylation,126,9,2.8,0.00204,1,0.019554741035856575,3.21,BP
GO:0071310,cellular response to organic substance,2470,76,54.89,0.00204,1,0.019554741035856575,1.38,BP
GO:0010972,negative regulation of G2/M transition o...,41,5,0.91,0.00206,1,0.01970719681908549,5.49,BP
GO:0043488,regulation of mRNA stability,103,8,2.29,0.00211,1,0.02014547619047619,3.49,BP
GO:1902017,regulation of cilium assembly,60,6,1.33,0.00212,1,0.020200871287128712,4.51,BP
GO:0140014,mitotic nuclear division,260,14,5.78,0.00215,1,0.020405917159763313,2.42,BP
GO:0061013,regulation of mRNA catabolic process,127,9,2.82,0.00215,1,0.020405917159763313,3.19,BP
GO:1901222,regulation of NIK/NF-kappaB signaling,104,8,2.31,0.00225,1,0.02131299212598425,3.46,BP
GO:0006457,protein folding,153,10,3.4,0.00227,1,0.02146019646365422,2.94,BP
GO:0048585,negative regulation of response to stimu...,1599,53,35.54,0.00228,1,0.021512470588235293,1.49,BP
GO:0010765,positive regulation of sodium ion transp...,42,5,0.93,0.00229,1,0.02156454011741683,5.38,BP
GO:0061061,muscle structure development,704,28,15.65,0.00230,1,0.02161640625,1.79,BP
GO:0043242,negative regulation of protein complex d...,83,7,1.84,0.00249,1,0.023311050583657587,3.8,BP
GO:1901888,regulation of cell junction assembly,83,7,1.84,0.00249,1,0.023311050583657587,3.8,BP
GO:0046605,regulation of centrosome cycle,62,6,1.38,0.00251,1,0.02345266019417476,4.35,BP
GO:0007093,mitotic cell cycle checkpoint,130,9,2.89,0.00252,1,0.023455009671179885,3.11,BP
GO:0044839,cell cycle G2/M phase transition,130,9,2.89,0.00252,1,0.023455009671179885,3.11,BP
GO:0008361,regulation of cell size,209,12,4.64,0.00258,1,0.023967104247104246,2.59,BP
GO:0120032,regulation of plasma membrane bounded ce...,182,11,4.04,0.00259,1,0.02401364161849711,2.72,BP
GO:0034249,negative regulation of cellular amide me...,156,10,3.47,0.00262,1,0.024245076923076925,2.88,BP
GO:1903321,negative regulation of protein modificat...,84,7,1.87,0.00266,1,0.024567984644913627,3.74,BP
GO:0051656,establishment of organelle localization,481,21,10.69,0.00272,1,0.02507402298850575,1.96,BP
GO:1901701,cellular response to oxygen-containing c...,1207,42,26.82,0.00276,1,0.025394110898661566,1.57,BP
GO:0051254,positive regulation of RNA metabolic pro...,1652,54,36.71,0.00279,1,0.025621145038167936,1.47,BP
GO:0060491,regulation of cell projection assembly,184,11,4.09,0.00282,1,0.0257492220113852,2.69,BP
GO:0033048,negative regulation of mitotic sister ch...,44,5,0.98,0.00282,1,0.0257492220113852,5.1,BP
GO:0010721,negative regulation of cell development,388,18,8.62,0.00282,1,0.0257492220113852,2.09,BP
GO:0051494,negative regulation of cytoskeleton orga...,158,10,3.51,0.00287,1,0.026156136363636364,2.85,BP
GO:0043434,response to peptide hormone,328,16,7.29,0.00291,1,0.02647054820415879,2.19,BP
GO:0009891,positive regulation of biosynthetic proc...,1960,62,43.56,0.00292,1,0.02651139622641509,1.42,BP
GO:0009895,negative regulation of catabolic process,299,15,6.64,0.00299,1,0.027095819209039546,2.26,BP
GO:0006810,transport,4327,121,96.16,0.00301,1,0.027225789473684214,1.26,BP
GO:0035304,regulation of protein dephosphorylation,86,7,1.91,0.00304,1,0.027394157303370786,3.66,BP
GO:0010647,positive regulation of cell communicatio...,1887,60,41.94,0.00304,1,0.027394157303370786,1.43,BP
GO:0010770,positive regulation of cell morphogenesi...,186,11,4.13,0.00306,1,0.027522841121495323,2.66,BP
GO:0018210,peptidyl-threonine modification,134,9,2.98,0.00309,1,0.027740820895522385,3.02,BP
GO:0010001,glial cell differentiation,242,13,5.38,0.00311,1,0.027868379888268156,2.42,BP
GO:0043044,ATP-dependent chromatin remodeling,45,5,1,0.00312,1,0.027906022304832714,5,BP
GO:0038061,NIK/NF-kappaB signaling,110,8,2.44,0.00318,1,0.028373900184842885,3.28,BP
GO:0006354,"DNA-templated transcription, elongation",65,6,1.44,0.00319,1,0.028373900184842885,4.17,BP
GO:2000134,negative regulation of G1/S transition o...,65,6,1.44,0.00319,1,0.028373900184842885,4.17,BP
GO:0048708,astrocyte differentiation,87,7,1.93,0.00324,1,0.02874816176470588,3.63,BP
GO:1902806,regulation of cell cycle G1/S phase tran...,135,9,3,0.00325,1,0.02874816176470588,3,BP
GO:0006402,mRNA catabolic process,215,12,4.78,0.00325,1,0.02874816176470588,2.51,BP
GO:0023056,positive regulation of signaling,1893,60,42.07,0.00327,1,0.028872,1.43,BP
GO:0051961,negative regulation of nervous system de...,363,17,8.07,0.00332,1,0.02925978021978022,2.11,BP
GO:0060271,cilium assembly,303,15,6.73,0.00339,1,0.029822084095063983,2.23,BP
GO:0007034,vacuolar transport,136,9,3.02,0.00341,1,0.029888743169398907,2.98,BP
GO:0017148,negative regulation of translation,136,9,3.02,0.00341,1,0.029888743169398907,2.98,BP
GO:0031111,negative regulation of microtubule polym...,46,5,1.02,0.00344,1,0.030042250453720505,4.9,BP
GO:0033046,negative regulation of sister chromatid ...,46,5,1.02,0.00344,1,0.030042250453720505,4.9,BP
GO:0016570,histone modification,427,19,9.49,0.00346,1,0.03005328519855596,2,BP
GO:0031110,regulation of microtubule polymerization...,88,7,1.96,0.00346,1,0.03005328519855596,3.57,BP
GO:0051234,establishment of localization,4469,124,99.32,0.00346,1,0.03005328519855596,1.25,BP
GO:0043487,regulation of RNA stability,112,8,2.49,0.00356,1,0.03086616216216216,3.21,BP
GO:0000027,ribosomal large subunit assembly,29,4,0.64,0.00368,1,0.03173505376344086,6.25,BP
GO:0090169,regulation of spindle assembly,29,4,0.64,0.00368,1,0.03173505376344086,6.25,BP
GO:0031647,regulation of protein stability,276,14,6.13,0.00368,1,0.03173505376344086,2.28,BP
GO:0023051,regulation of signaling,3409,98,75.76,0.00370,1,0.031850447227191415,1.29,BP
GO:2000378,negative regulation of reactive oxygen s...,67,6,1.49,0.00371,1,0.031879500000000005,4.03,BP
GO:0000086,G2/M transition of mitotic cell cycle,113,8,2.51,0.00376,1,0.03219416370106762,3.19,BP
GO:0001952,regulation of cell-matrix adhesion,113,8,2.51,0.00376,1,0.03219416370106762,3.19,BP
GO:0061028,establishment of endothelial barrier,47,5,1.04,0.00378,1,0.03230792184724689,4.81,BP
GO:0000187,activation of MAPK activity,114,8,2.53,0.00396,1,0.03372658407079646,3.16,BP
GO:0031334,positive regulation of protein complex a...,249,13,5.53,0.00396,1,0.03372658407079646,2.35,BP
GO:0010563,negative regulation of phosphorus metabo...,563,23,12.51,0.00398,1,0.0337773544973545,1.84,BP
GO:0045936,negative regulation of phosphate metabol...,563,23,12.51,0.00398,1,0.0337773544973545,1.84,BP
GO:0051258,protein polymerization,279,14,6.2,0.00405,1,0.03431091549295774,2.26,BP
GO:0008285,negative regulation of cell proliferatio...,700,27,15.56,0.00413,1,0.0349271704745167,1.74,BP
GO:0006368,transcription elongation from RNA polyme...,48,5,1.07,0.00414,1,0.034950315789473684,4.67,BP
GO:0016242,negative regulation of macroautophagy,30,4,0.67,0.00417,1,0.03514192644483363,5.97,BP
GO:0007088,regulation of mitotic nuclear division,167,10,3.71,0.00426,1,0.03583762237762238,2.7,BP
GO:0007155,cell adhesion,1311,44,29.13,0.00427,1,0.03585905759162304,1.51,BP
GO:0010646,regulation of cell communication,3387,97,75.27,0.00435,1,0.036467247386759584,1.29,BP
GO:0031589,cell-substrate adhesion,342,16,7.6,0.00436,1,0.03648751304347826,2.11,BP
GO:1903828,negative regulation of cellular protein ...,116,8,2.58,0.00440,1,0.03675833333333333,3.1,BP
GO:0002028,regulation of sodium ion transport,92,7,2.04,0.00443,1,0.03688089965397924,3.43,BP
GO:0030838,positive regulation of actin filament po...,92,7,2.04,0.00443,1,0.03688089965397924,3.43,BP
GO:0051985,negative regulation of chromosome segreg...,49,5,1.09,0.00453,1,0.03764829015544041,4.59,BP
GO:1990138,neuron projection extension,196,11,4.36,0.00455,1,0.037749310344827584,2.52,BP
GO:1902807,negative regulation of cell cycle G1/S p...,70,6,1.56,0.00461,1,0.038181273666092946,3.85,BP
GO:0043244,regulation of protein complex disassembl...,117,8,2.6,0.00464,1,0.03836371134020619,3.08,BP
GO:0001558,regulation of cell growth,439,19,9.76,0.00465,1,0.03838044596912521,1.95,BP
GO:0007266,Rho protein signal transduction,197,11,4.38,0.00473,1,0.03897390410958904,2.51,BP
GO:0007166,cell surface receptor signaling pathway,2396,72,53.25,0.00482,1,0.039647589743589735,1.35,BP
GO:0007051,spindle organization,170,10,3.78,0.00483,1,0.03966204778156996,2.65,BP
GO:0010769,regulation of cell morphogenesis involve...,346,16,7.69,0.00487,1,0.039922385008517886,2.08,BP
GO:0051783,regulation of nuclear division,198,11,4.4,0.00491,1,0.04012718644067797,2.5,BP
GO:0042221,response to chemical,4182,116,92.94,0.00492,1,0.04012718644067797,1.25,BP
GO:0045935,positive regulation of nucleobase-contai...,1852,58,41.16,0.00492,1,0.04012718644067797,1.41,BP
GO:0006949,syncytium formation,71,6,1.58,0.00494,1,0.04022213197969543,3.8,BP
GO:0022610,biological adhesion,1323,44,29.4,0.00502,1,0.040804459459459465,1.5,BP
GO:0051049,regulation of transport,1973,61,43.85,0.00520,1,0.042196290050590224,1.39,BP
GO:0016569,covalent chromatin modification,444,19,9.87,0.00523,1,0.042368282828282824,1.93,BP
GO:0044248,cellular catabolic process,2013,62,44.74,0.00527,1,0.04262057142857143,1.39,BP
GO:0051642,centrosome localization,32,4,0.71,0.00529,1,0.04271053691275168,5.63,BP
GO:0032206,positive regulation of telomere maintena...,51,5,1.13,0.00538,1,0.04336442211055277,4.42,BP
GO:0031109,microtubule polymerization or depolymeri...,120,8,2.67,0.00540,1,0.043380300500834724,3,BP
GO:2000045,regulation of G1/S transition of mitotic...,120,8,2.67,0.00540,1,0.043380300500834724,3,BP
GO:2001251,negative regulation of chromosome organi...,146,9,3.24,0.00543,1,0.0435486,2.78,BP
GO:0065004,protein-DNA complex assembly,173,10,3.84,0.00545,1,0.043636272878535776,2.6,BP
GO:0042176,regulation of protein catabolic process,383,17,8.51,0.00565,1,0.04516245847176079,2,BP
GO:0045216,cell-cell junction organization,147,9,3.27,0.00568,1,0.045326965174129354,2.75,BP
GO:0031396,regulation of protein ubiquitination,202,11,4.49,0.00569,1,0.045331589403973506,2.45,BP
GO:0007059,chromosome segregation,321,15,7.13,0.00574,1,0.045654347107438015,2.1,BP
GO:0006897,endocytosis,615,24,13.67,0.00578,1,0.04589663366336634,1.76,BP
GO:0007019,microtubule depolymerization,52,5,1.16,0.00585,1,0.04622364532019704,4.31,BP
GO:0030071,regulation of mitotic metaphase/anaphase...,52,5,1.16,0.00585,1,0.04622364532019704,4.31,BP
GO:0061014,positive regulation of mRNA catabolic pr...,52,5,1.16,0.00585,1,0.04622364532019704,4.31,BP
GO:0072359,circulatory system development,1150,39,25.56,0.00591,1,0.046547450980392154,1.53,BP
GO:0061157,mRNA destabilization,33,4,0.73,0.00592,1,0.046547450980392154,5.48,BP
GO:0061842,microtubule organizing center localizati...,33,4,0.73,0.00592,1,0.046547450980392154,5.48,BP
GO:0010508,positive regulation of autophagy,122,8,2.71,0.00595,1,0.04670701468189233,2.95,BP
GO:0045665,negative regulation of neuron differenti...,262,13,5.82,0.00604,1,0.04726071428571429,2.23,BP
GO:0046626,regulation of insulin receptor signaling...,74,6,1.64,0.00605,1,0.04726071428571429,3.66,BP
GO:1901880,negative regulation of protein depolymer...,74,6,1.64,0.00605,1,0.04726071428571429,3.66,BP
GO:0031098,stress-activated protein kinase signalin...,293,14,6.51,0.00619,1,0.04827598055105349,2.15,BP
GO:0031058,positive regulation of histone modificat...,98,7,2.18,0.00624,1,0.048587184466019416,3.21,BP
GO:0048584,positive regulation of response to stimu...,2187,66,48.6,0.00633,1,0.04920658064516129,1.36,BP
GO:0032388,positive regulation of intracellular tra...,205,11,4.56,0.00634,1,0.04920658064516129,2.41,BP
GO:0043405,regulation of MAP kinase activity,294,14,6.53,0.00637,1,0.0492785874799358,2.14,BP
GO:0006479,protein methylation,177,10,3.93,0.00638,1,0.0492785874799358,2.54,BP
GO:0008213,protein alkylation,177,10,3.93,0.00638,1,0.0492785874799358,2.54,BP
GO:0040008,regulation of growth,724,27,16.09,0.00641,1,0.04943096153846154,1.68,BP
GO:0009628,response to abiotic stimulus,1048,36,23.29,0.00662,1,0.050964153354632585,1.55,BP
GO:0000075,cell cycle checkpoint,178,10,3.96,0.00663,1,0.050964153354632585,2.53,BP
GO:0048193,Golgi vesicle transport,266,13,5.91,0.00682,1,0.05234105263157894,2.2,BP
GO:0043268,positive regulation of potassium ion tra...,54,5,1.2,0.00686,1,0.05237706161137441,4.17,BP
GO:0045839,negative regulation of mitotic nuclear d...,54,5,1.2,0.00686,1,0.05237706161137441,4.17,BP
GO:0007045,cell-substrate adherens junction assembl...,76,6,1.69,0.00688,1,0.05237706161137441,3.55,BP
GO:0048041,focal adhesion assembly,76,6,1.69,0.00688,1,0.05237706161137441,3.55,BP
GO:0043524,negative regulation of neuron apoptotic ...,179,10,3.98,0.00688,1,0.05237706161137441,2.51,BP
GO:0007264,small GTPase mediated signal transductio...,489,20,10.87,0.00689,1,0.05237706161137441,1.84,BP
GO:0030111,regulation of Wnt signaling pathway,297,14,6.6,0.00694,1,0.052673943217665616,2.12,BP
GO:0014013,regulation of gliogenesis,152,9,3.38,0.00703,1,0.053273007874015746,2.66,BP
GO:0034332,adherens junction organization,126,8,2.8,0.00720,1,0.05447547169811321,2.86,BP
GO:0043161,proteasome-mediated ubiquitin-dependent ...,393,17,8.73,0.00723,1,0.054616577708006285,1.95,BP
GO:0050779,RNA destabilization,35,4,0.78,0.00731,1,0.05510152886115445,5.13,BP
GO:0014855,striated muscle cell proliferation,77,6,1.71,0.00732,1,0.05510152886115445,3.51,BP
GO:0007041,lysosomal transport,101,7,2.24,0.00734,1,0.05510152886115445,3.12,BP
GO:0110020,regulation of actomyosin structure organ...,101,7,2.24,0.00734,1,0.05510152886115445,3.12,BP
GO:1902099,regulation of metaphase/anaphase transit...,55,5,1.22,0.00741,1,0.0555403738317757,4.1,BP
GO:0044782,cilium organization,331,15,7.36,0.00753,1,0.05625190697674419,2.04,BP
GO:0010498,proteasomal protein catabolic process,460,19,10.22,0.00753,1,0.05625190697674419,1.86,BP
GO:0071103,DNA conformation change,210,11,4.67,0.00754,1,0.05625190697674419,2.36,BP
GO:0050678,regulation of epithelial cell proliferat...,363,16,8.07,0.00760,1,0.056611764705882354,1.98,BP
GO:0000077,DNA damage checkpoint,102,7,2.27,0.00773,1,0.0574024074074074,3.08,BP
GO:0006892,post-Golgi vesicle-mediated transport,102,7,2.27,0.00773,1,0.0574024074074074,3.08,BP
GO:0080134,regulation of response to stress,1357,44,30.16,0.00776,1,0.057405022970903524,1.46,BP
GO:0051050,positive regulation of transport,1096,37,24.36,0.00777,1,0.057405022970903524,1.52,BP
GO:0042692,muscle cell differentiation,396,17,8.8,0.00777,1,0.057405022970903524,1.93,BP
GO:0045893,"positive regulation of transcription, DN...",1547,49,34.38,0.00779,1,0.057405022970903524,1.43,BP
GO:1905897,regulation of response to endoplasmic re...,78,6,1.73,0.00779,1,0.057405022970903524,3.47,BP
GO:0007091,metaphase/anaphase transition of mitotic...,56,5,1.24,0.00799,1,0.05878880733944954,4.03,BP
GO:0048009,insulin-like growth factor receptor sign...,36,4,0.8,0.00808,1,0.05926975609756097,5,BP
GO:1902991,regulation of amyloid precursor protein ...,36,4,0.8,0.00808,1,0.05926975609756097,5,BP
GO:1903508,positive regulation of nucleic acid-temp...,1551,49,34.47,0.00816,1,0.0597654794520548,1.42,BP
GO:0050673,epithelial cell proliferation,431,18,9.58,0.00822,1,0.060113434650455926,1.88,BP
GO:1902680,positive regulation of RNA biosynthetic ...,1552,49,34.49,0.00825,1,0.060241274658573596,1.42,BP
GO:0033157,regulation of intracellular protein tran...,213,11,4.73,0.00834,1,0.06080618181818182,2.33,BP
GO:0030038,contractile actin filament bundle assemb...,104,7,2.31,0.00857,1,0.0619814328358209,3.03,BP
GO:0032231,regulation of actin filament bundle asse...,104,7,2.31,0.00857,1,0.0619814328358209,3.03,BP
GO:0043149,stress fiber assembly,104,7,2.31,0.00857,1,0.0619814328358209,3.03,BP
GO:0010965,regulation of mitotic sister chromatid s...,57,5,1.27,0.00861,1,0.0619814328358209,3.94,BP
GO:0044773,mitotic DNA damage checkpoint,57,5,1.27,0.00861,1,0.0619814328358209,3.94,BP
GO:0051893,regulation of focal adhesion assembly,57,5,1.27,0.00861,1,0.0619814328358209,3.94,BP
GO:0072678,T cell migration,57,5,1.27,0.00861,1,0.0619814328358209,3.94,BP
GO:0090109,regulation of cell-substrate junction as...,57,5,1.27,0.00861,1,0.0619814328358209,3.94,BP
GO:1901343,negative regulation of vasculature devel...,130,8,2.89,0.00862,1,0.0619814328358209,2.77,BP
GO:0010810,regulation of cell-substrate adhesion,214,11,4.76,0.00863,1,0.0619814328358209,2.31,BP
GO:1903362,regulation of cellular protein catabolic...,244,12,5.42,0.00872,1,0.06253448584202684,2.21,BP
GO:1902117,positive regulation of organelle assembl...,80,6,1.78,0.00878,1,0.06287107142857143,3.37,BP
GO:0048169,regulation of long-term neuronal synapti...,37,4,0.82,0.00891,1,0.06370716196136701,4.88,BP
GO:0032101,regulation of response to external stimu...,779,28,17.31,0.00894,1,0.06382682492581603,1.62,BP
GO:0046777,protein autophosphorylation,245,12,5.44,0.00899,1,0.06385290132547865,2.21,BP
GO:1901215,negative regulation of neuron death,245,12,5.44,0.00899,1,0.06385290132547865,2.21,BP
GO:0006413,translational initiation,105,7,2.33,0.00901,1,0.06385290132547865,3,BP
GO:1905477,positive regulation of protein localizat...,105,7,2.33,0.00901,1,0.06385290132547865,3,BP
GO:0042177,negative regulation of protein catabolic...,131,8,2.91,0.00901,1,0.06385290132547865,2.75,BP
GO:1901214,regulation of neuron death,370,16,8.22,0.00903,1,0.0639005294117647,1.95,BP
GO:1902532,negative regulation of intracellular sig...,537,21,11.93,0.00927,1,0.0655025550660793,1.76,BP
GO:0002088,lens development in camera-type eye,81,6,1.8,0.00931,1,0.06568873900293255,3.33,BP
GO:0071157,negative regulation of cell cycle arrest,20,3,0.44,0.00938,1,0.06608573938506589,6.82,BP
GO:0009408,response to heat,106,7,2.36,0.00947,1,0.06662228070175438,2.97,BP
GO:0048598,embryonic morphogenesis,642,24,14.27,0.00957,1,0.06722750364963505,1.68,BP
GO:0048638,regulation of developmental growth,405,17,9,0.00959,1,0.06726979591836733,1.89,BP
GO:0045597,positive regulation of cell differentiat...,1113,37,24.73,0.00979,1,0.06857275109170306,1.5,BP
GO:0044784,metaphase/anaphase transition of cell cy...,59,5,1.31,0.00993,1,0.06925095652173913,3.82,BP
GO:0051148,negative regulation of muscle cell diffe...,59,5,1.31,0.00993,1,0.06925095652173913,3.82,BP
GO:2000401,regulation of lymphocyte migration,59,5,1.31,0.00993,1,0.06925095652173913,3.82,BP
GO:0051098,regulation of binding,407,17,9.04,0.01003,1,0.06984712011577425,1.88,BP
GO:0006401,RNA catabolic process,249,12,5.53,0.01014,1,0.07051109826589595,2.17,BP
GO:0097190,apoptotic signaling pathway,612,23,13.6,0.01042,1,0.07235309352517985,1.69,BP
GO:0030833,regulation of actin filament polymerizat...,162,9,3.6,0.01045,1,0.07235309352517985,2.5,BP
GO:0051147,regulation of muscle cell differentiatio...,162,9,3.6,0.01045,1,0.07235309352517985,2.5,BP
GO:0048545,response to steroid hormone,220,11,4.89,0.01048,1,0.07245655172413792,2.25,BP
GO:0046328,regulation of JNK cascade,191,10,4.24,0.01062,1,0.07303805991440798,2.36,BP
GO:1905475,regulation of protein localization to me...,191,10,4.24,0.01062,1,0.07303805991440798,2.36,BP
GO:0042982,amyloid precursor protein metabolic proc...,60,5,1.33,0.01064,1,0.07303805991440798,3.76,BP
GO:0046847,filopodium assembly,60,5,1.33,0.01064,1,0.07303805991440798,3.76,BP
GO:0051306,mitotic sister chromatid separation,60,5,1.33,0.01064,1,0.07303805991440798,3.76,BP
GO:0070646,protein modification by small protein re...,135,8,3,0.01070,1,0.07334529914529914,2.67,BP
GO:0010613,positive regulation of cardiac muscle hy...,39,4,0.87,0.01072,1,0.07337786628733997,4.6,BP
GO:0007095,mitotic G2 DNA damage checkpoint,21,3,0.47,0.01077,1,0.07361539772727273,6.38,BP
GO:1901565,organonitrogen compound catabolic proces...,1158,38,25.73,0.01083,1,0.07392051063829787,1.48,BP
GO:0030902,hindbrain development,163,9,3.62,0.01085,1,0.07395212464589236,2.49,BP
GO:0007043,cell-cell junction assembly,109,7,2.42,0.01094,1,0.07446008486562943,2.89,BP
GO:0070997,neuron death,411,17,9.13,0.01097,1,0.07455881355932203,1.86,BP
GO:0032204,regulation of telomere maintenance,84,6,1.87,0.01104,1,0.07492874471086036,3.21,BP
GO:0000280,nuclear division,412,17,9.16,0.01122,1,0.07604315492957747,1.86,BP
GO:0014742,positive regulation of muscle hypertroph...,40,4,0.89,0.01170,1,0.07896269284712483,4.49,BP
GO:0032594,protein transport within lipid bilayer,40,4,0.89,0.01170,1,0.07896269284712483,4.49,BP
GO:0045841,negative regulation of mitotic metaphase...,40,4,0.89,0.01170,1,0.07896269284712483,4.49,BP
GO:0030324,lung development,224,11,4.98,0.01188,1,0.08006521008403361,2.21,BP
GO:0009790,embryo development,1241,40,27.58,0.01194,1,0.08035703496503496,1.45,BP
GO:0016571,histone methylation,138,8,3.07,0.01211,1,0.08110335164835164,2.61,BP
GO:0009266,response to temperature stimulus,166,9,3.69,0.01212,1,0.08110335164835164,2.44,BP
GO:0044843,cell cycle G1/S phase transition,195,10,4.33,0.01215,1,0.08110335164835164,2.31,BP
GO:0070887,cellular response to chemical stimulus,3063,86,68.07,0.01216,1,0.08110335164835164,1.26,BP
GO:0051241,negative regulation of multicellular org...,1357,43,30.16,0.01225,1,0.08110335164835164,1.43,BP
GO:0002183,cytoplasmic translational initiation,22,3,0.49,0.01227,1,0.08110335164835164,6.12,BP
GO:0006353,"DNA-templated transcription, termination",22,3,0.49,0.01227,1,0.08110335164835164,6.12,BP
GO:0007063,regulation of sister chromatid cohesion,22,3,0.49,0.01227,1,0.08110335164835164,6.12,BP
GO:0031579,membrane raft organization,22,3,0.49,0.01227,1,0.08110335164835164,6.12,BP
GO:0046628,positive regulation of insulin receptor ...,22,3,0.49,0.01227,1,0.08110335164835164,6.12,BP
GO:0072215,regulation of metanephros development,22,3,0.49,0.01227,1,0.08110335164835164,6.12,BP
GO:1901223,negative regulation of NIK/NF-kappaB sig...,22,3,0.49,0.01227,1,0.08110335164835164,6.12,BP
GO:1901889,negative regulation of cell junction ass...,22,3,0.49,0.01227,1,0.08110335164835164,6.12,BP
GO:0007265,Ras protein signal transduction,417,17,9.27,0.01252,1,0.08264230452674896,1.83,BP
GO:0031570,DNA integrity checkpoint,112,7,2.49,0.01258,1,0.08281116279069767,2.81,BP
GO:0051028,mRNA transport,112,7,2.49,0.01258,1,0.08281116279069767,2.81,BP
GO:0048871,multicellular organismal homeostasis,485,19,10.78,0.01271,1,0.083408,1.76,BP
GO:0048873,homeostasis of number of cells within a ...,41,4,0.91,0.01274,1,0.083408,4.4,BP
GO:1903672,positive regulation of sprouting angioge...,41,4,0.91,0.01274,1,0.083408,4.4,BP
GO:2000816,negative regulation of mitotic sister ch...,41,4,0.91,0.01274,1,0.083408,4.4,BP
GO:1905818,regulation of chromosome separation,63,5,1.4,0.01297,1,0.08471464140730717,3.57,BP
GO:1901879,regulation of protein depolymerization,87,6,1.93,0.01298,1,0.08471464140730717,3.11,BP
GO:1901700,response to oxygen-containing compound,1593,49,35.4,0.01300,1,0.08471464140730717,1.38,BP
GO:0030323,respiratory tube development,227,11,5.04,0.01301,1,0.08471464140730717,2.18,BP
GO:0030048,actin filament-based movement,113,7,2.51,0.01316,1,0.08546008097165993,2.79,BP
GO:0043401,steroid hormone mediated signaling pathw...,113,7,2.51,0.01316,1,0.08546008097165993,2.79,BP
GO:0071407,cellular response to organic cyclic comp...,487,19,10.82,0.01323,1,0.0857988679245283,1.76,BP
GO:0016072,rRNA metabolic process,228,11,5.07,0.01341,1,0.08684915208613728,2.17,BP
GO:0043122,regulation of I-kappaB kinase/NF-kappaB ...,169,9,3.76,0.01350,1,0.08719731543624161,2.39,BP
GO:0045931,positive regulation of mitotic cell cycl...,169,9,3.76,0.01350,1,0.08719731543624161,2.39,BP
GO:0030155,regulation of cell adhesion,698,25,15.51,0.01360,1,0.08772546916890081,1.61,BP
GO:2001233,regulation of apoptotic signaling pathwa...,421,17,9.36,0.01364,1,0.08777795275590551,1.82,BP
GO:1900076,regulation of cellular response to insul...,88,6,1.96,0.01368,1,0.08777795275590551,3.06,BP
GO:0008630,intrinsic apoptotic signaling pathway in...,114,7,2.53,0.01377,1,0.08777795275590551,2.77,BP
GO:0016525,negative regulation of angiogenesis,114,7,2.53,0.01377,1,0.08777795275590551,2.77,BP
GO:0046822,regulation of nucleocytoplasmic transpor...,114,7,2.53,0.01377,1,0.08777795275590551,2.77,BP
GO:0060828,regulation of canonical Wnt signaling pa...,229,11,5.09,0.01381,1,0.08777795275590551,2.16,BP
GO:1903391,regulation of adherens junction organiza...,64,5,1.42,0.01382,1,0.08777795275590551,3.52,BP
GO:1902100,negative regulation of metaphase/anaphas...,42,4,0.93,0.01384,1,0.08777795275590551,4.3,BP
GO:0071702,organic substance transport,2551,73,56.69,0.01387,1,0.08777795275590551,1.29,BP
GO:0032968,positive regulation of transcription elo...,23,3,0.51,0.01388,1,0.08777795275590551,5.88,BP
GO:0051220,cytoplasmic sequestering of protein,23,3,0.51,0.01388,1,0.08777795275590551,5.88,BP
GO:0060390,regulation of SMAD protein signal transd...,23,3,0.51,0.01388,1,0.08777795275590551,5.88,BP
GO:0072202,cell differentiation involved in metanep...,23,3,0.51,0.01388,1,0.08777795275590551,5.88,BP
GO:1904469,positive regulation of tumor necrosis fa...,23,3,0.51,0.01388,1,0.08777795275590551,5.88,BP
GO:0051056,regulation of small GTPase mediated sign...,260,12,5.78,0.01390,1,0.08777795275590551,2.08,BP
GO:0051403,stress-activated MAPK cascade,260,12,5.78,0.01390,1,0.08777795275590551,2.08,BP
GO:0050821,protein stabilization,170,9,3.78,0.01398,1,0.08816744429882045,2.38,BP
GO:0050679,positive regulation of epithelial cell p...,200,10,4.44,0.01430,1,0.0900675392670157,2.25,BP
GO:0007229,integrin-mediated signaling pathway,89,6,1.98,0.01440,1,0.09046057441253263,3.03,BP
GO:0051492,regulation of stress fiber assembly,89,6,1.98,0.01440,1,0.09046057441253263,3.03,BP
GO:1901566,organonitrogen compound biosynthetic pro...,1564,48,34.76,0.01443,1,0.09053084745762711,1.38,BP
GO:0033627,cell adhesion mediated by integrin,65,5,1.44,0.01471,1,0.09192794805194805,3.47,BP
GO:0044774,mitotic DNA integrity checkpoint,65,5,1.44,0.01471,1,0.09192794805194805,3.47,BP
GO:0051784,negative regulation of nuclear division,65,5,1.44,0.01471,1,0.09192794805194805,3.47,BP
GO:0007050,cell cycle arrest,143,8,3.18,0.01475,1,0.09205836575875485,2.52,BP
GO:0007369,gastrulation,172,9,3.82,0.01499,1,0.09325581395348838,2.36,BP
GO:0090224,regulation of spindle organization,43,4,0.96,0.01500,1,0.09325581395348838,4.17,BP
GO:1905819,negative regulation of chromosome separa...,43,4,0.96,0.01500,1,0.09325581395348838,4.17,BP
GO:0014070,response to organic cyclic compound,742,26,16.49,0.01547,1,0.09605372903225806,1.58,BP
GO:0048285,organelle fission,461,18,10.24,0.01550,1,0.0961159793814433,1.76,BP
GO:0034394,protein localization to cell surface,66,5,1.47,0.01564,1,0.09685930501930502,3.4,BP
GO:0016579,protein deubiquitination,117,7,2.6,0.01569,1,0.0970440616966581,2.69,BP
GO:1904018,positive regulation of vasculature devel...,204,10,4.53,0.01621,1,0.10013160462130936,2.21,BP
GO:0043523,regulation of neuron apoptotic process,266,12,5.91,0.01636,1,0.10086099871959027,2.03,BP
GO:2000181,negative regulation of blood vessel morp...,118,7,2.62,0.01637,1,0.10086099871959027,2.67,BP
GO:0051402,neuron apoptotic process,298,13,6.62,0.01644,1,0.10109501915708813,1.96,BP
GO:0032872,regulation of stress-activated MAPK casc...,235,11,5.22,0.01645,1,0.10109501915708813,2.11,BP
GO:0009968,negative regulation of signal transducti...,1192,38,26.49,0.01649,1,0.10121158163265306,1.43,BP
GO:0031099,regeneration,146,8,3.24,0.01652,1,0.10126654777070064,2.47,BP
GO:0046824,positive regulation of nucleocytoplasmic...,67,5,1.49,0.01660,1,0.10162748091603054,3.36,BP
GO:0007254,JNK cascade,205,10,4.56,0.01672,1,0.10190475949367087,2.19,BP
GO:0051640,organelle localization,604,22,13.42,0.01672,1,0.10190475949367087,1.64,BP
GO:0043535,regulation of blood vessel endothelial c...,92,6,2.04,0.01673,1,0.10190475949367087,2.94,BP
GO:1903313,positive regulation of mRNA metabolic pr...,92,6,2.04,0.01673,1,0.10190475949367087,2.94,BP
GO:0006281,DNA repair,465,18,10.33,0.01677,1,0.10201926675094816,1.74,BP
GO:0098657,import into cell,749,26,16.65,0.01720,1,0.1045030303030303,1.56,BP
GO:0070302,regulation of stress-activated protein k...,237,11,5.27,0.01740,1,0.1054891959798995,2.09,BP
GO:0031100,animal organ regeneration,25,3,0.56,0.01745,1,0.1054891959798995,5.36,BP
GO:0046688,response to copper ion,25,3,0.56,0.01745,1,0.1054891959798995,5.36,BP
GO:2000679,positive regulation of transcription reg...,25,3,0.56,0.01745,1,0.1054891959798995,5.36,BP
GO:0010464,regulation of mesenchymal cell prolifera...,45,4,1,0.01750,1,0.1055263157894737,4,BP
GO:0042987,amyloid precursor protein catabolic proc...,45,4,1,0.01750,1,0.1055263157894737,4,BP
GO:0042273,ribosomal large subunit biogenesis,68,5,1.51,0.01760,1,0.10599649561952441,3.31,BP
GO:0010977,negative regulation of neuron projection...,177,9,3.93,0.01774,1,0.10657288389513107,2.29,BP
GO:0043409,negative regulation of MAPK cascade,177,9,3.93,0.01774,1,0.10657288389513107,2.29,BP
GO:0045944,positive regulation of transcription by ...,1238,39,27.51,0.01810,1,0.1086,1.42,BP
GO:0009314,response to radiation,401,16,8.91,0.01813,1,0.10864453300124532,1.8,BP
GO:0031345,negative regulation of cell projection o...,208,10,4.62,0.01830,1,0.10939080745341614,2.16,BP
GO:0051099,positive regulation of binding,208,10,4.62,0.01830,1,0.10939080745341614,2.16,BP
GO:0030041,actin filament polymerization,178,9,3.96,0.01834,1,0.1094938957816377,2.27,BP
GO:0018022,peptidyl-lysine methylation,121,7,2.69,0.01854,1,0.11041396039603962,2.6,BP
GO:0031497,chromatin assembly,121,7,2.69,0.01854,1,0.11041396039603962,2.6,BP
GO:0000768,syncytium formation by plasma membrane f...,69,5,1.53,0.01864,1,0.11059886559802713,3.27,BP
GO:0051298,centrosome duplication,69,5,1.53,0.01864,1,0.11059886559802713,3.27,BP
GO:0140253,cell-cell fusion,69,5,1.53,0.01864,1,0.11059886559802713,3.27,BP
GO:0006378,mRNA polyadenylation,46,4,1.02,0.01884,1,0.11123690797546011,3.92,BP
GO:0016574,histone ubiquitination,46,4,1.02,0.01884,1,0.11123690797546011,3.92,BP
GO:0042307,positive regulation of protein import in...,46,4,1.02,0.01884,1,0.11123690797546011,3.92,BP
GO:2000404,regulation of T cell migration,46,4,1.02,0.01884,1,0.11123690797546011,3.92,BP
GO:0008064,regulation of actin polymerization or de...,179,9,3.98,0.01894,1,0.11169029411764705,2.26,BP
GO:0016311,dephosphorylation,370,15,8.22,0.01912,1,0.11261375764993882,1.82,BP
GO:0051346,negative regulation of hydrolase activit...,404,16,8.98,0.01929,1,0.11347613691931542,1.78,BP
GO:0006891,intra-Golgi vesicle-mediated transport,26,3,0.58,0.01941,1,0.11382343483556638,5.17,BP
GO:1900078,positive regulation of cellular response...,26,3,0.58,0.01941,1,0.11382343483556638,5.17,BP
GO:0035264,multicellular organism growth,210,10,4.67,0.01942,1,0.11382343483556638,2.14,BP
GO:0000082,G1/S transition of mitotic cell cycle,180,9,4,0.01956,1,0.11442386391251519,2.25,BP
GO:0043009,chordate embryonic development,831,28,18.47,0.01957,1,0.11442386391251519,1.52,BP
GO:0001885,endothelial cell development,70,5,1.56,0.01972,1,0.11488213075060534,3.21,BP
GO:1903670,regulation of sprouting angiogenesis,70,5,1.56,0.01972,1,0.11488213075060534,3.21,BP
GO:2001244,positive regulation of intrinsic apoptot...,70,5,1.56,0.01972,1,0.11488213075060534,3.21,BP
GO:2000058,regulation of ubiquitin-dependent protei...,151,8,3.36,0.01982,1,0.11532507859733979,2.38,BP
GO:0003158,endothelium development,123,7,2.73,0.02010,1,0.11667213510253317,2.56,BP
GO:1900180,regulation of protein localization to nu...,123,7,2.73,0.02010,1,0.11667213510253317,2.56,BP
GO:0000045,autophagosome assembly,96,6,2.13,0.02021,1,0.11702830324909747,2.82,BP
GO:1901989,positive regulation of cell cycle phase ...,96,6,2.13,0.02021,1,0.11702830324909747,2.82,BP
GO:0051489,regulation of filopodium assembly,47,4,1.04,0.02024,1,0.11706115384615384,3.85,BP
GO:0006470,protein dephosphorylation,243,11,5.4,0.02052,1,0.11839597122302158,2.04,BP
GO:0043393,regulation of protein binding,243,11,5.4,0.02052,1,0.11839597122302158,2.04,BP
GO:0051057,positive regulation of small GTPase medi...,71,5,1.58,0.02084,1,0.1200122009569378,3.16,BP
GO:0030832,regulation of actin filament length,182,9,4.04,0.02085,1,0.1200122009569378,2.23,BP
GO:0060996,dendritic spine development,124,7,2.76,0.02091,1,0.12021376344086021,2.54,BP
GO:0043010,camera-type eye development,341,14,7.58,0.02098,1,0.12047226730310262,1.85,BP
GO:1903050,regulation of proteolysis involved in ce...,213,10,4.73,0.02120,1,0.12158739595719383,2.11,BP
GO:0050657,nucleic acid transport,153,8,3.4,0.02125,1,0.12158739595719383,2.35,BP
GO:0050658,RNA transport,153,8,3.4,0.02125,1,0.12158739595719383,2.35,BP
GO:0035987,endodermal cell differentiation,27,3,0.6,0.02148,1,0.12246654028436017,5,BP
GO:0039694,viral RNA genome replication,27,3,0.6,0.02148,1,0.12246654028436017,5,BP
GO:1904353,regulation of telomere capping,27,3,0.6,0.02148,1,0.12246654028436017,5,BP
GO:0030857,negative regulation of epithelial cell d...,48,4,1.07,0.02170,1,0.12313726415094339,3.74,BP
GO:0043631,RNA polyadenylation,48,4,1.07,0.02170,1,0.12313726415094339,3.74,BP
GO:0045104,intermediate filament cytoskeleton organ...,48,4,1.07,0.02170,1,0.12313726415094339,3.74,BP
GO:1902808,positive regulation of cell cycle G1/S p...,48,4,1.07,0.02170,1,0.12313726415094339,3.74,BP
GO:0032760,positive regulation of tumor necrosis fa...,98,6,2.18,0.02213,1,0.12542939929328623,2.75,BP
GO:0051091,positive regulation of DNA-binding trans...,246,11,5.47,0.02222,1,0.1257913411764706,2.01,BP
GO:0070848,response to growth factor,623,22,13.85,0.02282,1,0.12903623971797887,1.59,BP
GO:0045766,positive regulation of angiogenesis,185,9,4.11,0.02289,1,0.12928014084507042,2.19,BP
GO:0032103,positive regulation of response to exter...,312,13,6.93,0.02298,1,0.12963629542790153,1.88,BP
GO:0048639,positive regulation of developmental gro...,216,10,4.8,0.02308,1,0.130047962529274,2.08,BP
GO:1903557,positive regulation of tumor necrosis fa...,99,6,2.2,0.02313,1,0.13017726315789474,2.73,BP
GO:0051145,smooth muscle cell differentiation,73,5,1.62,0.02320,1,0.13028293706293706,3.09,BP
GO:0045103,intermediate filament-based process,49,4,1.09,0.02323,1,0.13028293706293706,3.67,BP
GO:0050435,amyloid-beta metabolic process,49,4,1.09,0.02323,1,0.13028293706293706,3.67,BP
GO:0051236,establishment of RNA localization,156,8,3.47,0.02355,1,0.13192386495925496,2.31,BP
GO:0021952,central nervous system projection neuron...,28,3,0.62,0.02367,1,0.13213461716937355,4.84,BP
GO:0031440,regulation of mRNA 3'-end processing,28,3,0.62,0.02367,1,0.13213461716937355,4.84,BP
GO:0045724,positive regulation of cilium assembly,28,3,0.62,0.02367,1,0.13213461716937355,4.84,BP
GO:0018193,peptidyl-amino acid modification,1147,36,25.49,0.02375,1,0.13242757821552725,1.41,BP
GO:1905037,autophagosome organization,100,6,2.22,0.02416,1,0.13455777777777778,2.7,BP
GO:0010811,positive regulation of cell-substrate ad...,128,7,2.84,0.02437,1,0.13557045086705202,2.46,BP
GO:0031397,negative regulation of protein ubiquitin...,74,5,1.64,0.02444,1,0.13580286374133949,3.05,BP
GO:0009792,embryo development ending in birth or eg...,848,28,18.85,0.02467,1,0.13692276816608998,1.49,BP
GO:0010761,fibroblast migration,50,4,1.11,0.02482,1,0.13759658986175113,3.6,BP
GO:0061351,neural precursor cell proliferation,188,9,4.18,0.02507,1,0.1388226006904488,2.15,BP
GO:0090263,positive regulation of canonical Wnt sig...,101,6,2.24,0.02523,1,0.139548,2.68,BP
GO:0051092,positive regulation of NF-kappaB transcr...,129,7,2.87,0.02530,1,0.13977451205510907,2.44,BP
GO:0060070,canonical Wnt signaling pathway,284,12,6.31,0.02569,1,0.141766376146789,1.9,BP
GO:0014743,regulation of muscle hypertrophy,75,5,1.67,0.02572,1,0.1417693470790378,2.99,BP
GO:0010506,regulation of autophagy,252,11,5.6,0.02594,1,0.14217023890784983,1.96,BP
GO:0031116,positive regulation of microtubule polym...,29,3,0.64,0.02597,1,0.14217023890784983,4.69,BP
GO:0034629,cellular protein-containing complex loca...,29,3,0.64,0.02597,1,0.14217023890784983,4.69,BP
GO:0051984,positive regulation of chromosome segreg...,29,3,0.64,0.02597,1,0.14217023890784983,4.69,BP
GO:0071353,cellular response to interleukin-4,29,3,0.64,0.02597,1,0.14217023890784983,4.69,BP
GO:0071480,cellular response to gamma radiation,29,3,0.64,0.02597,1,0.14217023890784983,4.69,BP
GO:0106027,neuron projection organization,102,6,2.27,0.02632,1,0.14392254545454544,2.64,BP
GO:1904591,positive regulation of protein import,51,4,1.13,0.02648,1,0.14463309875141886,3.54,BP
GO:0050808,synapse organization,455,17,10.11,0.02661,1,0.14517836734693879,1.68,BP
GO:0071383,cellular response to steroid hormone sti...,160,8,3.56,0.02687,1,0.14643084937712345,2.25,BP
GO:0006364,rRNA processing,191,9,4.24,0.02739,1,0.14909579185520364,2.12,BP
GO:0009755,hormone-mediated signaling pathway,161,8,3.58,0.02775,1,0.15088474576271188,2.23,BP
GO:0060541,respiratory system development,255,11,5.67,0.02795,1,0.15180067720090293,1.94,BP
GO:0001954,positive regulation of cell-matrix adhes...,52,4,1.16,0.02819,1,0.1529315445321308,3.45,BP
GO:0009303,rRNA transcription,30,3,0.67,0.02840,1,0.15314338185890256,4.48,BP
GO:0034260,negative regulation of GTPase activity,30,3,0.67,0.02840,1,0.15314338185890256,4.48,BP
GO:0051569,regulation of histone H3-K4 methylation,30,3,0.67,0.02840,1,0.15314338185890256,4.48,BP
GO:1902003,regulation of amyloid-beta formation,30,3,0.67,0.02840,1,0.15314338185890256,4.48,BP
GO:0000380,"alternative mRNA splicing, via spliceoso...",77,5,1.71,0.02842,1,0.15314338185890256,2.92,BP
GO:1901224,positive regulation of NIK/NF-kappaB sig...,77,5,1.71,0.02842,1,0.15314338185890256,2.92,BP
GO:0048704,embryonic skeletal system morphogenesis,104,6,2.31,0.02860,1,0.15394093959731542,2.6,BP
GO:0030177,positive regulation of Wnt signaling pat...,133,7,2.96,0.02924,1,0.1572099217877095,2.36,BP
GO:0009056,catabolic process,2279,64,50.65,0.02953,1,0.15859191964285715,1.26,BP
GO:0055017,cardiac muscle tissue growth,105,6,2.33,0.02979,1,0.15980989966555184,2.58,BP
GO:0000079,regulation of cyclin-dependent protein s...,78,5,1.73,0.02983,1,0.159846280623608,2.89,BP
GO:0014014,negative regulation of gliogenesis,53,4,1.18,0.02998,1,0.16011516093229747,3.39,BP
GO:0031113,regulation of microtubule polymerization,53,4,1.18,0.02998,1,0.16011516093229747,3.39,BP
GO:0071242,cellular response to ammonium ion,53,4,1.18,0.02998,1,0.16011516093229747,3.39,BP
GO:0090316,positive regulation of intracellular pro...,134,7,2.98,0.03029,1,0.16159144124168515,2.35,BP
GO:0010648,negative regulation of cell communicatio...,1326,40,29.47,0.03089,1,0.1632605251641138,1.36,BP
GO:0032232,negative regulation of actin filament bu...,31,3,0.69,0.03093,1,0.1632605251641138,4.35,BP
GO:0035767,endothelial cell chemotaxis,31,3,0.69,0.03093,1,0.1632605251641138,4.35,BP
GO:0043276,anoikis,31,3,0.69,0.03093,1,0.1632605251641138,4.35,BP
GO:0044818,mitotic G2/M transition checkpoint,31,3,0.69,0.03093,1,0.1632605251641138,4.35,BP
GO:0060795,cell fate commitment involved in formati...,31,3,0.69,0.03093,1,0.1632605251641138,4.35,BP
GO:0070670,response to interleukin-4,31,3,0.69,0.03093,1,0.1632605251641138,4.35,BP
GO:2000778,positive regulation of interleukin-6 sec...,31,3,0.69,0.03093,1,0.1632605251641138,4.35,BP
GO:0014897,striated muscle hypertrophy,106,6,2.36,0.03101,1,0.1632605251641138,2.54,BP
GO:0030518,intracellular steroid hormone receptor s...,106,6,2.36,0.03101,1,0.1632605251641138,2.54,BP
GO:0051225,spindle assembly,106,6,2.36,0.03101,1,0.1632605251641138,2.54,BP
GO:0120034,positive regulation of plasma membrane b...,106,6,2.36,0.03101,1,0.1632605251641138,2.54,BP
GO:0044092,negative regulation of molecular functio...,1018,32,22.62,0.03126,1,0.16439685245901642,1.41,BP
GO:0099173,postsynapse organization,196,9,4.36,0.03159,1,0.16595096069868998,2.06,BP
GO:0006914,autophagy,395,15,8.78,0.03171,1,0.16621843137254902,1.71,BP
GO:0061919,process utilizing autophagic mechanism,395,15,8.78,0.03171,1,0.16621843137254902,1.71,BP
GO:0051496,positive regulation of stress fiber asse...,54,4,1.2,0.03183,1,0.1666658977149075,3.33,BP
GO:0023057,negative regulation of signaling,1330,40,29.56,0.03216,1,0.16821078260869565,1.35,BP
GO:0035023,regulation of Rho protein signal transdu...,136,7,3.02,0.03246,1,0.1695955700325733,2.32,BP
GO:0014896,muscle hypertrophy,108,6,2.4,0.03354,1,0.1739882454251884,2.5,BP
GO:0072331,signal transduction by p53 class mediato...,137,7,3.04,0.03358,1,0.1739882454251884,2.3,BP
GO:0000462,maturation of SSU-rRNA from tricistronic...,32,3,0.71,0.03359,1,0.1739882454251884,4.23,BP
GO:0008608,attachment of spindle microtubules to ki...,32,3,0.71,0.03359,1,0.1739882454251884,4.23,BP
GO:0031572,G2 DNA damage checkpoint,32,3,0.71,0.03359,1,0.1739882454251884,4.23,BP
GO:0032212,positive regulation of telomere maintena...,32,3,0.71,0.03359,1,0.1739882454251884,4.23,BP
GO:0032508,DNA duplex unwinding,32,3,0.71,0.03359,1,0.1739882454251884,4.23,BP
GO:0051150,regulation of smooth muscle cell differe...,32,3,0.71,0.03359,1,0.1739882454251884,4.23,BP
GO:0014009,glial cell proliferation,55,4,1.22,0.03374,1,0.17438977443609024,3.28,BP
GO:0048662,negative regulation of smooth muscle cel...,55,4,1.22,0.03374,1,0.17438977443609024,3.28,BP
GO:0051650,establishment of vesicle localization,263,11,5.84,0.03388,1,0.17492549356223178,1.88,BP
GO:0016236,macroautophagy,199,9,4.42,0.03432,1,0.17668017112299464,2.04,BP
GO:0030307,positive regulation of cell growth,199,9,4.42,0.03432,1,0.17668017112299464,2.04,BP
GO:0032479,regulation of type I interferon producti...,81,5,1.8,0.03433,1,0.17668017112299464,2.78,BP
GO:0006323,DNA packaging,168,8,3.73,0.03447,1,0.17721115384615385,2.14,BP
GO:0034968,histone lysine methylation,109,6,2.42,0.03486,1,0.1790248879402348,2.48,BP
GO:0001701,in utero embryonic development,542,19,12.05,0.03490,1,0.1790392324093817,1.58,BP
GO:0043087,regulation of GTPase activity,298,12,6.62,0.03527,1,0.18074466453674123,1.81,BP
GO:0019827,stem cell population maintenance,169,8,3.76,0.03551,1,0.18178097872340424,2.13,BP
GO:0007267,cell-cell signaling,1617,47,35.94,0.03559,1,0.18199689691817214,1.31,BP
GO:0007062,sister chromatid cohesion,56,4,1.24,0.03572,1,0.18227427359490986,3.23,BP
GO:0031641,regulation of myelination,56,4,1.24,0.03572,1,0.18227427359490986,3.23,BP
GO:0043086,negative regulation of catalytic activit...,690,23,15.33,0.03582,1,0.18259093220338984,1.5,BP
GO:1903312,negative regulation of mRNA metabolic pr...,82,5,1.82,0.03592,1,0.18271357293868923,2.75,BP
GO:1904029,regulation of cyclin-dependent protein k...,82,5,1.82,0.03592,1,0.18271357293868923,2.75,BP
GO:0071214,cellular response to abiotic stimulus,299,12,6.64,0.03604,1,0.1827755485893417,1.81,BP
GO:0104004,cellular response to environmental stimu...,299,12,6.64,0.03604,1,0.1827755485893417,1.81,BP
GO:0051090,regulation of DNA-binding transcription ...,402,15,8.93,0.03613,1,0.1827755485893417,1.68,BP
GO:0030316,osteoclast differentiation,110,6,2.44,0.03621,1,0.1827755485893417,2.46,BP
GO:0045446,endothelial cell differentiation,110,6,2.44,0.03621,1,0.1827755485893417,2.46,BP
GO:0001706,endoderm formation,33,3,0.73,0.03635,1,0.1827755485893417,4.11,BP
GO:0031112,positive regulation of microtubule polym...,33,3,0.73,0.03635,1,0.1827755485893417,4.11,BP
GO:0032467,positive regulation of cytokinesis,33,3,0.73,0.03635,1,0.1827755485893417,4.11,BP
GO:0048841,regulation of axon extension involved in...,33,3,0.73,0.03635,1,0.1827755485893417,4.11,BP
GO:0071709,membrane assembly,33,3,0.73,0.03635,1,0.1827755485893417,4.11,BP
GO:1901890,positive regulation of cell junction ass...,33,3,0.73,0.03635,1,0.1827755485893417,4.11,BP
GO:2001234,negative regulation of apoptotic signali...,234,10,5.2,0.03702,1,0.18595014613778704,1.92,BP
GO:1901992,positive regulation of mitotic cell cycl...,83,5,1.84,0.03756,1,0.18846581856100106,2.72,BP
GO:0010463,mesenchymal cell proliferation,57,4,1.27,0.03777,1,0.1889285239085239,3.15,BP
GO:0050879,multicellular organismal movement,57,4,1.27,0.03777,1,0.1889285239085239,3.15,BP
GO:0050881,musculoskeletal movement,57,4,1.27,0.03777,1,0.1889285239085239,3.15,BP
GO:0006259,DNA metabolic process,920,29,20.45,0.03788,1,0.18928199376947039,1.42,BP
GO:0090087,regulation of peptide transport,769,25,17.09,0.03802,1,0.18978448132780082,1.46,BP
GO:0021782,glial cell development,112,6,2.49,0.03900,1,0.1942622222222222,2.41,BP
GO:0001649,osteoblast differentiation,204,9,4.53,0.03921,1,0.1942622222222222,1.99,BP
GO:0034620,cellular response to unfolded protein,84,5,1.87,0.03924,1,0.1942622222222222,2.67,BP
GO:0032786,positive regulation of DNA-templated tra...,34,3,0.76,0.03924,1,0.1942622222222222,3.95,BP
GO:1904467,regulation of tumor necrosis factor secr...,34,3,0.76,0.03924,1,0.1942622222222222,3.95,BP
GO:1905898,positive regulation of response to endop...,34,3,0.76,0.03924,1,0.1942622222222222,3.95,BP
GO:2000406,positive regulation of T cell migration,34,3,0.76,0.03924,1,0.1942622222222222,3.95,BP
GO:2000785,regulation of autophagosome assembly,34,3,0.76,0.03924,1,0.1942622222222222,3.95,BP
GO:0033002,muscle cell proliferation,237,10,5.27,0.03982,1,0.19667077868852462,1.9,BP
GO:0008333,endosome to lysosome transport,58,4,1.29,0.03988,1,0.19667077868852462,3.1,BP
GO:0051310,metaphase plate congression,58,4,1.29,0.03988,1,0.19667077868852462,3.1,BP
GO:0098727,maintenance of cell number,173,8,3.84,0.03989,1,0.19667077868852462,2.08,BP
GO:0007417,central nervous system development,887,28,19.71,0.04023,1,0.1980398773006135,1.42,BP
GO:0008154,actin polymerization or depolymerization,205,9,4.56,0.04025,1,0.1980398773006135,1.97,BP
GO:1901575,organic substance catabolic process,1874,53,41.65,0.04090,1,0.20103248212461694,1.27,BP
GO:0032606,type I interferon production,85,5,1.89,0.04096,1,0.20112195918367348,2.65,BP
GO:0043123,positive regulation of I-kappaB kinase/N...,114,6,2.53,0.04194,1,0.20547094034378155,2.37,BP
GO:0060419,heart growth,114,6,2.53,0.04194,1,0.20547094034378155,2.37,BP
GO:0007029,endoplasmic reticulum organization,59,4,1.31,0.04206,1,0.20547094034378155,3.05,BP
GO:0046330,positive regulation of JNK cascade,144,7,3.2,0.04215,1,0.20547094034378155,2.19,BP
GO:0010737,protein kinase A signaling,35,3,0.78,0.04223,1,0.20547094034378155,3.85,BP
GO:0016572,histone phosphorylation,35,3,0.78,0.04223,1,0.20547094034378155,3.85,BP
GO:0032228,"regulation of synaptic transmission, GAB...",35,3,0.78,0.04223,1,0.20547094034378155,3.85,BP
GO:0045686,negative regulation of glial cell differ...,35,3,0.78,0.04223,1,0.20547094034378155,3.85,BP
GO:1902116,negative regulation of organelle assembl...,35,3,0.78,0.04223,1,0.20547094034378155,3.85,BP
GO:0051222,positive regulation of protein transport,448,16,9.96,0.04354,1,0.2116307878787879,1.61,BP
GO:0031124,mRNA 3'-end processing,60,4,1.33,0.04431,1,0.21472277945619336,3.01,BP
GO:0090183,regulation of kidney development,60,4,1.33,0.04431,1,0.21472277945619336,3.01,BP
GO:0090307,mitotic spindle assembly,60,4,1.33,0.04431,1,0.21472277945619336,3.01,BP
GO:0006403,RNA localization,177,8,3.93,0.04462,1,0.2157546587537092,2.04,BP
GO:0001935,endothelial cell proliferation,146,7,3.24,0.04484,1,0.2157546587537092,2.16,BP
GO:0051261,protein depolymerization,116,6,2.58,0.04500,1,0.2157546587537092,2.33,BP
GO:0034504,protein localization to nucleus,276,11,6.13,0.04533,1,0.2157546587537092,1.79,BP
GO:0000184,nuclear-transcribed mRNA catabolic proce...,36,3,0.8,0.04533,1,0.2157546587537092,3.75,BP
GO:0006383,transcription by RNA polymerase III,36,3,0.8,0.04533,1,0.2157546587537092,3.75,BP
GO:0007094,mitotic spindle assembly checkpoint,36,3,0.8,0.04533,1,0.2157546587537092,3.75,BP
GO:0021846,cell proliferation in forebrain,36,3,0.8,0.04533,1,0.2157546587537092,3.75,BP
GO:0034205,amyloid-beta formation,36,3,0.8,0.04533,1,0.2157546587537092,3.75,BP
GO:0035886,vascular smooth muscle cell differentiat...,36,3,0.8,0.04533,1,0.2157546587537092,3.75,BP
GO:0043114,regulation of vascular permeability,36,3,0.8,0.04533,1,0.2157546587537092,3.75,BP
GO:0051973,positive regulation of telomerase activi...,36,3,0.8,0.04533,1,0.2157546587537092,3.75,BP
GO:0060441,epithelial tube branching involved in lu...,36,3,0.8,0.04533,1,0.2157546587537092,3.75,BP
GO:0071173,spindle assembly checkpoint,36,3,0.8,0.04533,1,0.2157546587537092,3.75,BP
GO:0072583,clathrin-dependent endocytosis,36,3,0.8,0.04533,1,0.2157546587537092,3.75,BP
GO:1903427,negative regulation of reactive oxygen s...,36,3,0.8,0.04533,1,0.2157546587537092,3.75,BP
GO:1904358,positive regulation of telomere maintena...,36,3,0.8,0.04533,1,0.2157546587537092,3.75,BP
GO:1990774,tumor necrosis factor secretion,36,3,0.8,0.04533,1,0.2157546587537092,3.75,BP
GO:0048813,dendrite morphogenesis,178,8,3.96,0.04586,1,0.21806158102766796,2.02,BP
GO:0045667,regulation of osteoblast differentiation,147,7,3.27,0.04623,1,0.21960390918065154,2.14,BP
GO:0035418,protein localization to synapse,88,5,1.96,0.04640,1,0.22019408284023667,2.55,BP
GO:0032414,positive regulation of ion transmembrane...,117,6,2.6,0.04659,1,0.22080259842519684,2.31,BP
GO:0071156,regulation of cell cycle arrest,61,4,1.36,0.04662,1,0.22080259842519684,2.94,BP
GO:0045785,positive regulation of cell adhesion,417,15,9.27,0.04708,1,0.222762005899705,1.62,BP
GO:0002040,sprouting angiogenesis,118,6,2.62,0.04821,1,0.22788459724950882,2.29,BP
GO:0001702,gastrulation with mouth forming second,37,3,0.82,0.04855,1,0.2281470703125,3.66,BP
GO:0033146,regulation of intracellular estrogen rec...,37,3,0.82,0.04855,1,0.2281470703125,3.66,BP
GO:0035850,epithelial cell differentiation involved...,37,3,0.82,0.04855,1,0.2281470703125,3.66,BP
GO:0048846,axon extension involved in axon guidance,37,3,0.82,0.04855,1,0.2281470703125,3.66,BP
GO:0061756,leukocyte adhesion to vascular endotheli...,37,3,0.82,0.04855,1,0.2281470703125,3.66,BP
GO:1902284,neuron projection extension involved in ...,37,3,0.82,0.04855,1,0.2281470703125,3.66,BP
GO:0014911,positive regulation of smooth muscle cel...,62,4,1.38,0.04899,1,0.22909609329446062,2.9,BP
GO:0048286,lung alveolus development,62,4,1.38,0.04899,1,0.22909609329446062,2.9,BP
GO:0048488,synaptic vesicle endocytosis,62,4,1.38,0.04899,1,0.22909609329446062,2.9,BP
GO:0060038,cardiac muscle cell proliferation,62,4,1.38,0.04899,1,0.22909609329446062,2.9,BP
GO:0140238,presynaptic endocytosis,62,4,1.38,0.04899,1,0.22909609329446062,2.9,BP
GO:0030900,forebrain development,385,14,8.56,0.05001,1,0.2336389514563107,1.64,BP
GO:1903008,organelle disassembly,90,5,2,0.05025,1,0.23453249272550922,2.5,BP
GO:0006839,mitochondrial transport,182,8,4.04,0.05103,1,0.23771186834462726,1.98,BP
GO:0061136,regulation of proteasomal protein catabo...,182,8,4.04,0.05103,1,0.23771186834462726,1.98,BP
GO:0051648,vesicle localization,282,11,6.27,0.05141,1,0.2388501818181818,1.75,BP
GO:0030858,positive regulation of epithelial cell d...,63,4,1.4,0.05143,1,0.2388501818181818,2.86,BP
GO:0043388,positive regulation of DNA binding,63,4,1.4,0.05143,1,0.2388501818181818,2.86,BP
GO:0050920,regulation of chemotaxis,215,9,4.78,0.05160,1,0.2388501818181818,1.88,BP
GO:0006284,base-excision repair,38,3,0.84,0.05187,1,0.2388501818181818,3.57,BP
GO:0006636,unsaturated fatty acid biosynthetic proc...,38,3,0.84,0.05187,1,0.2388501818181818,3.57,BP
GO:0010762,regulation of fibroblast migration,38,3,0.84,0.05187,1,0.2388501818181818,3.57,BP
GO:0032392,DNA geometric change,38,3,0.84,0.05187,1,0.2388501818181818,3.57,BP
GO:0032506,cytokinetic process,38,3,0.84,0.05187,1,0.2388501818181818,3.57,BP
GO:0071174,mitotic spindle checkpoint,38,3,0.84,0.05187,1,0.2388501818181818,3.57,BP
GO:0071320,cellular response to cAMP,38,3,0.84,0.05187,1,0.2388501818181818,3.57,BP
GO:2000403,positive regulation of lymphocyte migrat...,38,3,0.84,0.05187,1,0.2388501818181818,3.57,BP
GO:0060627,regulation of vesicle-mediated transport,570,19,12.67,0.05292,1,0.24345223709369027,1.5,BP
GO:0001654,eye development,389,14,8.64,0.05360,1,0.24634498567335242,1.62,BP
GO:0010959,regulation of metal ion transport,425,15,9.44,0.05379,1,0.2467293536121673,1.59,BP
GO:0032233,positive regulation of actin filament bu...,64,4,1.42,0.05394,1,0.2467293536121673,2.82,BP
GO:0046579,positive regulation of Ras protein signa...,64,4,1.42,0.05394,1,0.2467293536121673,2.82,BP
GO:0060999,positive regulation of dendritic spine d...,64,4,1.42,0.05394,1,0.2467293536121673,2.82,BP
GO:0061951,establishment of protein localization to...,64,4,1.42,0.05394,1,0.2467293536121673,2.82,BP
GO:0035265,organ growth,217,9,4.82,0.05410,1,0.24722621082621085,1.87,BP
GO:0003013,circulatory system process,498,17,11.07,0.05417,1,0.24731123339658445,1.54,BP
GO:0070252,actin-mediated cell contraction,92,5,2.04,0.05429,1,0.24762415165876775,2.45,BP
GO:0043414,macromolecule methylation,285,11,6.33,0.05464,1,0.24898454545454546,1.74,BP
GO:0016233,telomere capping,39,3,0.87,0.05530,1,0.2505683615819209,3.45,BP
GO:0044088,regulation of vacuole organization,39,3,0.87,0.05530,1,0.2505683615819209,3.45,BP
GO:0060236,regulation of mitotic spindle organizati...,39,3,0.87,0.05530,1,0.2505683615819209,3.45,BP
GO:1900087,positive regulation of G1/S transition o...,39,3,0.87,0.05530,1,0.2505683615819209,3.45,BP
GO:1902229,regulation of intrinsic apoptotic signal...,39,3,0.87,0.05530,1,0.2505683615819209,3.45,BP
GO:2001024,negative regulation of response to drug,39,3,0.87,0.05530,1,0.2505683615819209,3.45,BP
GO:0051304,chromosome separation,93,5,2.07,0.05638,1,0.25483775280898874,2.42,BP
GO:0150063,visual system development,392,14,8.71,0.05640,1,0.25483775280898874,1.61,BP
GO:0006278,RNA-dependent DNA biosynthetic process,65,4,1.44,0.05651,1,0.25483775280898874,2.78,BP
GO:0007004,telomere maintenance via telomerase,65,4,1.44,0.05651,1,0.25483775280898874,2.78,BP
GO:0071479,cellular response to ionizing radiation,65,4,1.44,0.05651,1,0.25483775280898874,2.78,BP
GO:2001235,positive regulation of apoptotic signali...,186,8,4.13,0.05656,1,0.25483775280898874,1.94,BP
GO:0015931,nucleobase-containing compound transport,187,8,4.16,0.05800,1,0.26092732710280375,1.92,BP
GO:0072593,reactive oxygen species metabolic proces...,288,11,6.4,0.05802,1,0.26092732710280375,1.72,BP
GO:0071478,cellular response to radiation,155,7,3.44,0.05829,1,0.26189680672268906,2.03,BP
GO:0031503,protein-containing complex localization,254,10,5.64,0.05837,1,0.2620116044776119,1.77,BP
GO:0008203,cholesterol metabolic process,124,6,2.76,0.05864,1,0.26212033333333334,2.17,BP
GO:0032411,positive regulation of transporter activ...,124,6,2.76,0.05864,1,0.26212033333333334,2.17,BP
GO:0032434,regulation of proteasomal ubiquitin-depe...,124,6,2.76,0.05864,1,0.26212033333333334,2.17,BP
GO:0043500,muscle adaptation,124,6,2.76,0.05864,1,0.26212033333333334,2.17,BP
GO:0031577,spindle checkpoint,40,3,0.89,0.05883,1,0.26212033333333334,3.37,BP
GO:0044091,membrane biogenesis,40,3,0.89,0.05883,1,0.26212033333333334,3.37,BP
GO:0046627,negative regulation of insulin receptor ...,40,3,0.89,0.05883,1,0.26212033333333334,3.37,BP
GO:0046825,regulation of protein export from nucleu...,40,3,0.89,0.05883,1,0.26212033333333334,3.37,BP
GO:1904951,positive regulation of establishment of ...,467,16,10.38,0.05890,1,0.2621894542090657,1.54,BP
GO:0030968,endoplasmic reticulum unfolded protein r...,66,4,1.47,0.05915,1,0.2623316129032258,2.72,BP
GO:0034605,cellular response to heat,66,4,1.47,0.05915,1,0.2623316129032258,2.72,BP
GO:0042306,regulation of protein import into nucleu...,66,4,1.47,0.05915,1,0.2623316129032258,2.72,BP
GO:0051591,response to cAMP,66,4,1.47,0.05915,1,0.2623316129032258,2.72,BP
GO:0048880,sensory system development,395,14,8.78,0.05930,1,0.26275469613259667,1.59,BP
GO:0030178,negative regulation of Wnt signaling pat...,156,7,3.47,0.05992,1,0.26505805147058825,2.02,BP
GO:0030162,regulation of proteolysis,730,23,16.22,0.05993,1,0.26505805147058825,1.42,BP
GO:0001570,vasculogenesis,95,5,2.11,0.06069,1,0.2674802197802198,2.37,BP
GO:0001704,formation of primary germ layer,95,5,2.11,0.06069,1,0.2674802197802198,2.37,BP
GO:0072676,lymphocyte migration,95,5,2.11,0.06069,1,0.2674802197802198,2.37,BP
GO:0042326,negative regulation of phosphorylation,469,16,10.42,0.06070,1,0.2674802197802198,1.54,BP
GO:0021953,central nervous system neuron differenti...,223,9,4.96,0.06206,1,0.27278188747731397,1.81,BP
GO:0000723,telomere maintenance,126,6,2.8,0.06240,1,0.27278188747731397,2.14,BP
GO:0006509,membrane protein ectodomain proteolysis,41,3,0.91,0.06247,1,0.27278188747731397,3.3,BP
GO:0021955,central nervous system neuron axonogenes...,41,3,0.91,0.06247,1,0.27278188747731397,3.3,BP
GO:0031062,positive regulation of histone methylati...,41,3,0.91,0.06247,1,0.27278188747731397,3.3,BP
GO:0033628,regulation of cell adhesion mediated by ...,41,3,0.91,0.06247,1,0.27278188747731397,3.3,BP
GO:0043001,Golgi to plasma membrane protein transpo...,41,3,0.91,0.06247,1,0.27278188747731397,3.3,BP
GO:0051154,negative regulation of striated muscle c...,41,3,0.91,0.06247,1,0.27278188747731397,3.3,BP
GO:1903053,regulation of extracellular matrix organ...,41,3,0.91,0.06247,1,0.27278188747731397,3.3,BP
GO:2000008,regulation of protein localization to ce...,41,3,0.91,0.06247,1,0.27278188747731397,3.3,BP
GO:0030100,regulation of endocytosis,292,11,6.49,0.06272,1,0.27362524025385315,1.69,BP
GO:0046683,response to organophosphorus,96,5,2.13,0.06292,1,0.2742491304347826,2.35,BP
GO:0033993,response to lipid,811,25,18.02,0.06302,1,0.27443641628959276,1.39,BP
GO:0009416,response to light stimulus,293,11,6.51,0.06394,1,0.27819103074141044,1.69,BP
GO:0006893,Golgi to plasma membrane transport,68,4,1.51,0.06462,1,0.2801364324324324,2.65,BP
GO:0008542,visual learning,68,4,1.51,0.06462,1,0.2801364324324324,2.65,BP
GO:0032387,negative regulation of intracellular tra...,68,4,1.51,0.06462,1,0.2801364324324324,2.65,BP
GO:1905515,non-motile cilium assembly,68,4,1.51,0.06462,1,0.2801364324324324,2.65,BP
GO:0036503,ERAD pathway,97,5,2.16,0.06518,1,0.28205589928057556,2.31,BP
GO:0072080,nephron tubule development,97,5,2.16,0.06518,1,0.28205589928057556,2.31,BP
GO:0060537,muscle tissue development,474,16,10.53,0.06539,1,0.2827104043126685,1.52,BP
GO:0032200,telomere organization,128,6,2.84,0.06629,1,0.28634423698384204,2.11,BP
GO:0006913,nucleocytoplasmic transport,295,11,6.56,0.06641,1,0.28634849462365586,1.68,BP
GO:0051169,nuclear transport,295,11,6.56,0.06641,1,0.28634849462365586,1.68,BP
GO:0016239,positive regulation of macroautophagy,69,4,1.53,0.06745,1,0.2900089285714286,2.61,BP
GO:0048168,regulation of neuronal synaptic plastici...,69,4,1.53,0.06745,1,0.2900089285714286,2.61,BP
GO:0006334,nucleosome assembly,98,5,2.18,0.06750,1,0.2900089285714286,2.29,BP
GO:0043502,regulation of muscle adaptation,98,5,2.18,0.06750,1,0.2900089285714286,2.29,BP
GO:1902652,secondary alcohol metabolic process,129,6,2.87,0.06829,1,0.29314137377341665,2.09,BP
GO:0032755,positive regulation of interleukin-6 pro...,99,5,2.2,0.06986,1,0.29883031914893615,2.27,BP
GO:2001243,negative regulation of intrinsic apoptot...,99,5,2.2,0.06986,1,0.29883031914893615,2.27,BP
GO:0008631,intrinsic apoptotic signaling pathway in...,43,3,0.96,0.07005,1,0.29883031914893615,3.12,BP
GO:0030490,maturation of SSU-rRNA,43,3,0.96,0.07005,1,0.29883031914893615,3.12,BP
GO:0031057,negative regulation of histone modificat...,43,3,0.96,0.07005,1,0.29883031914893615,3.12,BP
GO:0031128,developmental induction,43,3,0.96,0.07005,1,0.29883031914893615,3.12,BP
GO:0051293,establishment of spindle localization,43,3,0.96,0.07005,1,0.29883031914893615,3.12,BP
GO:0051101,regulation of DNA binding,130,6,2.89,0.07033,1,0.29975904340124004,2.08,BP
GO:0046578,regulation of Ras protein signal transdu...,229,9,5.09,0.07074,1,0.3012397168141593,1.77,BP
GO:0006508,proteolysis,1661,46,36.91,0.07157,1,0.3032571278458845,1.25,BP
GO:0002755,MyD88-dependent toll-like receptor signa...,20,2,0.44,0.07197,1,0.3032571278458845,4.55,BP
GO:0010842,retina layer formation,20,2,0.44,0.07197,1,0.3032571278458845,4.55,BP
GO:0036344,platelet morphogenesis,20,2,0.44,0.07197,1,0.3032571278458845,4.55,BP
GO:0044783,G1 DNA damage checkpoint,20,2,0.44,0.07197,1,0.3032571278458845,4.55,BP
GO:0044819,mitotic G1/S transition checkpoint,20,2,0.44,0.07197,1,0.3032571278458845,4.55,BP
GO:0051383,kinetochore organization,20,2,0.44,0.07197,1,0.3032571278458845,4.55,BP
GO:0060123,regulation of growth hormone secretion,20,2,0.44,0.07197,1,0.3032571278458845,4.55,BP
GO:0061162,establishment of monopolar cell polarity,20,2,0.44,0.07197,1,0.3032571278458845,4.55,BP
GO:0072243,metanephric nephron epithelium developme...,20,2,0.44,0.07197,1,0.3032571278458845,4.55,BP
GO:1902993,positive regulation of amyloid precursor...,20,2,0.44,0.07197,1,0.3032571278458845,4.55,BP
GO:1904385,cellular response to angiotensin,20,2,0.44,0.07197,1,0.3032571278458845,4.55,BP
GO:0007006,mitochondrial membrane organization,100,5,2.22,0.07226,1,0.3042127034120735,2.25,BP
GO:0007420,brain development,632,20,14.05,0.07298,1,0.30697531468531475,1.42,BP
GO:0007492,endoderm development,71,4,1.58,0.07330,1,0.3072470383275262,2.53,BP
GO:0007632,visual behavior,71,4,1.58,0.07330,1,0.3072470383275262,2.53,BP
GO:0045669,positive regulation of osteoblast differ...,71,4,1.58,0.07330,1,0.3072470383275262,2.53,BP
GO:1904589,regulation of protein import,71,4,1.58,0.07330,1,0.3072470383275262,2.53,BP
GO:0010824,regulation of centrosome duplication,44,3,0.98,0.07399,1,0.30906239583333334,3.06,BP
GO:0070849,response to epidermal growth factor,44,3,0.98,0.07399,1,0.30906239583333334,3.06,BP
GO:0098781,ncRNA transcription,44,3,0.98,0.07399,1,0.30906239583333334,3.06,BP
GO:1900077,negative regulation of cellular response...,44,3,0.98,0.07399,1,0.30906239583333334,3.06,BP
GO:0001936,regulation of endothelial cell prolifera...,132,6,2.93,0.07450,1,0.3109228100607112,2.05,BP
GO:0110110,positive regulation of animal organ morp...,101,5,2.24,0.07471,1,0.31152904679376087,2.23,BP
GO:1903532,positive regulation of secretion by cell,484,16,10.76,0.07549,1,0.314508987012987,1.49,BP
GO:0060041,retina development in camera-type eye,165,7,3.67,0.07587,1,0.3158187197231834,1.91,BP
GO:0010611,regulation of cardiac muscle hypertrophy,72,4,1.6,0.07631,1,0.31737573033707867,2.5,BP
GO:0016125,sterol metabolic process,133,6,2.96,0.07664,1,0.3184729533678756,2.03,BP
GO:0003300,cardiac muscle hypertrophy,102,5,2.27,0.07721,1,0.3197533220338983,2.2,BP
GO:0008306,associative learning,102,5,2.27,0.07721,1,0.3197533220338983,2.2,BP
GO:0031123,RNA 3'-end processing,102,5,2.27,0.07721,1,0.3197533220338983,2.2,BP
GO:0032259,methylation,339,12,7.53,0.07727,1,0.3197533220338983,1.59,BP
GO:0050807,regulation of synapse organization,268,10,5.96,0.07732,1,0.3197533220338983,1.68,BP
GO:0007033,vacuole organization,166,7,3.69,0.07778,1,0.3197533220338983,1.9,BP
GO:0032680,regulation of tumor necrosis factor prod...,166,7,3.69,0.07778,1,0.3197533220338983,1.9,BP
GO:0006695,cholesterol biosynthetic process,45,3,1,0.07803,1,0.3197533220338983,3,BP
GO:0000413,protein peptidyl-prolyl isomerization,21,2,0.47,0.07841,1,0.3197533220338983,4.26,BP
GO:0031065,positive regulation of histone deacetyla...,21,2,0.47,0.07841,1,0.3197533220338983,4.26,BP
GO:0042535,positive regulation of tumor necrosis fa...,21,2,0.47,0.07841,1,0.3197533220338983,4.26,BP
GO:0046716,muscle cell cellular homeostasis,21,2,0.47,0.07841,1,0.3197533220338983,4.26,BP
GO:0048143,astrocyte activation,21,2,0.47,0.07841,1,0.3197533220338983,4.26,BP
GO:0060457,negative regulation of digestive system ...,21,2,0.47,0.07841,1,0.3197533220338983,4.26,BP
GO:0061339,establishment or maintenance of monopola...,21,2,0.47,0.07841,1,0.3197533220338983,4.26,BP
GO:0072170,metanephric tubule development,21,2,0.47,0.07841,1,0.3197533220338983,4.26,BP
GO:0090050,positive regulation of cell migration in...,21,2,0.47,0.07841,1,0.3197533220338983,4.26,BP
GO:0098780,response to mitochondrial depolarisation,21,2,0.47,0.07841,1,0.3197533220338983,4.26,BP
GO:1901623,regulation of lymphocyte chemotaxis,21,2,0.47,0.07841,1,0.3197533220338983,4.26,BP
GO:1904666,regulation of ubiquitin protein ligase a...,21,2,0.47,0.07841,1,0.3197533220338983,4.26,BP
GO:1990776,response to angiotensin,21,2,0.47,0.07841,1,0.3197533220338983,4.26,BP
GO:2000209,regulation of anoikis,21,2,0.47,0.07841,1,0.3197533220338983,4.26,BP
GO:0045778,positive regulation of ossification,103,5,2.29,0.07975,1,0.3246675126903553,2.18,BP
GO:0061326,renal tubule development,103,5,2.29,0.07975,1,0.3246675126903553,2.18,BP
GO:0001837,epithelial to mesenchymal transition,135,6,3,0.08102,1,0.32955895181741335,2,BP
GO:0002793,positive regulation of peptide secretion,342,12,7.6,0.08123,1,0.3301340878378379,1.58,BP
GO:1903555,regulation of tumor necrosis factor supe...,168,7,3.73,0.08169,1,0.3317234430379747,1.88,BP
GO:0032873,negative regulation of stress-activated ...,46,3,1.02,0.08216,1,0.33223018487394956,2.94,BP
GO:0043124,negative regulation of I-kappaB kinase/N...,46,3,1.02,0.08216,1,0.33223018487394956,2.94,BP
GO:0070303,negative regulation of stress-activated ...,46,3,1.02,0.08216,1,0.33223018487394956,2.94,BP
GO:1902653,secondary alcohol biosynthetic process,46,3,1.02,0.08216,1,0.33223018487394956,2.94,BP
GO:1902667,regulation of axon guidance,46,3,1.02,0.08216,1,0.33223018487394956,2.94,BP
GO:0050764,regulation of phagocytosis,104,5,2.31,0.08233,1,0.33260834170854275,2.16,BP
GO:2000377,regulation of reactive oxygen species me...,202,8,4.49,0.08240,1,0.33260834170854275,1.78,BP
GO:0036465,synaptic vesicle recycling,74,4,1.64,0.08253,1,0.33260834170854275,2.44,BP
GO:0050766,positive regulation of phagocytosis,74,4,1.64,0.08253,1,0.33260834170854275,2.44,BP
GO:0043624,cellular protein complex disassembly,136,6,3.02,0.08326,1,0.33526955648535567,1.99,BP
GO:0032640,tumor necrosis factor production,169,7,3.76,0.08368,1,0.3366790635451505,1.86,BP
GO:0035967,cellular response to topologically incor...,105,5,2.33,0.08496,1,0.3375546534653465,2.15,BP
GO:0000423,mitophagy,22,2,0.49,0.08502,1,0.3375546534653465,4.08,BP
GO:0022616,DNA strand elongation,22,2,0.49,0.08502,1,0.3375546534653465,4.08,BP
GO:0031643,positive regulation of myelination,22,2,0.49,0.08502,1,0.3375546534653465,4.08,BP
GO:0032331,negative regulation of chondrocyte diffe...,22,2,0.49,0.08502,1,0.3375546534653465,4.08,BP
GO:0050857,positive regulation of antigen receptor-...,22,2,0.49,0.08502,1,0.3375546534653465,4.08,BP
GO:0051043,regulation of membrane protein ectodomai...,22,2,0.49,0.08502,1,0.3375546534653465,4.08,BP
GO:0051654,establishment of mitochondrion localizat...,22,2,0.49,0.08502,1,0.3375546534653465,4.08,BP
GO:0060009,Sertoli cell development,22,2,0.49,0.08502,1,0.3375546534653465,4.08,BP
GO:0060602,branch elongation of an epithelium,22,2,0.49,0.08502,1,0.3375546534653465,4.08,BP
GO:0070734,histone H3-K27 methylation,22,2,0.49,0.08502,1,0.3375546534653465,4.08,BP
GO:0071870,cellular response to catecholamine stimu...,22,2,0.49,0.08502,1,0.3375546534653465,4.08,BP
GO:1901626,regulation of postsynaptic membrane orga...,22,2,0.49,0.08502,1,0.3375546534653465,4.08,BP
GO:1901673,regulation of mitotic spindle assembly,22,2,0.49,0.08502,1,0.3375546534653465,4.08,BP
GO:1902307,positive regulation of sodium ion transm...,22,2,0.49,0.08502,1,0.3375546534653465,4.08,BP
GO:2001026,regulation of endothelial cell chemotaxi...,22,2,0.49,0.08502,1,0.3375546534653465,4.08,BP
GO:0009791,post-embryonic development,137,6,3.04,0.08553,1,0.3389751520131471,1.97,BP
GO:0071396,cellular response to lipid,607,19,13.49,0.08565,1,0.3389751520131471,1.41,BP
GO:0010507,negative regulation of autophagy,75,4,1.67,0.08573,1,0.3389751520131471,2.4,BP
GO:0030433,ubiquitin-dependent ERAD pathway,75,4,1.67,0.08573,1,0.3389751520131471,2.4,BP
GO:0045670,regulation of osteoclast differentiation,75,4,1.67,0.08573,1,0.3389751520131471,2.4,BP
GO:0001941,postsynaptic membrane organization,47,3,1.04,0.08638,1,0.34098487284659557,2.88,BP
GO:0072604,interleukin-6 secretion,47,3,1.04,0.08638,1,0.34098487284659557,2.88,BP
GO:0060322,head development,686,21,15.25,0.08771,1,0.34595124590163934,1.38,BP
GO:0009411,response to UV,138,6,3.07,0.08784,1,0.34596824202780047,1.95,BP
GO:0001666,response to hypoxia,205,8,4.56,0.08791,1,0.34596824202780047,1.75,BP
GO:0051223,regulation of protein transport,725,22,16.11,0.08793,1,0.34596824202780047,1.37,BP
GO:0060485,mesenchyme development,275,10,6.11,0.08808,1,0.34627529411764707,1.64,BP
GO:0070372,regulation of ERK1 and ERK2 cascade,311,11,6.91,0.08843,1,0.34715422982885086,1.59,BP
GO:0030278,regulation of ossification,240,9,5.33,0.08852,1,0.34715422982885086,1.69,BP
GO:0090257,regulation of muscle system process,240,9,5.33,0.08852,1,0.34715422982885086,1.69,BP
GO:0001933,negative regulation of protein phosphory...,421,14,9.36,0.08869,1,0.34753768729641693,1.5,BP
GO:0071363,cellular response to growth factor stimu...,610,19,13.56,0.08878,1,0.3476072904800651,1.4,BP
GO:0018209,peptidyl-serine modification,348,12,7.73,0.08953,1,0.35024099518459073,1.55,BP
GO:0006909,phagocytosis,206,8,4.58,0.08979,1,0.35024099518459073,1.75,BP
GO:0032874,positive regulation of stress-activated ...,172,7,3.82,0.08984,1,0.35024099518459073,1.83,BP
GO:0071706,tumor necrosis factor superfamily cytoki...,172,7,3.82,0.08984,1,0.35024099518459073,1.83,BP
GO:0045927,positive regulation of growth,312,11,6.93,0.08994,1,0.35024099518459073,1.59,BP
GO:0048872,homeostasis of number of cells,312,11,6.93,0.08994,1,0.35024099518459073,1.59,BP
GO:0048706,embryonic skeletal system development,139,6,3.09,0.09019,1,0.35024099518459073,1.94,BP
GO:0000956,nuclear-transcribed mRNA catabolic proce...,107,5,2.38,0.09034,1,0.35024099518459073,2.1,BP
GO:0014812,muscle cell migration,107,5,2.38,0.09034,1,0.35024099518459073,2.1,BP
GO:0016241,regulation of macroautophagy,107,5,2.38,0.09034,1,0.35024099518459073,2.1,BP
GO:0043266,regulation of potassium ion transport,107,5,2.38,0.09034,1,0.35024099518459073,2.1,BP
GO:0042592,homeostatic process,1899,51,42.2,0.09040,1,0.35024099518459073,1.21,BP
GO:0010718,positive regulation of epithelial to mes...,48,3,1.07,0.09069,1,0.35024099518459073,2.8,BP
GO:0044786,cell cycle DNA replication,48,3,1.07,0.09069,1,0.35024099518459073,2.8,BP
GO:0051438,regulation of ubiquitin-protein transfer...,48,3,1.07,0.09069,1,0.35024099518459073,2.8,BP
GO:0051653,spindle localization,48,3,1.07,0.09069,1,0.35024099518459073,2.8,BP
GO:0061005,cell differentiation involved in kidney ...,48,3,1.07,0.09069,1,0.35024099518459073,2.8,BP
GO:0014912,negative regulation of smooth muscle cel...,23,2,0.51,0.09180,1,0.35038686756542425,3.92,BP
GO:0030252,growth hormone secretion,23,2,0.51,0.09180,1,0.35038686756542425,3.92,BP
GO:0032727,positive regulation of interferon-alpha ...,23,2,0.51,0.09180,1,0.35038686756542425,3.92,BP
GO:0036010,protein localization to endosome,23,2,0.51,0.09180,1,0.35038686756542425,3.92,BP
GO:0043501,skeletal muscle adaptation,23,2,0.51,0.09180,1,0.35038686756542425,3.92,BP
GO:0043687,post-translational protein modification,23,2,0.51,0.09180,1,0.35038686756542425,3.92,BP
GO:0048485,sympathetic nervous system development,23,2,0.51,0.09180,1,0.35038686756542425,3.92,BP
GO:0060972,left/right pattern formation,23,2,0.51,0.09180,1,0.35038686756542425,3.92,BP
GO:0071868,cellular response to monoamine stimulus,23,2,0.51,0.09180,1,0.35038686756542425,3.92,BP
GO:0071869,response to catecholamine,23,2,0.51,0.09180,1,0.35038686756542425,3.92,BP
GO:0101023,vascular endothelial cell proliferation,23,2,0.51,0.09180,1,0.35038686756542425,3.92,BP
GO:1902914,regulation of protein polyubiquitination,23,2,0.51,0.09180,1,0.35038686756542425,3.92,BP
GO:1903055,positive regulation of extracellular mat...,23,2,0.51,0.09180,1,0.35038686756542425,3.92,BP
GO:1905562,regulation of vascular endothelial cell ...,23,2,0.51,0.09180,1,0.35038686756542425,3.92,BP
GO:0048513,animal organ development,3502,89,77.83,0.09182,1,0.35038686756542425,1.14,BP
GO:0070304,positive regulation of stress-activated ...,173,7,3.84,0.09194,1,0.3505667828843106,1.82,BP
GO:0051303,establishment of chromosome localization,77,4,1.71,0.09231,1,0.3516989073634204,2.34,BP
GO:0051168,nuclear export,140,6,3.11,0.09256,1,0.35237240506329115,1.93,BP
GO:0010256,endomembrane system organization,387,13,8.6,0.09274,1,0.35277856126482215,1.51,BP
GO:0050803,regulation of synapse structure or activ...,278,10,6.18,0.09295,1,0.35329810426540287,1.62,BP
GO:0007052,mitotic spindle organization,108,5,2.4,0.09310,1,0.35331009463722396,2.08,BP
GO:0072009,nephron epithelium development,108,5,2.4,0.09310,1,0.35331009463722396,2.08,BP
GO:0006260,DNA replication,243,9,5.4,0.09379,1,0.3556481323877069,1.67,BP
GO:0050729,positive regulation of inflammatory resp...,141,6,3.13,0.09497,1,0.35916254317111457,1.92,BP
GO:0050921,positive regulation of chemotaxis,141,6,3.13,0.09497,1,0.35916254317111457,1.92,BP
GO:0007520,myoblast fusion,49,3,1.09,0.09509,1,0.35916254317111457,2.75,BP
GO:0030520,intracellular estrogen receptor signalin...,49,3,1.09,0.09509,1,0.35916254317111457,2.75,BP
GO:1903115,regulation of actin filament-based movem...,49,3,1.09,0.09509,1,0.35916254317111457,2.75,BP
GO:0043507,positive regulation of JUN kinase activi...,78,4,1.73,0.09569,1,0.3600158561376075,2.31,BP
GO:0046785,microtubule polymerization,78,4,1.73,0.09569,1,0.3600158561376075,2.31,BP
GO:0050000,chromosome localization,78,4,1.73,0.09569,1,0.3600158561376075,2.31,BP
GO:1900182,positive regulation of protein localizat...,78,4,1.73,0.09569,1,0.3600158561376075,2.31,BP
GO:1901862,negative regulation of muscle tissue dev...,78,4,1.73,0.09569,1,0.3600158561376075,2.31,BP
GO:0008344,adult locomotory behavior,109,5,2.42,0.09590,1,0.3602426229508197,2.07,BP
GO:0045185,maintenance of protein location,109,5,2.42,0.09590,1,0.3602426229508197,2.07,BP
GO:0045861,negative regulation of proteolysis,353,12,7.84,0.09684,1,0.36348992199687985,1.53,BP
GO:0072073,kidney epithelium development,142,6,3.16,0.09742,1,0.36538194855806705,1.9,BP
GO:0071559,response to transforming growth factor b...,210,8,4.67,0.09755,1,0.3655845794392523,1.71,BP
GO:0051146,striated muscle cell differentiation,317,11,7.04,0.09771,1,0.36589923735408564,1.56,BP
GO:0007064,mitotic sister chromatid cohesion,24,2,0.53,0.09872,1,0.3665437037037037,3.77,BP
GO:0010738,regulation of protein kinase A signaling,24,2,0.53,0.09872,1,0.3665437037037037,3.77,BP
GO:0031061,negative regulation of histone methylati...,24,2,0.53,0.09872,1,0.3665437037037037,3.77,BP
GO:0031954,positive regulation of protein autophosp...,24,2,0.53,0.09872,1,0.3665437037037037,3.77,BP
GO:0032770,positive regulation of monooxygenase act...,24,2,0.53,0.09872,1,0.3665437037037037,3.77,BP
GO:0048670,regulation of collateral sprouting,24,2,0.53,0.09872,1,0.3665437037037037,3.77,BP
GO:0062009,secondary palate development,24,2,0.53,0.09872,1,0.3665437037037037,3.77,BP
GO:0070584,mitochondrion morphogenesis,24,2,0.53,0.09872,1,0.3665437037037037,3.77,BP
GO:0071867,response to monoamine,24,2,0.53,0.09872,1,0.3665437037037037,3.77,BP
GO:0072207,metanephric epithelium development,24,2,0.53,0.09872,1,0.3665437037037037,3.77,BP
GO:1903204,negative regulation of oxidative stress-...,24,2,0.53,0.09872,1,0.3665437037037037,3.77,BP
GO:0010833,telomere maintenance via telomere length...,79,4,1.76,0.09913,1,0.36721598152424945,2.27,BP
GO:0060976,coronary vasculature development,79,4,1.76,0.09913,1,0.36721598152424945,2.27,BP
GO:0070373,negative regulation of ERK1 and ERK2 cas...,79,4,1.76,0.09913,1,0.36721598152424945,2.27,BP
GO:0021545,cranial nerve development,50,3,1.11,0.09957,1,0.36856218461538465,2.7,BP
GO:0002791,regulation of peptide secretion,544,17,12.09,0.10092,1,0.37327212913143737,1.41,BP
GO:0099003,vesicle-mediated transport in synapse,247,9,5.49,0.10109,1,0.3734377897160399,1.64,BP
GO:0007005,mitochondrion organization,468,15,10.4,0.10112,1,0.3734377897160399,1.44,BP
GO:0045732,positive regulation of protein catabolic...,212,8,4.71,0.10158,1,0.3748488957055215,1.7,BP
GO:0034655,nucleobase-containing compound catabolic...,431,14,9.58,0.10209,1,0.3764422068965517,1.46,BP
GO:0045682,regulation of epidermis development,80,4,1.78,0.10262,1,0.377528623853211,2.25,BP
GO:0050688,regulation of defense response to virus,80,4,1.78,0.10262,1,0.377528623853211,2.25,BP
GO:2001259,positive regulation of cation channel ac...,80,4,1.78,0.10262,1,0.377528623853211,2.25,BP
GO:0034612,response to tumor necrosis factor,178,7,3.96,0.10288,1,0.3781959969442322,1.77,BP
GO:0010332,response to gamma radiation,51,3,1.13,0.10414,1,0.38021371775417295,2.65,BP
GO:0016126,sterol biosynthetic process,51,3,1.13,0.10414,1,0.38021371775417295,2.65,BP
GO:0031146,SCF-dependent proteasomal ubiquitin-depe...,51,3,1.13,0.10414,1,0.38021371775417295,2.65,BP
GO:0032648,regulation of interferon-beta production,51,3,1.13,0.10414,1,0.38021371775417295,2.65,BP
GO:0033619,membrane protein proteolysis,51,3,1.13,0.10414,1,0.38021371775417295,2.65,BP
GO:0051353,positive regulation of oxidoreductase ac...,51,3,1.13,0.10414,1,0.38021371775417295,2.65,BP
GO:0051972,regulation of telomerase activity,51,3,1.13,0.10414,1,0.38021371775417295,2.65,BP
GO:1902373,negative regulation of mRNA catabolic pr...,51,3,1.13,0.10414,1,0.38021371775417295,2.65,BP
GO:2000649,regulation of sodium ion transmembrane t...,51,3,1.13,0.10414,1,0.38021371775417295,2.65,BP
GO:0032092,positive regulation of protein binding,112,5,2.49,0.10456,1,0.3814577103866566,2.01,BP
GO:0021537,telencephalon development,249,9,5.53,0.10486,1,0.3818915828957239,1.63,BP
GO:1901861,regulation of muscle tissue development,179,7,3.98,0.10515,1,0.3818915828957239,1.76,BP
GO:0010640,regulation of platelet-derived growth fa...,25,2,0.56,0.10579,1,0.3818915828957239,3.57,BP
GO:0021801,cerebral cortex radial glia guided migra...,25,2,0.56,0.10579,1,0.3818915828957239,3.57,BP
GO:0022030,telencephalon glial cell migration,25,2,0.56,0.10579,1,0.3818915828957239,3.57,BP
GO:0032469,endoplasmic reticulum calcium ion homeos...,25,2,0.56,0.10579,1,0.3818915828957239,3.57,BP
GO:0043567,regulation of insulin-like growth factor...,25,2,0.56,0.10579,1,0.3818915828957239,3.57,BP
GO:0051580,regulation of neurotransmitter uptake,25,2,0.56,0.10579,1,0.3818915828957239,3.57,BP
GO:0051894,positive regulation of focal adhesion as...,25,2,0.56,0.10579,1,0.3818915828957239,3.57,BP
GO:0071312,cellular response to alkaloid,25,2,0.56,0.10579,1,0.3818915828957239,3.57,BP
GO:1902230,negative regulation of intrinsic apoptot...,25,2,0.56,0.10579,1,0.3818915828957239,3.57,BP
GO:1903649,regulation of cytoplasmic transport,25,2,0.56,0.10579,1,0.3818915828957239,3.57,BP
GO:1904738,vascular associated smooth muscle cell m...,25,2,0.56,0.10579,1,0.3818915828957239,3.57,BP
GO:1904752,regulation of vascular associated smooth...,25,2,0.56,0.10579,1,0.3818915828957239,3.57,BP
GO:0033143,regulation of intracellular steroid horm...,81,4,1.8,0.10616,1,0.3829399700149925,2.22,BP
GO:0007626,locomotory behavior,250,9,5.56,0.10678,1,0.3848879101123595,1.62,BP
GO:0072006,nephron development,146,6,3.24,0.10753,1,0.38711946148092746,1.85,BP
GO:0018105,peptidyl-serine phosphorylation,323,11,7.18,0.10756,1,0.38711946148092746,1.53,BP
GO:0002064,epithelial cell development,251,9,5.58,0.10871,1,0.3900875409836066,1.61,BP
GO:0001895,retina homeostasis,52,3,1.16,0.10879,1,0.3900875409836066,2.59,BP
GO:0032481,positive regulation of type I interferon...,52,3,1.16,0.10879,1,0.3900875409836066,2.59,BP
GO:0070542,response to fatty acid,52,3,1.16,0.10879,1,0.3900875409836066,2.59,BP
GO:2000677,regulation of transcription regulatory r...,52,3,1.16,0.10879,1,0.3900875409836066,2.59,BP
GO:0051716,cellular response to stimulus,7732,185,171.83,0.11038,1,0.3954940878629933,1.08,BP
GO:0003012,muscle system process,400,13,8.89,0.11179,1,0.400248125,1.46,BP
GO:0045165,cell fate commitment,289,10,6.42,0.11217,1,0.40037399116347566,1.56,BP
GO:0043270,positive regulation of ion transport,326,11,7.24,0.11269,1,0.40037399116347566,1.52,BP
GO:0000289,nuclear-transcribed mRNA poly(A) tail sh...,26,2,0.58,0.11299,1,0.40037399116347566,3.45,BP
GO:0000460,maturation of 5.8S rRNA,26,2,0.58,0.11299,1,0.40037399116347566,3.45,BP
GO:0032104,regulation of response to extracellular ...,26,2,0.58,0.11299,1,0.40037399116347566,3.45,BP
GO:0032107,regulation of response to nutrient level...,26,2,0.58,0.11299,1,0.40037399116347566,3.45,BP
GO:0045737,positive regulation of cyclin-dependent ...,26,2,0.58,0.11299,1,0.40037399116347566,3.45,BP
GO:0048642,negative regulation of skeletal muscle t...,26,2,0.58,0.11299,1,0.40037399116347566,3.45,BP
GO:0051497,negative regulation of stress fiber asse...,26,2,0.58,0.11299,1,0.40037399116347566,3.45,BP
GO:0051570,regulation of histone H3-K9 methylation,26,2,0.58,0.11299,1,0.40037399116347566,3.45,BP
GO:0072574,hepatocyte proliferation,26,2,0.58,0.11299,1,0.40037399116347566,3.45,BP
GO:0072575,epithelial cell proliferation involved i...,26,2,0.58,0.11299,1,0.40037399116347566,3.45,BP
GO:0099010,modification of postsynaptic structure,26,2,0.58,0.11299,1,0.40037399116347566,3.45,BP
GO:1902175,regulation of oxidative stress-induced i...,26,2,0.58,0.11299,1,0.40037399116347566,3.45,BP
GO:0030099,myeloid cell differentiation,401,13,8.91,0.11334,1,0.40077640498899486,1.46,BP
GO:0032608,interferon-beta production,53,3,1.18,0.11352,1,0.40077640498899486,2.54,BP
GO:0051932,"synaptic transmission, GABAergic",53,3,1.18,0.11352,1,0.40077640498899486,2.54,BP
GO:1904705,regulation of vascular smooth muscle cel...,53,3,1.18,0.11352,1,0.40077640498899486,2.54,BP
GO:1990874,vascular smooth muscle cell proliferatio...,53,3,1.18,0.11352,1,0.40077640498899486,2.54,BP
GO:0002790,peptide secretion,671,20,14.91,0.11383,1,0.40157621700879764,1.34,BP
GO:0070371,ERK1 and ERK2 cascade,328,11,7.29,0.11619,1,0.4096016703296703,1.51,BP
GO:0048762,mesenchymal cell differentiation,219,8,4.87,0.11637,1,0.40993590043923867,1.64,BP
GO:0002831,regulation of response to biotic stimulu...,150,6,3.33,0.11815,1,0.41590182882223853,1.8,BP
GO:0045604,regulation of epidermal cell differentia...,54,3,1.2,0.11833,1,0.41592692476260046,2.5,BP
GO:0051568,histone H3-K4 methylation,54,3,1.2,0.11833,1,0.41592692476260046,2.5,BP
GO:0010971,positive regulation of G2/M transition o...,27,2,0.6,0.12031,1,0.4204297167755991,3.33,BP
GO:0021697,cerebellar cortex formation,27,2,0.6,0.12031,1,0.4204297167755991,3.33,BP
GO:0032801,receptor catabolic process,27,2,0.6,0.12031,1,0.4204297167755991,3.33,BP
GO:0050901,leukocyte tethering or rolling,27,2,0.6,0.12031,1,0.4204297167755991,3.33,BP
GO:0051560,mitochondrial calcium ion homeostasis,27,2,0.6,0.12031,1,0.4204297167755991,3.33,BP
GO:0060008,Sertoli cell differentiation,27,2,0.6,0.12031,1,0.4204297167755991,3.33,BP
GO:1905144,response to acetylcholine,27,2,0.6,0.12031,1,0.4204297167755991,3.33,BP
GO:1905145,cellular response to acetylcholine,27,2,0.6,0.12031,1,0.4204297167755991,3.33,BP
GO:0007423,sensory organ development,598,18,13.29,0.12047,1,0.4206833381712627,1.35,BP
GO:0050707,regulation of cytokine secretion,221,8,4.91,0.12079,1,0.42149490935460476,1.63,BP
GO:0034502,protein localization to chromosome,85,4,1.89,0.12089,1,0.42153817391304343,2.12,BP
GO:0051052,regulation of DNA metabolic process,444,14,9.87,0.12124,1,0.42245248370745836,1.42,BP
GO:0070201,regulation of establishment of protein l...,757,22,16.82,0.12222,1,0.42555907380607816,1.31,BP
GO:0051345,positive regulation of hydrolase activit...,522,16,11.6,0.12289,1,0.4275825596529284,1.38,BP
GO:0007528,neuromuscular junction development,55,3,1.22,0.12321,1,0.42807690974729246,2.46,BP
GO:0032210,regulation of telomere maintenance via t...,55,3,1.22,0.12321,1,0.42807690974729246,2.46,BP
GO:0044057,regulation of system process,601,18,13.36,0.12447,1,0.43214259740259736,1.35,BP
GO:0014910,regulation of smooth muscle cell migrati...,86,4,1.91,0.12471,1,0.4323519596541787,2.09,BP
GO:1901379,regulation of potassium ion transmembran...,86,4,1.91,0.12471,1,0.4323519596541787,2.09,BP
GO:0030534,adult behavior,188,7,4.18,0.12677,1,0.4390606285714286,1.67,BP
GO:0006605,protein targeting,260,9,5.78,0.12700,1,0.4390606285714286,1.56,BP
GO:0001759,organ induction,28,2,0.62,0.12774,1,0.4390606285714286,3.23,BP
GO:0002089,lens morphogenesis in camera-type eye,28,2,0.62,0.12774,1,0.4390606285714286,3.23,BP
GO:0010939,regulation of necrotic cell death,28,2,0.62,0.12774,1,0.4390606285714286,3.23,BP
GO:0031063,regulation of histone deacetylation,28,2,0.62,0.12774,1,0.4390606285714286,3.23,BP
GO:0032647,regulation of interferon-alpha productio...,28,2,0.62,0.12774,1,0.4390606285714286,3.23,BP
GO:0048596,embryonic camera-type eye morphogenesis,28,2,0.62,0.12774,1,0.4390606285714286,3.23,BP
GO:0071168,protein localization to chromatin,28,2,0.62,0.12774,1,0.4390606285714286,3.23,BP
GO:0072576,liver morphogenesis,28,2,0.62,0.12774,1,0.4390606285714286,3.23,BP
GO:0090312,positive regulation of protein deacetyla...,28,2,0.62,0.12774,1,0.4390606285714286,3.23,BP
GO:1904292,regulation of ERAD pathway,28,2,0.62,0.12774,1,0.4390606285714286,3.23,BP
GO:0003015,heart process,225,8,5,0.12991,1,0.4462005139186296,1.6,BP
GO:0090150,establishment of protein localization to...,226,8,5.02,0.13225,1,0.45373221352313164,1.59,BP
GO:0014706,striated muscle tissue development,451,14,10.02,0.13236,1,0.45373221352313164,1.4,BP
GO:0010717,regulation of epithelial to mesenchymal ...,88,4,1.96,0.13248,1,0.45373221352313164,2.04,BP
GO:0040014,regulation of multicellular organism gro...,88,4,1.96,0.13248,1,0.45373221352313164,2.04,BP
GO:1903409,reactive oxygen species biosynthetic pro...,121,5,2.69,0.13270,1,0.4541624466571836,1.86,BP
GO:0002042,cell migration involved in sprouting ang...,57,3,1.27,0.13318,1,0.45515778409090907,2.36,BP
GO:0019080,viral gene expression,57,3,1.27,0.13318,1,0.45515778409090907,2.36,BP
GO:0009887,animal organ morphogenesis,1090,30,24.22,0.13392,1,0.4573619872249823,1.24,BP
GO:0032501,multicellular organismal process,8233,195,182.96,0.13518,1,0.45939827805222305,1.07,BP
GO:0006376,mRNA splice site selection,29,2,0.64,0.13528,1,0.45939827805222305,3.12,BP
GO:0007007,inner mitochondrial membrane organizatio...,29,2,0.64,0.13528,1,0.45939827805222305,3.12,BP
GO:0034508,centromere complex assembly,29,2,0.64,0.13528,1,0.45939827805222305,3.12,BP
GO:0042026,protein refolding,29,2,0.64,0.13528,1,0.45939827805222305,3.12,BP
GO:0090181,regulation of cholesterol metabolic proc...,29,2,0.64,0.13528,1,0.45939827805222305,3.12,BP
GO:1902235,regulation of endoplasmic reticulum stre...,29,2,0.64,0.13528,1,0.45939827805222305,3.12,BP
GO:1904031,positive regulation of cyclin-dependent ...,29,2,0.64,0.13528,1,0.45939827805222305,3.12,BP
GO:2000278,regulation of DNA biosynthetic process,122,5,2.71,0.13602,1,0.46158550070521864,1.85,BP
GO:0050715,positive regulation of cytokine secretio...,157,6,3.49,0.13795,1,0.46780507399577165,1.72,BP
GO:0060759,regulation of response to cytokine stimu...,123,5,2.73,0.13938,1,0.47232152112676057,1.83,BP
GO:0032102,negative regulation of response to exter...,341,11,7.58,0.14040,1,0.475443209007741,1.45,BP
GO:0051153,regulation of striated muscle cell diffe...,124,5,2.76,0.14277,1,0.4795892887029289,1.81,BP
GO:0090090,negative regulation of canonical Wnt sig...,124,5,2.76,0.14277,1,0.4795892887029289,1.81,BP
GO:0010390,histone monoubiquitination,30,2,0.67,0.14292,1,0.4795892887029289,2.99,BP
GO:0010803,regulation of tumor necrosis factor-medi...,30,2,0.67,0.14292,1,0.4795892887029289,2.99,BP
GO:0031297,replication fork processing,30,2,0.67,0.14292,1,0.4795892887029289,2.99,BP
GO:0032607,interferon-alpha production,30,2,0.67,0.14292,1,0.4795892887029289,2.99,BP
GO:0042533,tumor necrosis factor biosynthetic proce...,30,2,0.67,0.14292,1,0.4795892887029289,2.99,BP
GO:0042534,regulation of tumor necrosis factor bios...,30,2,0.67,0.14292,1,0.4795892887029289,2.99,BP
GO:0043951,negative regulation of cAMP-mediated sig...,30,2,0.67,0.14292,1,0.4795892887029289,2.99,BP
GO:0061037,negative regulation of cartilage develop...,30,2,0.67,0.14292,1,0.4795892887029289,2.99,BP
GO:0070266,necroptotic process,30,2,0.67,0.14292,1,0.4795892887029289,2.99,BP
GO:0070306,lens fiber cell differentiation,30,2,0.67,0.14292,1,0.4795892887029289,2.99,BP
GO:1902751,positive regulation of cell cycle G2/M p...,30,2,0.67,0.14292,1,0.4795892887029289,2.99,BP
GO:0070936,protein K48-linked ubiquitination,59,3,1.31,0.14342,1,0.48059682451253477,2.29,BP
GO:1902369,negative regulation of RNA catabolic pro...,59,3,1.31,0.14342,1,0.48059682451253477,2.29,BP
GO:0046677,response to antibiotic,305,10,6.78,0.14381,1,0.4815683507306889,1.47,BP
GO:0036293,response to decreased oxygen levels,231,8,5.13,0.14423,1,0.4826389151599444,1.56,BP
GO:0021954,central nervous system neuron developmen...,91,4,2.02,0.14451,1,0.4832398332175122,1.98,BP
GO:0042552,myelination,160,6,3.56,0.14688,1,0.49082400000000004,1.69,BP
GO:0048771,tissue remodeling,196,7,4.36,0.14772,1,0.4932884385843164,1.61,BP
GO:0001938,positive regulation of endothelial cell ...,92,4,2.04,0.14861,1,0.4949770954356847,1.96,BP
GO:0045685,regulation of glial cell differentiation,92,4,2.04,0.14861,1,0.4949770954356847,1.96,BP
GO:0008347,glial cell migration,60,3,1.33,0.14864,1,0.4949770954356847,2.26,BP
GO:0033209,tumor necrosis factor-mediated signaling...,60,3,1.33,0.14864,1,0.4949770954356847,2.26,BP
GO:0051047,positive regulation of secretion,539,16,11.98,0.14874,1,0.4949770954356847,1.34,BP
GO:0021602,cranial nerve morphogenesis,31,2,0.69,0.15064,1,0.4975152230610844,2.9,BP
GO:0022617,extracellular matrix disassembly,31,2,0.69,0.15064,1,0.4975152230610844,2.9,BP
GO:0045932,negative regulation of muscle contractio...,31,2,0.69,0.15064,1,0.4975152230610844,2.9,BP
GO:0050999,regulation of nitric-oxide synthase acti...,31,2,0.69,0.15064,1,0.4975152230610844,2.9,BP
GO:0051491,positive regulation of filopodium assemb...,31,2,0.69,0.15064,1,0.4975152230610844,2.9,BP
GO:0090075,relaxation of muscle,31,2,0.69,0.15064,1,0.4975152230610844,2.9,BP
GO:0090162,establishment of epithelial cell polarit...,31,2,0.69,0.15064,1,0.4975152230610844,2.9,BP
GO:0098884,postsynaptic neurotransmitter receptor i...,31,2,0.69,0.15064,1,0.4975152230610844,2.9,BP
GO:0140239,postsynaptic endocytosis,31,2,0.69,0.15064,1,0.4975152230610844,2.9,BP
GO:1903393,positive regulation of adherens junction...,31,2,0.69,0.15064,1,0.4975152230610844,2.9,BP
GO:2001014,regulation of skeletal muscle cell diffe...,31,2,0.69,0.15064,1,0.4975152230610844,2.9,BP
GO:0014909,smooth muscle cell migration,93,4,2.07,0.15276,1,0.5034802191780823,1.93,BP
GO:0036473,cell death in response to oxidative stre...,93,4,2.07,0.15276,1,0.5034802191780823,1.93,BP
GO:0060998,regulation of dendritic spine developmen...,93,4,2.07,0.15276,1,0.5034802191780823,1.93,BP
GO:0010212,response to ionizing radiation,127,5,2.82,0.15316,1,0.5042396716826266,1.77,BP
GO:0007519,skeletal muscle tissue development,198,7,4.4,0.15320,1,0.5042396716826266,1.59,BP
GO:0006749,glutathione metabolic process,61,3,1.36,0.15392,1,0.5048827811860941,2.21,BP
GO:0031102,neuron projection regeneration,61,3,1.36,0.15392,1,0.5048827811860941,2.21,BP
GO:0072665,protein localization to vacuole,61,3,1.36,0.15392,1,0.5048827811860941,2.21,BP
GO:1901016,regulation of potassium ion transmembran...,61,3,1.36,0.15392,1,0.5048827811860941,2.21,BP
GO:1902305,regulation of sodium ion transmembrane t...,61,3,1.36,0.15392,1,0.5048827811860941,2.21,BP
GO:0007272,ensheathment of neurons,163,6,3.62,0.15606,1,0.5112053914227366,1.66,BP
GO:0008366,axon ensheathment,163,6,3.62,0.15606,1,0.5112053914227366,1.66,BP
GO:0044403,symbiont process,349,11,7.76,0.15654,1,0.5124288979591838,1.42,BP
GO:0050714,positive regulation of protein secretion,311,10,6.91,0.15676,1,0.5126919755600814,1.45,BP
GO:0043506,regulation of JUN kinase activity,94,4,2.09,0.15694,1,0.5126919755600814,1.91,BP
GO:0097061,dendritic spine organization,94,4,2.09,0.15694,1,0.5126919755600814,1.91,BP
GO:0007276,gamete generation,704,20,15.65,0.15760,1,0.5134096161616162,1.28,BP
GO:0001964,startle response,32,2,0.71,0.15844,1,0.5134096161616162,2.82,BP
GO:0031069,hair follicle morphogenesis,32,2,0.71,0.15844,1,0.5134096161616162,2.82,BP
GO:0032728,positive regulation of interferon-beta p...,32,2,0.71,0.15844,1,0.5134096161616162,2.82,BP
GO:0036475,neuron death in response to oxidative st...,32,2,0.71,0.15844,1,0.5134096161616162,2.82,BP
GO:0045616,regulation of keratinocyte differentiati...,32,2,0.71,0.15844,1,0.5134096161616162,2.82,BP
GO:0048048,embryonic eye morphogenesis,32,2,0.71,0.15844,1,0.5134096161616162,2.82,BP
GO:0050686,negative regulation of mRNA processing,32,2,0.71,0.15844,1,0.5134096161616162,2.82,BP
GO:0060306,regulation of membrane repolarization,32,2,0.71,0.15844,1,0.5134096161616162,2.82,BP
GO:0060977,coronary vasculature morphogenesis,32,2,0.71,0.15844,1,0.5134096161616162,2.82,BP
GO:1900181,negative regulation of protein localizat...,32,2,0.71,0.15844,1,0.5134096161616162,2.82,BP
GO:1903203,regulation of oxidative stress-induced n...,32,2,0.71,0.15844,1,0.5134096161616162,2.82,BP
GO:0048008,platelet-derived growth factor receptor ...,62,3,1.38,0.15925,1,0.5151556451612903,2.17,BP
GO:1905268,negative regulation of chromatin organiz...,62,3,1.38,0.15925,1,0.5151556451612903,2.17,BP
GO:0034764,positive regulation of transmembrane tra...,237,8,5.27,0.15930,1,0.5151556451612903,1.52,BP
GO:0008277,regulation of G protein-coupled receptor...,129,5,2.87,0.16025,1,0.5178797850906649,1.74,BP
GO:0044270,cellular nitrogen compound catabolic pro...,469,14,10.42,0.16349,1,0.5279958926174496,1.34,BP
GO:0070059,intrinsic apoptotic signaling pathway in...,63,3,1.4,0.16464,1,0.5313532394366197,2.14,BP
GO:0007283,spermatogenesis,549,16,12.2,0.16524,1,0.5328951807228917,1.31,BP
GO:0006352,"DNA-templated transcription, initiation",96,4,2.13,0.16545,1,0.5328951807228917,1.88,BP
GO:0071456,cellular response to hypoxia,96,4,2.13,0.16545,1,0.5328951807228917,1.88,BP
GO:0007097,nuclear migration,33,2,0.73,0.16632,1,0.5331990939373751,2.74,BP
GO:0035025,positive regulation of Rho protein signa...,33,2,0.73,0.16632,1,0.5331990939373751,2.74,BP
GO:0048013,ephrin receptor signaling pathway,33,2,0.73,0.16632,1,0.5331990939373751,2.74,BP
GO:0070897,transcription preinitiation complex asse...,33,2,0.73,0.16632,1,0.5331990939373751,2.74,BP
GO:0099563,modification of synaptic structure,33,2,0.73,0.16632,1,0.5331990939373751,2.74,BP
GO:1901976,regulation of cell cycle checkpoint,33,2,0.73,0.16632,1,0.5331990939373751,2.74,BP
GO:1904646,cellular response to amyloid-beta,33,2,0.73,0.16632,1,0.5331990939373751,2.74,BP
GO:0046887,positive regulation of hormone secretion,167,6,3.71,0.16869,1,0.5404369374167777,1.62,BP
GO:0007173,epidermal growth factor receptor signali...,97,4,2.16,0.16976,1,0.5420351523178808,1.85,BP
GO:0120162,positive regulation of cold-induced ther...,97,4,2.16,0.16976,1,0.5420351523178808,1.85,BP
GO:0001658,branching involved in ureteric bud morph...,64,3,1.42,0.17009,1,0.5420351523178808,2.11,BP
GO:0007566,embryo implantation,64,3,1.42,0.17009,1,0.5420351523178808,2.11,BP
GO:0009988,cell-cell recognition,64,3,1.42,0.17009,1,0.5420351523178808,2.11,BP
GO:0043462,regulation of ATPase activity,64,3,1.42,0.17009,1,0.5420351523178808,2.11,BP
GO:0090398,cellular senescence,64,3,1.42,0.17009,1,0.5420351523178808,2.11,BP
GO:1904356,regulation of telomere maintenance via t...,64,3,1.42,0.17009,1,0.5420351523178808,2.11,BP
GO:0050727,regulation of inflammatory response,356,11,7.91,0.17139,1,0.5458164659166115,1.39,BP
GO:0048562,embryonic organ morphogenesis,318,10,7.07,0.17257,1,0.549210873015873,1.41,BP
GO:0060993,kidney morphogenesis,98,4,2.18,0.17411,1,0.5520336537195524,1.83,BP
GO:0070585,protein localization to mitochondrion,98,4,2.18,0.17411,1,0.5520336537195524,1.83,BP
GO:0000186,activation of MAPKK activity,34,2,0.76,0.17426,1,0.5520336537195524,2.63,BP
GO:0006984,ER-nucleus signaling pathway,34,2,0.76,0.17426,1,0.5520336537195524,2.63,BP
GO:0010837,regulation of keratinocyte proliferation,34,2,0.76,0.17426,1,0.5520336537195524,2.63,BP
GO:0018208,peptidyl-proline modification,34,2,0.76,0.17426,1,0.5520336537195524,2.63,BP
GO:0097242,amyloid-beta clearance,34,2,0.76,0.17426,1,0.5520336537195524,2.63,BP
GO:0008037,cell recognition,133,5,2.96,0.17483,1,0.5531110848126234,1.69,BP
GO:1902850,microtubule cytoskeleton organization in...,133,5,2.96,0.17483,1,0.5531110848126234,1.69,BP
GO:0071897,DNA biosynthetic process,169,6,3.76,0.17516,1,0.5537910118265441,1.6,BP
GO:0000381,"regulation of alternative mRNA splicing,...",65,3,1.44,0.17558,1,0.5540268590163935,2.08,BP
GO:0030330,"DNA damage response, signal transduction...",65,3,1.44,0.17558,1,0.5540268590163935,2.08,BP
GO:0099024,plasma membrane invagination,65,3,1.44,0.17558,1,0.5540268590163935,2.08,BP
GO:0046700,heterocycle catabolic process,476,14,10.58,0.17654,1,0.5566910091743119,1.32,BP
GO:0099072,regulation of postsynaptic membrane neur...,99,4,2.2,0.17850,1,0.5622922774869109,1.82,BP
GO:0006633,fatty acid biosynthetic process,134,5,2.98,0.17855,1,0.5622922774869109,1.68,BP
GO:0060538,skeletal muscle organ development,207,7,4.6,0.17898,1,0.5632778024852845,1.52,BP
GO:0030855,epithelial cell differentiation,638,18,14.18,0.18016,1,0.5666208627450979,1.27,BP
GO:0000422,autophagy of mitochondrion,66,3,1.47,0.18113,1,0.567784854368932,2.04,BP
GO:0060425,lung morphogenesis,66,3,1.47,0.18113,1,0.567784854368932,2.04,BP
GO:0061726,mitochondrion disassembly,66,3,1.47,0.18113,1,0.567784854368932,2.04,BP
GO:1904888,cranial skeletal system development,66,3,1.47,0.18113,1,0.567784854368932,2.04,BP
GO:0045807,positive regulation of endocytosis,171,6,3.8,0.18173,1,0.567784854368932,1.58,BP
GO:0002082,regulation of oxidative phosphorylation,35,2,0.78,0.18227,1,0.567784854368932,2.56,BP
GO:0008045,motor neuron axon guidance,35,2,0.78,0.18227,1,0.567784854368932,2.56,BP
GO:0009954,proximal/distal pattern formation,35,2,0.78,0.18227,1,0.567784854368932,2.56,BP
GO:0038084,vascular endothelial growth factor signa...,35,2,0.78,0.18227,1,0.567784854368932,2.56,BP
GO:0045940,positive regulation of steroid metabolic...,35,2,0.78,0.18227,1,0.567784854368932,2.56,BP
GO:0051567,histone H3-K9 methylation,35,2,0.78,0.18227,1,0.567784854368932,2.56,BP
GO:0060479,lung cell differentiation,35,2,0.78,0.18227,1,0.567784854368932,2.56,BP
GO:2000036,regulation of stem cell population maint...,35,2,0.78,0.18227,1,0.567784854368932,2.56,BP
GO:0006261,DNA-dependent DNA replication,135,5,3,0.18230,1,0.567784854368932,1.67,BP
GO:0050905,neuromuscular process,135,5,3,0.18230,1,0.567784854368932,1.67,BP
GO:0010771,negative regulation of cell morphogenesi...,100,4,2.22,0.18293,1,0.5693784993531695,1.8,BP
GO:2001257,regulation of cation channel activity,172,6,3.82,0.18505,1,0.5756047834518423,1.57,BP
GO:0016032,viral process,285,9,6.33,0.18559,1,0.576911550387597,1.42,BP
GO:0006979,response to oxidative stress,402,12,8.93,0.18645,1,0.5792107165913493,1.34,BP
GO:0006801,superoxide metabolic process,67,3,1.49,0.18672,1,0.5796752516129032,2.01,BP
GO:0001578,microtubule bundle formation,101,4,2.24,0.18739,1,0.5802578378378378,1.79,BP
GO:0051651,maintenance of location in cell,101,4,2.24,0.18739,1,0.5802578378378378,1.79,BP
GO:0060359,response to ammonium ion,101,4,2.24,0.18739,1,0.5802578378378378,1.79,BP
GO:0090174,organelle membrane fusion,101,4,2.24,0.18739,1,0.5802578378378378,1.79,BP
GO:0048593,camera-type eye morphogenesis,137,5,3.04,0.18989,1,0.587064,1.64,BP
GO:0003401,axis elongation,36,2,0.8,0.19032,1,0.587064,2.5,BP
GO:0006739,NADP metabolic process,36,2,0.8,0.19032,1,0.587064,2.5,BP
GO:0033238,regulation of cellular amine metabolic p...,36,2,0.8,0.19032,1,0.587064,2.5,BP
GO:1904037,positive regulation of epithelial cell a...,36,2,0.8,0.19032,1,0.587064,2.5,BP
GO:1905209,positive regulation of cardiocyte differ...,36,2,0.8,0.19032,1,0.587064,2.5,BP
GO:0007159,leukocyte cell-cell adhesion,326,10,7.24,0.19152,1,0.588422250476796,1.38,BP
GO:0051235,maintenance of location,326,10,7.24,0.19152,1,0.588422250476796,1.38,BP
GO:0035107,appendage morphogenesis,174,6,3.87,0.19176,1,0.588422250476796,1.55,BP
GO:0035108,limb morphogenesis,174,6,3.87,0.19176,1,0.588422250476796,1.55,BP
GO:1901654,response to ketone,174,6,3.87,0.19176,1,0.588422250476796,1.55,BP
GO:0021549,cerebellum development,102,4,2.27,0.19189,1,0.588422250476796,1.76,BP
GO:0031532,actin cytoskeleton reorganization,102,4,2.27,0.19189,1,0.588422250476796,1.76,BP
GO:0050886,endocrine process,102,4,2.27,0.19189,1,0.588422250476796,1.76,BP
GO:0098876,vesicle-mediated transport to the plasma...,102,4,2.27,0.19189,1,0.588422250476796,1.76,BP
GO:0043113,receptor clustering,68,3,1.51,0.19235,1,0.588422250476796,1.99,BP
GO:0048002,antigen processing and presentation of p...,68,3,1.51,0.19235,1,0.588422250476796,1.99,BP
GO:0050771,negative regulation of axonogenesis,68,3,1.51,0.19235,1,0.588422250476796,1.99,BP
GO:0090278,negative regulation of peptide hormone s...,68,3,1.51,0.19235,1,0.588422250476796,1.99,BP
GO:0006814,sodium ion transport,212,7,4.71,0.19404,1,0.5928384,1.49,BP
GO:2001020,regulation of response to DNA damage sti...,212,7,4.71,0.19404,1,0.5928384,1.49,BP
GO:0001708,cell fate specification,103,4,2.29,0.19642,1,0.5993487888395688,1.75,BP
GO:1903426,regulation of reactive oxygen species bi...,103,4,2.29,0.19642,1,0.5993487888395688,1.75,BP
GO:0060997,dendritic spine morphogenesis,69,3,1.53,0.19803,1,0.6005775235700817,1.96,BP
GO:0008015,blood circulation,487,14,10.82,0.19805,1,0.6005775235700817,1.29,BP
GO:0002053,positive regulation of mesenchymal cell ...,37,2,0.82,0.19842,1,0.6005775235700817,2.44,BP
GO:0006458,'de novo' protein folding,37,2,0.82,0.19842,1,0.6005775235700817,2.44,BP
GO:0021799,cerebral cortex radially oriented cell m...,37,2,0.82,0.19842,1,0.6005775235700817,2.44,BP
GO:0033144,negative regulation of intracellular ste...,37,2,0.82,0.19842,1,0.6005775235700817,2.44,BP
GO:0033260,nuclear DNA replication,37,2,0.82,0.19842,1,0.6005775235700817,2.44,BP
GO:0048147,negative regulation of fibroblast prolif...,37,2,0.82,0.19842,1,0.6005775235700817,2.44,BP
GO:0048730,epidermis morphogenesis,37,2,0.82,0.19842,1,0.6005775235700817,2.44,BP
GO:0060142,regulation of syncytium formation by pla...,37,2,0.82,0.19842,1,0.6005775235700817,2.44,BP
GO:1901385,regulation of voltage-gated calcium chan...,37,2,0.82,0.19842,1,0.6005775235700817,2.44,BP
GO:0016202,regulation of striated muscle tissue dev...,176,6,3.91,0.19857,1,0.6005775235700817,1.53,BP
GO:0035148,tube formation,176,6,3.91,0.19857,1,0.6005775235700817,1.53,BP
GO:0048592,eye morphogenesis,176,6,3.91,0.19857,1,0.6005775235700817,1.53,BP
GO:0001501,skeletal system development,528,15,11.73,0.19972,1,0.6036762814070352,1.28,BP
GO:0017038,protein import,214,7,4.76,0.20020,1,0.6047472693032014,1.47,BP
GO:0048232,male gamete generation,569,16,12.65,0.20095,1,0.6066319949811794,1.26,BP
GO:0043484,regulation of RNA splicing,140,5,3.11,0.20148,1,0.6078506332288401,1.61,BP
GO:0048641,regulation of skeletal muscle tissue dev...,70,3,1.56,0.20375,1,0.6135450563204005,1.92,BP
GO:1990868,response to chemokine,70,3,1.56,0.20375,1,0.6135450563204005,1.92,BP
GO:1990869,cellular response to chemokine,70,3,1.56,0.20375,1,0.6135450563204005,1.92,BP
GO:0019439,aromatic compound catabolic process,490,14,10.89,0.20412,1,0.6142748217636023,1.29,BP
GO:0007009,plasma membrane organization,105,4,2.33,0.20558,1,0.6181962273579013,1.72,BP
GO:0050663,cytokine secretion,254,8,5.64,0.20568,1,0.6181962273579013,1.42,BP
GO:0040019,positive regulation of embryonic develop...,38,2,0.84,0.20656,1,0.6189082938978829,2.38,BP
GO:0045005,DNA-dependent DNA replication maintenanc...,38,2,0.84,0.20656,1,0.6189082938978829,2.38,BP
GO:0046329,negative regulation of JNK cascade,38,2,0.84,0.20656,1,0.6189082938978829,2.38,BP
GO:0051647,nucleus localization,38,2,0.84,0.20656,1,0.6189082938978829,2.38,BP
GO:0071158,positive regulation of cell cycle arrest,38,2,0.84,0.20656,1,0.6189082938978829,2.38,BP
GO:0006513,protein monoubiquitination,71,3,1.58,0.20950,1,0.6253808933002482,1.9,BP
GO:0016575,histone deacetylation,71,3,1.58,0.20950,1,0.6253808933002482,1.9,BP
GO:0060675,ureteric bud morphogenesis,71,3,1.58,0.20950,1,0.6253808933002482,1.9,BP
GO:0070192,chromosome organization involved in meio...,71,3,1.58,0.20950,1,0.6253808933002482,1.9,BP
GO:1901796,regulation of signal transduction by p53...,71,3,1.58,0.20950,1,0.6253808933002482,1.9,BP
GO:2001021,negative regulation of response to DNA d...,71,3,1.58,0.20950,1,0.6253808933002482,1.9,BP
GO:0050896,response to stimulus,9311,216,206.92,0.21010,1,0.6267831370117792,1.04,BP
GO:0048634,regulation of muscle organ development,180,6,4,0.21244,1,0.6333713011152416,1.5,BP
GO:0106106,cold-induced thermogenesis,143,5,3.18,0.21330,1,0.6351482673267327,1.57,BP
GO:0120161,regulation of cold-induced thermogenesis,143,5,3.18,0.21330,1,0.6351482673267327,1.57,BP
GO:0007257,activation of JUN kinase activity,39,2,0.87,0.21474,1,0.6354679287031346,2.3,BP
GO:0007616,long-term memory,39,2,0.87,0.21474,1,0.6354679287031346,2.3,BP
GO:0031076,embryonic camera-type eye development,39,2,0.87,0.21474,1,0.6354679287031346,2.3,BP
GO:0032781,positive regulation of ATPase activity,39,2,0.87,0.21474,1,0.6354679287031346,2.3,BP
GO:0060251,regulation of glial cell proliferation,39,2,0.87,0.21474,1,0.6354679287031346,2.3,BP
GO:0070570,regulation of neuron projection regenera...,39,2,0.87,0.21474,1,0.6354679287031346,2.3,BP
GO:1900026,positive regulation of substrate adhesio...,39,2,0.87,0.21474,1,0.6354679287031346,2.3,BP
GO:1901021,positive regulation of calcium ion trans...,39,2,0.87,0.21474,1,0.6354679287031346,2.3,BP
GO:1904645,response to amyloid-beta,39,2,0.87,0.21474,1,0.6354679287031346,2.3,BP
GO:0006275,regulation of DNA replication,107,4,2.38,0.21486,1,0.6354679287031346,1.68,BP
GO:0038127,ERBB signaling pathway,107,4,2.38,0.21486,1,0.6354679287031346,1.68,BP
GO:0010324,membrane invagination,72,3,1.6,0.21529,1,0.6355677791411043,1.88,BP
GO:0030239,myofibril assembly,72,3,1.6,0.21529,1,0.6355677791411043,1.88,BP
GO:0072171,mesonephric tubule morphogenesis,72,3,1.6,0.21529,1,0.6355677791411043,1.88,BP
GO:0002573,myeloid leukocyte differentiation,219,7,4.87,0.21594,1,0.6370958185162476,1.44,BP
GO:0032412,regulation of ion transmembrane transpor...,258,8,5.73,0.21731,1,0.6407449264705883,1.4,BP
GO:0034767,positive regulation of ion transmembrane...,182,6,4.04,0.21950,1,0.6465278335373318,1.49,BP
GO:1904659,glucose transmembrane transport,108,4,2.4,0.21954,1,0.6465278335373318,1.67,BP
GO:0007422,peripheral nervous system development,73,3,1.62,0.22112,1,0.6484030712979891,1.85,BP
GO:0021766,hippocampus development,73,3,1.62,0.22112,1,0.6484030712979891,1.85,BP
GO:0021885,forebrain cell migration,73,3,1.62,0.22112,1,0.6484030712979891,1.85,BP
GO:0042733,embryonic digit morphogenesis,73,3,1.62,0.22112,1,0.6484030712979891,1.85,BP
GO:0043627,response to estrogen,73,3,1.62,0.22112,1,0.6484030712979891,1.85,BP
GO:0097120,receptor localization to synapse,73,3,1.62,0.22112,1,0.6484030712979891,1.85,BP
GO:1990542,mitochondrial transmembrane transport,73,3,1.62,0.22112,1,0.6484030712979891,1.85,BP
GO:0007099,centriole replication,40,2,0.89,0.22295,1,0.6505240727272728,2.25,BP
GO:0010092,specification of animal organ identity,40,2,0.89,0.22295,1,0.6505240727272728,2.25,BP
GO:0021696,cerebellar cortex morphogenesis,40,2,0.89,0.22295,1,0.6505240727272728,2.25,BP
GO:0060325,face morphogenesis,40,2,0.89,0.22295,1,0.6505240727272728,2.25,BP
GO:0086004,regulation of cardiac muscle cell contra...,40,2,0.89,0.22295,1,0.6505240727272728,2.25,BP
GO:0090049,regulation of cell migration involved in...,40,2,0.89,0.22295,1,0.6505240727272728,2.25,BP
GO:0099590,neurotransmitter receptor internalizatio...,40,2,0.89,0.22295,1,0.6505240727272728,2.25,BP
GO:0110111,negative regulation of animal organ morp...,40,2,0.89,0.22295,1,0.6505240727272728,2.25,BP
GO:0035051,cardiocyte differentiation,183,6,4.07,0.22306,1,0.6505240727272728,1.47,BP
GO:0034097,response to cytokine,1037,27,23.05,0.22354,1,0.6515290611750454,1.17,BP
GO:0009306,protein secretion,622,17,13.82,0.22408,1,0.6520187311178248,1.23,BP
GO:0008645,hexose transmembrane transport,109,4,2.42,0.22425,1,0.6520187311178248,1.65,BP
GO:0048145,regulation of fibroblast proliferation,109,4,2.42,0.22425,1,0.6520187311178248,1.65,BP
GO:1900006,positive regulation of dendrite developm...,109,4,2.42,0.22425,1,0.6520187311178248,1.65,BP
GO:0007613,memory,146,5,3.24,0.22534,1,0.6543971514785758,1.54,BP
GO:0050680,negative regulation of epithelial cell p...,146,5,3.24,0.22534,1,0.6543971514785758,1.54,BP
GO:0016050,vesicle organization,261,8,5.8,0.22619,1,0.6564694089264174,1.38,BP
GO:0006626,protein targeting to mitochondrion,74,3,1.64,0.22697,1,0.657147797833935,1.83,BP
GO:0008543,fibroblast growth factor receptor signal...,74,3,1.64,0.22697,1,0.657147797833935,1.83,BP
GO:1903201,regulation of oxidative stress-induced c...,74,3,1.64,0.22697,1,0.657147797833935,1.83,BP
GO:2000573,positive regulation of DNA biosynthetic ...,74,3,1.64,0.22697,1,0.657147797833935,1.83,BP
GO:0072001,renal system development,301,9,6.69,0.22835,1,0.6607457606734816,1.35,BP
GO:0045926,negative regulation of growth,262,8,5.82,0.22918,1,0.6609852406417113,1.37,BP
GO:0002832,negative regulation of response to bioti...,41,2,0.91,0.23118,1,0.6609852406417113,2.2,BP
GO:0003298,physiological muscle hypertrophy,41,2,0.91,0.23118,1,0.6609852406417113,2.2,BP
GO:0003301,physiological cardiac muscle hypertrophy,41,2,0.91,0.23118,1,0.6609852406417113,2.2,BP
GO:0014037,Schwann cell differentiation,41,2,0.91,0.23118,1,0.6609852406417113,2.2,BP
GO:0021522,spinal cord motor neuron differentiation,41,2,0.91,0.23118,1,0.6609852406417113,2.2,BP
GO:0034105,positive regulation of tissue remodeling,41,2,0.91,0.23118,1,0.6609852406417113,2.2,BP
GO:0035774,positive regulation of insulin secretion...,41,2,0.91,0.23118,1,0.6609852406417113,2.2,BP
GO:0045494,photoreceptor cell maintenance,41,2,0.91,0.23118,1,0.6609852406417113,2.2,BP
GO:0046326,positive regulation of glucose import,41,2,0.91,0.23118,1,0.6609852406417113,2.2,BP
GO:0046854,phosphatidylinositol phosphorylation,41,2,0.91,0.23118,1,0.6609852406417113,2.2,BP
GO:0050856,regulation of T cell receptor signaling ...,41,2,0.91,0.23118,1,0.6609852406417113,2.2,BP
GO:0061049,cell growth involved in cardiac muscle c...,41,2,0.91,0.23118,1,0.6609852406417113,2.2,BP
GO:0071364,cellular response to epidermal growth fa...,41,2,0.91,0.23118,1,0.6609852406417113,2.2,BP
GO:0086009,membrane repolarization,41,2,0.91,0.23118,1,0.6609852406417113,2.2,BP
GO:0097300,programmed necrotic cell death,41,2,0.91,0.23118,1,0.6609852406417113,2.2,BP
GO:0098534,centriole assembly,41,2,0.91,0.23118,1,0.6609852406417113,2.2,BP
GO:1900744,regulation of p38MAPK cascade,41,2,0.91,0.23118,1,0.6609852406417113,2.2,BP
GO:2000273,positive regulation of signaling recepto...,41,2,0.91,0.23118,1,0.6609852406417113,2.2,BP
GO:2000772,regulation of cellular senescence,41,2,0.91,0.23118,1,0.6609852406417113,2.2,BP
GO:0050708,regulation of protein secretion,503,14,11.18,0.23137,1,0.6611356532066508,1.25,BP
GO:0006898,receptor-mediated endocytosis,224,7,4.98,0.23211,1,0.6624634163701068,1.41,BP
GO:0099504,synaptic vesicle cycle,224,7,4.98,0.23211,1,0.6624634163701068,1.41,BP
GO:0045843,negative regulation of striated muscle t...,75,3,1.67,0.23286,1,0.6638165402843602,1.8,BP
GO:0046323,glucose import,75,3,1.67,0.23286,1,0.6638165402843602,1.8,BP
GO:0001843,neural tube closure,111,4,2.47,0.23374,1,0.6647499290780142,1.62,BP
GO:0014074,response to purine-containing compound,111,4,2.47,0.23374,1,0.6647499290780142,1.62,BP
GO:0015749,monosaccharide transmembrane transport,111,4,2.47,0.23374,1,0.6647499290780142,1.62,BP
GO:0048144,fibroblast proliferation,111,4,2.47,0.23374,1,0.6647499290780142,1.62,BP
GO:0051321,meiotic cell cycle,303,9,6.73,0.23394,1,0.6649257412876551,1.34,BP
GO:0051051,negative regulation of transport,546,15,12.13,0.23596,1,0.6702712632821725,1.24,BP
GO:0006939,smooth muscle contraction,112,4,2.49,0.23853,1,0.6737644210526316,1.61,BP
GO:0019079,viral genome replication,112,4,2.49,0.23853,1,0.6737644210526316,1.61,BP
GO:0034219,carbohydrate transmembrane transport,112,4,2.49,0.23853,1,0.6737644210526316,1.61,BP
GO:0060606,tube closure,112,4,2.49,0.23853,1,0.6737644210526316,1.61,BP
GO:0007517,muscle organ development,425,12,9.44,0.23859,1,0.6737644210526316,1.27,BP
GO:0032507,maintenance of protein location in cell,76,3,1.69,0.23877,1,0.6737644210526316,1.78,BP
GO:0048844,artery morphogenesis,76,3,1.69,0.23877,1,0.6737644210526316,1.78,BP
GO:0051193,regulation of cofactor metabolic process,76,3,1.69,0.23877,1,0.6737644210526316,1.78,BP
GO:0097327,response to antineoplastic agent,76,3,1.69,0.23877,1,0.6737644210526316,1.78,BP
GO:0032768,regulation of monooxygenase activity,42,2,0.93,0.23943,1,0.6737644210526316,2.15,BP
GO:0033059,cellular pigmentation,42,2,0.93,0.23943,1,0.6737644210526316,2.15,BP
GO:0038083,peptidyl-tyrosine autophosphorylation,42,2,0.93,0.23943,1,0.6737644210526316,2.15,BP
GO:0045197,establishment or maintenance of epitheli...,42,2,0.93,0.23943,1,0.6737644210526316,2.15,BP
GO:0045740,positive regulation of DNA replication,42,2,0.93,0.23943,1,0.6737644210526316,2.15,BP
GO:0055023,positive regulation of cardiac muscle ti...,42,2,0.93,0.23943,1,0.6737644210526316,2.15,BP
GO:2000826,regulation of heart morphogenesis,42,2,0.93,0.23943,1,0.6737644210526316,2.15,BP
GO:0051704,multi-organism process,2245,55,49.89,0.23959,1,0.6738206195207481,1.1,BP
GO:0018205,peptidyl-lysine modification,345,10,7.67,0.23990,1,0.6742983644859813,1.3,BP
GO:0032940,secretion by cell,1091,28,24.25,0.24122,1,0.6773858576429405,1.15,BP
GO:0022898,regulation of transmembrane transporter ...,266,8,5.91,0.24128,1,0.6773858576429405,1.35,BP
GO:0006140,regulation of nucleotide metabolic proce...,113,4,2.51,0.24334,1,0.6827708921282799,1.59,BP
GO:0034599,cellular response to oxidative stress,267,8,5.93,0.24434,1,0.6850171727748691,1.35,BP
GO:0001503,ossification,387,11,8.6,0.24455,1,0.6850171727748691,1.28,BP
GO:0048635,negative regulation of muscle organ deve...,77,3,1.71,0.24471,1,0.6850171727748691,1.75,BP
GO:0055021,regulation of cardiac muscle tissue grow...,77,3,1.71,0.24471,1,0.6850171727748691,1.75,BP
GO:0022612,gland morphogenesis,151,5,3.36,0.24583,1,0.6877523023255814,1.49,BP
GO:0001937,negative regulation of endothelial cell ...,43,2,0.96,0.24769,1,0.6913481902552204,2.08,BP
GO:0007080,mitotic metaphase plate congression,43,2,0.96,0.24769,1,0.6913481902552204,2.08,BP
GO:0048255,mRNA stabilization,43,2,0.96,0.24769,1,0.6913481902552204,2.08,BP
GO:1903573,negative regulation of response to endop...,43,2,0.96,0.24769,1,0.6913481902552204,2.08,BP
GO:0008637,apoptotic mitochondrial changes,114,4,2.53,0.24817,1,0.6914846786334684,1.58,BP
GO:0022037,metencephalon development,114,4,2.53,0.24817,1,0.6914846786334684,1.58,BP
GO:1904019,epithelial cell apoptotic process,114,4,2.53,0.24817,1,0.6914846786334684,1.58,BP
GO:0048609,multicellular organismal reproductive pr...,843,22,18.73,0.24845,1,0.6918642361111111,1.17,BP
GO:0006405,RNA export from nucleus,78,3,1.73,0.25067,1,0.6968365337954939,1.73,BP
GO:0034644,cellular response to UV,78,3,1.73,0.25067,1,0.6968365337954939,1.73,BP
GO:0045471,response to ethanol,78,3,1.73,0.25067,1,0.6968365337954939,1.73,BP
GO:0051209,release of sequestered calcium ion into ...,115,4,2.56,0.25302,1,0.7029631870669747,1.56,BP
GO:0051046,regulation of secretion,930,24,20.67,0.25342,1,0.7036682285054818,1.16,BP
GO:0042593,glucose homeostasis,270,8,6,0.25358,1,0.7037064359861592,1.33,BP
GO:0001824,blastocyst development,153,5,3.4,0.25416,1,0.7045034101382488,1.47,BP
GO:0006606,protein import into nucleus,153,5,3.4,0.25416,1,0.7045034101382488,1.47,BP
GO:0097191,extrinsic apoptotic signaling pathway,231,7,5.13,0.25538,1,0.7054292783505155,1.36,BP
GO:0050773,regulation of dendrite development,192,6,4.27,0.25589,1,0.7054292783505155,1.41,BP
GO:0003156,regulation of animal organ formation,44,2,0.98,0.25596,1,0.7054292783505155,2.04,BP
GO:0018023,peptidyl-lysine trimethylation,44,2,0.98,0.25596,1,0.7054292783505155,2.04,BP
GO:0043277,apoptotic cell clearance,44,2,0.98,0.25596,1,0.7054292783505155,2.04,BP
GO:0048854,brain morphogenesis,44,2,0.98,0.25596,1,0.7054292783505155,2.04,BP
GO:0050691,regulation of defense response to virus ...,44,2,0.98,0.25596,1,0.7054292783505155,2.04,BP
GO:0050918,positive chemotaxis,44,2,0.98,0.25596,1,0.7054292783505155,2.04,BP
GO:0051898,negative regulation of protein kinase B ...,44,2,0.98,0.25596,1,0.7054292783505155,2.04,BP
GO:2000279,negative regulation of DNA biosynthetic ...,44,2,0.98,0.25596,1,0.7054292783505155,2.04,BP
GO:0032088,negative regulation of NF-kappaB transcr...,79,3,1.76,0.25665,1,0.7062277186963979,1.7,BP
GO:0072078,nephron tubule morphogenesis,79,3,1.76,0.25665,1,0.7062277186963979,1.7,BP
GO:0033500,carbohydrate homeostasis,271,8,6.02,0.25669,1,0.7062277186963979,1.33,BP
GO:0010927,cellular component assembly involved in ...,116,4,2.58,0.25789,1,0.7091238171428571,1.55,BP
GO:0006937,regulation of muscle contraction,154,5,3.42,0.25835,1,0.7095777397260274,1.46,BP
GO:0046661,male sex differentiation,154,5,3.42,0.25835,1,0.7095777397260274,1.46,BP
GO:0090276,regulation of peptide hormone secretion,232,7,5.16,0.25877,1,0.7102226681870011,1.36,BP
GO:1903530,regulation of secretion by cell,849,22,18.87,0.25888,1,0.7102226681870011,1.17,BP
GO:0007610,behavior,724,19,16.09,0.26045,1,0.714122735042735,1.18,BP
GO:0001838,embryonic epithelial tube formation,155,5,3.44,0.26255,1,0.7163780281690141,1.45,BP
GO:0032675,regulation of interleukin-6 production,155,5,3.44,0.26255,1,0.7163780281690141,1.45,BP
GO:0051053,negative regulation of DNA metabolic pro...,155,5,3.44,0.26255,1,0.7163780281690141,1.45,BP
GO:0030500,regulation of bone mineralization,80,3,1.78,0.26265,1,0.7163780281690141,1.69,BP
GO:0043154,negative regulation of cysteine-type end...,80,3,1.78,0.26265,1,0.7163780281690141,1.69,BP
GO:0043525,positive regulation of neuron apoptotic ...,80,3,1.78,0.26265,1,0.7163780281690141,1.69,BP
GO:0003073,regulation of systemic arterial blood pr...,117,4,2.6,0.26277,1,0.7163780281690141,1.54,BP
GO:0051283,negative regulation of sequestering of c...,117,4,2.6,0.26277,1,0.7163780281690141,1.54,BP
GO:0005978,glycogen biosynthetic process,45,2,1,0.26423,1,0.7163780281690141,2,BP
GO:0006414,translational elongation,45,2,1,0.26423,1,0.7163780281690141,2,BP
GO:0009250,glucan biosynthetic process,45,2,1,0.26423,1,0.7163780281690141,2,BP
GO:0035136,forelimb morphogenesis,45,2,1,0.26423,1,0.7163780281690141,2,BP
GO:0043616,keratinocyte proliferation,45,2,1,0.26423,1,0.7163780281690141,2,BP
GO:0050919,negative chemotaxis,45,2,1,0.26423,1,0.7163780281690141,2,BP
GO:0051646,mitochondrion localization,45,2,1,0.26423,1,0.7163780281690141,2,BP
GO:0060421,positive regulation of heart growth,45,2,1,0.26423,1,0.7163780281690141,2,BP
GO:0061647,histone H3-K9 modification,45,2,1,0.26423,1,0.7163780281690141,2,BP
GO:0071526,semaphorin-plexin signaling pathway,45,2,1,0.26423,1,0.7163780281690141,2,BP
GO:1901381,positive regulation of potassium ion tra...,45,2,1,0.26423,1,0.7163780281690141,2,BP
GO:1904062,regulation of cation transmembrane trans...,354,10,7.87,0.26425,1,0.7163780281690141,1.27,BP
GO:0014020,primary neural tube formation,118,4,2.62,0.26768,1,0.7249141249296567,1.53,BP
GO:0032504,multicellular organism reproduction,854,22,18.98,0.26770,1,0.7249141249296567,1.16,BP
GO:0042147,"retrograde transport, endosome to Golgi",81,3,1.8,0.26867,1,0.7267229005059023,1.67,BP
GO:0072088,nephron epithelium morphogenesis,81,3,1.8,0.26867,1,0.7267229005059023,1.67,BP
GO:0009161,ribonucleoside monophosphate metabolic p...,275,8,6.11,0.26924,1,0.7278555505617977,1.31,BP
GO:0021543,pallium development,157,5,3.49,0.27101,1,0.73115966367713,1.43,BP
GO:0051170,import into nucleus,157,5,3.49,0.27101,1,0.73115966367713,1.43,BP
GO:0051896,regulation of protein kinase B signaling,157,5,3.49,0.27101,1,0.73115966367713,1.43,BP
GO:0006935,chemotaxis,604,16,13.42,0.27107,1,0.73115966367713,1.19,BP
GO:1901361,organic cyclic compound catabolic proces...,521,14,11.58,0.27136,1,0.7315318319327732,1.21,BP
GO:0032409,regulation of transporter activity,276,8,6.13,0.27240,1,0.7324127303182579,1.31,BP
GO:0051607,defense response to virus,236,7,5.24,0.27242,1,0.7324127303182579,1.34,BP
GO:0021772,olfactory bulb development,46,2,1.02,0.27251,1,0.7324127303182579,1.96,BP
GO:0060323,head morphogenesis,46,2,1.02,0.27251,1,0.7324127303182579,1.96,BP
GO:1903580,positive regulation of ATP metabolic pro...,46,2,1.02,0.27251,1,0.7324127303182579,1.96,BP
GO:0051282,regulation of sequestering of calcium io...,119,4,2.64,0.27260,1,0.7324127303182579,1.52,BP
GO:0098609,cell-cell adhesion,731,19,16.25,0.27390,1,0.7351815350389321,1.17,BP
GO:0007165,signal transduction,5929,138,131.76,0.27414,1,0.7351815350389321,1.05,BP
GO:0030308,negative regulation of cell growth,197,6,4.38,0.27468,1,0.7351815350389321,1.37,BP
GO:1903046,meiotic cell cycle process,197,6,4.38,0.27468,1,0.7351815350389321,1.37,BP
GO:0021675,nerve development,82,3,1.82,0.27470,1,0.7351815350389321,1.65,BP
GO:0031646,positive regulation of neurological syst...,82,3,1.82,0.27470,1,0.7351815350389321,1.65,BP
GO:0072028,nephron morphogenesis,82,3,1.82,0.27470,1,0.7351815350389321,1.65,BP
GO:0062013,positive regulation of small molecule me...,158,5,3.51,0.27527,1,0.7358884666666667,1.42,BP
GO:1990845,adaptive thermogenesis,158,5,3.51,0.27527,1,0.7358884666666667,1.42,BP
GO:0044419,interspecies interaction between organis...,399,11,8.87,0.27557,1,0.7362814214325374,1.24,BP
GO:0042330,taxis,607,16,13.49,0.27746,1,0.7407223960066556,1.19,BP
GO:0051208,sequestering of calcium ion,120,4,2.67,0.27754,1,0.7407223960066556,1.5,BP
GO:0008217,regulation of blood pressure,198,6,4.4,0.27847,1,0.7427924833702882,1.36,BP
GO:0009615,response to virus,278,8,6.18,0.27876,1,0.7431540831024931,1.29,BP
GO:0007569,cell aging,159,5,3.53,0.27953,1,0.7447942192691029,1.42,BP
GO:0035050,embryonic heart tube development,83,3,1.84,0.28075,1,0.74605928216455,1.63,BP
GO:0061178,regulation of insulin secretion involved...,83,3,1.84,0.28075,1,0.74605928216455,1.63,BP
GO:1901019,regulation of calcium ion transmembrane ...,83,3,1.84,0.28075,1,0.74605928216455,1.63,BP
GO:0070534,protein K63-linked ubiquitination,47,2,1.04,0.28078,1,0.74605928216455,1.92,BP
GO:0071300,cellular response to retinoic acid,47,2,1.04,0.28078,1,0.74605928216455,1.92,BP
GO:0001817,regulation of cytokine production,693,18,15.4,0.28190,1,0.748124314804623,1.17,BP
GO:0048736,appendage development,199,6,4.42,0.28228,1,0.748124314804623,1.36,BP
GO:0060173,limb development,199,6,4.42,0.28228,1,0.748124314804623,1.36,BP
GO:0036294,cellular response to decreased oxygen le...,121,4,2.69,0.28249,1,0.748124314804623,1.49,BP
GO:0042542,response to hydrogen peroxide,121,4,2.69,0.28249,1,0.748124314804623,1.49,BP
GO:1901216,positive regulation of neuron death,121,4,2.69,0.28249,1,0.748124314804623,1.49,BP
GO:1903169,regulation of calcium ion transmembrane ...,160,5,3.56,0.28381,1,0.7512066666666667,1.4,BP
GO:0001822,kidney development,280,8,6.22,0.28516,1,0.7543649917537109,1.29,BP
GO:0045844,positive regulation of striated muscle t...,84,3,1.87,0.28681,1,0.7563396411092985,1.6,BP
GO:0048636,positive regulation of muscle organ deve...,84,3,1.87,0.28681,1,0.7563396411092985,1.6,BP
GO:0055072,iron ion homeostasis,84,3,1.87,0.28681,1,0.7563396411092985,1.6,BP
GO:0060420,regulation of heart growth,84,3,1.87,0.28681,1,0.7563396411092985,1.6,BP
GO:0001889,liver development,122,4,2.71,0.28746,1,0.7563396411092985,1.48,BP
GO:0008584,male gonad development,122,4,2.71,0.28746,1,0.7563396411092985,1.48,BP
GO:0090277,positive regulation of peptide hormone s...,122,4,2.71,0.28746,1,0.7563396411092985,1.48,BP
GO:0071356,cellular response to tumor necrosis fact...,161,5,3.58,0.28810,1,0.7563396411092985,1.4,BP
GO:0072175,epithelial tube formation,161,5,3.58,0.28810,1,0.7563396411092985,1.4,BP
GO:0046903,secretion,1250,31,27.78,0.28848,1,0.7563396411092985,1.12,BP
GO:0000245,spliceosomal complex assembly,48,2,1.07,0.28905,1,0.7563396411092985,1.87,BP
GO:0001504,neurotransmitter uptake,48,2,1.07,0.28905,1,0.7563396411092985,1.87,BP
GO:0002474,antigen processing and presentation of p...,48,2,1.07,0.28905,1,0.7563396411092985,1.87,BP
GO:0003382,epithelial cell morphogenesis,48,2,1.07,0.28905,1,0.7563396411092985,1.87,BP
GO:0010107,potassium ion import,48,2,1.07,0.28905,1,0.7563396411092985,1.87,BP
GO:0021988,olfactory lobe development,48,2,1.07,0.28905,1,0.7563396411092985,1.87,BP
GO:0031952,regulation of protein autophosphorylatio...,48,2,1.07,0.28905,1,0.7563396411092985,1.87,BP
GO:0038066,p38MAPK cascade,48,2,1.07,0.28905,1,0.7563396411092985,1.87,BP
GO:0044848,biological phase,48,2,1.07,0.28905,1,0.7563396411092985,1.87,BP
GO:0090311,regulation of protein deacetylation,48,2,1.07,0.28905,1,0.7563396411092985,1.87,BP
GO:0002685,regulation of leukocyte migration,201,6,4.47,0.28993,1,0.7578181205866378,1.34,BP
GO:0019058,viral life cycle,201,6,4.47,0.28993,1,0.7578181205866378,1.34,BP
GO:0022414,reproductive process,1467,36,32.6,0.29113,1,0.7605415635179152,1.1,BP
GO:0030072,peptide hormone secretion,282,8,6.27,0.29159,1,0.7605712682137075,1.28,BP
GO:0070482,response to oxygen levels,282,8,6.27,0.29159,1,0.7605712682137075,1.28,BP
GO:0007565,female pregnancy,162,5,3.6,0.29241,1,0.7605712682137075,1.39,BP
GO:0051291,protein heterooligomerization,162,5,3.6,0.29241,1,0.7605712682137075,1.39,BP
GO:0046546,development of primary male sexual chara...,123,4,2.73,0.29243,1,0.7605712682137075,1.47,BP
GO:0048284,organelle fusion,123,4,2.73,0.29243,1,0.7605712682137075,1.47,BP
GO:0000003,reproduction,1468,36,32.62,0.29255,1,0.7605712682137075,1.1,BP
GO:0048524,positive regulation of viral process,85,3,1.89,0.29288,1,0.7605712682137075,1.59,BP
GO:0061333,renal tubule morphogenesis,85,3,1.89,0.29288,1,0.7605712682137075,1.59,BP
GO:1900407,regulation of cellular response to oxida...,85,3,1.89,0.29288,1,0.7605712682137075,1.59,BP
GO:1901863,positive regulation of muscle tissue dev...,85,3,1.89,0.29288,1,0.7605712682137075,1.59,BP
GO:0030522,intracellular receptor signaling pathway,202,6,4.49,0.29377,1,0.762471003236246,1.34,BP
GO:0070588,calcium ion transmembrane transport,283,8,6.29,0.29483,1,0.7648096819407008,1.27,BP
GO:0043901,negative regulation of multi-organism pr...,163,5,3.62,0.29672,1,0.7682152657004832,1.38,BP
GO:0014888,striated muscle adaptation,49,2,1.09,0.29730,1,0.7682152657004832,1.83,BP
GO:0043489,RNA stabilization,49,2,1.09,0.29730,1,0.7682152657004832,1.83,BP
GO:0048483,autonomic nervous system development,49,2,1.09,0.29730,1,0.7682152657004832,1.83,BP
GO:0061912,selective autophagy,49,2,1.09,0.29730,1,0.7682152657004832,1.83,BP
GO:0090199,regulation of release of cytochrome c fr...,49,2,1.09,0.29730,1,0.7682152657004832,1.83,BP
GO:0090342,regulation of cell aging,49,2,1.09,0.29730,1,0.7682152657004832,1.83,BP
GO:0014902,myotube differentiation,124,4,2.76,0.29742,1,0.7682152657004832,1.45,BP
GO:0009123,nucleoside monophosphate metabolic proce...,284,8,6.31,0.29807,1,0.7694811373390559,1.27,BP
GO:0018212,peptidyl-tyrosine modification,325,9,7.22,0.29833,1,0.7697393887399464,1.25,BP
GO:0006970,response to osmotic stress,86,3,1.91,0.29896,1,0.7701260813704497,1.57,BP
GO:0010827,regulation of glucose transmembrane tran...,86,3,1.91,0.29896,1,0.7701260813704497,1.57,BP
GO:0051341,regulation of oxidoreductase activity,86,3,1.91,0.29896,1,0.7701260813704497,1.57,BP
GO:0062012,regulation of small molecule metabolic p...,367,10,8.16,0.30072,1,0.7742453932584269,1.23,BP
GO:0032635,interleukin-6 production,164,5,3.64,0.30105,1,0.7746805347593583,1.37,BP
GO:0003018,vascular process in circulatory system,204,6,4.53,0.30149,1,0.7753981186531267,1.32,BP
GO:0006665,sphingolipid metabolic process,125,4,2.78,0.30242,1,0.7769594447410572,1.44,BP
GO:0061008,hepaticobiliary system development,125,4,2.78,0.30242,1,0.7769594447410572,1.44,BP
GO:0002690,positive regulation of leukocyte chemota...,87,3,1.93,0.30504,1,0.7787386016949153,1.55,BP
GO:0043648,dicarboxylic acid metabolic process,87,3,1.93,0.30504,1,0.7787386016949153,1.55,BP
GO:2000117,negative regulation of cysteine-type end...,87,3,1.93,0.30504,1,0.7787386016949153,1.55,BP
GO:0002792,negative regulation of peptide secretion,165,5,3.67,0.30538,1,0.7787386016949153,1.36,BP
GO:0006360,transcription by RNA polymerase I,50,2,1.11,0.30554,1,0.7787386016949153,1.8,BP
GO:0010828,positive regulation of glucose transmemb...,50,2,1.11,0.30554,1,0.7787386016949153,1.8,BP
GO:0032330,regulation of chondrocyte differentiatio...,50,2,1.11,0.30554,1,0.7787386016949153,1.8,BP
GO:0032941,secretion by tissue,50,2,1.11,0.30554,1,0.7787386016949153,1.8,BP
GO:0035088,establishment or maintenance of apical/b...,50,2,1.11,0.30554,1,0.7787386016949153,1.8,BP
GO:0042491,inner ear auditory receptor cell differe...,50,2,1.11,0.30554,1,0.7787386016949153,1.8,BP
GO:0051055,negative regulation of lipid biosyntheti...,50,2,1.11,0.30554,1,0.7787386016949153,1.8,BP
GO:0060043,regulation of cardiac muscle cell prolif...,50,2,1.11,0.30554,1,0.7787386016949153,1.8,BP
GO:0061245,establishment or maintenance of bipolar ...,50,2,1.11,0.30554,1,0.7787386016949153,1.8,BP
GO:0090329,regulation of DNA-dependent DNA replicat...,50,2,1.11,0.30554,1,0.7787386016949153,1.8,BP
GO:1902930,regulation of alcohol biosynthetic proce...,50,2,1.11,0.30554,1,0.7787386016949153,1.8,BP
GO:0006611,protein export from nucleus,126,4,2.8,0.30743,1,0.7823126176626123,1.43,BP
GO:0007631,feeding behavior,126,4,2.8,0.30743,1,0.7823126176626123,1.43,BP
GO:0055076,transition metal ion homeostasis,126,4,2.8,0.30743,1,0.7823126176626123,1.43,BP
GO:0048568,embryonic organ development,495,13,11,0.30877,1,0.7853072093023256,1.18,BP
GO:0071560,cellular response to transforming growth...,206,6,4.58,0.30924,1,0.7860870998415215,1.31,BP
GO:0048660,regulation of smooth muscle cell prolife...,166,5,3.69,0.30973,1,0.7865017203166227,1.36,BP
GO:1904064,positive regulation of cation transmembr...,166,5,3.69,0.30973,1,0.7865017203166227,1.36,BP
GO:0008544,epidermis development,329,9,7.31,0.31050,1,0.7880411392405063,1.23,BP
GO:0044344,cellular response to fibroblast growth f...,88,3,1.96,0.31114,1,0.7892491723774382,1.53,BP
GO:0002761,regulation of myeloid leukocyte differen...,127,4,2.82,0.31245,1,0.7917374407582938,1.42,BP
GO:0099175,regulation of postsynapse organization,127,4,2.82,0.31245,1,0.7917374407582938,1.42,BP
GO:0001974,blood vessel remodeling,51,2,1.13,0.31376,1,0.792136998950682,1.77,BP
GO:0008038,neuron recognition,51,2,1.13,0.31376,1,0.792136998950682,1.77,BP
GO:0021587,cerebellum morphogenesis,51,2,1.13,0.31376,1,0.792136998950682,1.77,BP
GO:0046189,phenol-containing compound biosynthetic ...,51,2,1.13,0.31376,1,0.792136998950682,1.77,BP
GO:0048247,lymphocyte chemotaxis,51,2,1.13,0.31376,1,0.792136998950682,1.77,BP
GO:0048806,genitalia development,51,2,1.13,0.31376,1,0.792136998950682,1.77,BP
GO:0071470,cellular response to osmotic stress,51,2,1.13,0.31376,1,0.792136998950682,1.77,BP
GO:0007411,axon guidance,248,7,5.51,0.31440,1,0.7933365495542738,1.27,BP
GO:0097305,response to alcohol,208,6,4.62,0.31702,1,0.7983842887029289,1.3,BP
GO:0001656,metanephros development,89,3,1.98,0.31723,1,0.7983842887029289,1.52,BP
GO:0033077,T cell differentiation in thymus,89,3,1.98,0.31723,1,0.7983842887029289,1.52,BP
GO:0035914,skeletal muscle cell differentiation,89,3,1.98,0.31723,1,0.7983842887029289,1.52,BP
GO:1904035,regulation of epithelial cell apoptotic ...,89,3,1.98,0.31723,1,0.7983842887029289,1.52,BP
GO:0071496,cellular response to external stimulus,290,8,6.44,0.31767,1,0.799073727130162,1.24,BP
GO:0051054,positive regulation of DNA metabolic pro...,249,7,5.53,0.31795,1,0.7993601880877743,1.27,BP
GO:0097485,neuron projection guidance,250,7,5.56,0.32151,1,0.8043985046728973,1.26,BP
GO:0000288,nuclear-transcribed mRNA catabolic proce...,52,2,1.16,0.32196,1,0.8043985046728973,1.72,BP
GO:0001662,behavioral fear response,52,2,1.16,0.32196,1,0.8043985046728973,1.72,BP
GO:0006406,mRNA export from nucleus,52,2,1.16,0.32196,1,0.8043985046728973,1.72,BP
GO:0010712,regulation of collagen metabolic process,52,2,1.16,0.32196,1,0.8043985046728973,1.72,BP
GO:0035924,cellular response to vascular endothelia...,52,2,1.16,0.32196,1,0.8043985046728973,1.72,BP
GO:0044058,regulation of digestive system process,52,2,1.16,0.32196,1,0.8043985046728973,1.72,BP
GO:0045981,positive regulation of nucleotide metabo...,52,2,1.16,0.32196,1,0.8043985046728973,1.72,BP
GO:0048713,regulation of oligodendrocyte differenti...,52,2,1.16,0.32196,1,0.8043985046728973,1.72,BP
GO:0071427,mRNA-containing ribonucleoprotein comple...,52,2,1.16,0.32196,1,0.8043985046728973,1.72,BP
GO:1900544,positive regulation of purine nucleotide...,52,2,1.16,0.32196,1,0.8043985046728973,1.72,BP
GO:1903202,negative regulation of oxidative stress-...,52,2,1.16,0.32196,1,0.8043985046728973,1.72,BP
GO:0071774,response to fibroblast growth factor,90,3,2,0.32332,1,0.8069584232365146,1.5,BP
GO:0072091,regulation of stem cell proliferation,90,3,2,0.32332,1,0.8069584232365146,1.5,BP
GO:0006936,muscle contraction,292,8,6.49,0.32426,1,0.8088849766718507,1.23,BP
GO:0009888,tissue development,1970,47,43.78,0.32518,1,0.8107596683937823,1.07,BP
GO:0044703,multi-organism reproductive process,1015,25,22.56,0.32646,1,0.8135295287415846,1.11,BP
GO:0060401,cytosolic calcium ion transport,170,5,3.78,0.32718,1,0.8149017391304348,1.32,BP
GO:0007611,learning or memory,293,8,6.51,0.32757,1,0.8154510294878426,1.23,BP
GO:0007568,aging,252,7,5.6,0.32865,1,0.8163337923946556,1.25,BP
GO:0051348,negative regulation of transferase activ...,252,7,5.6,0.32865,1,0.8163337923946556,1.25,BP
GO:0040013,negative regulation of locomotion,335,9,7.44,0.32896,1,0.8163337923946556,1.21,BP
GO:0006112,energy reserve metabolic process,91,3,2.02,0.32942,1,0.8163337923946556,1.49,BP
GO:0006476,protein deacetylation,91,3,2.02,0.32942,1,0.8163337923946556,1.49,BP
GO:0014015,positive regulation of gliogenesis,91,3,2.02,0.32942,1,0.8163337923946556,1.49,BP
GO:0035773,insulin secretion involved in cellular r...,91,3,2.02,0.32942,1,0.8163337923946556,1.49,BP
GO:0002209,behavioral defense response,53,2,1.18,0.33013,1,0.8163337923946556,1.69,BP
GO:0030850,prostate gland development,53,2,1.18,0.33013,1,0.8163337923946556,1.69,BP
GO:0042743,hydrogen peroxide metabolic process,53,2,1.18,0.33013,1,0.8163337923946556,1.69,BP
GO:0045214,sarcomere organization,53,2,1.18,0.33013,1,0.8163337923946556,1.69,BP
GO:0046834,lipid phosphorylation,53,2,1.18,0.33013,1,0.8163337923946556,1.69,BP
GO:1900408,negative regulation of cellular response...,53,2,1.18,0.33013,1,0.8163337923946556,1.69,BP
GO:0007612,learning,171,5,3.8,0.33157,1,0.8190527926078027,1.32,BP
GO:0048659,smooth muscle cell proliferation,171,5,3.8,0.33157,1,0.8190527926078027,1.32,BP
GO:0034470,ncRNA processing,336,9,7.47,0.33206,1,0.8198423396613649,1.2,BP
GO:2000027,regulation of animal organ morphogenesis,212,6,4.71,0.33268,1,0.8209518769230768,1.27,BP
GO:0048878,chemical homeostasis,1192,29,26.49,0.33351,1,0.8225782265504868,1.09,BP
GO:0009798,axis specification,92,3,2.04,0.33552,1,0.8262652200614125,1.47,BP
GO:0042770,signal transduction in response to DNA d...,92,3,2.04,0.33552,1,0.8262652200614125,1.47,BP
GO:0072655,establishment of protein localization to...,92,3,2.04,0.33552,1,0.8262652200614125,1.47,BP
GO:0009855,determination of bilateral symmetry,132,4,2.93,0.33763,1,0.8288204480651732,1.37,BP
GO:0043467,regulation of generation of precursor me...,132,4,2.93,0.33763,1,0.8288204480651732,1.37,BP
GO:0006289,nucleotide-excision repair,54,2,1.2,0.33828,1,0.8288204480651732,1.67,BP
GO:0010517,regulation of phospholipase activity,54,2,1.2,0.33828,1,0.8288204480651732,1.67,BP
GO:0034113,heterotypic cell-cell adhesion,54,2,1.2,0.33828,1,0.8288204480651732,1.67,BP
GO:0043392,negative regulation of DNA binding,54,2,1.2,0.33828,1,0.8288204480651732,1.67,BP
GO:0055025,positive regulation of cardiac muscle ti...,54,2,1.2,0.33828,1,0.8288204480651732,1.67,BP
GO:0061900,glial cell activation,54,2,1.2,0.33828,1,0.8288204480651732,1.67,BP
GO:0070265,necrotic cell death,54,2,1.2,0.33828,1,0.8288204480651732,1.67,BP
GO:0098815,modulation of excitatory postsynaptic po...,54,2,1.2,0.33828,1,0.8288204480651732,1.67,BP
GO:0002262,myeloid cell homeostasis,173,5,3.84,0.34034,1,0.8334432977099235,1.3,BP
GO:0060562,epithelial tube morphogenesis,381,10,8.47,0.34130,1,0.8351400915099135,1.18,BP
GO:0045862,positive regulation of proteolysis,339,9,7.53,0.34138,1,0.8351400915099135,1.2,BP
GO:0060395,SMAD protein signal transduction,93,3,2.07,0.34161,1,0.8352781097560977,1.45,BP
GO:0001841,neural tube formation,133,4,2.96,0.34267,1,0.8370193096446701,1.35,BP
GO:0009799,specification of symmetry,133,4,2.96,0.34267,1,0.8370193096446701,1.35,BP
GO:0051100,negative regulation of binding,174,5,3.87,0.34474,1,0.8416483409436835,1.29,BP
GO:0021575,hindbrain morphogenesis,55,2,1.22,0.34640,1,0.8418569696969697,1.64,BP
GO:0021795,cerebral cortex cell migration,55,2,1.22,0.34640,1,0.8418569696969697,1.64,BP
GO:0030166,proteoglycan biosynthetic process,55,2,1.22,0.34640,1,0.8418569696969697,1.64,BP
GO:0035306,positive regulation of dephosphorylation,55,2,1.22,0.34640,1,0.8418569696969697,1.64,BP
GO:0035315,hair cell differentiation,55,2,1.22,0.34640,1,0.8418569696969697,1.64,BP
GO:0043030,regulation of macrophage activation,55,2,1.22,0.34640,1,0.8418569696969697,1.64,BP
GO:0045599,negative regulation of fat cell differen...,55,2,1.22,0.34640,1,0.8418569696969697,1.64,BP
GO:0046902,regulation of mitochondrial membrane per...,55,2,1.22,0.34640,1,0.8418569696969697,1.64,BP
GO:1900024,regulation of substrate adhesion-depende...,55,2,1.22,0.34640,1,0.8418569696969697,1.64,BP
GO:0035690,cellular response to drug,383,10,8.51,0.34718,1,0.8433266834931853,1.18,BP
GO:0042116,macrophage activation,94,3,2.09,0.34770,1,0.8433612096774192,1.44,BP
GO:1902882,regulation of response to oxidative stre...,94,3,2.09,0.34770,1,0.8433612096774192,1.44,BP
GO:0061025,membrane fusion,134,4,2.98,0.34772,1,0.8433612096774192,1.34,BP
GO:0009913,epidermal cell differentiation,216,6,4.8,0.34843,1,0.8442322054380665,1.25,BP
GO:0045637,regulation of myeloid cell differentiati...,216,6,4.8,0.34843,1,0.8442322054380665,1.25,BP
GO:0031644,regulation of neurological system proces...,175,5,3.89,0.34914,1,0.8455267639657776,1.29,BP
GO:0042493,response to drug,898,22,19.96,0.34963,1,0.8462875050301811,1.1,BP
GO:0071453,cellular response to oxygen levels,135,4,3,0.35277,1,0.8472532102962604,1.33,BP
GO:0007389,pattern specification process,470,12,10.44,0.35326,1,0.8472532102962604,1.15,BP
GO:0006906,vesicle fusion,95,3,2.11,0.35378,1,0.8472532102962604,1.42,BP
GO:0060021,roof of mouth development,95,3,2.11,0.35378,1,0.8472532102962604,1.42,BP
GO:1903578,regulation of ATP metabolic process,95,3,2.11,0.35378,1,0.8472532102962604,1.42,BP
GO:0048705,skeletal system morphogenesis,259,7,5.76,0.35383,1,0.8472532102962604,1.22,BP
GO:0060326,cell chemotaxis,301,8,6.69,0.35420,1,0.8472532102962604,1.2,BP
GO:0002204,somatic recombination of immunoglobulin ...,56,2,1.24,0.35448,1,0.8472532102962604,1.61,BP
GO:0002208,somatic diversification of immunoglobuli...,56,2,1.24,0.35448,1,0.8472532102962604,1.61,BP
GO:0006879,cellular iron ion homeostasis,56,2,1.24,0.35448,1,0.8472532102962604,1.61,BP
GO:0006911,"phagocytosis, engulfment",56,2,1.24,0.35448,1,0.8472532102962604,1.61,BP
GO:0035019,somatic stem cell population maintenance,56,2,1.24,0.35448,1,0.8472532102962604,1.61,BP
GO:0042596,fear response,56,2,1.24,0.35448,1,0.8472532102962604,1.61,BP
GO:0043330,response to exogenous dsRNA,56,2,1.24,0.35448,1,0.8472532102962604,1.61,BP
GO:0043620,regulation of DNA-templated transcriptio...,56,2,1.24,0.35448,1,0.8472532102962604,1.61,BP
GO:0045190,isotype switching,56,2,1.24,0.35448,1,0.8472532102962604,1.61,BP
GO:0048538,thymus development,56,2,1.24,0.35448,1,0.8472532102962604,1.61,BP
GO:0060760,positive regulation of response to cytok...,56,2,1.24,0.35448,1,0.8472532102962604,1.61,BP
GO:0099172,presynapse organization,56,2,1.24,0.35448,1,0.8472532102962604,1.61,BP
GO:1902883,negative regulation of response to oxida...,56,2,1.24,0.35448,1,0.8472532102962604,1.61,BP
GO:0001816,cytokine production,771,19,17.13,0.35484,1,0.8472532102962604,1.11,BP
GO:0070374,positive regulation of ERK1 and ERK2 cas...,218,6,4.84,0.35633,1,0.8472532102962604,1.24,BP
GO:0090596,sensory organ morphogenesis,302,8,6.71,0.35755,1,0.8472532102962604,1.19,BP
GO:0097553,calcium ion transmembrane import into cy...,136,4,3.02,0.35783,1,0.8472532102962604,1.32,BP
GO:1903322,positive regulation of protein modificat...,136,4,3.02,0.35783,1,0.8472532102962604,1.32,BP
GO:0046916,cellular transition metal ion homeostasi...,96,3,2.13,0.35985,1,0.8472532102962604,1.41,BP
GO:0001655,urogenital system development,345,9,7.67,0.36014,1,0.8472532102962604,1.17,BP
GO:0043547,positive regulation of GTPase activity,219,6,4.87,0.36028,1,0.8472532102962604,1.23,BP
GO:0048738,cardiac muscle tissue development,261,7,5.8,0.36106,1,0.8472532102962604,1.21,BP
GO:0006525,arginine metabolic process,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0019430,removal of superoxide radicals,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0032095,regulation of response to food,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0032148,activation of protein kinase B activity,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0033599,regulation of mammary gland epithelial c...,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0033605,positive regulation of catecholamine sec...,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0033630,positive regulation of cell adhesion med...,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0033962,cytoplasmic mRNA processing body assembl...,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0035855,megakaryocyte development,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0042451,purine nucleoside biosynthetic process,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0043931,ossification involved in bone maturation,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0045821,positive regulation of glycolytic proces...,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0045986,negative regulation of smooth muscle con...,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0046129,purine ribonucleoside biosynthetic proce...,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0048172,regulation of short-term neuronal synapt...,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0050434,positive regulation of viral transcripti...,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0051481,negative regulation of cytosolic calcium...,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0060252,positive regulation of glial cell prolif...,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0060307,regulation of ventricular cardiac muscle...,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0070828,heterochromatin organization,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0072079,nephron tubule formation,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0072087,renal vesicle development,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0072520,seminiferous tubule development,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0090036,regulation of protein kinase C signaling,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0090502,"RNA phosphodiester bond hydrolysis, endo...",20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:1900409,positive regulation of cellular response...,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:1900451,positive regulation of glutamate recepto...,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:1903392,negative regulation of adherens junction...,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:1903975,regulation of glial cell migration,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:1904994,regulation of leukocyte adhesion to vasc...,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:1990403,embryonic brain development,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:2000136,regulation of cell proliferation involve...,20,1,0.44,0.36217,1,0.8472532102962604,2.27,BP
GO:0048489,synaptic vesicle transport,178,5,3.96,0.36235,1,0.8472532102962604,1.26,BP
GO:0097480,establishment of synaptic vesicle locali...,178,5,3.96,0.36235,1,0.8472532102962604,1.26,BP
GO:0010823,negative regulation of mitochondrion org...,57,2,1.27,0.36253,1,0.8472532102962604,1.57,BP
GO:0021517,ventral spinal cord development,57,2,1.27,0.36253,1,0.8472532102962604,1.57,BP
GO:0046622,positive regulation of organ growth,57,2,1.27,0.36253,1,0.8472532102962604,1.57,BP
GO:0046676,negative regulation of insulin secretion,57,2,1.27,0.36253,1,0.8472532102962604,1.57,BP
GO:0050854,regulation of antigen receptor-mediated ...,57,2,1.27,0.36253,1,0.8472532102962604,1.57,BP
GO:0051196,regulation of coenzyme metabolic process,57,2,1.27,0.36253,1,0.8472532102962604,1.57,BP
GO:0072347,response to anesthetic,57,2,1.27,0.36253,1,0.8472532102962604,1.57,BP
GO:0072577,endothelial cell apoptotic process,57,2,1.27,0.36253,1,0.8472532102962604,1.57,BP
GO:1903364,positive regulation of cellular protein ...,137,4,3.04,0.36288,1,0.8476594951456311,1.32,BP
GO:0021761,limbic system development,97,3,2.16,0.36592,1,0.8531041860465117,1.39,BP
GO:0046888,negative regulation of hormone secretion,97,3,2.16,0.36592,1,0.8531041860465117,1.39,BP
GO:0070167,regulation of biomineral tissue developm...,97,3,2.16,0.36592,1,0.8531041860465117,1.39,BP
GO:0071482,cellular response to light stimulus,97,3,2.16,0.36592,1,0.8531041860465117,1.39,BP
GO:0001659,temperature homeostasis,179,5,3.98,0.36676,1,0.8546484842615011,1.26,BP
GO:0061512,protein localization to cilium,58,2,1.29,0.37054,1,0.8615815033301617,1.55,BP
GO:2001237,negative regulation of extrinsic apoptot...,98,3,2.18,0.37198,1,0.8615815033301617,1.38,BP
GO:0034101,erythrocyte homeostasis,139,4,3.09,0.37297,1,0.8615815033301617,1.29,BP
GO:0050730,regulation of peptidyl-tyrosine phosphor...,265,7,5.89,0.37555,1,0.8615815033301617,1.19,BP
GO:0019953,sexual reproduction,868,21,19.29,0.37599,1,0.8615815033301617,1.09,BP
GO:0031348,negative regulation of defense response,223,6,4.96,0.37612,1,0.8615815033301617,1.21,BP
GO:0061138,morphogenesis of a branching epithelium,223,6,4.96,0.37612,1,0.8615815033301617,1.21,BP
GO:0000466,maturation of 5.8S rRNA from tricistroni...,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0000469,cleavage involved in rRNA processing,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0002495,antigen processing and presentation of p...,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0006120,"mitochondrial electron transport, NADH t...",21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0006516,glycoprotein catabolic process,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0006907,pinocytosis,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0010560,positive regulation of glycoprotein bios...,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0017000,antibiotic biosynthetic process,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0022010,central nervous system myelination,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0030813,positive regulation of nucleotide catabo...,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0031290,retinal ganglion cell axon guidance,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0032291,axon ensheathment in central nervous sys...,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0034694,response to prostaglandin,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0036336,dendritic cell migration,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0042053,regulation of dopamine metabolic process,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0043369,"CD4-positive or CD8-positive, alpha-beta...",21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0043586,tongue development,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0044346,fibroblast apoptotic process,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0046174,polyol catabolic process,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0050908,detection of light stimulus involved in ...,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0050962,detection of light stimulus involved in ...,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0051197,positive regulation of coenzyme metaboli...,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0051770,positive regulation of nitric-oxide synt...,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0061323,cell proliferation involved in heart mor...,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0070633,transepithelial transport,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0140058,neuron projection arborization,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:1900101,regulation of endoplasmic reticulum unfo...,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:1900151,regulation of nuclear-transcribed mRNA c...,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:1901017,negative regulation of potassium ion tra...,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:2000482,regulation of interleukin-8 secretion,21,1,0.47,0.37636,1,0.8615815033301617,2.13,BP
GO:0043473,pigmentation,99,3,2.2,0.37802,1,0.8636045519203414,1.36,BP
GO:0001755,neural crest cell migration,59,2,1.31,0.37850,1,0.8636045519203414,1.53,BP
GO:0032835,glomerulus development,59,2,1.31,0.37850,1,0.8636045519203414,1.53,BP
GO:0042775,mitochondrial ATP synthesis coupled elec...,59,2,1.31,0.37850,1,0.8636045519203414,1.53,BP
GO:0043954,cellular component maintenance,59,2,1.31,0.37850,1,0.8636045519203414,1.53,BP
GO:0045806,negative regulation of endocytosis,59,2,1.31,0.37850,1,0.8636045519203414,1.53,BP
GO:1903902,positive regulation of viral life cycle,59,2,1.31,0.37850,1,0.8636045519203414,1.53,BP
GO:0031668,cellular response to extracellular stimu...,224,6,4.98,0.38009,1,0.8668213649289098,1.2,BP
GO:0051048,negative regulation of secretion,267,7,5.93,0.38281,1,0.8673379953810625,1.18,BP
GO:0046165,alcohol biosynthetic process,141,4,3.13,0.38306,1,0.8673379953810625,1.28,BP
GO:0021515,cell differentiation in spinal cord,60,2,1.33,0.38643,1,0.8673379953810625,1.5,BP
GO:0060324,face development,60,2,1.33,0.38643,1,0.8673379953810625,1.5,BP
GO:0060986,endocrine hormone secretion,60,2,1.33,0.38643,1,0.8673379953810625,1.5,BP
GO:0070098,chemokine-mediated signaling pathway,60,2,1.33,0.38643,1,0.8673379953810625,1.5,BP
GO:0055088,lipid homeostasis,142,4,3.16,0.38809,1,0.8673379953810625,1.27,BP
GO:0016331,morphogenesis of embryonic epithelium,184,5,4.09,0.38881,1,0.8673379953810625,1.22,BP
GO:0006119,oxidative phosphorylation,101,3,2.24,0.39008,1,0.8673379953810625,1.34,BP
GO:0033559,unsaturated fatty acid metabolic process,101,3,2.24,0.39008,1,0.8673379953810625,1.34,BP
GO:0055024,regulation of cardiac muscle tissue deve...,101,3,2.24,0.39008,1,0.8673379953810625,1.34,BP
GO:0000470,maturation of LSU-rRNA,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0002504,antigen processing and presentation of p...,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0002834,regulation of response to tumor cell,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0002837,regulation of immune response to tumor c...,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0003084,positive regulation of systemic arterial...,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0003094,glomerular filtration,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0006837,serotonin transport,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0007130,synaptonemal complex assembly,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0009110,vitamin biosynthetic process,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0016048,detection of temperature stimulus,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0018230,peptidyl-L-cysteine S-palmitoylation,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0018231,peptidyl-S-diacylglycerol-L-cysteine bio...,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0021516,dorsal spinal cord development,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0032098,regulation of appetite,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0032462,regulation of protein homooligomerizatio...,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0032780,negative regulation of ATPase activity,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0032930,positive regulation of superoxide anion ...,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0033008,positive regulation of mast cell activat...,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0036314,response to sterol,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0042069,regulation of catecholamine metabolic pr...,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0042438,melanin biosynthetic process,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0043306,positive regulation of mast cell degranu...,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0044851,hair cycle phase,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0046597,negative regulation of viral entry into ...,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0046823,negative regulation of nucleocytoplasmic...,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0048339,paraxial mesoderm development,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0048486,parasympathetic nervous system developme...,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0051797,regulation of hair follicle development,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0060438,trachea development,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0060749,mammary gland alveolus development,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0061377,mammary gland lobule development,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0070977,bone maturation,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0071359,cellular response to dsRNA,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0071450,cellular response to oxygen radical,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0071451,cellular response to superoxide,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0071459,"protein localization to chromosome, cent...",22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0071800,podosome assembly,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0072111,cell proliferation involved in kidney de...,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0072273,metanephric nephron morphogenesis,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0090201,negative regulation of release of cytoch...,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0097062,dendritic spine maintenance,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0099625,ventricular cardiac muscle cell membrane...,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:2000010,positive regulation of protein localizat...,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:2000353,positive regulation of endothelial cell ...,22,1,0.49,0.39023,1,0.8673379953810625,2.04,BP
GO:0006066,alcohol metabolic process,312,8,6.93,0.39118,1,0.8690480886426594,1.15,BP
GO:0006493,protein O-linked glycosylation,61,2,1.36,0.39431,1,0.8743869677419354,1.47,BP
GO:0016447,somatic recombination of immunoglobulin ...,61,2,1.36,0.39431,1,0.8743869677419354,1.47,BP
GO:0021695,cerebellar cortex development,61,2,1.36,0.39431,1,0.8743869677419354,1.47,BP
GO:1905207,regulation of cardiocyte differentiation,61,2,1.36,0.39431,1,0.8743869677419354,1.47,BP
GO:0021510,spinal cord development,102,3,2.27,0.39608,1,0.8770993833410031,1.32,BP
GO:0035601,protein deacylation,102,3,2.27,0.39608,1,0.8770993833410031,1.32,BP
GO:0098732,macromolecule deacylation,102,3,2.27,0.39608,1,0.8770993833410031,1.32,BP
GO:0009167,purine ribonucleoside monophosphate meta...,271,7,6.02,0.39734,1,0.8777879132791329,1.16,BP
GO:0048754,branching morphogenesis of an epithelial...,186,5,4.13,0.39761,1,0.8777879132791329,1.21,BP
GO:0002687,positive regulation of leukocyte migrati...,144,4,3.2,0.39814,1,0.8777879132791329,1.25,BP
GO:0009267,cellular response to starvation,144,4,3.2,0.39814,1,0.8777879132791329,1.25,BP
GO:0009126,purine nucleoside monophosphate metaboli...,272,7,6.04,0.40098,1,0.8777879132791329,1.16,BP
GO:0030198,extracellular matrix organization,272,7,6.04,0.40098,1,0.8777879132791329,1.16,BP
GO:0019218,regulation of steroid metabolic process,103,3,2.29,0.40207,1,0.8777879132791329,1.31,BP
GO:0048709,oligodendrocyte differentiation,103,3,2.29,0.40207,1,0.8777879132791329,1.31,BP
GO:0051897,positive regulation of protein kinase B ...,103,3,2.29,0.40207,1,0.8777879132791329,1.31,BP
GO:0001836,release of cytochrome c from mitochondri...,62,2,1.38,0.40215,1,0.8777879132791329,1.45,BP
GO:0007040,lysosome organization,62,2,1.38,0.40215,1,0.8777879132791329,1.45,BP
GO:0010171,body morphogenesis,62,2,1.38,0.40215,1,0.8777879132791329,1.45,BP
GO:0080171,lytic vacuole organization,62,2,1.38,0.40215,1,0.8777879132791329,1.45,BP
GO:0030326,embryonic limb morphogenesis,145,4,3.22,0.40316,1,0.8777879132791329,1.24,BP
GO:0035113,embryonic appendage morphogenesis,145,4,3.22,0.40316,1,0.8777879132791329,1.24,BP
GO:0002093,auditory receptor cell morphogenesis,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:0002719,negative regulation of cytokine producti...,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:0006346,methylation-dependent chromatin silencin...,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:0010874,regulation of cholesterol efflux,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:0022403,cell cycle phase,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:0030539,male genitalia development,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:0032495,response to muramyl dipeptide,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:0033145,positive regulation of intracellular ste...,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:0045056,transcytosis,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:0045943,positive regulation of transcription by ...,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:0048532,anatomical structure arrangement,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:0050765,negative regulation of phagocytosis,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:0060080,inhibitory postsynaptic potential,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:0070269,pyroptosis,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:0071276,cellular response to cadmium ion,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:0071475,cellular hyperosmotic salinity response,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:0097205,renal filtration,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:0098869,cellular oxidant detoxification,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:0099149,regulation of postsynaptic neurotransmit...,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:1900242,regulation of synaptic vesicle endocytos...,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:1902410,mitotic cytokinetic process,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:1902884,positive regulation of response to oxida...,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:1903020,positive regulation of glycoprotein meta...,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:1903077,negative regulation of protein localizat...,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:2000831,regulation of steroid hormone secretion,23,1,0.51,0.40380,1,0.8777879132791329,1.96,BP
GO:1901617,organic hydroxy compound biosynthetic pr...,230,6,5.11,0.40387,1,0.8777879132791329,1.17,BP
GO:0051924,regulation of calcium ion transport,273,7,6.07,0.40461,1,0.8789992415349887,1.15,BP
GO:0051259,protein complex oligomerization,620,15,13.78,0.40543,1,0.8803831949458485,1.09,BP
GO:0001657,ureteric bud development,104,3,2.31,0.40805,1,0.8840777127420082,1.3,BP
GO:0002367,cytokine production involved in immune r...,104,3,2.31,0.40805,1,0.8840777127420082,1.3,BP
GO:0072163,mesonephric epithelium development,104,3,2.31,0.40805,1,0.8840777127420082,1.3,BP
GO:0072164,mesonephric tubule development,104,3,2.31,0.40805,1,0.8840777127420082,1.3,BP
GO:2001022,positive regulation of response to DNA d...,104,3,2.31,0.40805,1,0.8840777127420082,1.3,BP
GO:0032722,positive regulation of chemokine product...,63,2,1.4,0.40994,1,0.885779649753031,1.43,BP
GO:0042246,tissue regeneration,63,2,1.4,0.40994,1,0.885779649753031,1.43,BP
GO:0042773,ATP synthesis coupled electron transport,63,2,1.4,0.40994,1,0.885779649753031,1.43,BP
GO:0043331,response to dsRNA,63,2,1.4,0.40994,1,0.885779649753031,1.43,BP
GO:0043949,regulation of cAMP-mediated signaling,63,2,1.4,0.40994,1,0.885779649753031,1.43,BP
GO:2000242,negative regulation of reproductive proc...,63,2,1.4,0.40994,1,0.885779649753031,1.43,BP
GO:0097479,synaptic vesicle localization,189,5,4.2,0.41080,1,0.8872394973070019,1.19,BP
GO:0009952,anterior/posterior pattern specification,232,6,5.16,0.41179,1,0.8885800358744395,1.16,BP
GO:0060348,bone development,232,6,5.16,0.41179,1,0.8885800358744395,1.16,BP
GO:0002224,toll-like receptor signaling pathway,105,3,2.33,0.41400,1,0.8915560728565082,1.29,BP
GO:0051271,negative regulation of cellular componen...,319,8,7.09,0.41480,1,0.8915560728565082,1.13,BP
GO:0043491,protein kinase B signaling,190,5,4.22,0.41519,1,0.8915560728565082,1.18,BP
GO:0002418,immune response to tumor cell,24,1,0.53,0.41706,1,0.8915560728565082,1.89,BP
GO:0006312,mitotic recombination,24,1,0.53,0.41706,1,0.8915560728565082,1.89,BP
GO:0006582,melanin metabolic process,24,1,0.53,0.41706,1,0.8915560728565082,1.89,BP
GO:0007205,protein kinase C-activating G protein-co...,24,1,0.53,0.41706,1,0.8915560728565082,1.89,BP
GO:0009154,purine ribonucleotide catabolic process,24,1,0.53,0.41706,1,0.8915560728565082,1.89,BP
GO:0009261,ribonucleotide catabolic process,24,1,0.53,0.41706,1,0.8915560728565082,1.89,BP
GO:0016578,histone deubiquitination,24,1,0.53,0.41706,1,0.8915560728565082,1.89,BP
GO:0019068,virion assembly,24,1,0.53,0.41706,1,0.8915560728565082,1.89,BP
GO:0021889,olfactory bulb interneuron differentiati...,24,1,0.53,0.41706,1,0.8915560728565082,1.89,BP
GO:0030903,notochord development,24,1,0.53,0.41706,1,0.8915560728565082,1.89,BP
GO:0032878,regulation of establishment or maintenan...,24,1,0.53,0.41706,1,0.8915560728565082,1.89,BP
GO:0033233,regulation of protein sumoylation,24,1,0.53,0.41706,1,0.8915560728565082,1.89,BP
GO:0035561,regulation of chromatin binding,24,1,0.53,0.41706,1,0.8915560728565082,1.89,BP
GO:0046685,response to arsenic-containing substance,24,1,0.53,0.41706,1,0.8915560728565082,1.89,BP
GO:0050687,negative regulation of defense response ...,24,1,0.53,0.41706,1,0.8915560728565082,1.89,BP
GO:0051602,response to electrical stimulus,24,1,0.53,0.41706,1,0.8915560728565082,1.89,BP
GO:0099623,regulation of cardiac muscle cell membra...,24,1,0.53,0.41706,1,0.8915560728565082,1.89,BP
GO:1902683,regulation of receptor localization to s...,24,1,0.53,0.41706,1,0.8915560728565082,1.89,BP
GO:0010830,regulation of myotube differentiation,64,2,1.42,0.41767,1,0.892067483355526,1.41,BP
GO:0045840,positive regulation of mitotic nuclear d...,64,2,1.42,0.41767,1,0.892067483355526,1.41,BP
GO:0008643,carbohydrate transport,148,4,3.29,0.41816,1,0.8927177994676131,1.22,BP
GO:0032091,negative regulation of protein binding,106,3,2.36,0.41994,1,0.8953262206468763,1.27,BP
GO:0048024,"regulation of mRNA splicing, via spliceo...",106,3,2.36,0.41994,1,0.8953262206468763,1.27,BP
GO:1903844,regulation of cellular response to trans...,106,3,2.36,0.41994,1,0.8953262206468763,1.27,BP
GO:0044706,multi-multicellular organism process,192,5,4.27,0.42394,1,0.8981355729166667,1.17,BP
GO:0018108,peptidyl-tyrosine phosphorylation,322,8,7.16,0.42491,1,0.8981355729166667,1.12,BP
GO:0060042,retina morphogenesis in camera-type eye,65,2,1.44,0.42536,1,0.8981355729166667,1.39,BP
GO:0150076,neuroinflammatory response,65,2,1.44,0.42536,1,0.8981355729166667,1.39,BP
GO:2000736,regulation of stem cell differentiation,65,2,1.44,0.42536,1,0.8981355729166667,1.39,BP
GO:0007154,cell communication,6556,148,145.7,0.42552,1,0.8981355729166667,1.02,BP
GO:0001823,mesonephros development,107,3,2.38,0.42585,1,0.8981355729166667,1.26,BP
GO:0055006,cardiac cell development,107,3,2.38,0.42585,1,0.8981355729166667,1.26,BP
GO:0060840,artery development,107,3,2.38,0.42585,1,0.8981355729166667,1.26,BP
GO:0050804,modulation of chemical synaptic transmis...,673,16,14.96,0.42726,1,0.8981355729166667,1.07,BP
GO:0021915,neural tube development,193,5,4.29,0.42831,1,0.8981355729166667,1.17,BP
GO:0071345,cellular response to cytokine stimulus,938,22,20.85,0.42839,1,0.8981355729166667,1.06,BP
GO:0099177,regulation of trans-synaptic signaling,674,16,14.98,0.42959,1,0.8981355729166667,1.07,BP
GO:0000303,response to superoxide,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0009065,glutamine family amino acid catabolic pr...,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0010165,response to X-ray,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0010894,negative regulation of steroid biosynthe...,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0014821,phasic smooth muscle contraction,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0032373,positive regulation of sterol transport,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0032376,positive regulation of cholesterol trans...,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0032480,negative regulation of type I interferon...,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0032928,regulation of superoxide anion generatio...,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0033522,histone H2A ubiquitination,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0035024,negative regulation of Rho protein signa...,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0035455,response to interferon-alpha,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0045648,positive regulation of erythrocyte diffe...,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0045939,negative regulation of steroid metabolic...,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0046426,negative regulation of JAK-STAT cascade,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0048148,behavioral response to cocaine,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0051443,positive regulation of ubiquitin-protein...,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0055094,response to lipoprotein particle,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0060004,reflex,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0070050,neuron cellular homeostasis,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0070193,synaptonemal complex organization,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0071711,basement membrane organization,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0072606,interleukin-8 secretion,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0085029,extracellular matrix assembly,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0095500,acetylcholine receptor signaling pathway,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0098810,neurotransmitter reuptake,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:1901032,negative regulation of response to react...,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:1901798,positive regulation of signal transducti...,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:1903206,negative regulation of hydrogen peroxide...,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:1903747,regulation of establishment of protein l...,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:1903831,signal transduction involved in cellular...,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:1904376,negative regulation of protein localizat...,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:2000637,positive regulation of gene silencing by...,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:2001039,negative regulation of cellular response...,25,1,0.56,0.43003,1,0.8981355729166667,1.79,BP
GO:0035725,sodium ion transmembrane transport,108,3,2.4,0.43175,1,0.8984903078869674,1.25,BP
GO:0003407,neural retina development,66,2,1.47,0.43299,1,0.8984903078869674,1.36,BP
GO:0009064,glutamine family amino acid metabolic pr...,66,2,1.47,0.43299,1,0.8984903078869674,1.36,BP
GO:0042440,pigment metabolic process,66,2,1.47,0.43299,1,0.8984903078869674,1.36,BP
GO:0043647,inositol phosphate metabolic process,66,2,1.47,0.43299,1,0.8984903078869674,1.36,BP
GO:0045123,cellular extravasation,66,2,1.47,0.43299,1,0.8984903078869674,1.36,BP
GO:0046324,regulation of glucose import,66,2,1.47,0.43299,1,0.8984903078869674,1.36,BP
GO:0071260,cellular response to mechanical stimulus,66,2,1.47,0.43299,1,0.8984903078869674,1.36,BP
GO:0086003,cardiac muscle cell contraction,66,2,1.47,0.43299,1,0.8984903078869674,1.36,BP
GO:1903845,negative regulation of cellular response...,66,2,1.47,0.43299,1,0.8984903078869674,1.36,BP
GO:0046879,hormone secretion,369,9,8.2,0.43593,1,0.8984903078869674,1.1,BP
GO:0031669,cellular response to nutrient levels,195,5,4.33,0.43704,1,0.8984903078869674,1.15,BP
GO:0001942,hair follicle development,109,3,2.42,0.43762,1,0.8984903078869674,1.24,BP
GO:0019882,antigen processing and presentation,109,3,2.42,0.43762,1,0.8984903078869674,1.24,BP
GO:0021987,cerebral cortex development,109,3,2.42,0.43762,1,0.8984903078869674,1.24,BP
GO:1900542,regulation of purine nucleotide metaboli...,109,3,2.42,0.43762,1,0.8984903078869674,1.24,BP
GO:0050728,negative regulation of inflammatory resp...,152,4,3.38,0.43802,1,0.8984903078869674,1.18,BP
GO:0007507,heart development,634,15,14.09,0.43926,1,0.8984903078869674,1.06,BP
GO:0002381,immunoglobulin production involved in im...,67,2,1.49,0.44057,1,0.8984903078869674,1.34,BP
GO:0003143,embryonic heart tube morphogenesis,67,2,1.49,0.44057,1,0.8984903078869674,1.34,BP
GO:0006940,regulation of smooth muscle contraction,67,2,1.49,0.44057,1,0.8984903078869674,1.34,BP
GO:0016445,somatic diversification of immunoglobuli...,67,2,1.49,0.44057,1,0.8984903078869674,1.34,BP
GO:0045739,positive regulation of DNA repair,67,2,1.49,0.44057,1,0.8984903078869674,1.34,BP
GO:0090559,regulation of membrane permeability,67,2,1.49,0.44057,1,0.8984903078869674,1.34,BP
GO:2000179,positive regulation of neural precursor ...,67,2,1.49,0.44057,1,0.8984903078869674,1.34,BP
GO:0050731,positive regulation of peptidyl-tyrosine...,196,5,4.36,0.44138,1,0.8984903078869674,1.15,BP
GO:0050890,cognition,327,8,7.27,0.44173,1,0.8984903078869674,1.1,BP
GO:0002478,antigen processing and presentation of e...,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0007176,regulation of epidermal growth factor-ac...,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0007413,axonal fasciculation,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0009299,mRNA transcription,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0009394,2'-deoxyribonucleotide metabolic process,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0009713,catechol-containing compound biosyntheti...,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0010863,positive regulation of phospholipase C a...,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0018200,peptidyl-glutamic acid modification,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0019692,deoxyribose phosphate metabolic process,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0021533,cell differentiation in hindbrain,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0032528,microvillus organization,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0034114,regulation of heterotypic cell-cell adhe...,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0035809,regulation of urine volume,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0035929,steroid hormone secretion,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0042044,fluid transport,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0042423,catecholamine biosynthetic process,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0043486,histone exchange,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0045109,intermediate filament organization,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0045761,regulation of adenylate cyclase activity,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0048799,animal organ maturation,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0050951,sensory perception of temperature stimul...,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0060148,positive regulation of posttranscription...,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0070168,negative regulation of biomineral tissue...,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0070861,regulation of protein exit from endoplas...,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0072012,glomerulus vasculature development,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0090140,regulation of mitochondrial fission,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0090344,negative regulation of cell aging,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0098901,regulation of cardiac muscle cell action...,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0106030,neuron projection fasciculation,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:1901071,glucosamine-containing compound metaboli...,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:1901380,negative regulation of potassium ion tra...,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:1901739,regulation of myoblast fusion,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:1902473,regulation of protein localization to sy...,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:1903671,negative regulation of sprouting angioge...,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:1904893,negative regulation of STAT cascade,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:2000050,regulation of non-canonical Wnt signalin...,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:2000737,negative regulation of stem cell differe...,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:2000738,positive regulation of stem cell differe...,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:2000765,regulation of cytoplasmic translation,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:2000780,negative regulation of double-strand bre...,26,1,0.58,0.44271,1,0.8984903078869674,1.72,BP
GO:0042035,regulation of cytokine biosynthetic proc...,110,3,2.44,0.44347,1,0.899653305227656,1.23,BP
GO:0023052,signaling,6490,146,144.23,0.44646,1,0.9028445634266887,1.01,BP
GO:0045444,fat cell differentiation,241,6,5.36,0.44724,1,0.9028445634266887,1.12,BP
GO:0032922,circadian regulation of gene expression,68,2,1.51,0.44809,1,0.9028445634266887,1.32,BP
GO:0035082,axoneme assembly,68,2,1.51,0.44809,1,0.9028445634266887,1.32,BP
GO:0045428,regulation of nitric oxide biosynthetic ...,68,2,1.51,0.44809,1,0.9028445634266887,1.32,BP
GO:0048678,response to axon injury,68,2,1.51,0.44809,1,0.9028445634266887,1.32,BP
GO:0050710,negative regulation of cytokine secretio...,68,2,1.51,0.44809,1,0.9028445634266887,1.32,BP
GO:0071426,ribonucleoprotein complex export from nu...,68,2,1.51,0.44809,1,0.9028445634266887,1.32,BP
GO:0002688,regulation of leukocyte chemotaxis,111,3,2.47,0.44930,1,0.9028445634266887,1.21,BP
GO:0022404,molting cycle process,111,3,2.47,0.44930,1,0.9028445634266887,1.21,BP
GO:0022405,hair cycle process,111,3,2.47,0.44930,1,0.9028445634266887,1.21,BP
GO:0098773,skin epidermis development,111,3,2.47,0.44930,1,0.9028445634266887,1.21,BP
GO:0001763,morphogenesis of a branching structure,242,6,5.38,0.45116,1,0.9028445634266887,1.12,BP
GO:0050709,negative regulation of protein secretion,155,4,3.44,0.45279,1,0.9028445634266887,1.16,BP
GO:0001959,regulation of cytokine-mediated signalin...,112,3,2.49,0.45510,1,0.9028445634266887,1.2,BP
GO:0000305,response to oxygen radical,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0002052,positive regulation of neuroblast prolif...,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0002347,response to tumor cell,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0003071,renal system process involved in regulat...,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0003338,metanephros morphogenesis,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0009163,nucleoside biosynthetic process,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0010893,positive regulation of steroid biosynthe...,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0016556,mRNA modification,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0021871,forebrain regionalization,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0030970,"retrograde protein transport, ER to cyto...",27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0031365,N-terminal protein amino acid modificati...,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0032365,intracellular lipid transport,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0032509,endosome transport via multivesicular bo...,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0035812,renal sodium excretion,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0042455,ribonucleoside biosynthetic process,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0045736,negative regulation of cyclin-dependent ...,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0045738,negative regulation of DNA repair,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0048521,negative regulation of behavior,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0048745,smooth muscle tissue development,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0048843,negative regulation of axon extension in...,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0051125,regulation of actin nucleation,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0051767,nitric-oxide synthase biosynthetic proce...,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0051769,regulation of nitric-oxide synthase bios...,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0060045,positive regulation of cardiac muscle ce...,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0061003,positive regulation of dendritic spine m...,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0061437,renal system vasculature development,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0061440,kidney vasculature development,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0071402,cellular response to lipoprotein particl...,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0071474,cellular hyperosmotic response,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:1900273,positive regulation of long-term synapti...,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:1903010,regulation of bone development,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:1903513,endoplasmic reticulum to cytosol transpo...,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:2000727,positive regulation of cardiac muscle ce...,27,1,0.6,0.45511,1,0.9028445634266887,1.67,BP
GO:0032370,positive regulation of lipid transport,69,2,1.53,0.45555,1,0.9028445634266887,1.31,BP
GO:0032482,Rab protein signal transduction,69,2,1.53,0.45555,1,0.9028445634266887,1.31,BP
GO:0033692,cellular polysaccharide biosynthetic pro...,69,2,1.53,0.45555,1,0.9028445634266887,1.31,BP
GO:0048146,positive regulation of fibroblast prolif...,69,2,1.53,0.45555,1,0.9028445634266887,1.31,BP
GO:0050885,neuromuscular process controlling balanc...,69,2,1.53,0.45555,1,0.9028445634266887,1.31,BP
GO:0055117,regulation of cardiac muscle contraction,69,2,1.53,0.45555,1,0.9028445634266887,1.31,BP
GO:0061035,regulation of cartilage development,69,2,1.53,0.45555,1,0.9028445634266887,1.31,BP
GO:0071166,ribonucleoprotein complex localization,69,2,1.53,0.45555,1,0.9028445634266887,1.31,BP
GO:0003002,regionalization,376,9,8.36,0.45798,1,0.9072868505557843,1.08,BP
GO:0034660,ncRNA metabolic process,465,11,10.33,0.45955,1,0.9087972363636364,1.06,BP
GO:0052547,regulation of peptidase activity,421,10,9.36,0.46035,1,0.9087972363636364,1.07,BP
GO:0007589,body fluid secretion,113,3,2.51,0.46087,1,0.9087972363636364,1.2,BP
GO:2000177,regulation of neural precursor cell prol...,113,3,2.51,0.46087,1,0.9087972363636364,1.2,BP
GO:0009914,hormone transport,377,9,8.38,0.46112,1,0.9087972363636364,1.07,BP
GO:0045834,positive regulation of lipid metabolic p...,157,4,3.49,0.46257,1,0.9087972363636364,1.15,BP
GO:0060402,calcium ion transport into cytosol,157,4,3.49,0.46257,1,0.9087972363636364,1.15,BP
GO:0002562,somatic diversification of immune recept...,70,2,1.56,0.46296,1,0.9087972363636364,1.28,BP
GO:0016444,somatic cell DNA recombination,70,2,1.56,0.46296,1,0.9087972363636364,1.28,BP
GO:0022029,telencephalon cell migration,70,2,1.56,0.46296,1,0.9087972363636364,1.28,BP
GO:0002009,morphogenesis of an epithelium,555,13,12.33,0.46306,1,0.9087972363636364,1.05,BP
GO:0048732,gland development,467,11,10.38,0.46520,1,0.9087972363636364,1.06,BP
GO:0007548,sex differentiation,290,7,6.44,0.46601,1,0.9087972363636364,1.09,BP
GO:0031398,positive regulation of protein ubiquitin...,114,3,2.53,0.46662,1,0.9087972363636364,1.19,BP
GO:0046034,ATP metabolic process,246,6,5.47,0.46675,1,0.9087972363636364,1.1,BP
GO:0002360,T cell lineage commitment,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0006195,purine nucleotide catabolic process,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0010719,negative regulation of epithelial to mes...,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0010954,positive regulation of protein processin...,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0016082,synaptic vesicle priming,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0032369,negative regulation of lipid transport,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0032891,negative regulation of organic acid tran...,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0035335,peptidyl-tyrosine dephosphorylation,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0036297,interstrand cross-link repair,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0042538,hyperosmotic salinity response,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0044003,modification by symbiont of host morphol...,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0044342,type B pancreatic cell proliferation,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0044550,secondary metabolite biosynthetic proces...,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0045408,regulation of interleukin-6 biosynthetic...,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0045671,negative regulation of osteoclast differ...,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0048820,hair follicle maturation,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0050849,negative regulation of calcium-mediated ...,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0051194,positive regulation of cofactor metaboli...,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0060445,branching involved in salivary gland mor...,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0061050,regulation of cell growth involved in ca...,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0061311,cell surface receptor signaling pathway ...,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0070198,"protein localization to chromosome, telo...",28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0071108,protein K48-linked deubiquitination,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0086005,ventricular cardiac muscle cell action p...,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0090103,cochlea morphogenesis,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0090200,positive regulation of release of cytoch...,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:1902668,negative regulation of axon guidance,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:1902932,positive regulation of alcohol biosynthe...,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:2000310,regulation of NMDA receptor activity,28,1,0.62,0.46724,1,0.9087972363636364,1.61,BP
GO:0000302,response to reactive oxygen species,202,5,4.49,0.46730,1,0.9087972363636364,1.11,BP
GO:0033135,regulation of peptidyl-serine phosphoryl...,158,4,3.51,0.46743,1,0.9087972363636364,1.14,BP
GO:0007162,negative regulation of cell adhesion,291,7,6.47,0.46959,1,0.9125898748486072,1.08,BP
GO:0060429,epithelium development,1182,27,26.27,0.46976,1,0.9125898748486072,1.03,BP
GO:0048015,phosphatidylinositol-mediated signaling,159,4,3.53,0.47228,1,0.9164919677419355,1.13,BP
GO:0032368,regulation of lipid transport,115,3,2.56,0.47234,1,0.9164919677419355,1.17,BP
GO:0042472,inner ear morphogenesis,115,3,2.56,0.47234,1,0.9164919677419355,1.17,BP
GO:0043588,skin development,293,7,6.51,0.47672,1,0.9199445650438947,1.08,BP
GO:2000779,regulation of double-strand break repair,72,2,1.6,0.47759,1,0.9199445650438947,1.25,BP
GO:0031347,regulation of defense response,650,15,14.45,0.47786,1,0.9199445650438947,1.04,BP
GO:2001023,regulation of response to drug,116,3,2.58,0.47804,1,0.9199445650438947,1.16,BP
GO:0001919,regulation of receptor recycling,29,1,0.64,0.47909,1,0.9199445650438947,1.56,BP
GO:0003148,outflow tract septum morphogenesis,29,1,0.64,0.47909,1,0.9199445650438947,1.56,BP
GO:0005979,regulation of glycogen biosynthetic proc...,29,1,0.64,0.47909,1,0.9199445650438947,1.56,BP
GO:0006270,DNA replication initiation,29,1,0.64,0.47909,1,0.9199445650438947,1.56,BP
GO:0010800,positive regulation of peptidyl-threonin...,29,1,0.64,0.47909,1,0.9199445650438947,1.56,BP
GO:0010962,regulation of glucan biosynthetic proces...,29,1,0.64,0.47909,1,0.9199445650438947,1.56,BP
GO:0030318,melanocyte differentiation,29,1,0.64,0.47909,1,0.9199445650438947,1.56,BP
GO:0033137,negative regulation of peptidyl-serine p...,29,1,0.64,0.47909,1,0.9199445650438947,1.56,BP
GO:0033273,response to vitamin,29,1,0.64,0.47909,1,0.9199445650438947,1.56,BP
GO:0034390,smooth muscle cell apoptotic process,29,1,0.64,0.47909,1,0.9199445650438947,1.56,BP
GO:0034391,regulation of smooth muscle cell apoptot...,29,1,0.64,0.47909,1,0.9199445650438947,1.56,BP
GO:0042226,interleukin-6 biosynthetic process,29,1,0.64,0.47909,1,0.9199445650438947,1.56,BP
GO:0043032,positive regulation of macrophage activa...,29,1,0.64,0.47909,1,0.9199445650438947,1.56,BP
GO:0045992,negative regulation of embryonic develop...,29,1,0.64,0.47909,1,0.9199445650438947,1.56,BP
GO:0051589,negative regulation of neurotransmitter ...,29,1,0.64,0.47909,1,0.9199445650438947,1.56,BP
GO:0060117,auditory receptor cell development,29,1,0.64,0.47909,1,0.9199445650438947,1.56,BP
GO:0071472,cellular response to salt stress,29,1,0.64,0.47909,1,0.9199445650438947,1.56,BP
GO:0071880,adenylate cyclase-activating adrenergic ...,29,1,0.64,0.47909,1,0.9199445650438947,1.56,BP
GO:0099622,cardiac muscle cell membrane repolarizat...,29,1,0.64,0.47909,1,0.9199445650438947,1.56,BP
GO:1901018,positive regulation of potassium ion tra...,29,1,0.64,0.47909,1,0.9199445650438947,1.56,BP
GO:1902042,negative regulation of extrinsic apoptot...,29,1,0.64,0.47909,1,0.9199445650438947,1.56,BP
GO:1904030,negative regulation of cyclin-dependent ...,29,1,0.64,0.47909,1,0.9199445650438947,1.56,BP
GO:0072594,establishment of protein localization to...,383,9,8.51,0.47989,1,0.9211131551655365,1.06,BP
GO:0043269,regulation of ion transport,741,17,16.47,0.48162,1,0.9240651674641148,1.03,BP
GO:0009605,response to external stimulus,2399,54,53.31,0.48183,1,0.9240996253487445,1.01,BP
GO:0006282,regulation of DNA repair,117,3,2.6,0.48370,1,0.926947192353644,1.15,BP
GO:0030282,bone mineralization,117,3,2.6,0.48370,1,0.926947192353644,1.15,BP
GO:0006091,generation of precursor metabolites and ...,385,9,8.56,0.48611,1,0.9291239246467817,1.05,BP
GO:0051260,protein homooligomerization,385,9,8.56,0.48611,1,0.9291239246467817,1.05,BP
GO:0048017,inositol lipid-mediated signaling,162,4,3.6,0.48673,1,0.9291239246467817,1.11,BP
GO:2001236,regulation of extrinsic apoptotic signal...,162,4,3.6,0.48673,1,0.9291239246467817,1.11,BP
GO:0006954,inflammatory response,699,16,15.53,0.48794,1,0.9291239246467817,1.03,BP
GO:0043112,receptor metabolic process,207,5,4.6,0.48861,1,0.9291239246467817,1.09,BP
GO:0051224,negative regulation of protein transport,207,5,4.6,0.48861,1,0.9291239246467817,1.09,BP
GO:0042476,odontogenesis,118,3,2.62,0.48934,1,0.9291239246467817,1.15,BP
GO:0051701,interaction with host,118,3,2.62,0.48934,1,0.9291239246467817,1.15,BP
GO:0009259,ribonucleotide metabolic process,431,10,9.58,0.48991,1,0.9291239246467817,1.04,BP
GO:0006336,DNA replication-independent nucleosome a...,30,1,0.67,0.49068,1,0.9291239246467817,1.49,BP
GO:0006536,glutamate metabolic process,30,1,0.67,0.49068,1,0.9291239246467817,1.49,BP
GO:0010922,positive regulation of phosphatase activ...,30,1,0.67,0.49068,1,0.9291239246467817,1.49,BP
GO:0015012,heparan sulfate proteoglycan biosyntheti...,30,1,0.67,0.49068,1,0.9291239246467817,1.49,BP
GO:0022011,myelination in peripheral nervous system,30,1,0.67,0.49068,1,0.9291239246467817,1.49,BP
GO:0032292,peripheral nervous system axon ensheathm...,30,1,0.67,0.49068,1,0.9291239246467817,1.49,BP
GO:0033005,positive regulation of mast cell activat...,30,1,0.67,0.49068,1,0.9291239246467817,1.49,BP
GO:0042168,heme metabolic process,30,1,0.67,0.49068,1,0.9291239246467817,1.49,BP
GO:0042481,regulation of odontogenesis,30,1,0.67,0.49068,1,0.9291239246467817,1.49,BP
GO:0044030,regulation of DNA methylation,30,1,0.67,0.49068,1,0.9291239246467817,1.49,BP
GO:0048384,retinoic acid receptor signaling pathway,30,1,0.67,0.49068,1,0.9291239246467817,1.49,BP
GO:0048643,positive regulation of skeletal muscle t...,30,1,0.67,0.49068,1,0.9291239246467817,1.49,BP
GO:0055022,negative regulation of cardiac muscle ti...,30,1,0.67,0.49068,1,0.9291239246467817,1.49,BP
GO:0060317,cardiac epithelial to mesenchymal transi...,30,1,0.67,0.49068,1,0.9291239246467817,1.49,BP
GO:0060571,morphogenesis of an epithelial fold,30,1,0.67,0.49068,1,0.9291239246467817,1.49,BP
GO:0061082,myeloid leukocyte cytokine production,30,1,0.67,0.49068,1,0.9291239246467817,1.49,BP
GO:0061117,negative regulation of heart growth,30,1,0.67,0.49068,1,0.9291239246467817,1.49,BP
GO:0070979,protein K11-linked ubiquitination,30,1,0.67,0.49068,1,0.9291239246467817,1.49,BP
GO:1900274,regulation of phospholipase C activity,30,1,0.67,0.49068,1,0.9291239246467817,1.49,BP
GO:1903319,positive regulation of protein maturatio...,30,1,0.67,0.49068,1,0.9291239246467817,1.49,BP
GO:0031047,gene silencing by RNA,163,4,3.62,0.49151,1,0.9291239246467817,1.1,BP
GO:0019216,regulation of lipid metabolic process,342,8,7.6,0.49168,1,0.9291239246467817,1.05,BP
GO:0050900,leukocyte migration,342,8,7.6,0.49168,1,0.9291239246467817,1.05,BP
GO:0007193,adenylate cyclase-inhibiting G protein-c...,74,2,1.64,0.49198,1,0.9291239246467817,1.22,BP
GO:0042108,positive regulation of cytokine biosynth...,74,2,1.64,0.49198,1,0.9291239246467817,1.22,BP
GO:0050810,regulation of steroid biosynthetic proce...,74,2,1.64,0.49198,1,0.9291239246467817,1.22,BP
GO:0060191,regulation of lipase activity,74,2,1.64,0.49198,1,0.9291239246467817,1.22,BP
GO:0002376,immune system process,2407,54,53.49,0.49227,1,0.9293068811298548,1.01,BP
GO:0016197,endosomal transport,208,5,4.62,0.49284,1,0.9300180705882353,1.08,BP
GO:0007498,mesoderm development,119,3,2.64,0.49494,1,0.932883384253819,1.14,BP
GO:0051963,regulation of synapse assembly,119,3,2.64,0.49494,1,0.932883384253819,1.14,BP
GO:0071346,cellular response to interferon-gamma,119,3,2.64,0.49494,1,0.932883384253819,1.14,BP
GO:0043433,negative regulation of DNA-binding trans...,164,4,3.64,0.49627,1,0.933431313755796,1.1,BP
GO:0008625,extrinsic apoptotic signaling pathway vi...,75,2,1.67,0.49908,1,0.933431313755796,1.2,BP
GO:0048645,animal organ formation,75,2,1.67,0.49908,1,0.933431313755796,1.2,BP
GO:0051705,multi-organism behavior,75,2,1.67,0.49908,1,0.933431313755796,1.2,BP
GO:0060563,neuroepithelial cell differentiation,75,2,1.67,0.49908,1,0.933431313755796,1.2,BP
GO:0043281,regulation of cysteine-type endopeptidas...,210,5,4.67,0.50125,1,0.933431313755796,1.07,BP
GO:0051216,cartilage development,210,5,4.67,0.50125,1,0.933431313755796,1.07,BP
GO:0008202,steroid metabolic process,300,7,6.67,0.50147,1,0.933431313755796,1.05,BP
GO:0009636,response to toxic substance,345,8,7.67,0.50154,1,0.933431313755796,1.04,BP
GO:0001832,blastocyst growth,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:0002230,positive regulation of defense response ...,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:0006099,tricarboxylic acid cycle,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:0006335,DNA replication-dependent nucleosome ass...,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:0006767,water-soluble vitamin metabolic process,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:0009225,nucleotide-sugar metabolic process,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:0009262,deoxyribonucleotide metabolic process,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:0009584,detection of visible light,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:0032967,positive regulation of collagen biosynth...,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:0033081,regulation of T cell differentiation in ...,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:0033561,regulation of water loss via skin,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:0034723,DNA replication-dependent nucleosome org...,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:0034724,DNA replication-independent nucleosome o...,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:0042634,regulation of hair cycle,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:0043302,positive regulation of leukocyte degranu...,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:0051085,chaperone cofactor-dependent protein ref...,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:0060914,heart formation,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:0070536,protein K63-linked deubiquitination,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:0071875,adrenergic receptor signaling pathway,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:0099633,protein localization to postsynaptic spe...,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:0099645,neurotransmitter receptor localization t...,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:1901659,glycosyl compound biosynthetic process,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:1903421,regulation of synaptic vesicle recycling,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:1905476,negative regulation of protein localizat...,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:2000144,positive regulation of DNA-templated tra...,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:2000781,positive regulation of double-strand bre...,31,1,0.69,0.50202,1,0.933431313755796,1.45,BP
GO:0099536,synaptic signaling,886,20,19.69,0.50399,1,0.9367322827346467,1.02,BP
GO:0007623,circadian rhythm,211,5,4.69,0.50544,1,0.9377748633038121,1.07,BP
GO:0048839,inner ear development,211,5,4.69,0.50544,1,0.9377748633038121,1.07,BP
GO:0006643,membrane lipid metabolic process,166,4,3.69,0.50574,1,0.9377748633038121,1.08,BP
GO:0046620,regulation of organ growth,121,3,2.69,0.50606,1,0.9377748633038121,1.12,BP
GO:0006809,nitric oxide biosynthetic process,76,2,1.69,0.50611,1,0.9377748633038121,1.18,BP
GO:0009060,aerobic respiration,76,2,1.69,0.50611,1,0.9377748633038121,1.18,BP
GO:0021879,forebrain neuron differentiation,76,2,1.69,0.50611,1,0.9377748633038121,1.18,BP
GO:0032418,lysosome localization,76,2,1.69,0.50611,1,0.9377748633038121,1.18,BP
GO:1904950,negative regulation of establishment of ...,212,5,4.71,0.50961,1,0.9431005347593583,1.06,BP
GO:0043900,regulation of multi-organism process,393,9,8.73,0.51081,1,0.9431005347593583,1.03,BP
GO:0006888,ER to Golgi vesicle-mediated transport,122,3,2.71,0.51157,1,0.9431005347593583,1.11,BP
GO:0042089,cytokine biosynthetic process,122,3,2.71,0.51157,1,0.9431005347593583,1.11,BP
GO:0000271,polysaccharide biosynthetic process,77,2,1.71,0.51309,1,0.9431005347593583,1.17,BP
GO:0001756,somitogenesis,77,2,1.71,0.51309,1,0.9431005347593583,1.17,BP
GO:0002200,somatic diversification of immune recept...,77,2,1.71,0.51309,1,0.9431005347593583,1.17,BP
GO:0072332,intrinsic apoptotic signaling pathway by...,77,2,1.71,0.51309,1,0.9431005347593583,1.17,BP
GO:0006101,citrate metabolic process,32,1,0.71,0.51310,1,0.9431005347593583,1.41,BP
GO:0010574,regulation of vascular endothelial growt...,32,1,0.71,0.51310,1,0.9431005347593583,1.41,BP
GO:0019884,antigen processing and presentation of e...,32,1,0.71,0.51310,1,0.9431005347593583,1.41,BP
GO:0021680,cerebellar Purkinje cell layer developme...,32,1,0.71,0.51310,1,0.9431005347593583,1.41,BP
GO:0040036,regulation of fibroblast growth factor r...,32,1,0.71,0.51310,1,0.9431005347593583,1.41,BP
GO:0043457,regulation of cellular respiration,32,1,0.71,0.51310,1,0.9431005347593583,1.41,BP
GO:0048011,neurotrophin TRK receptor signaling path...,32,1,0.71,0.51310,1,0.9431005347593583,1.41,BP
GO:0060143,positive regulation of syncytium formati...,32,1,0.71,0.51310,1,0.9431005347593583,1.41,BP
GO:0060561,apoptotic process involved in morphogene...,32,1,0.71,0.51310,1,0.9431005347593583,1.41,BP
GO:0070286,axonemal dynein complex assembly,32,1,0.71,0.51310,1,0.9431005347593583,1.41,BP
GO:0071985,multivesicular body sorting pathway,32,1,0.71,0.51310,1,0.9431005347593583,1.41,BP
GO:0090504,epiboly,32,1,0.71,0.51310,1,0.9431005347593583,1.41,BP
GO:1902186,regulation of viral release from host ce...,32,1,0.71,0.51310,1,0.9431005347593583,1.41,BP
GO:0042594,response to starvation,168,4,3.73,0.51512,1,0.9464518671248568,1.07,BP
GO:0071216,cellular response to biotic stimulus,304,7,6.76,0.51545,1,0.9466967175572518,1.04,BP
GO:0034762,regulation of transmembrane transport,576,13,12.8,0.51703,1,0.9481877286585365,1.02,BP
GO:0006997,nucleus organization,123,3,2.73,0.51705,1,0.9481877286585365,1.1,BP
GO:0007030,Golgi organization,123,3,2.73,0.51705,1,0.9481877286585365,1.1,BP
GO:0007368,determination of left/right symmetry,123,3,2.73,0.51705,1,0.9481877286585365,1.1,BP
GO:0023061,signal release,531,12,11.8,0.51762,1,0.9488714057142856,1.02,BP
GO:0055065,metal ion homeostasis,667,15,14.82,0.51841,1,0.9499576999238386,1.01,BP
GO:0061515,myeloid cell development,78,2,1.73,0.51999,1,0.952490247430529,1.16,BP
GO:0072330,monocarboxylic acid biosynthetic process,260,6,5.78,0.52028,1,0.9526588127853881,1.04,BP
GO:0002274,myeloid leukocyte activation,215,5,4.78,0.52204,1,0.9529978684807255,1.05,BP
GO:0048515,spermatid differentiation,215,5,4.78,0.52204,1,0.9529978684807255,1.05,BP
GO:0060047,heart contraction,215,5,4.78,0.52204,1,0.9529978684807255,1.05,BP
GO:0006084,acetyl-CoA metabolic process,33,1,0.73,0.52394,1,0.9529978684807255,1.37,BP
GO:0006623,protein targeting to vacuole,33,1,0.73,0.52394,1,0.9529978684807255,1.37,BP
GO:0014044,Schwann cell development,33,1,0.73,0.52394,1,0.9529978684807255,1.37,BP
GO:0021591,ventricular system development,33,1,0.73,0.52394,1,0.9529978684807255,1.37,BP
GO:0032660,regulation of interleukin-17 production,33,1,0.73,0.52394,1,0.9529978684807255,1.37,BP
GO:0032743,positive regulation of interleukin-2 pro...,33,1,0.73,0.52394,1,0.9529978684807255,1.37,BP
GO:0033598,mammary gland epithelial cell proliferat...,33,1,0.73,0.52394,1,0.9529978684807255,1.37,BP
GO:0045577,regulation of B cell differentiation,33,1,0.73,0.52394,1,0.9529978684807255,1.37,BP
GO:0045879,negative regulation of smoothened signal...,33,1,0.73,0.52394,1,0.9529978684807255,1.37,BP
GO:0046596,regulation of viral entry into host cell,33,1,0.73,0.52394,1,0.9529978684807255,1.37,BP
GO:1903146,regulation of autophagy of mitochondrion,33,1,0.73,0.52394,1,0.9529978684807255,1.37,BP
GO:1903205,regulation of hydrogen peroxide-induced ...,33,1,0.73,0.52394,1,0.9529978684807255,1.37,BP
GO:1905606,regulation of presynapse assembly,33,1,0.73,0.52394,1,0.9529978684807255,1.37,BP
GO:2001171,positive regulation of ATP biosynthetic ...,33,1,0.73,0.52394,1,0.9529978684807255,1.37,BP
GO:0016458,gene silencing,261,6,5.8,0.52403,1,0.9529978684807255,1.03,BP
GO:0010952,positive regulation of peptidase activit...,170,4,3.78,0.52443,1,0.9533650018889308,1.06,BP
GO:0046883,regulation of hormone secretion,307,7,6.82,0.52584,1,0.9552019442351168,1.03,BP
GO:0008406,gonad development,216,5,4.8,0.52615,1,0.9552019442351168,1.04,BP
GO:0003208,cardiac ventricle morphogenesis,79,2,1.76,0.52683,1,0.9552019442351168,1.14,BP
GO:0006029,proteoglycan metabolic process,79,2,1.76,0.52683,1,0.9552019442351168,1.14,BP
GO:0048663,neuron fate commitment,79,2,1.76,0.52683,1,0.9552019442351168,1.14,BP
GO:0051279,regulation of release of sequestered cal...,79,2,1.76,0.52683,1,0.9552019442351168,1.14,BP
GO:0051881,regulation of mitochondrial membrane pot...,79,2,1.76,0.52683,1,0.9552019442351168,1.14,BP
GO:0015980,energy derivation by oxidation of organi...,262,6,5.82,0.52776,1,0.9564212349397592,1.03,BP
GO:0033138,positive regulation of peptidyl-serine p...,125,3,2.78,0.52790,1,0.9564212349397592,1.08,BP
GO:0046890,regulation of lipid biosynthetic process,171,4,3.8,0.52904,1,0.9572602754000744,1.05,BP
GO:0001818,negative regulation of cytokine producti...,263,6,5.84,0.53149,1,0.9572602754000744,1.03,BP
GO:0034637,cellular carbohydrate biosynthetic proce...,80,2,1.78,0.53361,1,0.9572602754000744,1.12,BP
GO:0046209,nitric oxide metabolic process,80,2,1.78,0.53361,1,0.9572602754000744,1.12,BP
GO:0051785,positive regulation of nuclear division,80,2,1.78,0.53361,1,0.9572602754000744,1.12,BP
GO:1904427,positive regulation of calcium ion trans...,80,2,1.78,0.53361,1,0.9572602754000744,1.12,BP
GO:0043271,negative regulation of ion transport,172,4,3.82,0.53364,1,0.9572602754000744,1.05,BP
GO:0006302,double-strand break repair,218,5,4.84,0.53434,1,0.9572602754000744,1.03,BP
GO:0000002,mitochondrial genome maintenance,34,1,0.76,0.53453,1,0.9572602754000744,1.32,BP
GO:0006356,regulation of transcription by RNA polym...,34,1,0.76,0.53453,1,0.9572602754000744,1.32,BP
GO:0007617,mating behavior,34,1,0.76,0.53453,1,0.9572602754000744,1.32,BP
GO:0010573,vascular endothelial growth factor produ...,34,1,0.76,0.53453,1,0.9572602754000744,1.32,BP
GO:0010667,negative regulation of cardiac muscle ce...,34,1,0.76,0.53453,1,0.9572602754000744,1.32,BP
GO:0010714,positive regulation of collagen metaboli...,34,1,0.76,0.53453,1,0.9572602754000744,1.32,BP
GO:0014047,glutamate secretion,34,1,0.76,0.53453,1,0.9572602754000744,1.32,BP
GO:0014741,negative regulation of muscle hypertroph...,34,1,0.76,0.53453,1,0.9572602754000744,1.32,BP
GO:0015804,neutral amino acid transport,34,1,0.76,0.53453,1,0.9572602754000744,1.32,BP
GO:0019076,viral release from host cell,34,1,0.76,0.53453,1,0.9572602754000744,1.32,BP
GO:0035116,embryonic hindlimb morphogenesis,34,1,0.76,0.53453,1,0.9572602754000744,1.32,BP
GO:0035890,exit from host,34,1,0.76,0.53453,1,0.9572602754000744,1.32,BP
GO:0035891,exit from host cell,34,1,0.76,0.53453,1,0.9572602754000744,1.32,BP
GO:0043243,positive regulation of protein complex d...,34,1,0.76,0.53453,1,0.9572602754000744,1.32,BP
GO:0045070,positive regulation of viral genome repl...,34,1,0.76,0.53453,1,0.9572602754000744,1.32,BP
GO:0048194,Golgi vesicle budding,34,1,0.76,0.53453,1,0.9572602754000744,1.32,BP
GO:0052126,movement in host environment,34,1,0.76,0.53453,1,0.9572602754000744,1.32,BP
GO:0052192,movement in environment of other organis...,34,1,0.76,0.53453,1,0.9572602754000744,1.32,BP
GO:0060487,lung epithelial cell differentiation,34,1,0.76,0.53453,1,0.9572602754000744,1.32,BP
GO:0097366,response to bronchodilator,34,1,0.76,0.53453,1,0.9572602754000744,1.32,BP
GO:0140115,export across plasma membrane,34,1,0.76,0.53453,1,0.9572602754000744,1.32,BP
GO:1902686,mitochondrial outer membrane permeabiliz...,34,1,0.76,0.53453,1,0.9572602754000744,1.32,BP
GO:1990748,cellular detoxification,34,1,0.76,0.53453,1,0.9572602754000744,1.32,BP
GO:0055074,calcium ion homeostasis,492,11,10.93,0.53475,1,0.9572979910714284,1.01,BP
GO:0033673,negative regulation of kinase activity,219,5,4.87,0.53840,1,0.9625589867841409,1.03,BP
GO:0019693,ribose phosphate metabolic process,448,10,9.96,0.53918,1,0.9625589867841409,1,BP
GO:0005977,glycogen metabolic process,81,2,1.8,0.54031,1,0.9625589867841409,1.11,BP
GO:0006073,cellular glucan metabolic process,81,2,1.8,0.54031,1,0.9625589867841409,1.11,BP
GO:0043279,response to alkaloid,81,2,1.8,0.54031,1,0.9625589867841409,1.11,BP
GO:0044042,glucan metabolic process,81,2,1.8,0.54031,1,0.9625589867841409,1.11,BP
GO:0060113,inner ear receptor cell differentiation,81,2,1.8,0.54031,1,0.9625589867841409,1.11,BP
GO:0045137,development of primary sexual characteri...,220,5,4.89,0.54245,1,0.9625589867841409,1.02,BP
GO:0010565,regulation of cellular ketone metabolic ...,128,3,2.84,0.54393,1,0.9625589867841409,1.06,BP
GO:0030218,erythrocyte differentiation,128,3,2.84,0.54393,1,0.9625589867841409,1.06,BP
GO:0031623,receptor internalization,128,3,2.84,0.54393,1,0.9625589867841409,1.06,BP
GO:0042107,cytokine metabolic process,128,3,2.84,0.54393,1,0.9625589867841409,1.06,BP
GO:0042303,molting cycle,128,3,2.84,0.54393,1,0.9625589867841409,1.06,BP
GO:0042633,hair cycle,128,3,2.84,0.54393,1,0.9625589867841409,1.06,BP
GO:0050852,T cell receptor signaling pathway,128,3,2.84,0.54393,1,0.9625589867841409,1.06,BP
GO:0001539,cilium or flagellum-dependent cell motil...,35,1,0.78,0.54489,1,0.9625589867841409,1.28,BP
GO:0002701,negative regulation of production of mol...,35,1,0.78,0.54489,1,0.9625589867841409,1.28,BP
GO:0002931,response to ischemia,35,1,0.78,0.54489,1,0.9625589867841409,1.28,BP
GO:0007143,female meiotic nuclear division,35,1,0.78,0.54489,1,0.9625589867841409,1.28,BP
GO:0008156,negative regulation of DNA replication,35,1,0.78,0.54489,1,0.9625589867841409,1.28,BP
GO:0018345,protein palmitoylation,35,1,0.78,0.54489,1,0.9625589867841409,1.28,BP
GO:0030201,heparan sulfate proteoglycan metabolic p...,35,1,0.78,0.54489,1,0.9625589867841409,1.28,BP
GO:0031338,regulation of vesicle fusion,35,1,0.78,0.54489,1,0.9625589867841409,1.28,BP
GO:0032094,response to food,35,1,0.78,0.54489,1,0.9625589867841409,1.28,BP
GO:0035909,aorta morphogenesis,35,1,0.78,0.54489,1,0.9625589867841409,1.28,BP
GO:0043304,regulation of mast cell degranulation,35,1,0.78,0.54489,1,0.9625589867841409,1.28,BP
GO:0046320,regulation of fatty acid oxidation,35,1,0.78,0.54489,1,0.9625589867841409,1.28,BP
GO:0046686,response to cadmium ion,35,1,0.78,0.54489,1,0.9625589867841409,1.28,BP
GO:0048679,regulation of axon regeneration,35,1,0.78,0.54489,1,0.9625589867841409,1.28,BP
GO:0060285,cilium-dependent cell motility,35,1,0.78,0.54489,1,0.9625589867841409,1.28,BP
GO:0090322,regulation of superoxide metabolic proce...,35,1,0.78,0.54489,1,0.9625589867841409,1.28,BP
GO:0097352,autophagosome maturation,35,1,0.78,0.54489,1,0.9625589867841409,1.28,BP
GO:1901068,guanosine-containing compound metabolic ...,35,1,0.78,0.54489,1,0.9625589867841409,1.28,BP
GO:1904707,positive regulation of vascular smooth m...,35,1,0.78,0.54489,1,0.9625589867841409,1.28,BP
GO:2000171,negative regulation of dendrite developm...,35,1,0.78,0.54489,1,0.9625589867841409,1.28,BP
GO:2001038,regulation of cellular response to drug,35,1,0.78,0.54489,1,0.9625589867841409,1.28,BP
GO:0042110,T cell activation,496,11,11.02,0.54562,1,0.9634948403669724,1,BP
GO:0006637,acyl-CoA metabolic process,82,2,1.82,0.54695,1,0.963721010248902,1.1,BP
GO:0022406,membrane docking,82,2,1.82,0.54695,1,0.963721010248902,1.1,BP
GO:0035383,thioester metabolic process,82,2,1.82,0.54695,1,0.963721010248902,1.1,BP
GO:0044106,cellular amine metabolic process,82,2,1.82,0.54695,1,0.963721010248902,1.1,BP
GO:0046530,photoreceptor cell differentiation,82,2,1.82,0.54695,1,0.963721010248902,1.1,BP
GO:1903901,negative regulation of viral life cycle,82,2,1.82,0.54695,1,0.963721010248902,1.1,BP
GO:0009991,response to extracellular stimulus,405,9,9,0.54715,1,0.963721010248902,1,BP
GO:0002312,B cell activation involved in immune res...,83,2,1.84,0.55353,1,0.9676827391304348,1.09,BP
GO:0006942,regulation of striated muscle contractio...,83,2,1.84,0.55353,1,0.9676827391304348,1.09,BP
GO:0022904,respiratory electron transport chain,83,2,1.84,0.55353,1,0.9676827391304348,1.09,BP
GO:0032436,positive regulation of proteasomal ubiqu...,83,2,1.84,0.55353,1,0.9676827391304348,1.09,BP
GO:0090630,activation of GTPase activity,83,2,1.84,0.55353,1,0.9676827391304348,1.09,BP
GO:0030217,T cell differentiation,269,6,5.98,0.55356,1,0.9676827391304348,1,BP
GO:0016999,antibiotic metabolic process,130,3,2.89,0.55444,1,0.9676827391304348,1.04,BP
GO:0001963,"synaptic transmission, dopaminergic",36,1,0.8,0.55503,1,0.9676827391304348,1.25,BP
GO:0006471,protein ADP-ribosylation,36,1,0.8,0.55503,1,0.9676827391304348,1.25,BP
GO:0006972,hyperosmotic response,36,1,0.8,0.55503,1,0.9676827391304348,1.25,BP
GO:0030574,collagen catabolic process,36,1,0.8,0.55503,1,0.9676827391304348,1.25,BP
GO:0032205,negative regulation of telomere maintena...,36,1,0.8,0.55503,1,0.9676827391304348,1.25,BP
GO:0032735,positive regulation of interleukin-12 pr...,36,1,0.8,0.55503,1,0.9676827391304348,1.25,BP
GO:0033006,regulation of mast cell activation invol...,36,1,0.8,0.55503,1,0.9676827391304348,1.25,BP
GO:0033363,secretory granule organization,36,1,0.8,0.55503,1,0.9676827391304348,1.25,BP
GO:0035115,embryonic forelimb morphogenesis,36,1,0.8,0.55503,1,0.9676827391304348,1.25,BP
GO:0040020,regulation of meiotic nuclear division,36,1,0.8,0.55503,1,0.9676827391304348,1.25,BP
GO:0042311,vasodilation,36,1,0.8,0.55503,1,0.9676827391304348,1.25,BP
GO:0043516,"regulation of DNA damage response, signa...",36,1,0.8,0.55503,1,0.9676827391304348,1.25,BP
GO:0045815,"positive regulation of gene expression, ...",36,1,0.8,0.55503,1,0.9676827391304348,1.25,BP
GO:0048710,regulation of astrocyte differentiation,36,1,0.8,0.55503,1,0.9676827391304348,1.25,BP
GO:0051084,'de novo' posttranslational protein fold...,36,1,0.8,0.55503,1,0.9676827391304348,1.25,BP
GO:0051953,negative regulation of amine transport,36,1,0.8,0.55503,1,0.9676827391304348,1.25,BP
GO:0070873,regulation of glycogen metabolic process,36,1,0.8,0.55503,1,0.9676827391304348,1.25,BP
GO:0097106,postsynaptic density organization,36,1,0.8,0.55503,1,0.9676827391304348,1.25,BP
GO:1903959,regulation of anion transmembrane transp...,36,1,0.8,0.55503,1,0.9676827391304348,1.25,BP
GO:1990089,response to nerve growth factor,36,1,0.8,0.55503,1,0.9676827391304348,1.25,BP
GO:1990090,cellular response to nerve growth factor...,36,1,0.8,0.55503,1,0.9676827391304348,1.25,BP
GO:0048608,reproductive structure development,454,10,10.09,0.55617,1,0.9691573507057546,0.99,BP
GO:0008016,regulation of heart contraction,177,4,3.93,0.55629,1,0.9691573507057546,1.02,BP
GO:0043062,extracellular structure organization,316,7,7.02,0.55648,1,0.9691573507057546,1,BP
GO:0045995,regulation of embryonic development,131,3,2.91,0.55964,1,0.9731762423368193,1.03,BP
GO:0003151,outflow tract morphogenesis,84,2,1.87,0.56003,1,0.9731762423368193,1.07,BP
GO:0006342,chromatin silencing,84,2,1.87,0.56003,1,0.9731762423368193,1.07,BP
GO:0006672,ceramide metabolic process,84,2,1.87,0.56003,1,0.9731762423368193,1.07,BP
GO:0045913,positive regulation of carbohydrate meta...,84,2,1.87,0.56003,1,0.9731762423368193,1.07,BP
GO:2001057,reactive nitrogen species metabolic proc...,84,2,1.87,0.56003,1,0.9731762423368193,1.07,BP
GO:0007268,chemical synaptic transmission,868,19,19.29,0.56042,1,0.9731762423368193,0.98,BP
GO:0098916,anterograde trans-synaptic signaling,868,19,19.29,0.56042,1,0.9731762423368193,0.98,BP
GO:0009205,purine ribonucleoside triphosphate metab...,271,6,6.02,0.56081,1,0.9731762423368193,1,BP
GO:0030336,negative regulation of cell migration,271,6,6.02,0.56081,1,0.9731762423368193,1,BP
GO:0007178,transmembrane receptor protein serine/th...,364,8,8.09,0.56241,1,0.9733058216971,0.99,BP
GO:0030073,insulin secretion,225,5,5,0.56245,1,0.9733058216971,1,BP
GO:0010664,negative regulation of striated muscle c...,37,1,0.82,0.56493,1,0.9733058216971,1.22,BP
GO:0014003,oligodendrocyte development,37,1,0.82,0.56493,1,0.9733058216971,1.22,BP
GO:0021884,forebrain neuron development,37,1,0.82,0.56493,1,0.9733058216971,1.22,BP
GO:0031279,regulation of cyclase activity,37,1,0.82,0.56493,1,0.9733058216971,1.22,BP
GO:0032733,positive regulation of interleukin-10 pr...,37,1,0.82,0.56493,1,0.9733058216971,1.22,BP
GO:0035794,positive regulation of mitochondrial mem...,37,1,0.82,0.56493,1,0.9733058216971,1.22,BP
GO:0036474,cell death in response to hydrogen perox...,37,1,0.82,0.56493,1,0.9733058216971,1.22,BP
GO:0043628,ncRNA 3'-end processing,37,1,0.82,0.56493,1,0.9733058216971,1.22,BP
GO:0048665,neuron fate specification,37,1,0.82,0.56493,1,0.9733058216971,1.22,BP
GO:0051482,positive regulation of cytosolic calcium...,37,1,0.82,0.56493,1,0.9733058216971,1.22,BP
GO:0051693,actin filament capping,37,1,0.82,0.56493,1,0.9733058216971,1.22,BP
GO:0071398,cellular response to fatty acid,37,1,0.82,0.56493,1,0.9733058216971,1.22,BP
GO:0072348,sulfur compound transport,37,1,0.82,0.56493,1,0.9733058216971,1.22,BP
GO:0072350,tricarboxylic acid metabolic process,37,1,0.82,0.56493,1,0.9733058216971,1.22,BP
GO:0098751,bone cell development,37,1,0.82,0.56493,1,0.9733058216971,1.22,BP
GO:0099174,regulation of presynapse organization,37,1,0.82,0.56493,1,0.9733058216971,1.22,BP
GO:1903432,regulation of TORC1 signaling,37,1,0.82,0.56493,1,0.9733058216971,1.22,BP
GO:1903792,negative regulation of anion transport,37,1,0.82,0.56493,1,0.9733058216971,1.22,BP
GO:0006575,cellular modified amino acid metabolic p...,179,4,3.98,0.56518,1,0.973388031496063,1.01,BP
GO:0071241,cellular response to inorganic substance,226,5,5.02,0.56640,1,0.9742150250178699,1,BP
GO:0014032,neural crest cell development,85,2,1.89,0.56647,1,0.9742150250178699,1.06,BP
GO:0032526,response to retinoic acid,85,2,1.89,0.56647,1,0.9742150250178699,1.06,BP
GO:0097581,lamellipodium organization,85,2,1.89,0.56647,1,0.9742150250178699,1.06,BP
GO:0061458,reproductive system development,458,10,10.18,0.56736,1,0.9753970418006431,0.98,BP
GO:0007416,synapse assembly,180,4,4,0.56959,1,0.9788811000000001,1,BP
GO:0002456,T cell mediated immunity,133,3,2.96,0.56993,1,0.9791157300963942,1.01,BP
GO:0090287,regulation of cellular response to growt...,274,6,6.09,0.57159,1,0.980730616583983,0.99,BP
GO:0034103,regulation of tissue remodeling,86,2,1.91,0.57284,1,0.980730616583983,1.05,BP
GO:0001819,positive regulation of cytokine producti...,460,10,10.22,0.57291,1,0.980730616583983,0.98,BP
GO:0002697,regulation of immune effector process,414,9,9.2,0.57370,1,0.980730616583983,0.98,BP
GO:0000578,embryonic axis specification,38,1,0.84,0.57462,1,0.980730616583983,1.19,BP
GO:0001953,negative regulation of cell-matrix adhes...,38,1,0.84,0.57462,1,0.980730616583983,1.19,BP
GO:0006778,porphyrin-containing compound metabolic ...,38,1,0.84,0.57462,1,0.980730616583983,1.19,BP
GO:0007435,salivary gland morphogenesis,38,1,0.84,0.57462,1,0.980730616583983,1.19,BP
GO:0016601,Rac protein signal transduction,38,1,0.84,0.57462,1,0.980730616583983,1.19,BP
GO:0032885,regulation of polysaccharide biosyntheti...,38,1,0.84,0.57462,1,0.980730616583983,1.19,BP
GO:0042149,cellular response to glucose starvation,38,1,0.84,0.57462,1,0.980730616583983,1.19,BP
GO:0042554,superoxide anion generation,38,1,0.84,0.57462,1,0.980730616583983,1.19,BP
GO:0043267,negative regulation of potassium ion tra...,38,1,0.84,0.57462,1,0.980730616583983,1.19,BP
GO:0043368,positive T cell selection,38,1,0.84,0.57462,1,0.980730616583983,1.19,BP
GO:0071391,cellular response to estrogen stimulus,38,1,0.84,0.57462,1,0.980730616583983,1.19,BP
GO:0072210,metanephric nephron development,38,1,0.84,0.57462,1,0.980730616583983,1.19,BP
GO:2000463,positive regulation of excitatory postsy...,38,1,0.84,0.57462,1,0.980730616583983,1.19,BP
GO:2001025,positive regulation of response to drug,38,1,0.84,0.57462,1,0.980730616583983,1.19,BP
GO:0010469,regulation of signaling receptor activit...,134,3,2.98,0.57502,1,0.980730616583983,1.01,BP
GO:0051928,positive regulation of calcium ion trans...,134,3,2.98,0.57502,1,0.980730616583983,1.01,BP
GO:0009199,ribonucleoside triphosphate metabolic pr...,275,6,6.11,0.57515,1,0.980730616583983,0.98,BP
GO:0048167,regulation of synaptic plasticity,369,8,8.2,0.57790,1,0.9843948004238785,0.98,BP
GO:0006790,sulfur compound metabolic process,276,6,6.13,0.57870,1,0.9843948004238785,0.98,BP
GO:0099537,trans-synaptic signaling,877,19,19.49,0.57875,1,0.9843948004238785,0.97,BP
GO:0022900,electron transport chain,87,2,1.93,0.57914,1,0.9843948004238785,1.04,BP
GO:0042475,odontogenesis of dentin-containing tooth,87,2,1.93,0.57914,1,0.9843948004238785,1.04,BP
GO:0042490,mechanoreceptor differentiation,87,2,1.93,0.57914,1,0.9843948004238785,1.04,BP
GO:0051384,response to glucocorticoid,87,2,1.93,0.57914,1,0.9843948004238785,1.04,BP
GO:0060079,excitatory postsynaptic potential,87,2,1.93,0.57914,1,0.9843948004238785,1.04,BP
GO:0070509,calcium ion import,87,2,1.93,0.57914,1,0.9843948004238785,1.04,BP
GO:0097306,cellular response to alcohol,135,3,3,0.58007,1,0.9852795058242145,1,BP
GO:1901655,cellular response to ketone,135,3,3,0.58007,1,0.9852795058242145,1,BP
GO:0009117,nucleotide metabolic process,556,12,12.36,0.58214,1,0.9875759241040056,0.97,BP
GO:0006826,iron ion transport,39,1,0.87,0.58409,1,0.9875759241040056,1.15,BP
GO:0030521,androgen receptor signaling pathway,39,1,0.87,0.58409,1,0.9875759241040056,1.15,BP
GO:0030810,positive regulation of nucleotide biosyn...,39,1,0.87,0.58409,1,0.9875759241040056,1.15,BP
GO:0050931,pigment cell differentiation,39,1,0.87,0.58409,1,0.9875759241040056,1.15,BP
GO:0061462,protein localization to lysosome,39,1,0.87,0.58409,1,0.9875759241040056,1.15,BP
GO:0070528,protein kinase C signaling,39,1,0.87,0.58409,1,0.9875759241040056,1.15,BP
GO:0072595,maintenance of protein localization in o...,39,1,0.87,0.58409,1,0.9875759241040056,1.15,BP
GO:1900373,positive regulation of purine nucleotide...,39,1,0.87,0.58409,1,0.9875759241040056,1.15,BP
GO:1901998,toxin transport,39,1,0.87,0.58409,1,0.9875759241040056,1.15,BP
GO:1902692,regulation of neuroblast proliferation,39,1,0.87,0.58409,1,0.9875759241040056,1.15,BP
GO:1905710,positive regulation of membrane permeabi...,39,1,0.87,0.58409,1,0.9875759241040056,1.15,BP
GO:2000142,regulation of DNA-templated transcriptio...,39,1,0.87,0.58409,1,0.9875759241040056,1.15,BP
GO:1903038,negative regulation of leukocyte cell-ce...,136,3,3.02,0.58508,1,0.9886979431379431,0.99,BP
GO:0019217,regulation of fatty acid metabolic proce...,88,2,1.96,0.58537,1,0.9886979431379431,1.02,BP
GO:0032024,positive regulation of insulin secretion,88,2,1.96,0.58537,1,0.9886979431379431,1.02,BP
GO:0050792,regulation of viral process,184,4,4.09,0.58697,1,0.9910525052631579,0.98,BP
GO:0009144,purine nucleoside triphosphate metabolic...,279,6,6.2,0.58925,1,0.9941504874651811,0.97,BP
GO:0042471,ear morphogenesis,137,3,3.04,0.59006,1,0.9941504874651811,0.99,BP
GO:0051588,regulation of neurotransmitter transport,185,4,4.11,0.59126,1,0.9941504874651811,0.97,BP
GO:0021872,forebrain generation of neurons,89,2,1.98,0.59154,1,0.9941504874651811,1.01,BP
GO:0003007,heart morphogenesis,280,6,6.22,0.59274,1,0.9941504874651811,0.96,BP
GO:0001835,blastocyst hatching,40,1,0.89,0.59335,1,0.9941504874651811,1.12,BP
GO:0001881,receptor recycling,40,1,0.89,0.59335,1,0.9941504874651811,1.12,BP
GO:0002369,T cell cytokine production,40,1,0.89,0.59335,1,0.9941504874651811,1.12,BP
GO:0002686,negative regulation of leukocyte migrati...,40,1,0.89,0.59335,1,0.9941504874651811,1.12,BP
GO:0003009,skeletal muscle contraction,40,1,0.89,0.59335,1,0.9941504874651811,1.12,BP
GO:0010661,positive regulation of muscle cell apopt...,40,1,0.89,0.59335,1,0.9941504874651811,1.12,BP
GO:0030225,macrophage differentiation,40,1,0.89,0.59335,1,0.9941504874651811,1.12,BP
GO:0032008,positive regulation of TOR signaling,40,1,0.89,0.59335,1,0.9941504874651811,1.12,BP
GO:0032620,interleukin-17 production,40,1,0.89,0.59335,1,0.9941504874651811,1.12,BP
GO:0035188,hatching,40,1,0.89,0.59335,1,0.9941504874651811,1.12,BP
GO:0035307,positive regulation of protein dephospho...,40,1,0.89,0.59335,1,0.9941504874651811,1.12,BP
GO:0045191,regulation of isotype switching,40,1,0.89,0.59335,1,0.9941504874651811,1.12,BP
GO:0051339,regulation of lyase activity,40,1,0.89,0.59335,1,0.9941504874651811,1.12,BP
GO:0071542,dopaminergic neuron differentiation,40,1,0.89,0.59335,1,0.9941504874651811,1.12,BP
GO:0071684,organism emergence from protective struc...,40,1,0.89,0.59335,1,0.9941504874651811,1.12,BP
GO:0072523,purine-containing compound catabolic pro...,40,1,0.89,0.59335,1,0.9941504874651811,1.12,BP
GO:1905332,positive regulation of morphogenesis of ...,40,1,0.89,0.59335,1,0.9941504874651811,1.12,BP
GO:0009150,purine ribonucleotide metabolic process,421,9,9.36,0.59387,1,0.9946754054994779,0.96,BP
GO:0016441,posttranscriptional gene silencing,138,3,3.07,0.59499,1,0.9962045511482255,0.98,BP
GO:0031667,response to nutrient levels,375,8,8.33,0.59615,1,0.9977995826086956,0.96,BP
GO:0014031,mesenchymal cell development,90,2,2,0.59763,1,0.9981917355371901,1,BP
GO:0032642,regulation of chemokine production,90,2,2,0.59763,1,0.9981917355371901,1,BP
GO:0045814,"negative regulation of gene expression, ...",90,2,2,0.59763,1,0.9981917355371901,1,BP
GO:0045833,negative regulation of lipid metabolic p...,90,2,2,0.59763,1,0.9981917355371901,1,BP
GO:1904063,negative regulation of cation transmembr...,90,2,2,0.59763,1,0.9981917355371901,1,BP
GO:1905954,positive regulation of lipid localizatio...,90,2,2,0.59763,1,0.9981917355371901,1,BP
GO:0022412,cellular process involved in reproductio...,423,9,9.4,0.59955,1,0.9981917355371901,0.96,BP
GO:0001764,neuron migration,187,4,4.16,0.59974,1,0.9981917355371901,0.96,BP
GO:0050796,regulation of insulin secretion,187,4,4.16,0.59974,1,0.9981917355371901,0.96,BP
GO:2000116,regulation of cysteine-type endopeptidas...,235,5,5.22,0.60107,1,0.9981917355371901,0.96,BP
GO:0006753,nucleoside phosphate metabolic process,564,12,12.53,0.60202,1,0.9981917355371901,0.96,BP
GO:0002227,innate immune response in mucosa,41,1,0.91,0.60240,1,0.9981917355371901,1.1,BP
GO:0002888,positive regulation of myeloid leukocyte...,41,1,0.91,0.60240,1,0.9981917355371901,1.1,BP
GO:0009409,response to cold,41,1,0.91,0.60240,1,0.9981917355371901,1.1,BP
GO:0009651,response to salt stress,41,1,0.91,0.60240,1,0.9981917355371901,1.1,BP
GO:0010470,regulation of gastrulation,41,1,0.91,0.60240,1,0.9981917355371901,1.1,BP
GO:0030501,positive regulation of bone mineralizati...,41,1,0.91,0.60240,1,0.9981917355371901,1.1,BP
GO:0033344,cholesterol efflux,41,1,0.91,0.60240,1,0.9981917355371901,1.1,BP
GO:0038179,neurotrophin signaling pathway,41,1,0.91,0.60240,1,0.9981917355371901,1.1,BP
GO:0044764,multi-organism cellular process,41,1,0.91,0.60240,1,0.9981917355371901,1.1,BP
GO:0046164,alcohol catabolic process,41,1,0.91,0.60240,1,0.9981917355371901,1.1,BP
GO:0046782,regulation of viral transcription,41,1,0.91,0.60240,1,0.9981917355371901,1.1,BP
GO:0051281,positive regulation of release of seques...,41,1,0.91,0.60240,1,0.9981917355371901,1.1,BP
GO:0055026,negative regulation of cardiac muscle ti...,41,1,0.91,0.60240,1,0.9981917355371901,1.1,BP
GO:0070884,regulation of calcineurin-NFAT signaling...,41,1,0.91,0.60240,1,0.9981917355371901,1.1,BP
GO:0098801,regulation of renal system process,41,1,0.91,0.60240,1,0.9981917355371901,1.1,BP
GO:0106056,regulation of calcineurin-mediated signa...,41,1,0.91,0.60240,1,0.9981917355371901,1.1,BP
GO:1903170,negative regulation of calcium ion trans...,41,1,0.91,0.60240,1,0.9981917355371901,1.1,BP
GO:1905953,negative regulation of lipid localizatio...,41,1,0.91,0.60240,1,0.9981917355371901,1.1,BP
GO:0006497,protein lipidation,91,2,2.02,0.60366,1,0.9989036863823934,0.99,BP
GO:0019226,transmission of nerve impulse,91,2,2.02,0.60366,1,0.9989036863823934,0.99,BP
GO:0031960,response to corticosteroid,91,2,2.02,0.60366,1,0.9989036863823934,0.99,BP
GO:0048864,stem cell development,91,2,2.02,0.60366,1,0.9989036863823934,0.99,BP
GO:0002221,pattern recognition receptor signaling p...,140,3,3.11,0.60475,1,1,0.96,BP
GO:0016079,synaptic vesicle exocytosis,140,3,3.11,0.60475,1,1,0.96,BP
GO:0001505,regulation of neurotransmitter levels,378,8,8.4,0.60513,1,1,0.95,BP
GO:0061448,connective tissue development,284,6,6.31,0.60653,1,1,0.95,BP
GO:2000146,negative regulation of cell motility,284,6,6.31,0.60653,1,1,0.95,BP
GO:0002252,immune effector process,752,16,16.71,0.60671,1,1,0.96,BP
GO:0006813,potassium ion transport,237,5,5.27,0.60856,1,1,0.95,BP
GO:1903531,negative regulation of secretion by cell,237,5,5.27,0.60856,1,1,0.95,BP
GO:0034341,response to interferon-gamma,141,3,3.13,0.60957,1,1,0.96,BP
GO:0001676,long-chain fatty acid metabolic process,92,2,2.04,0.60962,1,1,0.98,BP
GO:0009308,amine metabolic process,92,2,2.04,0.60962,1,1,0.98,BP
GO:0014033,neural crest cell differentiation,92,2,2.04,0.60962,1,1,0.98,BP
GO:0006816,calcium ion transport,427,9,9.49,0.61080,1,1,0.95,BP
GO:0000266,mitochondrial fission,42,1,0.93,0.61125,1,1,1.08,BP
GO:0001709,cell fate determination,42,1,0.93,0.61125,1,1,1.08,BP
GO:0006687,glycosphingolipid metabolic process,42,1,0.93,0.61125,1,1,1.08,BP
GO:0007431,salivary gland development,42,1,0.93,0.61125,1,1,1.08,BP
GO:0010559,regulation of glycoprotein biosynthetic ...,42,1,0.93,0.61125,1,1,1.08,BP
GO:0030835,negative regulation of actin filament de...,42,1,0.93,0.61125,1,1,1.08,BP
GO:0032459,regulation of protein oligomerization,42,1,0.93,0.61125,1,1,1.08,BP
GO:0034198,cellular response to amino acid starvati...,42,1,0.93,0.61125,1,1,1.08,BP
GO:0042220,response to cocaine,42,1,0.93,0.61125,1,1,1.08,BP
GO:0042417,dopamine metabolic process,42,1,0.93,0.61125,1,1,1.08,BP
GO:0045923,positive regulation of fatty acid metabo...,42,1,0.93,0.61125,1,1,1.08,BP
GO:0050685,positive regulation of mRNA processing,42,1,0.93,0.61125,1,1,1.08,BP
GO:0060122,inner ear receptor cell stereocilium org...,42,1,0.93,0.61125,1,1,1.08,BP
GO:0097178,ruffle assembly,42,1,0.93,0.61125,1,1,1.08,BP
GO:0099084,postsynaptic specialization organization,42,1,0.93,0.61125,1,1,1.08,BP
GO:1900015,regulation of cytokine production involv...,42,1,0.93,0.61125,1,1,1.08,BP
GO:1902742,apoptotic process involved in developmen...,42,1,0.93,0.61125,1,1,1.08,BP
GO:0030001,metal ion transport,848,18,18.85,0.61332,1,1,0.95,BP
GO:0002758,innate immune response-activating signal...,142,3,3.16,0.61435,1,1,0.95,BP
GO:0007292,female gamete generation,142,3,3.16,0.61435,1,1,0.95,BP
GO:0030216,keratinocyte differentiation,142,3,3.16,0.61435,1,1,0.95,BP
GO:0045445,myoblast differentiation,93,2,2.07,0.61551,1,1,0.97,BP
GO:0046889,positive regulation of lipid biosyntheti...,93,2,2.07,0.61551,1,1,0.97,BP
GO:0015850,organic hydroxy compound transport,239,5,5.31,0.61597,1,1,0.94,BP
GO:0006874,cellular calcium ion homeostasis,476,10,10.58,0.61618,1,1,0.95,BP
GO:0072089,stem cell proliferation,143,3,3.18,0.61909,1,1,0.94,BP
GO:0003416,endochondral bone growth,43,1,0.96,0.61991,1,1,1.04,BP
GO:0006040,amino sugar metabolic process,43,1,0.96,0.61991,1,1,1.04,BP
GO:0010518,positive regulation of phospholipase act...,43,1,0.96,0.61991,1,1,1.04,BP
GO:0010907,positive regulation of glucose metabolic...,43,1,0.96,0.61991,1,1,1.04,BP
GO:0031670,cellular response to nutrient,43,1,0.96,0.61991,1,1,1.04,BP
GO:0032371,regulation of sterol transport,43,1,0.96,0.61991,1,1,1.04,BP
GO:0032374,regulation of cholesterol transport,43,1,0.96,0.61991,1,1,1.04,BP
GO:0032958,inositol phosphate biosynthetic process,43,1,0.96,0.61991,1,1,1.04,BP
GO:0038202,TORC1 signaling,43,1,0.96,0.61991,1,1,1.04,BP
GO:0040018,positive regulation of multicellular org...,43,1,0.96,0.61991,1,1,1.04,BP
GO:0042771,intrinsic apoptotic signaling pathway in...,43,1,0.96,0.61991,1,1,1.04,BP
GO:0043403,skeletal muscle tissue regeneration,43,1,0.96,0.61991,1,1,1.04,BP
GO:0044743,protein transmembrane import into intrac...,43,1,0.96,0.61991,1,1,1.04,BP
GO:0046621,negative regulation of organ growth,43,1,0.96,0.61991,1,1,1.04,BP
GO:0086002,cardiac muscle cell action potential inv...,43,1,0.96,0.61991,1,1,1.04,BP
GO:0090317,negative regulation of intracellular pro...,43,1,0.96,0.61991,1,1,1.04,BP
GO:1901031,regulation of response to reactive oxyge...,43,1,0.96,0.61991,1,1,1.04,BP
GO:0040029,"regulation of gene expression, epigeneti...",288,6,6.4,0.62006,1,1,0.94,BP
GO:0072507,divalent inorganic cation homeostasis,525,11,11.67,0.62132,1,1,0.94,BP
GO:0007215,glutamate receptor signaling pathway,94,2,2.09,0.62133,1,1,0.96,BP
GO:0032602,chemokine production,94,2,2.09,0.62133,1,1,0.96,BP
GO:0048477,oogenesis,94,2,2.09,0.62133,1,1,0.96,BP
GO:0070555,response to interleukin-1,94,2,2.09,0.62133,1,1,0.96,BP
GO:2000060,positive regulation of ubiquitin-depende...,94,2,2.09,0.62133,1,1,0.96,BP
GO:0043583,ear development,241,5,5.36,0.62329,1,1,0.93,BP
GO:0031333,negative regulation of protein complex a...,144,3,3.2,0.62379,1,1,0.94,BP
GO:0055007,cardiac muscle cell differentiation,144,3,3.2,0.62379,1,1,0.94,BP
GO:0071333,cellular response to glucose stimulus,144,3,3.2,0.62379,1,1,0.94,BP
GO:0022408,negative regulation of cell-cell adhesio...,193,4,4.29,0.62455,1,1,0.93,BP
GO:0055002,striated muscle cell development,193,4,4.29,0.62455,1,1,0.93,BP
GO:0001569,branching involved in blood vessel morph...,44,1,0.98,0.62837,1,1,1.02,BP
GO:0006890,"retrograde vesicle-mediated transport, G...",44,1,0.98,0.62837,1,1,1.02,BP
GO:0016925,protein sumoylation,44,1,0.98,0.62837,1,1,1.02,BP
GO:0019083,viral transcription,44,1,0.98,0.62837,1,1,1.02,BP
GO:0032527,protein exit from endoplasmic reticulum,44,1,0.98,0.62837,1,1,1.02,BP
GO:0032924,activin receptor signaling pathway,44,1,0.98,0.62837,1,1,1.02,BP
GO:0060964,regulation of gene silencing by miRNA,44,1,0.98,0.62837,1,1,1.02,BP
GO:0071804,cellular potassium ion transport,194,4,4.31,0.62859,1,1,0.93,BP
GO:0071805,potassium ion transmembrane transport,194,4,4.31,0.62859,1,1,0.93,BP
GO:0010466,negative regulation of peptidase activit...,243,5,5.4,0.63054,1,1,0.93,BP
GO:0098542,defense response to other organism,529,11,11.76,0.63127,1,1,0.94,BP
GO:1901615,organic hydroxy compound metabolic proce...,482,10,10.71,0.63183,1,1,0.93,BP
GO:0042158,lipoprotein biosynthetic process,96,2,2.13,0.63277,1,1,0.94,BP
GO:0061053,somite development,96,2,2.13,0.63277,1,1,0.94,BP
GO:0007224,smoothened signaling pathway,146,3,3.24,0.63307,1,1,0.93,BP
GO:1903900,regulation of viral life cycle,146,3,3.24,0.63307,1,1,0.93,BP
GO:1905952,regulation of lipid localization,146,3,3.24,0.63307,1,1,0.93,BP
GO:0002063,chondrocyte development,45,1,1,0.63665,1,1,1,BP
GO:0002534,cytokine production involved in inflamma...,45,1,1,0.63665,1,1,1,BP
GO:0007628,adult walking behavior,45,1,1,0.63665,1,1,1,BP
GO:0014046,dopamine secretion,45,1,1,0.63665,1,1,1,BP
GO:0014059,regulation of dopamine secretion,45,1,1,0.63665,1,1,1,BP
GO:0019228,neuronal action potential,45,1,1,0.63665,1,1,1,BP
GO:0032881,regulation of polysaccharide metabolic p...,45,1,1,0.63665,1,1,1,BP
GO:0032965,regulation of collagen biosynthetic proc...,45,1,1,0.63665,1,1,1,BP
GO:0090184,positive regulation of kidney developmen...,45,1,1,0.63665,1,1,1,BP
GO:0071331,cellular response to hexose stimulus,147,3,3.27,0.63765,1,1,0.92,BP
GO:0098693,regulation of synaptic vesicle cycle,147,3,3.27,0.63765,1,1,0.92,BP
GO:0045638,negative regulation of myeloid cell diff...,97,2,2.16,0.63839,1,1,0.93,BP
GO:0048525,negative regulation of viral process,97,2,2.16,0.63839,1,1,0.93,BP
GO:0099565,"chemical synaptic transmission, postsyna...",97,2,2.16,0.63839,1,1,0.93,BP
GO:0034765,regulation of ion transmembrane transpor...,485,10,10.78,0.63953,1,1,0.93,BP
GO:0019221,cytokine-mediated signaling pathway,342,7,7.6,0.63958,1,1,0.92,BP
GO:1903037,regulation of leukocyte cell-cell adhesi...,294,6,6.53,0.63986,1,1,0.92,BP
GO:0022409,positive regulation of cell-cell adhesio...,246,5,5.47,0.64124,1,1,0.91,BP
GO:0042133,neurotransmitter metabolic process,148,3,3.29,0.64220,1,1,0.91,BP
GO:0071326,cellular response to monosaccharide stim...,148,3,3.29,0.64220,1,1,0.91,BP
GO:0050801,ion homeostasis,816,17,18.13,0.64247,1,1,0.94,BP
GO:0009141,nucleoside triphosphate metabolic proces...,295,6,6.56,0.64310,1,1,0.91,BP
GO:0006469,negative regulation of protein kinase ac...,198,4,4.4,0.64447,1,1,0.91,BP
GO:0001774,microglial cell activation,46,1,1.02,0.64474,1,1,0.98,BP
GO:0001990,regulation of systemic arterial blood pr...,46,1,1.02,0.64474,1,1,0.98,BP
GO:0002269,leukocyte activation involved in inflamm...,46,1,1.02,0.64474,1,1,0.98,BP
GO:0010799,regulation of peptidyl-threonine phospho...,46,1,1.02,0.64474,1,1,0.98,BP
GO:0018198,peptidyl-cysteine modification,46,1,1.02,0.64474,1,1,0.98,BP
GO:0032007,negative regulation of TOR signaling,46,1,1.02,0.64474,1,1,0.98,BP
GO:0033013,tetrapyrrole metabolic process,46,1,1.02,0.64474,1,1,0.98,BP
GO:0042073,intraciliary transport,46,1,1.02,0.64474,1,1,0.98,BP
GO:0071385,cellular response to glucocorticoid stim...,46,1,1.02,0.64474,1,1,0.98,BP
GO:0072666,establishment of protein localization to...,46,1,1.02,0.64474,1,1,0.98,BP
GO:0098754,detoxification,46,1,1.02,0.64474,1,1,0.98,BP
GO:0098868,bone growth,46,1,1.02,0.64474,1,1,0.98,BP
GO:1990928,response to amino acid starvation,46,1,1.02,0.64474,1,1,0.98,BP
GO:0034614,cellular response to reactive oxygen spe...,149,3,3.31,0.64670,1,1,0.91,BP
GO:0043903,"regulation of symbiosis, encompassing mu...",199,4,4.42,0.64837,1,1,0.9,BP
GO:0045321,leukocyte activation,866,18,19.25,0.64861,1,1,0.94,BP
GO:0006641,triglyceride metabolic process,99,2,2.2,0.64942,1,1,0.91,BP
GO:0009135,purine nucleoside diphosphate metabolic ...,99,2,2.2,0.64942,1,1,0.91,BP
GO:0009179,purine ribonucleoside diphosphate metabo...,99,2,2.2,0.64942,1,1,0.91,BP
GO:0030279,negative regulation of ossification,99,2,2.2,0.64942,1,1,0.91,BP
GO:0033865,nucleoside bisphosphate metabolic proces...,99,2,2.2,0.64942,1,1,0.91,BP
GO:0033875,ribonucleoside bisphosphate metabolic pr...,99,2,2.2,0.64942,1,1,0.91,BP
GO:0034032,purine nucleoside bisphosphate metabolic...,99,2,2.2,0.64942,1,1,0.91,BP
GO:0048729,tissue morphogenesis,679,14,15.09,0.65074,1,1,0.93,BP
GO:0006875,cellular metal ion homeostasis,585,12,13,0.65203,1,1,0.92,BP
GO:0006110,regulation of glycolytic process,47,1,1.04,0.65265,1,1,0.96,BP
GO:0019098,reproductive behavior,47,1,1.04,0.65265,1,1,0.96,BP
GO:0030517,negative regulation of axon extension,47,1,1.04,0.65265,1,1,0.96,BP
GO:0030811,regulation of nucleotide catabolic proce...,47,1,1.04,0.65265,1,1,0.96,BP
GO:0035137,hindlimb morphogenesis,47,1,1.04,0.65265,1,1,0.96,BP
GO:0035196,production of miRNAs involved in gene si...,47,1,1.04,0.65265,1,1,0.96,BP
GO:0045429,positive regulation of nitric oxide bios...,47,1,1.04,0.65265,1,1,0.96,BP
GO:0060147,regulation of posttranscriptional gene s...,47,1,1.04,0.65265,1,1,0.96,BP
GO:0060966,regulation of gene silencing by RNA,47,1,1.04,0.65265,1,1,0.96,BP
GO:0090279,regulation of calcium ion import,47,1,1.04,0.65265,1,1,0.96,BP
GO:0090659,walking behavior,47,1,1.04,0.65265,1,1,0.96,BP
GO:0120163,negative regulation of cold-induced ther...,47,1,1.04,0.65265,1,1,0.96,BP
GO:1902041,regulation of extrinsic apoptotic signal...,47,1,1.04,0.65265,1,1,0.96,BP
GO:1903018,regulation of glycoprotein metabolic pro...,47,1,1.04,0.65265,1,1,0.96,BP
GO:1902105,regulation of leukocyte differentiation,298,6,6.62,0.65271,1,1,0.91,BP
GO:0052548,regulation of endopeptidase activity,347,7,7.71,0.65449,1,1,0.91,BP
GO:0009611,response to wounding,491,10,10.91,0.65466,1,1,0.92,BP
GO:0010660,regulation of muscle cell apoptotic proc...,100,2,2.22,0.65484,1,1,0.9,BP
GO:0006865,amino acid transport,151,3,3.36,0.65558,1,1,0.89,BP
GO:0048469,cell maturation,201,4,4.47,0.65608,1,1,0.89,BP
GO:0007584,response to nutrient,101,2,2.24,0.66018,1,1,0.89,BP
GO:0032006,regulation of TOR signaling,101,2,2.24,0.66018,1,1,0.89,BP
GO:0046939,nucleotide phosphorylation,101,2,2.24,0.66018,1,1,0.89,BP
GO:0055013,cardiac muscle cell development,101,2,2.24,0.66018,1,1,0.89,BP
GO:0002762,negative regulation of myeloid leukocyte...,48,1,1.07,0.66039,1,1,0.93,BP
GO:0032456,endocytic recycling,48,1,1.07,0.66039,1,1,0.93,BP
GO:0043303,mast cell degranulation,48,1,1.07,0.66039,1,1,0.93,BP
GO:0045581,negative regulation of T cell differenti...,48,1,1.07,0.66039,1,1,0.93,BP
GO:0045646,regulation of erythrocyte differentiatio...,48,1,1.07,0.66039,1,1,0.93,BP
GO:0048010,vascular endothelial growth factor recep...,48,1,1.07,0.66039,1,1,0.93,BP
GO:0048599,oocyte development,48,1,1.07,0.66039,1,1,0.93,BP
GO:0048701,embryonic cranial skeleton morphogenesis,48,1,1.07,0.66039,1,1,0.93,BP
GO:0050850,positive regulation of calcium-mediated ...,48,1,1.07,0.66039,1,1,0.93,BP
GO:0071384,cellular response to corticosteroid stim...,48,1,1.07,0.66039,1,1,0.93,BP
GO:1904407,positive regulation of nitric oxide meta...,48,1,1.07,0.66039,1,1,0.93,BP
GO:2000725,regulation of cardiac muscle cell differ...,48,1,1.07,0.66039,1,1,0.93,BP
GO:0006163,purine nucleotide metabolic process,446,9,9.91,0.66193,1,1,0.91,BP
GO:0010522,regulation of calcium ion transport into...,102,2,2.27,0.66547,1,1,0.88,BP
GO:0033555,multicellular organismal response to str...,102,2,2.27,0.66547,1,1,0.88,BP
GO:0050848,regulation of calcium-mediated signaling,102,2,2.27,0.66547,1,1,0.88,BP
GO:0001961,positive regulation of cytokine-mediated...,49,1,1.09,0.66796,1,1,0.92,BP
GO:0002279,mast cell activation involved in immune ...,49,1,1.09,0.66796,1,1,0.92,BP
GO:0002448,mast cell mediated immunity,49,1,1.09,0.66796,1,1,0.92,BP
GO:0010862,positive regulation of pathway-restricte...,49,1,1.09,0.66796,1,1,0.92,BP
GO:0031050,dsRNA processing,49,1,1.09,0.66796,1,1,0.92,BP
GO:0043300,regulation of leukocyte degranulation,49,1,1.09,0.66796,1,1,0.92,BP
GO:0050873,brown fat cell differentiation,49,1,1.09,0.66796,1,1,0.92,BP
GO:0070169,positive regulation of biomineral tissue...,49,1,1.09,0.66796,1,1,0.92,BP
GO:0070918,production of small RNA involved in gene...,49,1,1.09,0.66796,1,1,0.92,BP
GO:0090102,cochlea development,49,1,1.09,0.66796,1,1,0.92,BP
GO:0099054,presynapse assembly,49,1,1.09,0.66796,1,1,0.92,BP
GO:1904036,negative regulation of epithelial cell a...,49,1,1.09,0.66796,1,1,0.92,BP
GO:0009185,ribonucleoside diphosphate metabolic pro...,103,2,2.29,0.67068,1,1,0.87,BP
GO:0034446,substrate adhesion-dependent cell spread...,103,2,2.29,0.67068,1,1,0.87,BP
GO:1902106,negative regulation of leukocyte differe...,103,2,2.29,0.67068,1,1,0.87,BP
GO:0055080,cation homeostasis,736,15,16.36,0.67091,1,1,0.92,BP
GO:1903039,positive regulation of leukocyte cell-ce...,205,4,4.56,0.67117,1,1,0.88,BP
GO:0003006,developmental process involved in reprod...,784,16,17.42,0.67216,1,1,0.92,BP
GO:0071322,cellular response to carbohydrate stimul...,155,3,3.44,0.67286,1,1,0.87,BP
GO:0007286,spermatid development,206,4,4.58,0.67487,1,1,0.87,BP
GO:0033003,regulation of mast cell activation,50,1,1.11,0.67535,1,1,0.9,BP
GO:0033173,calcineurin-NFAT signaling cascade,50,1,1.11,0.67535,1,1,0.9,BP
GO:0050891,multicellular organismal water homeostas...,50,1,1.11,0.67535,1,1,0.9,BP
GO:0051955,regulation of amino acid transport,50,1,1.11,0.67535,1,1,0.9,BP
GO:0009953,dorsal/ventral pattern formation,104,2,2.31,0.67583,1,1,0.87,BP
GO:0017015,regulation of transforming growth factor...,104,2,2.31,0.67583,1,1,0.87,BP
GO:0042136,neurotransmitter biosynthetic process,104,2,2.31,0.67583,1,1,0.87,BP
GO:0051289,protein homotetramerization,104,2,2.31,0.67583,1,1,0.87,BP
GO:2000300,regulation of synaptic vesicle exocytosi...,104,2,2.31,0.67583,1,1,0.87,BP
GO:0006694,steroid biosynthetic process,156,3,3.47,0.67708,1,1,0.86,BP
GO:0046496,nicotinamide nucleotide metabolic proces...,156,3,3.47,0.67708,1,1,0.86,BP
GO:0071248,cellular response to metal ion,156,3,3.47,0.67708,1,1,0.86,BP
GO:0055001,muscle cell development,207,4,4.6,0.67854,1,1,0.87,BP
GO:0072503,cellular divalent inorganic cation homeo...,501,10,11.13,0.67908,1,1,0.9,BP
GO:0000018,regulation of DNA recombination,105,2,2.33,0.68092,1,1,0.86,BP
GO:0010657,muscle cell apoptotic process,105,2,2.33,0.68092,1,1,0.86,BP
GO:0046849,bone remodeling,105,2,2.33,0.68092,1,1,0.86,BP
GO:1901800,positive regulation of proteasomal prote...,105,2,2.33,0.68092,1,1,0.86,BP
GO:0022407,regulation of cell-cell adhesion,405,8,9,0.68105,1,1,0.89,BP
GO:0044283,small molecule biosynthetic process,646,13,14.36,0.68156,1,1,0.91,BP
GO:0045055,regulated exocytosis,258,5,5.73,0.68209,1,1,0.87,BP
GO:0007032,endosome organization,51,1,1.13,0.68258,1,1,0.88,BP
GO:0007129,synapsis,51,1,1.13,0.68258,1,1,0.88,BP
GO:0030834,regulation of actin filament depolymeriz...,51,1,1.13,0.68258,1,1,0.88,BP
GO:0032355,response to estradiol,51,1,1.13,0.68258,1,1,0.88,BP
GO:0043550,regulation of lipid kinase activity,51,1,1.13,0.68258,1,1,0.88,BP
GO:0043618,regulation of transcription from RNA pol...,51,1,1.13,0.68258,1,1,0.88,BP
GO:0051954,positive regulation of amine transport,51,1,1.13,0.68258,1,1,0.88,BP
GO:0061001,regulation of dendritic spine morphogene...,51,1,1.13,0.68258,1,1,0.88,BP
GO:0072132,mesenchyme morphogenesis,51,1,1.13,0.68258,1,1,0.88,BP
GO:0019362,pyridine nucleotide metabolic process,158,3,3.51,0.68539,1,1,0.85,BP
GO:0034766,negative regulation of ion transmembrane...,106,2,2.36,0.68593,1,1,0.85,BP
GO:0035282,segmentation,106,2,2.36,0.68593,1,1,0.85,BP
GO:0050863,regulation of T cell activation,309,6,6.87,0.68658,1,1,0.87,BP
GO:0009607,response to biotic stimulus,1076,22,23.91,0.68765,1,1,0.92,BP
GO:1903707,negative regulation of hemopoiesis,159,3,3.53,0.68949,1,1,0.85,BP
GO:0009994,oocyte differentiation,52,1,1.16,0.68965,1,1,0.86,BP
GO:0017145,stem cell division,52,1,1.16,0.68965,1,1,0.86,BP
GO:0030901,midbrain development,52,1,1.16,0.68965,1,1,0.86,BP
GO:0031103,axon regeneration,52,1,1.16,0.68965,1,1,0.86,BP
GO:0048066,developmental pigmentation,52,1,1.16,0.68965,1,1,0.86,BP
GO:0060428,lung epithelium development,52,1,1.16,0.68965,1,1,0.86,BP
GO:0061614,pri-miRNA transcription by RNA polymeras...,52,1,1.16,0.68965,1,1,0.86,BP
GO:2001222,regulation of neuron migration,52,1,1.16,0.68965,1,1,0.86,BP
GO:0044264,cellular polysaccharide metabolic proces...,107,2,2.38,0.69089,1,1,0.84,BP
GO:0051186,cofactor metabolic process,506,10,11.24,0.69090,1,1,0.89,BP
GO:0019722,calcium-mediated signaling,211,4,4.69,0.69293,1,1,0.85,BP
GO:1903706,regulation of hemopoiesis,410,8,9.11,0.69407,1,1,0.88,BP
GO:0015672,monovalent inorganic cation transport,459,9,10.2,0.69457,1,1,0.88,BP
GO:0003014,renal system process,108,2,2.4,0.69578,1,1,0.83,BP
GO:0015844,monoamine transport,108,2,2.4,0.69578,1,1,0.83,BP
GO:0022600,digestive system process,108,2,2.4,0.69578,1,1,0.83,BP
GO:0009583,detection of light stimulus,53,1,1.18,0.69657,1,1,0.85,BP
GO:0030219,megakaryocyte differentiation,53,1,1.18,0.69657,1,1,0.85,BP
GO:0031529,ruffle organization,53,1,1.18,0.69657,1,1,0.85,BP
GO:0035176,social behavior,53,1,1.18,0.69657,1,1,0.85,BP
GO:0045777,positive regulation of blood pressure,53,1,1.18,0.69657,1,1,0.85,BP
GO:0046148,pigment biosynthetic process,53,1,1.18,0.69657,1,1,0.85,BP
GO:0051703,intraspecies interaction between organis...,53,1,1.18,0.69657,1,1,0.85,BP
GO:0055010,ventricular cardiac muscle tissue morpho...,53,1,1.18,0.69657,1,1,0.85,BP
GO:0061077,chaperone-mediated protein folding,53,1,1.18,0.69657,1,1,0.85,BP
GO:0097720,calcineurin-mediated signaling,53,1,1.18,0.69657,1,1,0.85,BP
GO:0006941,striated muscle contraction,161,3,3.58,0.69757,1,1,0.84,BP
GO:0010950,positive regulation of endopeptidase act...,161,3,3.58,0.69757,1,1,0.84,BP
GO:0031214,biomineral tissue development,161,3,3.58,0.69757,1,1,0.84,BP
GO:0071466,cellular response to xenobiotic stimulus,161,3,3.58,0.69757,1,1,0.84,BP
GO:0098771,inorganic ion homeostasis,750,15,16.67,0.69842,1,1,0.9,BP
GO:0032963,collagen metabolic process,109,2,2.42,0.70060,1,1,0.83,BP
GO:0048259,regulation of receptor-mediated endocyto...,109,2,2.42,0.70060,1,1,0.83,BP
GO:1902803,regulation of synaptic vesicle transport,109,2,2.42,0.70060,1,1,0.83,BP
GO:0001101,response to acid chemical,364,7,8.09,0.70237,1,1,0.87,BP
GO:0002385,mucosal immune response,54,1,1.2,0.70333,1,1,0.83,BP
GO:0003044,regulation of systemic arterial blood pr...,54,1,1.2,0.70333,1,1,0.83,BP
GO:0007618,mating,54,1,1.2,0.70333,1,1,0.83,BP
GO:0009948,anterior/posterior axis specification,54,1,1.2,0.70333,1,1,0.83,BP
GO:0030199,collagen fibril organization,54,1,1.2,0.70333,1,1,0.83,BP
GO:0032731,positive regulation of interleukin-1 bet...,54,1,1.2,0.70333,1,1,0.83,BP
GO:0032964,collagen biosynthetic process,54,1,1.2,0.70333,1,1,0.83,BP
GO:0035065,regulation of histone acetylation,54,1,1.2,0.70333,1,1,0.83,BP
GO:0048546,digestive tract morphogenesis,54,1,1.2,0.70333,1,1,0.83,BP
GO:0055078,sodium ion homeostasis,54,1,1.2,0.70333,1,1,0.83,BP
GO:0086001,cardiac muscle cell action potential,54,1,1.2,0.70333,1,1,0.83,BP
GO:1900271,regulation of long-term synaptic potenti...,54,1,1.2,0.70333,1,1,0.83,BP
GO:1903533,regulation of protein targeting,54,1,1.2,0.70333,1,1,0.83,BP
GO:2000351,regulation of endothelial cell apoptotic...,54,1,1.2,0.70333,1,1,0.83,BP
GO:2000379,positive regulation of reactive oxygen s...,110,2,2.44,0.70536,1,1,0.82,BP
GO:0030879,mammary gland development,163,3,3.62,0.70548,1,1,0.83,BP
GO:0050851,antigen receptor-mediated signaling path...,163,3,3.62,0.70548,1,1,0.83,BP
GO:0072524,pyridine-containing compound metabolic p...,163,3,3.62,0.70548,1,1,0.83,BP
GO:0001678,cellular glucose homeostasis,164,3,3.64,0.70938,1,1,0.82,BP
GO:0006900,vesicle budding from membrane,55,1,1.22,0.70994,1,1,0.82,BP
GO:0019369,arachidonic acid metabolic process,55,1,1.22,0.70994,1,1,0.82,BP
GO:0030042,actin filament depolymerization,55,1,1.22,0.70994,1,1,0.82,BP
GO:0032655,regulation of interleukin-12 production,55,1,1.22,0.70994,1,1,0.82,BP
GO:0035272,exocrine system development,55,1,1.22,0.70994,1,1,0.82,BP
GO:0044060,regulation of endocrine process,55,1,1.22,0.70994,1,1,0.82,BP
GO:0045058,T cell selection,55,1,1.22,0.70994,1,1,0.82,BP
GO:0045687,positive regulation of glial cell differ...,55,1,1.22,0.70994,1,1,0.82,BP
GO:0046580,negative regulation of Ras protein signa...,55,1,1.22,0.70994,1,1,0.82,BP
GO:0046718,viral entry into host cell,55,1,1.22,0.70994,1,1,0.82,BP
GO:0050732,negative regulation of peptidyl-tyrosine...,55,1,1.22,0.70994,1,1,0.82,BP
GO:0050775,positive regulation of dendrite morphoge...,55,1,1.22,0.70994,1,1,0.82,BP
GO:0050922,negative regulation of chemotaxis,55,1,1.22,0.70994,1,1,0.82,BP
GO:0060193,positive regulation of lipase activity,55,1,1.22,0.70994,1,1,0.82,BP
GO:0018958,phenol-containing compound metabolic pro...,111,2,2.47,0.71006,1,1,0.81,BP
GO:0002251,organ or tissue specific immune response,56,1,1.24,0.71640,1,1,0.81,BP
GO:0002833,positive regulation of response to bioti...,56,1,1.24,0.71640,1,1,0.81,BP
GO:0019731,antibacterial humoral response,56,1,1.24,0.71640,1,1,0.81,BP
GO:0030104,water homeostasis,56,1,1.24,0.71640,1,1,0.81,BP
GO:0046513,ceramide biosynthetic process,56,1,1.24,0.71640,1,1,0.81,BP
GO:0060761,negative regulation of response to cytok...,56,1,1.24,0.71640,1,1,0.81,BP
GO:2000648,positive regulation of stem cell prolife...,56,1,1.24,0.71640,1,1,0.81,BP
GO:0002440,production of molecular mediator of immu...,218,4,4.84,0.71700,1,1,0.83,BP
GO:0007179,transforming growth factor beta receptor...,166,3,3.69,0.71706,1,1,0.81,BP
GO:0050830,defense response to Gram-positive bacter...,113,2,2.51,0.71927,1,1,0.8,BP
GO:0060078,regulation of postsynaptic membrane pote...,113,2,2.51,0.71927,1,1,0.8,BP
GO:0002218,activation of innate immune response,167,3,3.71,0.72084,1,1,0.81,BP
GO:0034404,nucleobase-containing small molecule bio...,167,3,3.71,0.72084,1,1,0.81,BP
GO:0002757,immune response-activating signal transd...,321,6,7.13,0.72098,1,1,0.84,BP
GO:0046649,lymphocyte activation,714,14,15.87,0.72136,1,1,0.88,BP
GO:0006584,catecholamine metabolic process,57,1,1.27,0.72272,1,1,0.79,BP
GO:0007588,excretion,57,1,1.27,0.72272,1,1,0.79,BP
GO:0009712,catechol-containing compound metabolic p...,57,1,1.27,0.72272,1,1,0.79,BP
GO:0010665,regulation of cardiac muscle cell apopto...,57,1,1.27,0.72272,1,1,0.79,BP
GO:0032653,regulation of interleukin-10 production,57,1,1.27,0.72272,1,1,0.79,BP
GO:0042551,neuron maturation,57,1,1.27,0.72272,1,1,0.79,BP
GO:0043470,regulation of carbohydrate catabolic pro...,57,1,1.27,0.72272,1,1,0.79,BP
GO:0045620,negative regulation of lymphocyte differ...,57,1,1.27,0.72272,1,1,0.79,BP
GO:0051445,regulation of meiotic cell cycle,57,1,1.27,0.72272,1,1,0.79,BP
GO:1903539,protein localization to postsynaptic mem...,57,1,1.27,0.72272,1,1,0.79,BP
GO:0031349,positive regulation of defense response,372,7,8.27,0.72333,1,1,0.85,BP
GO:0006090,pyruvate metabolic process,114,2,2.53,0.72378,1,1,0.79,BP
GO:0045333,cellular respiration,168,3,3.73,0.72458,1,1,0.8,BP
GO:0002521,leukocyte differentiation,570,11,12.67,0.72479,1,1,0.87,BP
GO:0030258,lipid modification,221,4,4.91,0.72688,1,1,0.81,BP
GO:0071901,negative regulation of protein serine/th...,115,2,2.56,0.72823,1,1,0.78,BP
GO:1905330,regulation of morphogenesis of an epithe...,115,2,2.56,0.72823,1,1,0.78,BP
GO:0097237,cellular response to toxic substance,169,3,3.76,0.72828,1,1,0.8,BP
GO:0006952,defense response,1481,30,32.91,0.72849,1,1,0.91,BP
GO:0071222,cellular response to lipopolysaccharide,273,5,6.07,0.72859,1,1,0.82,BP
GO:0001754,eye photoreceptor cell differentiation,58,1,1.29,0.72890,1,1,0.78,BP
GO:0032615,interleukin-12 production,58,1,1.29,0.72890,1,1,0.78,BP
GO:0048016,inositol phosphate-mediated signaling,58,1,1.29,0.72890,1,1,0.78,BP
GO:0060443,mammary gland morphogenesis,58,1,1.29,0.72890,1,1,0.78,BP
GO:0065002,intracellular protein transmembrane tran...,58,1,1.29,0.72890,1,1,0.78,BP
GO:0070972,protein localization to endoplasmic reti...,58,1,1.29,0.72890,1,1,0.78,BP
GO:0098900,regulation of action potential,58,1,1.29,0.72890,1,1,0.78,BP
GO:1900449,regulation of glutamate receptor signali...,58,1,1.29,0.72890,1,1,0.78,BP
GO:0098662,inorganic cation transmembrane transport,621,12,13.8,0.72922,1,1,0.87,BP
GO:0006631,fatty acid metabolic process,375,7,8.33,0.73092,1,1,0.84,BP
GO:0010038,response to metal ion,274,5,6.09,0.73151,1,1,0.82,BP
GO:2000241,regulation of reproductive process,170,3,3.78,0.73194,1,1,0.79,BP
GO:0007281,germ cell development,326,6,7.24,0.73451,1,1,0.83,BP
GO:0002011,morphogenesis of an epithelial sheet,59,1,1.31,0.73494,1,1,0.76,BP
GO:0010524,positive regulation of calcium ion trans...,59,1,1.31,0.73494,1,1,0.76,BP
GO:0010656,negative regulation of muscle cell apopt...,59,1,1.31,0.73494,1,1,0.76,BP
GO:0015872,dopamine transport,59,1,1.31,0.73494,1,1,0.76,BP
GO:0030260,entry into host cell,59,1,1.31,0.73494,1,1,0.76,BP
GO:0032663,regulation of interleukin-2 production,59,1,1.31,0.73494,1,1,0.76,BP
GO:0035567,non-canonical Wnt signaling pathway,59,1,1.31,0.73494,1,1,0.76,BP
GO:0044409,entry into host,59,1,1.31,0.73494,1,1,0.76,BP
GO:0046128,purine ribonucleoside metabolic process,59,1,1.31,0.73494,1,1,0.76,BP
GO:0051806,entry into cell of other organism involv...,59,1,1.31,0.73494,1,1,0.76,BP
GO:0051828,entry into other organism involved in sy...,59,1,1.31,0.73494,1,1,0.76,BP
GO:0071806,protein transmembrane transport,59,1,1.31,0.73494,1,1,0.76,BP
GO:1901616,organic hydroxy compound catabolic proce...,59,1,1.31,0.73494,1,1,0.76,BP
GO:0006887,exocytosis,377,7,8.38,0.73591,1,1,0.84,BP
GO:0070838,divalent metal ion transport,477,9,10.6,0.73640,1,1,0.85,BP
GO:0009132,nucleoside diphosphate metabolic process,117,2,2.6,0.73695,1,1,0.77,BP
GO:0090305,nucleic acid phosphodiester bond hydroly...,117,2,2.6,0.73695,1,1,0.77,BP
GO:0002263,cell activation involved in immune respo...,276,5,6.13,0.73728,1,1,0.82,BP
GO:0007204,positive regulation of cytosolic calcium...,328,6,7.29,0.73979,1,1,0.82,BP
GO:0001825,blastocyst formation,60,1,1.33,0.74085,1,1,0.75,BP
GO:0007595,lactation,60,1,1.33,0.74085,1,1,0.75,BP
GO:0010662,regulation of striated muscle cell apopt...,60,1,1.33,0.74085,1,1,0.75,BP
GO:0060119,inner ear receptor cell development,60,1,1.33,0.74085,1,1,0.75,BP
GO:2001238,positive regulation of extrinsic apoptot...,60,1,1.33,0.74085,1,1,0.75,BP
GO:0005976,polysaccharide metabolic process,118,2,2.62,0.74122,1,1,0.76,BP
GO:0019751,polyol metabolic process,118,2,2.62,0.74122,1,1,0.76,BP
GO:1903052,positive regulation of proteolysis invol...,118,2,2.62,0.74122,1,1,0.76,BP
GO:0035296,regulation of tube diameter,173,3,3.84,0.74270,1,1,0.78,BP
GO:0050880,regulation of blood vessel size,173,3,3.84,0.74270,1,1,0.78,BP
GO:0097746,regulation of blood vessel diameter,173,3,3.84,0.74270,1,1,0.78,BP
GO:0072511,divalent inorganic cation transport,480,9,10.67,0.74298,1,1,0.84,BP
GO:0002682,regulation of immune system process,1351,27,30.02,0.74455,1,1,0.9,BP
GO:0006732,coenzyme metabolic process,330,6,7.33,0.74500,1,1,0.82,BP
GO:0002062,chondrocyte differentiation,119,2,2.64,0.74543,1,1,0.76,BP
GO:0051952,regulation of amine transport,119,2,2.64,0.74543,1,1,0.76,BP
GO:0035150,regulation of tube size,174,3,3.87,0.74620,1,1,0.78,BP
GO:0002712,regulation of B cell mediated immunity,61,1,1.36,0.74662,1,1,0.74,BP
GO:0002886,regulation of myeloid leukocyte mediated...,61,1,1.36,0.74662,1,1,0.74,BP
GO:0002889,regulation of immunoglobulin mediated im...,61,1,1.36,0.74662,1,1,0.74,BP
GO:0006446,regulation of translational initiation,61,1,1.36,0.74662,1,1,0.74,BP
GO:0010659,cardiac muscle cell apoptotic process,61,1,1.36,0.74662,1,1,0.74,BP
GO:0030837,negative regulation of actin filament po...,61,1,1.36,0.74662,1,1,0.74,BP
GO:0032613,interleukin-10 production,61,1,1.36,0.74662,1,1,0.74,BP
GO:0042058,regulation of epidermal growth factor re...,61,1,1.36,0.74662,1,1,0.74,BP
GO:0051058,negative regulation of small GTPase medi...,61,1,1.36,0.74662,1,1,0.74,BP
GO:1903428,positive regulation of reactive oxygen s...,61,1,1.36,0.74662,1,1,0.74,BP
GO:0030097,hemopoiesis,922,18,20.49,0.74700,1,1,0.88,BP
GO:0055086,nucleobase-containing small molecule met...,631,12,14.02,0.74857,1,1,0.86,BP
GO:1901136,carbohydrate derivative catabolic proces...,120,2,2.67,0.74958,1,1,0.75,BP
GO:0006733,oxidoreduction coenzyme metabolic proces...,175,3,3.89,0.74967,1,1,0.77,BP
GO:0009101,glycoprotein biosynthetic process,281,5,6.24,0.75130,1,1,0.8,BP
GO:0071219,cellular response to molecule of bacteri...,281,5,6.24,0.75130,1,1,0.8,BP
GO:0001775,cell activation,973,19,21.62,0.75131,1,1,0.88,BP
GO:0003229,ventricular cardiac muscle tissue develo...,62,1,1.38,0.75227,1,1,0.72,BP
GO:0010812,negative regulation of cell-substrate ad...,62,1,1.38,0.75227,1,1,0.72,BP
GO:0032732,positive regulation of interleukin-1 pro...,62,1,1.38,0.75227,1,1,0.72,BP
GO:0042461,photoreceptor cell development,62,1,1.38,0.75227,1,1,0.72,BP
GO:0045143,homologous chromosome segregation,62,1,1.38,0.75227,1,1,0.72,BP
GO:0090501,RNA phosphodiester bond hydrolysis,62,1,1.38,0.75227,1,1,0.72,BP
GO:0031929,TOR signaling,121,2,2.69,0.75368,1,1,0.74,BP
GO:0071229,cellular response to acid chemical,282,5,6.27,0.75404,1,1,0.8,BP
GO:0048863,stem cell differentiation,230,4,5.11,0.75498,1,1,0.78,BP
GO:0002764,immune response-regulating signaling pat...,334,6,7.42,0.75519,1,1,0.81,BP
GO:0043902,positive regulation of multi-organism pr...,177,3,3.93,0.75650,1,1,0.76,BP
GO:0010906,regulation of glucose metabolic process,122,2,2.71,0.75771,1,1,0.74,BP
GO:0048565,digestive tract development,122,2,2.71,0.75771,1,1,0.74,BP
GO:0015800,acidic amino acid transport,63,1,1.4,0.75779,1,1,0.71,BP
GO:0032677,regulation of interleukin-8 production,63,1,1.4,0.75779,1,1,0.71,BP
GO:0045661,regulation of myoblast differentiation,63,1,1.4,0.75779,1,1,0.71,BP
GO:0060393,regulation of pathway-restricted SMAD pr...,63,1,1.4,0.75779,1,1,0.71,BP
GO:1903307,positive regulation of regulated secreto...,63,1,1.4,0.75779,1,1,0.71,BP
GO:2000756,regulation of peptidyl-lysine acetylatio...,63,1,1.4,0.75779,1,1,0.71,BP
GO:0017156,calcium ion regulated exocytosis,178,3,3.96,0.75985,1,1,0.76,BP
GO:0002377,immunoglobulin production,123,2,2.73,0.76169,1,1,0.73,BP
GO:0006639,acylglycerol metabolic process,123,2,2.73,0.76169,1,1,0.73,BP
GO:0015837,amine transport,123,2,2.73,0.76169,1,1,0.73,BP
GO:0050868,negative regulation of T cell activation,123,2,2.73,0.76169,1,1,0.73,BP
GO:0007219,Notch signaling pathway,179,3,3.98,0.76317,1,1,0.75,BP
GO:0010951,negative regulation of endopeptidase act...,179,3,3.98,0.76317,1,1,0.75,BP
GO:0140013,meiotic nuclear division,179,3,3.98,0.76317,1,1,0.75,BP
GO:0001510,RNA methylation,64,1,1.42,0.76319,1,1,0.7,BP
GO:0009880,embryonic pattern specification,64,1,1.42,0.76319,1,1,0.7,BP
GO:0010658,striated muscle cell apoptotic process,64,1,1.42,0.76319,1,1,0.7,BP
GO:0010676,positive regulation of cellular carbohyd...,64,1,1.42,0.76319,1,1,0.7,BP
GO:0030512,negative regulation of transforming grow...,64,1,1.42,0.76319,1,1,0.7,BP
GO:0032720,negative regulation of tumor necrosis fa...,64,1,1.42,0.76319,1,1,0.7,BP
GO:0035904,aorta development,64,1,1.42,0.76319,1,1,0.7,BP
GO:0042278,purine nucleoside metabolic process,64,1,1.42,0.76319,1,1,0.7,BP
GO:0002520,immune system development,1030,20,22.89,0.76433,1,1,0.87,BP
GO:0007586,digestion,124,2,2.76,0.76561,1,1,0.72,BP
GO:0042157,lipoprotein metabolic process,124,2,2.76,0.76561,1,1,0.72,BP
GO:0007187,G protein-coupled receptor signaling pat...,234,4,5.2,0.76673,1,1,0.77,BP
GO:0072521,purine-containing compound metabolic pro...,492,9,10.93,0.76817,1,1,0.82,BP
GO:0001707,mesoderm formation,65,1,1.44,0.76847,1,1,0.69,BP
GO:0030032,lamellipodium assembly,65,1,1.44,0.76847,1,1,0.69,BP
GO:0045668,negative regulation of osteoblast differ...,65,1,1.44,0.76847,1,1,0.69,BP
GO:0048278,vesicle docking,65,1,1.44,0.76847,1,1,0.69,BP
GO:0051926,negative regulation of calcium ion trans...,65,1,1.44,0.76847,1,1,0.69,BP
GO:0099601,regulation of neurotransmitter receptor ...,65,1,1.44,0.76847,1,1,0.69,BP
GO:1901264,carbohydrate derivative transport,65,1,1.44,0.76847,1,1,0.69,BP
GO:1903556,negative regulation of tumor necrosis fa...,65,1,1.44,0.76847,1,1,0.69,BP
GO:2001169,regulation of ATP biosynthetic process,65,1,1.44,0.76847,1,1,0.69,BP
GO:0042391,regulation of membrane potential,442,8,9.82,0.76920,1,1,0.81,BP
GO:0006638,neutral lipid metabolic process,125,2,2.78,0.76948,1,1,0.72,BP
GO:0045089,positive regulation of innate immune res...,235,4,5.22,0.76960,1,1,0.77,BP
GO:0090092,regulation of transmembrane receptor pro...,235,4,5.22,0.76960,1,1,0.77,BP
GO:0019933,cAMP-mediated signaling,181,3,4.02,0.76970,1,1,0.75,BP
GO:0009100,glycoprotein metabolic process,341,6,7.58,0.77230,1,1,0.79,BP
GO:0016064,immunoglobulin mediated immune response,126,2,2.8,0.77328,1,1,0.71,BP
GO:0019748,secondary metabolic process,66,1,1.47,0.77363,1,1,0.68,BP
GO:0060389,pathway-restricted SMAD protein phosphor...,66,1,1.47,0.77363,1,1,0.68,BP
GO:1901184,regulation of ERBB signaling pathway,66,1,1.47,0.77363,1,1,0.68,BP
GO:0030003,cellular cation homeostasis,645,12,14.33,0.77408,1,1,0.84,BP
GO:0019725,cellular homeostasis,940,18,20.89,0.77454,1,1,0.86,BP
GO:0043280,positive regulation of cysteine-type end...,127,2,2.82,0.77704,1,1,0.71,BP
GO:0060048,cardiac muscle contraction,127,2,2.82,0.77704,1,1,0.71,BP
GO:0032623,interleukin-2 production,67,1,1.49,0.77868,1,1,0.67,BP
GO:0060688,regulation of morphogenesis of a branchi...,67,1,1.49,0.77868,1,1,0.67,BP
GO:0061371,determination of heart left/right asymme...,67,1,1.49,0.77868,1,1,0.67,BP
GO:0051262,protein tetramerization,184,3,4.09,0.77921,1,1,0.73,BP
GO:0008610,lipid biosynthetic process,548,10,12.18,0.77929,1,1,0.82,BP
GO:0098655,cation transmembrane transport,698,13,15.51,0.77990,1,1,0.84,BP
GO:0010035,response to inorganic substance,498,9,11.07,0.78010,1,1,0.81,BP
GO:0009582,detection of abiotic stimulus,128,2,2.84,0.78074,1,1,0.7,BP
GO:1903522,regulation of blood circulation,239,4,5.31,0.78080,1,1,0.75,BP
GO:0050878,regulation of body fluid levels,345,6,7.67,0.78167,1,1,0.78,BP
GO:0009749,response to glucose,185,3,4.11,0.78231,1,1,0.73,BP
GO:0002711,positive regulation of T cell mediated i...,68,1,1.51,0.78361,1,1,0.66,BP
GO:0006305,DNA alkylation,68,1,1.51,0.78361,1,1,0.66,BP
GO:0006306,DNA methylation,68,1,1.51,0.78361,1,1,0.66,BP
GO:0003279,cardiac septum development,129,2,2.87,0.78439,1,1,0.7,BP
GO:0009581,detection of external stimulus,129,2,2.87,0.78439,1,1,0.7,BP
GO:0014065,phosphatidylinositol 3-kinase signaling,129,2,2.87,0.78439,1,1,0.7,BP
GO:0035195,gene silencing by miRNA,129,2,2.87,0.78439,1,1,0.7,BP
GO:0048640,negative regulation of developmental gro...,129,2,2.87,0.78439,1,1,0.7,BP
GO:0051592,response to calcium ion,129,2,2.87,0.78439,1,1,0.7,BP
GO:0019724,B cell mediated immunity,130,2,2.89,0.78798,1,1,0.69,BP
GO:0001541,ovarian follicle development,69,1,1.53,0.78843,1,1,0.65,BP
GO:0006766,vitamin metabolic process,69,1,1.53,0.78843,1,1,0.65,BP
GO:0007405,neuroblast proliferation,69,1,1.53,0.78843,1,1,0.65,BP
GO:0021536,diencephalon development,69,1,1.53,0.78843,1,1,0.65,BP
GO:0032637,interleukin-8 production,69,1,1.53,0.78843,1,1,0.65,BP
GO:0043299,leukocyte degranulation,69,1,1.53,0.78843,1,1,0.65,BP
GO:0043407,negative regulation of MAP kinase activi...,69,1,1.53,0.78843,1,1,0.65,BP
GO:0045576,mast cell activation,69,1,1.53,0.78843,1,1,0.65,BP
GO:0048332,mesoderm morphogenesis,69,1,1.53,0.78843,1,1,0.65,BP
GO:0048511,rhythmic process,296,5,6.58,0.79002,1,1,0.76,BP
GO:0006109,regulation of carbohydrate metabolic pro...,188,3,4.18,0.79139,1,1,0.72,BP
GO:0015696,ammonium transport,131,2,2.91,0.79152,1,1,0.69,BP
GO:0002090,regulation of receptor internalization,70,1,1.56,0.79315,1,1,0.64,BP
GO:0003341,cilium movement,70,1,1.56,0.79315,1,1,0.64,BP
GO:0007269,neurotransmitter secretion,189,3,4.2,0.79434,1,1,0.71,BP
GO:0009746,response to hexose,189,3,4.2,0.79434,1,1,0.71,BP
GO:0050870,positive regulation of T cell activation,189,3,4.2,0.79434,1,1,0.71,BP
GO:1903305,regulation of regulated secretory pathwa...,189,3,4.2,0.79434,1,1,0.71,BP
GO:1901135,carbohydrate derivative metabolic proces...,1003,19,22.29,0.79457,1,1,0.85,BP
GO:0001508,action potential,132,2,2.93,0.79501,1,1,0.68,BP
GO:0009166,nucleotide catabolic process,132,2,2.93,0.79501,1,1,0.68,BP
GO:0034284,response to monosaccharide,190,3,4.22,0.79726,1,1,0.71,BP
GO:0099643,signal release from synapse,190,3,4.22,0.79726,1,1,0.71,BP
GO:0006873,cellular ion homeostasis,659,12,14.65,0.79774,1,1,0.82,BP
GO:0001913,T cell mediated cytotoxicity,71,1,1.58,0.79776,1,1,0.63,BP
GO:0009119,ribonucleoside metabolic process,71,1,1.58,0.79776,1,1,0.63,BP
GO:0032413,negative regulation of ion transmembrane...,71,1,1.58,0.79776,1,1,0.63,BP
GO:0046173,polyol biosynthetic process,71,1,1.58,0.79776,1,1,0.63,BP
GO:0050433,regulation of catecholamine secretion,71,1,1.58,0.79776,1,1,0.63,BP
GO:0046488,phosphatidylinositol metabolic process,133,2,2.96,0.79844,1,1,0.68,BP
GO:0050906,detection of stimulus involved in sensor...,133,2,2.96,0.79844,1,1,0.68,BP
GO:0002698,negative regulation of immune effector p...,134,2,2.98,0.80183,1,1,0.67,BP
GO:0034763,negative regulation of transmembrane tra...,134,2,2.98,0.80183,1,1,0.67,BP
GO:0017157,regulation of exocytosis,247,4,5.49,0.80190,1,1,0.73,BP
GO:0042509,regulation of tyrosine phosphorylation o...,72,1,1.6,0.80227,1,1,0.62,BP
GO:0097755,positive regulation of blood vessel diam...,72,1,1.6,0.80227,1,1,0.62,BP
GO:0071695,anatomical structure maturation,192,3,4.27,0.80300,1,1,0.7,BP
GO:0035194,posttranscriptional gene silencing by RN...,135,2,3,0.80516,1,1,0.67,BP
GO:0055123,digestive system development,135,2,3,0.80516,1,1,0.67,BP
GO:0098660,inorganic ion transmembrane transport,664,12,14.76,0.80575,1,1,0.81,BP
GO:0006836,neurotransmitter transport,303,5,6.73,0.80641,1,1,0.74,BP
GO:0006812,cation transport,1110,21,24.67,0.80653,1,1,0.85,BP
GO:0050864,regulation of B cell activation,136,2,3.02,0.80845,1,1,0.66,BP
GO:0002429,immune response-activating cell surface ...,194,3,4.31,0.80860,1,1,0.7,BP
GO:0002066,columnar/cuboidal epithelial cell develo...,74,1,1.64,0.81099,1,1,0.61,BP
GO:0002532,production of molecular mediator involve...,74,1,1.64,0.81099,1,1,0.61,BP
GO:0042130,negative regulation of T cell proliferat...,74,1,1.64,0.81099,1,1,0.61,BP
GO:0050432,catecholamine secretion,74,1,1.64,0.81099,1,1,0.61,BP
GO:0051155,positive regulation of striated muscle c...,74,1,1.64,0.81099,1,1,0.61,BP
GO:1901983,regulation of protein acetylation,74,1,1.64,0.81099,1,1,0.61,BP
GO:1903036,positive regulation of response to wound...,74,1,1.64,0.81099,1,1,0.61,BP
GO:0045598,regulation of fat cell differentiation,137,2,3.04,0.81168,1,1,0.66,BP
GO:0046928,regulation of neurotransmitter secretion,137,2,3.04,0.81168,1,1,0.66,BP
GO:0046394,carboxylic acid biosynthetic process,359,6,7.98,0.81217,1,1,0.75,BP
GO:0055082,cellular chemical homeostasis,819,15,18.2,0.81289,1,1,0.82,BP
GO:0003205,cardiac chamber development,196,3,4.36,0.81407,1,1,0.69,BP
GO:0042180,cellular ketone metabolic process,196,3,4.36,0.81407,1,1,0.69,BP
GO:0016053,organic acid biosynthetic process,360,6,8,0.81422,1,1,0.75,BP
GO:0002637,regulation of immunoglobulin production,75,1,1.67,0.81521,1,1,0.6,BP
GO:0003333,amino acid transmembrane transport,75,1,1.67,0.81521,1,1,0.6,BP
GO:0061097,regulation of protein tyrosine kinase ac...,75,1,1.67,0.81521,1,1,0.6,BP
GO:0017158,regulation of calcium ion-dependent exoc...,139,2,3.09,0.81801,1,1,0.65,BP
GO:0050806,positive regulation of synaptic transmis...,362,6,8.04,0.81826,1,1,0.75,BP
GO:0048534,hematopoietic or lymphoid organ developm...,972,18,21.6,0.81836,1,1,0.83,BP
GO:0007260,tyrosine phosphorylation of STAT protein,76,1,1.69,0.81933,1,1,0.59,BP
GO:0010822,positive regulation of mitochondrion org...,76,1,1.69,0.81933,1,1,0.59,BP
GO:0032272,negative regulation of protein polymeriz...,76,1,1.69,0.81933,1,1,0.59,BP
GO:0045453,bone resorption,76,1,1.69,0.81933,1,1,0.59,BP
GO:0051865,protein autoubiquitination,76,1,1.69,0.81933,1,1,0.59,BP
GO:0055008,cardiac muscle tissue morphogenesis,76,1,1.69,0.81933,1,1,0.59,BP
GO:0016573,histone acetylation,140,2,3.11,0.82110,1,1,0.64,BP
GO:0071236,cellular response to antibiotic,199,3,4.42,0.82202,1,1,0.68,BP
GO:0015918,sterol transport,77,1,1.71,0.82336,1,1,0.58,BP
GO:0030301,cholesterol transport,77,1,1.71,0.82336,1,1,0.58,BP
GO:0051965,positive regulation of synapse assembly,77,1,1.71,0.82336,1,1,0.58,BP
GO:0140056,organelle localization by membrane tethe...,77,1,1.71,0.82336,1,1,0.58,BP
GO:0010821,regulation of mitochondrion organization,141,2,3.13,0.82414,1,1,0.64,BP
GO:0042060,wound healing,365,6,8.11,0.82418,1,1,0.74,BP
GO:0030148,sphingolipid biosynthetic process,78,1,1.73,0.82730,1,1,0.58,BP
GO:0032729,positive regulation of interferon-gamma ...,78,1,1.73,0.82730,1,1,0.58,BP
GO:0061180,mammary gland epithelium development,78,1,1.73,0.82730,1,1,0.58,BP
GO:1901606,alpha-amino acid catabolic process,78,1,1.73,0.82730,1,1,0.58,BP
GO:0035637,multicellular organismal signaling,143,2,3.18,0.83009,1,1,0.63,BP
GO:1901292,nucleoside phosphate catabolic process,143,2,3.18,0.83009,1,1,0.63,BP
GO:0006835,dicarboxylic acid transport,79,1,1.76,0.83115,1,1,0.57,BP
GO:0030808,regulation of nucleotide biosynthetic pr...,79,1,1.76,0.83115,1,1,0.57,BP
GO:0061844,antimicrobial humoral immune response me...,79,1,1.76,0.83115,1,1,0.57,BP
GO:0071277,cellular response to calcium ion,79,1,1.76,0.83115,1,1,0.57,BP
GO:1900371,regulation of purine nucleotide biosynth...,79,1,1.76,0.83115,1,1,0.57,BP
GO:0009743,response to carbohydrate,203,3,4.51,0.83217,1,1,0.67,BP
GO:0090288,negative regulation of cellular response...,144,2,3.2,0.83300,1,1,0.62,BP
GO:2001056,positive regulation of cysteine-type end...,144,2,3.2,0.83300,1,1,0.62,BP
GO:0002694,regulation of leukocyte activation,528,9,11.73,0.83308,1,1,0.77,BP
GO:0006919,activation of cysteine-type endopeptidas...,80,1,1.78,0.83492,1,1,0.56,BP
GO:0032410,negative regulation of transporter activ...,80,1,1.78,0.83492,1,1,0.56,BP
GO:0032890,regulation of organic acid transport,80,1,1.78,0.83492,1,1,0.56,BP
GO:0018393,internal peptidyl-lysine acetylation,145,2,3.22,0.83586,1,1,0.62,BP
GO:0007188,adenylate cyclase-modulating G protein-c...,205,3,4.56,0.83706,1,1,0.66,BP
GO:0006664,glycolipid metabolic process,81,1,1.8,0.83860,1,1,0.56,BP
GO:0038034,signal transduction in absence of ligand,81,1,1.8,0.83860,1,1,0.56,BP
GO:0051702,interaction with symbiont,81,1,1.8,0.83860,1,1,0.56,BP
GO:0070613,regulation of protein processing,81,1,1.8,0.83860,1,1,0.56,BP
GO:0097192,extrinsic apoptotic signaling pathway in...,81,1,1.8,0.83860,1,1,0.56,BP
GO:2000243,positive regulation of reproductive proc...,81,1,1.8,0.83860,1,1,0.56,BP
GO:0002065,columnar/cuboidal epithelial cell differ...,146,2,3.24,0.83867,1,1,0.62,BP
GO:0002768,immune response-regulating cell surface ...,206,3,4.58,0.83946,1,1,0.66,BP
GO:0051707,response to other organism,1040,19,23.11,0.84038,1,1,0.82,BP
GO:0001738,morphogenesis of a polarized epithelium,82,1,1.82,0.84220,1,1,0.55,BP
GO:0002718,regulation of cytokine production involv...,82,1,1.82,0.84220,1,1,0.55,BP
GO:0032651,regulation of interleukin-1 beta product...,82,1,1.82,0.84220,1,1,0.55,BP
GO:1903509,liposaccharide metabolic process,82,1,1.82,0.84220,1,1,0.55,BP
GO:0043207,response to external biotic stimulus,1042,19,23.16,0.84262,1,1,0.82,BP
GO:0051480,regulation of cytosolic calcium ion conc...,375,6,8.33,0.84284,1,1,0.72,BP
GO:0021700,developmental maturation,321,5,7.13,0.84392,1,1,0.7,BP
GO:0003206,cardiac chamber morphogenesis,148,2,3.29,0.84418,1,1,0.61,BP
GO:0006475,internal protein amino acid acetylation,148,2,3.29,0.84418,1,1,0.61,BP
GO:0051249,regulation of lymphocyte activation,430,7,9.56,0.84497,1,1,0.73,BP
GO:1903317,regulation of protein maturation,83,1,1.84,0.84572,1,1,0.54,BP
GO:0003231,cardiac ventricle development,149,2,3.31,0.84686,1,1,0.6,BP
GO:0019932,second-messenger-mediated signaling,432,7,9.6,0.84826,1,1,0.73,BP
GO:0044728,DNA methylation or demethylation,84,1,1.87,0.84916,1,1,0.53,BP
GO:0002700,regulation of production of molecular me...,150,2,3.33,0.84951,1,1,0.6,BP
GO:0007605,sensory perception of sound,268,4,5.96,0.84953,1,1,0.67,BP
GO:0042098,T cell proliferation,211,3,4.69,0.85099,1,1,0.64,BP
GO:0045580,regulation of T cell differentiation,151,2,3.36,0.85211,1,1,0.6,BP
GO:0008589,regulation of smoothened signaling pathw...,85,1,1.89,0.85253,1,1,0.53,BP
GO:0030595,leukocyte chemotaxis,212,3,4.71,0.85321,1,1,0.64,BP
GO:0019935,cyclic-nucleotide-mediated signaling,213,3,4.73,0.85540,1,1,0.63,BP
GO:0002275,myeloid cell activation involved in immu...,86,1,1.91,0.85582,1,1,0.52,BP
GO:0006096,glycolytic process,86,1,1.91,0.85582,1,1,0.52,BP
GO:0042632,cholesterol homeostasis,86,1,1.91,0.85582,1,1,0.52,BP
GO:0060411,cardiac septum morphogenesis,86,1,1.91,0.85582,1,1,0.52,BP
GO:0006757,ATP generation from ADP,87,1,1.93,0.85904,1,1,0.52,BP
GO:0009593,detection of chemical stimulus,87,1,1.93,0.85904,1,1,0.52,BP
GO:0055092,sterol homeostasis,87,1,1.93,0.85904,1,1,0.52,BP
GO:0019637,organophosphate metabolic process,957,17,21.27,0.85924,1,1,0.8,BP
GO:0010675,regulation of cellular carbohydrate meta...,154,2,3.42,0.85968,1,1,0.58,BP
GO:0046486,glycerolipid metabolic process,330,5,7.33,0.86031,1,1,0.68,BP
GO:0032945,negative regulation of mononuclear cell ...,88,1,1.96,0.86218,1,1,0.51,BP
GO:0050672,negative regulation of lymphocyte prolif...,88,1,1.96,0.86218,1,1,0.51,BP
GO:0006869,lipid transport,332,5,7.38,0.86375,1,1,0.68,BP
GO:0018394,peptidyl-lysine acetylation,156,2,3.47,0.86452,1,1,0.58,BP
GO:0051149,positive regulation of muscle cell diffe...,89,1,1.98,0.86526,1,1,0.51,BP
GO:0051937,catecholamine transport,89,1,1.98,0.86526,1,1,0.51,BP
GO:0060415,muscle tissue morphogenesis,89,1,1.98,0.86526,1,1,0.51,BP
GO:0070301,cellular response to hydrogen peroxide,89,1,1.98,0.86526,1,1,0.51,BP
GO:0051250,negative regulation of lymphocyte activa...,157,2,3.49,0.86689,1,1,0.57,BP
GO:0009116,nucleoside metabolic process,90,1,2,0.86826,1,1,0.5,BP
GO:0031016,pancreas development,90,1,2,0.86826,1,1,0.5,BP
GO:0042866,pyruvate biosynthetic process,90,1,2,0.86826,1,1,0.5,BP
GO:0042113,B cell activation,278,4,6.18,0.86858,1,1,0.65,BP
GO:0045087,innate immune response,710,12,15.78,0.86875,1,1,0.76,BP
GO:0009156,ribonucleoside monophosphate biosyntheti...,158,2,3.51,0.86921,1,1,0.57,BP
GO:0000041,transition metal ion transport,91,1,2.02,0.87120,1,1,0.5,BP
GO:0002709,regulation of T cell mediated immunity,91,1,2.02,0.87120,1,1,0.5,BP
GO:0042742,defense response to bacterium,281,4,6.24,0.87388,1,1,0.64,BP
GO:0009063,cellular amino acid catabolic process,92,1,2.04,0.87408,1,1,0.49,BP
GO:0006310,DNA recombination,282,4,6.27,0.87560,1,1,0.64,BP
GO:0002253,activation of immune response,396,6,8.8,0.87680,1,1,0.68,BP
GO:0030098,lymphocyte differentiation,396,6,8.8,0.87680,1,1,0.68,BP
GO:0002027,regulation of heart rate,93,1,2.07,0.87689,1,1,0.48,BP
GO:0070664,negative regulation of leukocyte prolife...,93,1,2.07,0.87689,1,1,0.48,BP
GO:0007601,visual perception,162,2,3.6,0.87815,1,1,0.56,BP
GO:0032611,interleukin-1 beta production,94,1,2.09,0.87964,1,1,0.48,BP
GO:0046031,ADP metabolic process,94,1,2.09,0.87964,1,1,0.48,BP
GO:0050829,defense response to Gram-negative bacter...,94,1,2.09,0.87964,1,1,0.48,BP
GO:0010817,regulation of hormone levels,562,9,12.49,0.88057,1,1,0.72,BP
GO:0002444,myeloid leukocyte mediated immunity,95,1,2.11,0.88232,1,1,0.47,BP
GO:0045069,regulation of viral genome replication,95,1,2.11,0.88232,1,1,0.47,BP
GO:0045582,positive regulation of T cell differenti...,95,1,2.11,0.88232,1,1,0.47,BP
GO:0050795,regulation of behavior,95,1,2.11,0.88232,1,1,0.47,BP
GO:0051817,modification of morphology or physiology...,95,1,2.11,0.88232,1,1,0.47,BP
GO:0060968,regulation of gene silencing,95,1,2.11,0.88232,1,1,0.47,BP
GO:0009124,nucleoside monophosphate biosynthetic pr...,164,2,3.64,0.88241,1,1,0.55,BP
GO:0032787,monocarboxylic acid metabolic process,564,9,12.53,0.88298,1,1,0.72,BP
GO:0002449,lymphocyte mediated immunity,287,4,6.38,0.88392,1,1,0.63,BP
GO:0009260,ribonucleotide biosynthetic process,228,3,5.07,0.88497,1,1,0.59,BP
GO:0044262,cellular carbohydrate metabolic process,288,4,6.4,0.88553,1,1,0.62,BP
GO:0050953,sensory perception of light stimulus,166,2,3.69,0.88652,1,1,0.54,BP
GO:0006650,glycerophospholipid metabolic process,229,3,5.09,0.88673,1,1,0.59,BP
GO:0017144,drug metabolic process,727,12,16.16,0.88748,1,1,0.74,BP
GO:0006304,DNA modification,97,1,2.16,0.88752,1,1,0.46,BP
GO:0007200,phospholipase C-activating G protein-cou...,97,1,2.16,0.88752,1,1,0.46,BP
GO:0014066,regulation of phosphatidylinositol 3-kin...,97,1,2.16,0.88752,1,1,0.46,BP
GO:0019395,fatty acid oxidation,97,1,2.16,0.88752,1,1,0.46,BP
GO:0048644,muscle organ morphogenesis,97,1,2.16,0.88752,1,1,0.46,BP
GO:0140029,exocytic process,97,1,2.16,0.88752,1,1,0.46,BP
GO:0050865,regulation of cell activation,570,9,12.67,0.88998,1,1,0.71,BP
GO:0019730,antimicrobial humoral response,98,1,2.18,0.89003,1,1,0.46,BP
GO:0045132,meiotic chromosome segregation,98,1,2.18,0.89003,1,1,0.46,BP
GO:0051606,detection of stimulus,231,3,5.13,0.89019,1,1,0.58,BP
GO:0032496,response to lipopolysaccharide,349,5,7.76,0.89021,1,1,0.64,BP
GO:0002705,positive regulation of leukocyte mediate...,169,2,3.76,0.89245,1,1,0.53,BP
GO:0006165,nucleoside diphosphate phosphorylation,99,1,2.2,0.89249,1,1,0.45,BP
GO:0034440,lipid oxidation,99,1,2.2,0.89249,1,1,0.45,BP
GO:0045639,positive regulation of myeloid cell diff...,99,1,2.2,0.89249,1,1,0.45,BP
GO:0043543,protein acylation,233,3,5.18,0.89355,1,1,0.58,BP
GO:0030509,BMP signaling pathway,170,2,3.78,0.89436,1,1,0.53,BP
GO:0032652,regulation of interleukin-1 production,100,1,2.22,0.89489,1,1,0.45,BP
GO:0046390,ribose phosphate biosynthetic process,235,3,5.22,0.89682,1,1,0.57,BP
GO:0045921,positive regulation of exocytosis,101,1,2.24,0.89723,1,1,0.45,BP
GO:0009410,response to xenobiotic stimulus,236,3,5.24,0.89843,1,1,0.57,BP
GO:0045088,regulation of innate immune response,297,4,6.6,0.89912,1,1,0.61,BP
GO:0062014,negative regulation of small molecule me...,102,1,2.27,0.89953,1,1,0.44,BP
GO:0019359,nicotinamide nucleotide biosynthetic pro...,103,1,2.29,0.90177,1,1,0.44,BP
GO:0050954,sensory perception of mechanical stimulu...,299,4,6.64,0.90194,1,1,0.6,BP
GO:0030317,flagellated sperm motility,104,1,2.31,0.90397,1,1,0.43,BP
GO:0043255,regulation of carbohydrate biosynthetic ...,104,1,2.31,0.90397,1,1,0.43,BP
GO:0042129,regulation of T cell proliferation,176,2,3.91,0.90518,1,1,0.51,BP
GO:0097722,sperm motility,105,1,2.33,0.90611,1,1,0.43,BP
GO:1903825,organic acid transmembrane transport,105,1,2.33,0.90611,1,1,0.43,BP
GO:1905039,carboxylic acid transmembrane transport,105,1,2.33,0.90611,1,1,0.43,BP
GO:0006629,lipid metabolic process,1266,22,28.13,0.90786,1,1,0.78,BP
GO:0019363,pyridine nucleotide biosynthetic process,106,1,2.36,0.90821,1,1,0.42,BP
GO:0002703,regulation of leukocyte mediated immunit...,243,3,5.4,0.90902,1,1,0.56,BP
GO:0002683,negative regulation of immune system pro...,478,7,10.62,0.90952,1,1,0.66,BP
GO:0002460,adaptive immune response based on somati...,305,4,6.78,0.90999,1,1,0.59,BP
GO:0048661,positive regulation of smooth muscle cel...,107,1,2.38,0.91026,1,1,0.42,BP
GO:0006612,protein targeting to membrane,108,1,2.4,0.91226,1,1,0.42,BP
GO:0002237,response to molecule of bacterial origin,367,5,8.16,0.91329,1,1,0.61,BP
GO:0071772,response to BMP,181,2,4.02,0.91339,1,1,0.5,BP
GO:0071773,cellular response to BMP stimulus,181,2,4.02,0.91339,1,1,0.5,BP
GO:0006690,icosanoid metabolic process,109,1,2.42,0.91422,1,1,0.41,BP
GO:0045621,positive regulation of lymphocyte differ...,109,1,2.42,0.91422,1,1,0.41,BP
GO:1903034,regulation of response to wounding,182,2,4.04,0.91495,1,1,0.5,BP
GO:0032649,regulation of interferon-gamma productio...,110,1,2.44,0.91614,1,1,0.41,BP
GO:0072525,pyridine-containing compound biosyntheti...,110,1,2.44,0.91614,1,1,0.41,BP
GO:0009612,response to mechanical stimulus,183,2,4.07,0.91649,1,1,0.49,BP
GO:0051188,cofactor biosynthetic process,249,3,5.53,0.91730,1,1,0.54,BP
GO:0045619,regulation of lymphocyte differentiation,184,2,4.09,0.91800,1,1,0.49,BP
GO:0007156,homophilic cell adhesion via plasma memb...,111,1,2.47,0.91801,1,1,0.4,BP
GO:0046632,alpha-beta T cell differentiation,111,1,2.47,0.91801,1,1,0.4,BP
GO:0002443,leukocyte mediated immunity,372,5,8.27,0.91890,1,1,0.6,BP
GO:0002822,regulation of adaptive immune response b...,185,2,4.11,0.91948,1,1,0.49,BP
GO:0046651,lymphocyte proliferation,313,4,6.96,0.91981,1,1,0.57,BP
GO:0007127,meiosis I,112,1,2.49,0.91984,1,1,0.4,BP
GO:0042100,B cell proliferation,112,1,2.49,0.91984,1,1,0.4,BP
GO:0090100,positive regulation of transmembrane rec...,112,1,2.49,0.91984,1,1,0.4,BP
GO:1901657,glycosyl compound metabolic process,112,1,2.49,0.91984,1,1,0.4,BP
GO:0010876,lipid localization,373,5,8.29,0.91998,1,1,0.6,BP
GO:0009566,fertilization,186,2,4.13,0.92094,1,1,0.48,BP
GO:0008585,female gonad development,113,1,2.51,0.92163,1,1,0.4,BP
GO:0032612,interleukin-1 production,113,1,2.51,0.92163,1,1,0.4,BP
GO:0090101,negative regulation of transmembrane rec...,113,1,2.51,0.92163,1,1,0.4,BP
GO:0032943,mononuclear cell proliferation,315,4,7,0.92210,1,1,0.57,BP
GO:0002695,negative regulation of leukocyte activat...,187,2,4.16,0.92237,1,1,0.48,BP
GO:0002706,regulation of lymphocyte mediated immuni...,187,2,4.16,0.92237,1,1,0.48,BP
GO:0002699,positive regulation of immune effector p...,253,3,5.62,0.92243,1,1,0.53,BP
GO:0001892,embryonic placenta development,114,1,2.53,0.92338,1,1,0.4,BP
GO:0048814,regulation of dendrite morphogenesis,114,1,2.53,0.92338,1,1,0.4,BP
GO:0006473,protein acetylation,188,2,4.18,0.92378,1,1,0.48,BP
GO:0046467,membrane lipid biosynthetic process,115,1,2.56,0.92510,1,1,0.39,BP
GO:0002696,positive regulation of leukocyte activat...,318,4,7.07,0.92544,1,1,0.57,BP
GO:0055114,oxidation-reduction process,878,14,19.51,0.92608,1,1,0.72,BP
GO:0046545,development of primary female sexual cha...,116,1,2.58,0.92677,1,1,0.39,BP
GO:0002250,adaptive immune response,439,6,9.76,0.92744,1,1,0.61,BP
GO:0060349,bone morphogenesis,117,1,2.6,0.92841,1,1,0.38,BP
GO:0061982,meiosis I cell cycle process,117,1,2.6,0.92841,1,1,0.38,BP
GO:0009108,coenzyme biosynthetic process,192,2,4.27,0.92918,1,1,0.47,BP
GO:0044255,cellular lipid metabolic process,936,15,20.8,0.92940,1,1,0.72,BP
GO:0002285,lymphocyte activation involved in immune...,195,2,4.33,0.93298,1,1,0.46,BP
GO:0006006,glucose metabolic process,196,2,4.36,0.93421,1,1,0.46,BP
GO:0016051,carbohydrate biosynthetic process,196,2,4.36,0.93421,1,1,0.46,BP
GO:0044070,regulation of anion transport,121,1,2.69,0.93460,1,1,0.37,BP
GO:0046717,acid secretion,122,1,2.71,0.93606,1,1,0.37,BP
GO:0051251,positive regulation of lymphocyte activa...,265,3,5.89,0.93613,1,1,0.51,BP
GO:1901605,alpha-amino acid metabolic process,198,2,4.4,0.93660,1,1,0.45,BP
GO:0032609,interferon-gamma production,123,1,2.73,0.93749,1,1,0.37,BP
GO:0006486,protein glycosylation,199,2,4.42,0.93776,1,1,0.45,BP
GO:0043413,macromolecule glycosylation,199,2,4.42,0.93776,1,1,0.45,BP
GO:0042752,regulation of circadian rhythm,124,1,2.76,0.93888,1,1,0.36,BP
GO:0002819,regulation of adaptive immune response,201,2,4.47,0.94003,1,1,0.45,BP
GO:0050867,positive regulation of cell activation,334,4,7.42,0.94117,1,1,0.54,BP
GO:0000724,double-strand break repair via homologou...,126,1,2.8,0.94159,1,1,0.36,BP
GO:0000725,recombinational repair,126,1,2.8,0.94159,1,1,0.36,BP
GO:0002366,leukocyte activation involved in immune ...,272,3,6.04,0.94305,1,1,0.5,BP
GO:0046434,organophosphate catabolic process,205,2,4.56,0.94433,1,1,0.44,BP
GO:0098742,cell-cell adhesion via plasma-membrane a...,205,2,4.56,0.94433,1,1,0.44,BP
GO:0070661,leukocyte proliferation,339,4,7.53,0.94543,1,1,0.53,BP
GO:0006955,immune response,1387,23,30.82,0.94667,1,1,0.75,BP
GO:0050866,negative regulation of cell activation,208,2,4.62,0.94736,1,1,0.43,BP
GO:0007189,adenylate cyclase-activating G protein-c...,131,1,2.91,0.94783,1,1,0.34,BP
GO:0015893,drug transport,209,2,4.64,0.94833,1,1,0.43,BP
GO:1903708,positive regulation of hemopoiesis,209,2,4.64,0.94833,1,1,0.43,BP
GO:1901568,fatty acid derivative metabolic process,132,1,2.93,0.94900,1,1,0.34,BP
GO:0006754,ATP biosynthetic process,133,1,2.96,0.95014,1,1,0.34,BP
GO:0070085,glycosylation,213,2,4.73,0.95206,1,1,0.42,BP
GO:0001909,leukocyte mediated cytotoxicity,135,1,3,0.95234,1,1,0.33,BP
GO:0009165,nucleotide biosynthetic process,284,3,6.31,0.95332,1,1,0.48,BP
GO:0002708,positive regulation of lymphocyte mediat...,136,1,3.02,0.95341,1,1,0.33,BP
GO:0002824,positive regulation of adaptive immune r...,136,1,3.02,0.95341,1,1,0.33,BP
GO:0009451,RNA modification,138,1,3.07,0.95547,1,1,0.33,BP
GO:0009152,purine ribonucleotide biosynthetic proce...,219,2,4.87,0.95718,1,1,0.41,BP
GO:0009617,response to bacterium,769,11,17.09,0.95743,1,1,0.64,BP
GO:1901293,nucleoside phosphate biosynthetic proces...,290,3,6.44,0.95778,1,1,0.47,BP
GO:0007338,single fertilization,141,1,3.13,0.95839,1,1,0.32,BP
GO:0016052,carbohydrate catabolic process,141,1,3.13,0.95839,1,1,0.32,BP
GO:1901137,carbohydrate derivative biosynthetic pro...,600,8,13.33,0.95848,1,1,0.6,BP
GO:0002821,positive regulation of adaptive immune r...,143,1,3.18,0.96023,1,1,0.31,BP
GO:0009206,purine ribonucleoside triphosphate biosy...,143,1,3.18,0.96023,1,1,0.31,BP
GO:0061041,regulation of wound healing,143,1,3.18,0.96023,1,1,0.31,BP
GO:0002684,positive regulation of immune system pro...,942,14,20.93,0.96041,1,1,0.67,BP
GO:0034220,ion transmembrane transport,887,13,19.71,0.96041,1,1,0.66,BP
GO:0005975,carbohydrate metabolic process,545,7,12.11,0.96043,1,1,0.58,BP
GO:0009145,purine nucleoside triphosphate biosynthe...,144,1,3.2,0.96112,1,1,0.31,BP
GO:0019233,sensory perception of pain,144,1,3.2,0.96112,1,1,0.31,BP
GO:0019318,hexose metabolic process,225,2,5,0.96177,1,1,0.4,BP
GO:0009201,ribonucleoside triphosphate biosynthetic...,146,1,3.24,0.96284,1,1,0.31,BP
GO:0035821,modification of morphology or physiology...,147,1,3.27,0.96367,1,1,0.31,BP
GO:0046660,female sex differentiation,147,1,3.27,0.96367,1,1,0.31,BP
GO:0050670,regulation of lymphocyte proliferation,230,2,5.11,0.96523,1,1,0.39,BP
GO:0030183,B cell differentiation,150,1,3.33,0.96606,1,1,0.3,BP
GO:0055067,monovalent inorganic cation homeostasis,150,1,3.33,0.96606,1,1,0.3,BP
GO:0046942,carboxylic acid transport,303,3,6.73,0.96612,1,1,0.45,BP
GO:0050778,positive regulation of immune response,617,8,13.71,0.96639,1,1,0.58,BP
GO:0032944,regulation of mononuclear cell prolifera...,232,2,5.16,0.96653,1,1,0.39,BP
GO:0015849,organic acid transport,304,3,6.76,0.96669,1,1,0.44,BP
GO:0009127,purine nucleoside monophosphate biosynth...,154,1,3.42,0.96900,1,1,0.29,BP
GO:0009168,purine ribonucleoside monophosphate bios...,154,1,3.42,0.96900,1,1,0.29,BP
GO:0006164,purine nucleotide biosynthetic process,238,2,5.29,0.97016,1,1,0.38,BP
GO:0016485,protein processing,238,2,5.29,0.97016,1,1,0.38,BP
GO:0009142,nucleoside triphosphate biosynthetic pro...,156,1,3.47,0.97037,1,1,0.29,BP
GO:0046631,alpha-beta T cell activation,157,1,3.49,0.97103,1,1,0.29,BP
GO:0002244,hematopoietic progenitor cell differenti...,158,1,3.51,0.97168,1,1,0.28,BP
GO:0050777,negative regulation of immune response,159,1,3.53,0.97232,1,1,0.28,BP
GO:0072522,purine-containing compound biosynthetic ...,243,2,5.4,0.97288,1,1,0.37,BP
GO:0070663,regulation of leukocyte proliferation,245,2,5.44,0.97391,1,1,0.37,BP
GO:0046425,regulation of JAK-STAT cascade,166,1,3.69,0.97637,1,1,0.27,BP
GO:0060291,long-term synaptic potentiation,253,2,5.62,0.97764,1,1,0.36,BP
GO:0043436,oxoacid metabolic process,940,13,20.89,0.97765,1,1,0.62,BP
GO:0005996,monosaccharide metabolic process,254,2,5.64,0.97807,1,1,0.35,BP
GO:0097164,ammonium ion metabolic process,170,1,3.78,0.97842,1,1,0.26,BP
GO:1902107,positive regulation of leukocyte differe...,170,1,3.78,0.97842,1,1,0.26,BP
GO:1904892,regulation of STAT cascade,171,1,3.8,0.97890,1,1,0.26,BP
GO:0001906,cell killing,172,1,3.82,0.97938,1,1,0.26,BP
GO:0001890,placenta development,173,1,3.84,0.97984,1,1,0.26,BP
GO:0050776,regulation of immune response,777,10,17.27,0.98009,1,1,0.58,BP
GO:0071230,cellular response to amino acid stimulus,175,1,3.89,0.98073,1,1,0.26,BP
GO:0019752,carboxylic acid metabolic process,901,12,20.02,0.98181,1,1,0.6,BP
GO:0006520,cellular amino acid metabolic process,266,2,5.91,0.98262,1,1,0.34,BP
GO:0098656,anion transmembrane transport,182,1,4.04,0.98356,1,1,0.25,BP
GO:0006082,organic acid metabolic process,968,13,21.51,0.98370,1,1,0.6,BP
GO:0006644,phospholipid metabolic process,352,3,7.82,0.98556,1,1,0.38,BP
GO:0043200,response to amino acid,188,1,4.18,0.98565,1,1,0.24,BP
GO:0007259,JAK-STAT cascade,190,1,4.22,0.98629,1,1,0.24,BP
GO:0044281,small molecule metabolic process,1760,27,39.11,0.98695,1,1,0.69,BP
GO:0097696,STAT cascade,195,1,4.33,0.98776,1,1,0.23,BP
GO:0055085,transmembrane transport,1281,18,28.47,0.98831,1,1,0.63,BP
GO:0044242,cellular lipid catabolic process,199,1,4.42,0.98882,1,1,0.23,BP
GO:0006959,humoral immune response,204,1,4.53,0.99002,1,1,0.22,BP
GO:0051604,protein maturation,300,2,6.67,0.99110,1,1,0.3,BP
GO:0016054,organic acid catabolic process,215,1,4.78,0.99222,1,1,0.21,BP
GO:0046395,carboxylic acid catabolic process,215,1,4.78,0.99222,1,1,0.21,BP
GO:0042445,hormone metabolic process,219,1,4.87,0.99290,1,1,0.21,BP
GO:0044282,small molecule catabolic process,314,2,6.98,0.99326,1,1,0.29,BP
GO:0006811,ion transport,1581,22,35.13,0.99480,1,1,0.63,BP
GO:1990823,response to leukemia inhibitory factor,328,2,7.29,0.99491,1,1,0.27,BP
GO:1990830,cellular response to leukemia inhibitory...,328,2,7.29,0.99491,1,1,0.27,BP
GO:0015711,organic anion transport,420,3,9.33,0.99581,1,1,0.32,BP
GO:0090407,organophosphate biosynthetic process,505,4,11.22,0.99642,1,1,0.36,BP
GO:0016042,lipid catabolic process,307,1,6.82,0.99904,1,1,0.15,BP
GO:0003008,system process,2937,42,65.27,0.99964,1,1,0.64,BP
GO:0006820,anion transport,555,3,12.33,0.99968,1,1,0.24,BP
GO:0050877,nervous system process,2290,20,50.89,1.00000,1,1,0.39,BP
GO:0007186,G protein-coupled receptor signaling pat...,1902,13,42.27,1.00000,1,1,0.31,BP
GO:0007600,sensory perception,1781,7,39.58,1.00000,1,1,0.18,BP
GO:0008150,biological_process,21194,471,471,1.00000,1,1,1,BP
GO:0000038,very long-chain fatty acid metabolic pro...,30,0,0.67,1.00000,1,1,0,BP
GO:0000096,sulfur amino acid metabolic process,38,0,0.84,1.00000,1,1,0,BP
GO:0000132,establishment of mitotic spindle orienta...,30,0,0.67,1.00000,1,1,0,BP
GO:0000154,rRNA modification,25,0,0.56,1.00000,1,1,0,BP
GO:0000272,polysaccharide catabolic process,25,0,0.56,1.00000,1,1,0,BP
GO:0000387,spliceosomal snRNP assembly,31,0,0.69,1.00000,1,1,0,BP
GO:0000726,non-recombinational repair,57,0,1.27,1.00000,1,1,0,BP
GO:0000731,DNA synthesis involved in DNA repair,28,0,0.62,1.00000,1,1,0,BP
GO:0000737,"DNA catabolic process, endonucleolytic",26,0,0.58,1.00000,1,1,0,BP
GO:0000959,mitochondrial RNA metabolic process,42,0,0.93,1.00000,1,1,0,BP
GO:0001516,prostaglandin biosynthetic process,25,0,0.56,1.00000,1,1,0,BP
GO:0001523,retinoid metabolic process,55,0,1.22,1.00000,1,1,0,BP
GO:0001556,oocyte maturation,30,0,0.67,1.00000,1,1,0,BP
GO:0001562,response to protozoan,37,0,0.82,1.00000,1,1,0,BP
GO:0001573,ganglioside metabolic process,20,0,0.44,1.00000,1,1,0,BP
GO:0001580,detection of chemical stimulus involved ...,48,0,1.07,1.00000,1,1,0,BP
GO:0001696,gastric acid secretion,20,0,0.44,1.00000,1,1,0,BP
GO:0001736,establishment of planar polarity,61,0,1.36,1.00000,1,1,0,BP
GO:0001773,myeloid dendritic cell activation,33,0,0.73,1.00000,1,1,0,BP
GO:0001776,leukocyte homeostasis,110,0,2.44,1.00000,1,1,0,BP
GO:0001779,natural killer cell differentiation,31,0,0.69,1.00000,1,1,0,BP
GO:0001780,neutrophil homeostasis,22,0,0.49,1.00000,1,1,0,BP
GO:0001782,B cell homeostasis,37,0,0.82,1.00000,1,1,0,BP
GO:0001783,B cell apoptotic process,41,0,0.91,1.00000,1,1,0,BP
GO:0001829,trophectodermal cell differentiation,25,0,0.56,1.00000,1,1,0,BP
GO:0001893,maternal placenta development,32,0,0.71,1.00000,1,1,0,BP
GO:0001910,regulation of leukocyte mediated cytotox...,103,0,2.29,1.00000,1,1,0,BP
GO:0001911,negative regulation of leukocyte mediate...,23,0,0.51,1.00000,1,1,0,BP
GO:0001912,positive regulation of leukocyte mediate...,80,0,1.78,1.00000,1,1,0,BP
GO:0001914,regulation of T cell mediated cytotoxici...,51,0,1.13,1.00000,1,1,0,BP
GO:0001916,positive regulation of T cell mediated c...,46,0,1.02,1.00000,1,1,0,BP
GO:0001945,lymph vessel development,29,0,0.64,1.00000,1,1,0,BP
GO:0001946,lymphangiogenesis,21,0,0.47,1.00000,1,1,0,BP
GO:0001947,heart looping,60,0,1.33,1.00000,1,1,0,BP
GO:0001956,positive regulation of neurotransmitter ...,26,0,0.58,1.00000,1,1,0,BP
GO:0001958,endochondral ossification,30,0,0.67,1.00000,1,1,0,BP
GO:0001960,negative regulation of cytokine-mediated...,52,0,1.16,1.00000,1,1,0,BP
GO:0001976,neurological system process involved in ...,21,0,0.47,1.00000,1,1,0,BP
GO:0002021,response to dietary excess,34,0,0.76,1.00000,1,1,0,BP
GO:0002026,regulation of the force of heart contrac...,31,0,0.69,1.00000,1,1,0,BP
GO:0002029,desensitization of G protein-coupled rec...,28,0,0.62,1.00000,1,1,0,BP
GO:0002067,glandular epithelial cell differentiatio...,59,0,1.31,1.00000,1,1,0,BP
GO:0002068,glandular epithelial cell development,28,0,0.62,1.00000,1,1,0,BP
GO:0002076,osteoblast development,20,0,0.44,1.00000,1,1,0,BP
GO:0002092,positive regulation of receptor internal...,29,0,0.64,1.00000,1,1,0,BP
GO:0002097,tRNA wobble base modification,21,0,0.47,1.00000,1,1,0,BP
GO:0002115,store-operated calcium entry,22,0,0.49,1.00000,1,1,0,BP
GO:0002228,natural killer cell mediated immunity,63,0,1.4,1.00000,1,1,0,BP
GO:0002260,lymphocyte homeostasis,78,0,1.73,1.00000,1,1,0,BP
GO:0002286,T cell activation involved in immune res...,113,0,2.51,1.00000,1,1,0,BP
GO:0002287,alpha-beta T cell activation involved in...,66,0,1.47,1.00000,1,1,0,BP
GO:0002292,T cell differentiation involved in immun...,71,0,1.58,1.00000,1,1,0,BP
GO:0002293,alpha-beta T cell differentiation involv...,65,0,1.44,1.00000,1,1,0,BP
GO:0002294,"CD4-positive, alpha-beta T cell differen...",64,0,1.42,1.00000,1,1,0,BP
GO:0002313,mature B cell differentiation involved i...,20,0,0.44,1.00000,1,1,0,BP
GO:0002320,lymphoid progenitor cell differentiation,23,0,0.51,1.00000,1,1,0,BP
GO:0002323,natural killer cell activation involved ...,39,0,0.87,1.00000,1,1,0,BP
GO:0002335,mature B cell differentiation,27,0,0.6,1.00000,1,1,0,BP
GO:0002374,cytokine secretion involved in immune re...,24,0,0.53,1.00000,1,1,0,BP
GO:0002428,antigen processing and presentation of p...,31,0,0.69,1.00000,1,1,0,BP
GO:0002437,inflammatory response to antigenic stimu...,58,0,1.29,1.00000,1,1,0,BP
GO:0002438,acute inflammatory response to antigenic...,25,0,0.56,1.00000,1,1,0,BP
GO:0002446,neutrophil mediated immunity,34,0,0.76,1.00000,1,1,0,BP
GO:0002455,humoral immune response mediated by circ...,44,0,0.98,1.00000,1,1,0,BP
GO:0002475,antigen processing and presentation via ...,35,0,0.78,1.00000,1,1,0,BP
GO:0002476,antigen processing and presentation of e...,30,0,0.67,1.00000,1,1,0,BP
GO:0002483,antigen processing and presentation of e...,37,0,0.82,1.00000,1,1,0,BP
GO:0002484,antigen processing and presentation of e...,30,0,0.67,1.00000,1,1,0,BP
GO:0002486,antigen processing and presentation of e...,29,0,0.64,1.00000,1,1,0,BP
GO:0002507,tolerance induction,28,0,0.62,1.00000,1,1,0,BP
GO:0002523,leukocyte migration involved in inflamma...,20,0,0.44,1.00000,1,1,0,BP
GO:0002526,acute inflammatory response,119,0,2.64,1.00000,1,1,0,BP
GO:0002548,monocyte chemotaxis,54,0,1.2,1.00000,1,1,0,BP
GO:0002577,regulation of antigen processing and pre...,21,0,0.47,1.00000,1,1,0,BP
GO:0002639,positive regulation of immunoglobulin pr...,50,0,1.11,1.00000,1,1,0,BP
GO:0002673,regulation of acute inflammatory respons...,63,0,1.4,1.00000,1,1,0,BP
GO:0002675,positive regulation of acute inflammator...,32,0,0.71,1.00000,1,1,0,BP
GO:0002691,regulation of cellular extravasation,32,0,0.71,1.00000,1,1,0,BP
GO:0002693,positive regulation of cellular extravas...,23,0,0.51,1.00000,1,1,0,BP
GO:0002702,positive regulation of production of mol...,103,0,2.29,1.00000,1,1,0,BP
GO:0002704,negative regulation of leukocyte mediate...,56,0,1.24,1.00000,1,1,0,BP
GO:0002707,negative regulation of lymphocyte mediat...,46,0,1.02,1.00000,1,1,0,BP
GO:0002714,positive regulation of B cell mediated i...,46,0,1.02,1.00000,1,1,0,BP
GO:0002715,regulation of natural killer cell mediat...,51,0,1.13,1.00000,1,1,0,BP
GO:0002716,negative regulation of natural killer ce...,20,0,0.44,1.00000,1,1,0,BP
GO:0002717,positive regulation of natural killer ce...,34,0,0.76,1.00000,1,1,0,BP
GO:0002720,positive regulation of cytokine producti...,53,0,1.18,1.00000,1,1,0,BP
GO:0002724,regulation of T cell cytokine production,30,0,0.67,1.00000,1,1,0,BP
GO:0002753,cytoplasmic pattern recognition receptor...,38,0,0.84,1.00000,1,1,0,BP
GO:0002763,positive regulation of myeloid leukocyte...,65,0,1.44,1.00000,1,1,0,BP
GO:0002820,negative regulation of adaptive immune r...,47,0,1.04,1.00000,1,1,0,BP
GO:0002823,negative regulation of adaptive immune r...,42,0,0.93,1.00000,1,1,0,BP
GO:0002825,regulation of T-helper 1 type immune res...,31,0,0.69,1.00000,1,1,0,BP
GO:0002827,positive regulation of T-helper 1 type i...,24,0,0.53,1.00000,1,1,0,BP
GO:0002828,regulation of type 2 immune response,32,0,0.71,1.00000,1,1,0,BP
GO:0002861,regulation of inflammatory response to a...,32,0,0.71,1.00000,1,1,0,BP
GO:0002891,positive regulation of immunoglobulin me...,46,0,1.02,1.00000,1,1,0,BP
GO:0002902,regulation of B cell apoptotic process,30,0,0.67,1.00000,1,1,0,BP
GO:0002903,negative regulation of B cell apoptotic ...,23,0,0.51,1.00000,1,1,0,BP
GO:0002920,regulation of humoral immune response,36,0,0.8,1.00000,1,1,0,BP
GO:0003016,respiratory system process,33,0,0.73,1.00000,1,1,0,BP
GO:0003081,regulation of systemic arterial blood pr...,32,0,0.71,1.00000,1,1,0,BP
GO:0003085,negative regulation of systemic arterial...,27,0,0.6,1.00000,1,1,0,BP
GO:0003170,heart valve development,58,0,1.29,1.00000,1,1,0,BP
GO:0003171,atrioventricular valve development,27,0,0.6,1.00000,1,1,0,BP
GO:0003176,aortic valve development,23,0,0.51,1.00000,1,1,0,BP
GO:0003177,pulmonary valve development,21,0,0.47,1.00000,1,1,0,BP
GO:0003179,heart valve morphogenesis,47,0,1.04,1.00000,1,1,0,BP
GO:0003181,atrioventricular valve morphogenesis,24,0,0.53,1.00000,1,1,0,BP
GO:0003197,endocardial cushion development,47,0,1.04,1.00000,1,1,0,BP
GO:0003203,endocardial cushion morphogenesis,34,0,0.76,1.00000,1,1,0,BP
GO:0003209,cardiac atrium morphogenesis,34,0,0.76,1.00000,1,1,0,BP
GO:0003230,cardiac atrium development,38,0,0.84,1.00000,1,1,0,BP
GO:0003254,regulation of membrane depolarization,45,0,1,1.00000,1,1,0,BP
GO:0003272,endocardial cushion formation,24,0,0.53,1.00000,1,1,0,BP
GO:0003281,ventricular septum development,87,0,1.93,1.00000,1,1,0,BP
GO:0003283,atrial septum development,21,0,0.47,1.00000,1,1,0,BP
GO:0003299,muscle hypertrophy in response to stress,26,0,0.58,1.00000,1,1,0,BP
GO:0003309,type B pancreatic cell differentiation,31,0,0.69,1.00000,1,1,0,BP
GO:0003323,type B pancreatic cell development,22,0,0.49,1.00000,1,1,0,BP
GO:0003351,epithelial cilium movement,25,0,0.56,1.00000,1,1,0,BP
GO:0003413,chondrocyte differentiation involved in ...,29,0,0.64,1.00000,1,1,0,BP
GO:0003417,growth plate cartilage development,36,0,0.8,1.00000,1,1,0,BP
GO:0003418,growth plate cartilage chondrocyte diffe...,22,0,0.49,1.00000,1,1,0,BP
GO:0003433,chondrocyte development involved in endo...,22,0,0.49,1.00000,1,1,0,BP
GO:0005980,glycogen catabolic process,20,0,0.44,1.00000,1,1,0,BP
GO:0006022,aminoglycan metabolic process,101,0,2.24,1.00000,1,1,0,BP
GO:0006023,aminoglycan biosynthetic process,53,0,1.18,1.00000,1,1,0,BP
GO:0006024,glycosaminoglycan biosynthetic process,43,0,0.96,1.00000,1,1,0,BP
GO:0006026,aminoglycan catabolic process,26,0,0.58,1.00000,1,1,0,BP
GO:0006081,cellular aldehyde metabolic process,70,0,1.56,1.00000,1,1,0,BP
GO:0006089,lactate metabolic process,21,0,0.47,1.00000,1,1,0,BP
GO:0006094,gluconeogenesis,73,0,1.62,1.00000,1,1,0,BP
GO:0006111,regulation of gluconeogenesis,51,0,1.13,1.00000,1,1,0,BP
GO:0006144,purine nucleobase metabolic process,23,0,0.51,1.00000,1,1,0,BP
GO:0006213,pyrimidine nucleoside metabolic process,26,0,0.58,1.00000,1,1,0,BP
GO:0006220,pyrimidine nucleotide metabolic process,32,0,0.71,1.00000,1,1,0,BP
GO:0006221,pyrimidine nucleotide biosynthetic proce...,24,0,0.53,1.00000,1,1,0,BP
GO:0006298,mismatch repair,26,0,0.58,1.00000,1,1,0,BP
GO:0006301,postreplication repair,23,0,0.51,1.00000,1,1,0,BP
GO:0006303,double-strand break repair via nonhomolo...,50,0,1.11,1.00000,1,1,0,BP
GO:0006308,DNA catabolic process,33,0,0.73,1.00000,1,1,0,BP
GO:0006349,regulation of gene expression by genetic...,21,0,0.47,1.00000,1,1,0,BP
GO:0006367,transcription initiation from RNA polyme...,62,0,1.38,1.00000,1,1,0,BP
GO:0006379,mRNA cleavage,20,0,0.44,1.00000,1,1,0,BP
GO:0006399,tRNA metabolic process,169,0,3.76,1.00000,1,1,0,BP
GO:0006400,tRNA modification,72,0,1.6,1.00000,1,1,0,BP
GO:0006418,tRNA aminoacylation for protein translat...,41,0,0.91,1.00000,1,1,0,BP
GO:0006482,protein demethylation,31,0,0.69,1.00000,1,1,0,BP
GO:0006487,protein N-linked glycosylation,67,0,1.49,1.00000,1,1,0,BP
GO:0006505,GPI anchor metabolic process,32,0,0.71,1.00000,1,1,0,BP
GO:0006506,GPI anchor biosynthetic process,31,0,0.69,1.00000,1,1,0,BP
GO:0006515,protein quality control for misfolded or...,27,0,0.6,1.00000,1,1,0,BP
GO:0006541,glutamine metabolic process,21,0,0.47,1.00000,1,1,0,BP
GO:0006576,cellular biogenic amine metabolic proces...,46,0,1.02,1.00000,1,1,0,BP
GO:0006625,protein targeting to peroxisome,20,0,0.44,1.00000,1,1,0,BP
GO:0006635,fatty acid beta-oxidation,67,0,1.49,1.00000,1,1,0,BP
GO:0006661,phosphatidylinositol biosynthetic proces...,59,0,1.31,1.00000,1,1,0,BP
GO:0006688,glycosphingolipid biosynthetic process,20,0,0.44,1.00000,1,1,0,BP
GO:0006692,prostanoid metabolic process,41,0,0.91,1.00000,1,1,0,BP
GO:0006693,prostaglandin metabolic process,41,0,0.91,1.00000,1,1,0,BP
GO:0006699,bile acid biosynthetic process,20,0,0.44,1.00000,1,1,0,BP
GO:0006706,steroid catabolic process,24,0,0.53,1.00000,1,1,0,BP
GO:0006720,isoprenoid metabolic process,81,0,1.8,1.00000,1,1,0,BP
GO:0006721,terpenoid metabolic process,62,0,1.38,1.00000,1,1,0,BP
GO:0006730,one-carbon metabolic process,27,0,0.6,1.00000,1,1,0,BP
GO:0006734,NADH metabolic process,29,0,0.64,1.00000,1,1,0,BP
GO:0006760,folic acid-containing compound metabolic...,25,0,0.56,1.00000,1,1,0,BP
GO:0006775,fat-soluble vitamin metabolic process,33,0,0.73,1.00000,1,1,0,BP
GO:0006779,porphyrin-containing compound biosynthet...,26,0,0.58,1.00000,1,1,0,BP
GO:0006783,heme biosynthetic process,21,0,0.47,1.00000,1,1,0,BP
GO:0006805,xenobiotic metabolic process,113,0,2.51,1.00000,1,1,0,BP
GO:0006817,phosphate ion transport,26,0,0.58,1.00000,1,1,0,BP
GO:0006821,chloride transport,100,0,2.22,1.00000,1,1,0,BP
GO:0006829,zinc ion transport,32,0,0.71,1.00000,1,1,0,BP
GO:0006855,drug transmembrane transport,70,0,1.56,1.00000,1,1,0,BP
GO:0006882,cellular zinc ion homeostasis,26,0,0.58,1.00000,1,1,0,BP
GO:0006884,cell volume homeostasis,31,0,0.69,1.00000,1,1,0,BP
GO:0006885,regulation of pH,93,0,2.07,1.00000,1,1,0,BP
GO:0006903,vesicle targeting,38,0,0.84,1.00000,1,1,0,BP
GO:0006904,vesicle docking involved in exocytosis,46,0,1.02,1.00000,1,1,0,BP
GO:0006921,cellular component disassembly involved ...,30,0,0.67,1.00000,1,1,0,BP
GO:0006925,inflammatory cell apoptotic process,25,0,0.56,1.00000,1,1,0,BP
GO:0006929,substrate-dependent cell migration,28,0,0.62,1.00000,1,1,0,BP
GO:0006953,acute-phase response,41,0,0.91,1.00000,1,1,0,BP
GO:0006956,complement activation,52,0,1.16,1.00000,1,1,0,BP
GO:0006958,"complement activation, classical pathway",30,0,0.67,1.00000,1,1,0,BP
GO:0006998,nuclear envelope organization,39,0,0.87,1.00000,1,1,0,BP
GO:0007020,microtubule nucleation,23,0,0.51,1.00000,1,1,0,BP
GO:0007031,peroxisome organization,35,0,0.78,1.00000,1,1,0,BP
GO:0007035,vacuolar acidification,20,0,0.44,1.00000,1,1,0,BP
GO:0007131,reciprocal meiotic recombination,48,0,1.07,1.00000,1,1,0,BP
GO:0007140,male meiotic nuclear division,51,0,1.13,1.00000,1,1,0,BP
GO:0007141,male meiosis I,22,0,0.49,1.00000,1,1,0,BP
GO:0007157,heterophilic cell-cell adhesion via plas...,48,0,1.07,1.00000,1,1,0,BP
GO:0007164,establishment of tissue polarity,62,0,1.38,1.00000,1,1,0,BP
GO:0007190,activation of adenylate cyclase activity,21,0,0.47,1.00000,1,1,0,BP
GO:0007212,dopamine receptor signaling pathway,43,0,0.96,1.00000,1,1,0,BP
GO:0007214,gamma-aminobutyric acid signaling pathwa...,27,0,0.6,1.00000,1,1,0,BP
GO:0007218,neuropeptide signaling pathway,81,0,1.8,1.00000,1,1,0,BP
GO:0007263,nitric oxide mediated signal transductio...,27,0,0.6,1.00000,1,1,0,BP
GO:0007271,"synaptic transmission, cholinergic",34,0,0.76,1.00000,1,1,0,BP
GO:0007274,neuromuscular synaptic transmission,34,0,0.76,1.00000,1,1,0,BP
GO:0007289,spermatid nucleus differentiation,26,0,0.58,1.00000,1,1,0,BP
GO:0007339,binding of sperm to zona pellucida,40,0,0.89,1.00000,1,1,0,BP
GO:0007340,acrosome reaction,39,0,0.87,1.00000,1,1,0,BP
GO:0007530,sex determination,29,0,0.64,1.00000,1,1,0,BP
GO:0007549,dosage compensation,27,0,0.6,1.00000,1,1,0,BP
GO:0007585,respiratory gaseous exchange,56,0,1.24,1.00000,1,1,0,BP
GO:0007596,blood coagulation,158,0,3.51,1.00000,1,1,0,BP
GO:0007599,hemostasis,160,0,3.56,1.00000,1,1,0,BP
GO:0007602,phototransduction,31,0,0.69,1.00000,1,1,0,BP
GO:0007606,sensory perception of chemical stimulus,1218,0,27.07,1.00000,1,1,0,BP
GO:0007608,sensory perception of smell,1120,0,24.89,1.00000,1,1,0,BP
GO:0007620,copulation,26,0,0.58,1.00000,1,1,0,BP
GO:0007622,rhythmic behavior,64,0,1.42,1.00000,1,1,0,BP
GO:0007625,grooming behavior,21,0,0.47,1.00000,1,1,0,BP
GO:0007635,chemosensory behavior,22,0,0.49,1.00000,1,1,0,BP
GO:0008033,tRNA processing,115,0,2.56,1.00000,1,1,0,BP
GO:0008053,mitochondrial fusion,21,0,0.47,1.00000,1,1,0,BP
GO:0008206,bile acid metabolic process,29,0,0.64,1.00000,1,1,0,BP
GO:0008207,C21-steroid hormone metabolic process,39,0,0.87,1.00000,1,1,0,BP
GO:0008210,estrogen metabolic process,21,0,0.47,1.00000,1,1,0,BP
GO:0008211,glucocorticoid metabolic process,23,0,0.51,1.00000,1,1,0,BP
GO:0008214,protein dealkylation,31,0,0.69,1.00000,1,1,0,BP
GO:0008299,isoprenoid biosynthetic process,30,0,0.67,1.00000,1,1,0,BP
GO:0008340,determination of adult lifespan,28,0,0.62,1.00000,1,1,0,BP
GO:0008356,asymmetric cell division,21,0,0.47,1.00000,1,1,0,BP
GO:0008535,respiratory chain complex IV assembly,23,0,0.51,1.00000,1,1,0,BP
GO:0008593,regulation of Notch signaling pathway,87,0,1.93,1.00000,1,1,0,BP
GO:0008652,cellular amino acid biosynthetic process,64,0,1.42,1.00000,1,1,0,BP
GO:0008654,phospholipid biosynthetic process,160,0,3.56,1.00000,1,1,0,BP
GO:0009048,dosage compensation by inactivation of X...,25,0,0.56,1.00000,1,1,0,BP
GO:0009062,fatty acid catabolic process,93,0,2.07,1.00000,1,1,0,BP
GO:0009066,aspartate family amino acid metabolic pr...,42,0,0.93,1.00000,1,1,0,BP
GO:0009067,aspartate family amino acid biosynthetic...,22,0,0.49,1.00000,1,1,0,BP
GO:0009069,serine family amino acid metabolic proce...,40,0,0.89,1.00000,1,1,0,BP
GO:0009072,aromatic amino acid family metabolic pro...,34,0,0.76,1.00000,1,1,0,BP
GO:0009112,nucleobase metabolic process,36,0,0.8,1.00000,1,1,0,BP
GO:0009187,cyclic nucleotide metabolic process,35,0,0.78,1.00000,1,1,0,BP
GO:0009190,cyclic nucleotide biosynthetic process,24,0,0.53,1.00000,1,1,0,BP
GO:0009247,glycolipid biosynthetic process,57,0,1.27,1.00000,1,1,0,BP
GO:0009251,glucan catabolic process,20,0,0.44,1.00000,1,1,0,BP
GO:0009268,response to pH,40,0,0.89,1.00000,1,1,0,BP
GO:0009311,oligosaccharide metabolic process,35,0,0.78,1.00000,1,1,0,BP
GO:0009395,phospholipid catabolic process,43,0,0.96,1.00000,1,1,0,BP
GO:0009404,toxin metabolic process,22,0,0.49,1.00000,1,1,0,BP
GO:0009595,detection of biotic stimulus,26,0,0.58,1.00000,1,1,0,BP
GO:0009620,response to fungus,39,0,0.87,1.00000,1,1,0,BP
GO:0009648,photoperiodism,24,0,0.53,1.00000,1,1,0,BP
GO:0009649,entrainment of circadian clock,26,0,0.58,1.00000,1,1,0,BP
GO:0010039,response to iron ion,20,0,0.44,1.00000,1,1,0,BP
GO:0010043,response to zinc ion,31,0,0.69,1.00000,1,1,0,BP
GO:0010155,regulation of proton transport,26,0,0.58,1.00000,1,1,0,BP
GO:0010257,NADH dehydrogenase complex assembly,45,0,1,1.00000,1,1,0,BP
GO:0010259,multicellular organism aging,46,0,1.02,1.00000,1,1,0,BP
GO:0010453,regulation of cell fate commitment,32,0,0.71,1.00000,1,1,0,BP
GO:0010458,exit from mitosis,28,0,0.62,1.00000,1,1,0,BP
GO:0010460,positive regulation of heart rate,27,0,0.6,1.00000,1,1,0,BP
GO:0010499,proteasomal ubiquitin-independent protei...,23,0,0.51,1.00000,1,1,0,BP
GO:0010543,regulation of platelet activation,34,0,0.76,1.00000,1,1,0,BP
GO:0010569,regulation of double-strand break repair...,43,0,0.96,1.00000,1,1,0,BP
GO:0010575,positive regulation of vascular endothel...,25,0,0.56,1.00000,1,1,0,BP
GO:0010586,miRNA metabolic process,29,0,0.64,1.00000,1,1,0,BP
GO:0010591,regulation of lamellipodium assembly,32,0,0.71,1.00000,1,1,0,BP
GO:0010592,positive regulation of lamellipodium ass...,23,0,0.51,1.00000,1,1,0,BP
GO:0010596,negative regulation of endothelial cell ...,51,0,1.13,1.00000,1,1,0,BP
GO:0010614,negative regulation of cardiac muscle hy...,32,0,0.71,1.00000,1,1,0,BP
GO:0010623,programmed cell death involved in cell d...,20,0,0.44,1.00000,1,1,0,BP
GO:0010633,negative regulation of epithelial cell m...,70,0,1.56,1.00000,1,1,0,BP
GO:0010663,positive regulation of striated muscle c...,24,0,0.53,1.00000,1,1,0,BP
GO:0010666,positive regulation of cardiac muscle ce...,23,0,0.51,1.00000,1,1,0,BP
GO:0010669,epithelial structure maintenance,25,0,0.56,1.00000,1,1,0,BP
GO:0010677,negative regulation of cellular carbohyd...,47,0,1.04,1.00000,1,1,0,BP
GO:0010742,macrophage derived foam cell differentia...,25,0,0.56,1.00000,1,1,0,BP
GO:0010743,regulation of macrophage derived foam ce...,21,0,0.47,1.00000,1,1,0,BP
GO:0010758,regulation of macrophage chemotaxis,31,0,0.69,1.00000,1,1,0,BP
GO:0010759,positive regulation of macrophage chemot...,21,0,0.47,1.00000,1,1,0,BP
GO:0010829,negative regulation of glucose transmemb...,26,0,0.58,1.00000,1,1,0,BP
GO:0010831,positive regulation of myotube different...,39,0,0.87,1.00000,1,1,0,BP
GO:0010866,regulation of triglyceride biosynthetic ...,21,0,0.47,1.00000,1,1,0,BP
GO:0010869,regulation of receptor biosynthetic proc...,20,0,0.44,1.00000,1,1,0,BP
GO:0010883,regulation of lipid storage,43,0,0.96,1.00000,1,1,0,BP
GO:0010884,positive regulation of lipid storage,23,0,0.51,1.00000,1,1,0,BP
GO:0010955,negative regulation of protein processin...,37,0,0.82,1.00000,1,1,0,BP
GO:0010996,response to auditory stimulus,23,0,0.51,1.00000,1,1,0,BP
GO:0014048,regulation of glutamate secretion,25,0,0.56,1.00000,1,1,0,BP
GO:0014068,positive regulation of phosphatidylinosi...,72,0,1.6,1.00000,1,1,0,BP
GO:0014075,response to amine,20,0,0.44,1.00000,1,1,0,BP
GO:0014808,release of sequestered calcium ion into ...,21,0,0.47,1.00000,1,1,0,BP
GO:0014823,response to activity,34,0,0.76,1.00000,1,1,0,BP
GO:0014829,vascular smooth muscle contraction,27,0,0.6,1.00000,1,1,0,BP
GO:0014850,response to muscle activity,21,0,0.47,1.00000,1,1,0,BP
GO:0014887,cardiac muscle adaptation,27,0,0.6,1.00000,1,1,0,BP
GO:0014898,cardiac muscle hypertrophy in response t...,26,0,0.58,1.00000,1,1,0,BP
GO:0014904,myotube cell development,43,0,0.96,1.00000,1,1,0,BP
GO:0015695,organic cation transport,37,0,0.82,1.00000,1,1,0,BP
GO:0015698,inorganic anion transport,141,0,3.13,1.00000,1,1,0,BP
GO:0015718,monocarboxylic acid transport,151,0,3.36,1.00000,1,1,0,BP
GO:0015721,bile acid and bile salt transport,23,0,0.51,1.00000,1,1,0,BP
GO:0015732,prostaglandin transport,21,0,0.47,1.00000,1,1,0,BP
GO:0015748,organophosphate ester transport,85,0,1.89,1.00000,1,1,0,BP
GO:0015807,L-amino acid transport,60,0,1.33,1.00000,1,1,0,BP
GO:0015813,L-glutamate transmembrane transport,22,0,0.49,1.00000,1,1,0,BP
GO:0015874,norepinephrine transport,22,0,0.49,1.00000,1,1,0,BP
GO:0015908,fatty acid transport,86,0,1.91,1.00000,1,1,0,BP
GO:0015909,long-chain fatty acid transport,58,0,1.29,1.00000,1,1,0,BP
GO:0015914,phospholipid transport,65,0,1.44,1.00000,1,1,0,BP
GO:0015985,"energy coupled proton transport, down el...",22,0,0.49,1.00000,1,1,0,BP
GO:0015986,ATP synthesis coupled proton transport,22,0,0.49,1.00000,1,1,0,BP
GO:0016073,snRNA metabolic process,42,0,0.93,1.00000,1,1,0,BP
GO:0016075,rRNA catabolic process,24,0,0.53,1.00000,1,1,0,BP
GO:0016101,diterpenoid metabolic process,57,0,1.27,1.00000,1,1,0,BP
GO:0016180,snRNA processing,25,0,0.56,1.00000,1,1,0,BP
GO:0016339,calcium-dependent cell-cell adhesion via...,39,0,0.87,1.00000,1,1,0,BP
GO:0016577,histone demethylation,28,0,0.62,1.00000,1,1,0,BP
GO:0016973,poly(A)+ mRNA export from nucleus,20,0,0.44,1.00000,1,1,0,BP
GO:0017001,antibiotic catabolic process,46,0,1.02,1.00000,1,1,0,BP
GO:0017004,cytochrome complex assembly,33,0,0.73,1.00000,1,1,0,BP
GO:0018126,protein hydroxylation,25,0,0.56,1.00000,1,1,0,BP
GO:0018149,peptide cross-linking,62,0,1.38,1.00000,1,1,0,BP
GO:0018195,peptidyl-arginine modification,27,0,0.6,1.00000,1,1,0,BP
GO:0018196,peptidyl-asparagine modification,21,0,0.47,1.00000,1,1,0,BP
GO:0018279,protein N-linked glycosylation via aspar...,20,0,0.44,1.00000,1,1,0,BP
GO:0019048,modulation by virus of host morphology o...,24,0,0.53,1.00000,1,1,0,BP
GO:0019229,regulation of vasoconstriction,76,0,1.69,1.00000,1,1,0,BP
GO:0019236,response to pheromone,105,0,2.33,1.00000,1,1,0,BP
GO:0019319,hexose biosynthetic process,76,0,1.69,1.00000,1,1,0,BP
GO:0019320,hexose catabolic process,26,0,0.58,1.00000,1,1,0,BP
GO:0019373,epoxygenase P450 pathway,31,0,0.69,1.00000,1,1,0,BP
GO:0019400,alditol metabolic process,22,0,0.49,1.00000,1,1,0,BP
GO:0019432,triglyceride biosynthetic process,35,0,0.78,1.00000,1,1,0,BP
GO:0019433,triglyceride catabolic process,26,0,0.58,1.00000,1,1,0,BP
GO:0019674,NAD metabolic process,47,0,1.04,1.00000,1,1,0,BP
GO:0019835,cytolysis,35,0,0.78,1.00000,1,1,0,BP
GO:0019883,antigen processing and presentation of e...,40,0,0.89,1.00000,1,1,0,BP
GO:0019885,antigen processing and presentation of e...,37,0,0.82,1.00000,1,1,0,BP
GO:0019915,lipid storage,71,0,1.58,1.00000,1,1,0,BP
GO:0019934,cGMP-mediated signaling,39,0,0.87,1.00000,1,1,0,BP
GO:0021511,spinal cord patterning,28,0,0.62,1.00000,1,1,0,BP
GO:0021513,spinal cord dorsal/ventral patterning,26,0,0.58,1.00000,1,1,0,BP
GO:0021532,neural tube patterning,47,0,1.04,1.00000,1,1,0,BP
GO:0021544,subpallium development,24,0,0.53,1.00000,1,1,0,BP
GO:0021895,cerebral cortex neuron differentiation,25,0,0.56,1.00000,1,1,0,BP
GO:0021904,dorsal/ventral neural tube patterning,30,0,0.67,1.00000,1,1,0,BP
GO:0021983,pituitary gland development,39,0,0.87,1.00000,1,1,0,BP
GO:0022401,negative adaptation of signaling pathway,28,0,0.62,1.00000,1,1,0,BP
GO:0022410,circadian sleep/wake cycle process,32,0,0.71,1.00000,1,1,0,BP
GO:0022602,ovulation cycle process,48,0,1.07,1.00000,1,1,0,BP
GO:0023019,signal transduction involved in regulati...,23,0,0.51,1.00000,1,1,0,BP
GO:0023058,adaptation of signaling pathway,30,0,0.67,1.00000,1,1,0,BP
GO:0030004,cellular monovalent inorganic cation hom...,97,0,2.16,1.00000,1,1,0,BP
GO:0030101,natural killer cell activation,100,0,2.22,1.00000,1,1,0,BP
GO:0030149,sphingolipid catabolic process,29,0,0.64,1.00000,1,1,0,BP
GO:0030168,platelet activation,79,0,1.76,1.00000,1,1,0,BP
GO:0030193,regulation of blood coagulation,78,0,1.73,1.00000,1,1,0,BP
GO:0030194,positive regulation of blood coagulation,26,0,0.58,1.00000,1,1,0,BP
GO:0030195,negative regulation of blood coagulation,49,0,1.09,1.00000,1,1,0,BP
GO:0030203,glycosaminoglycan metabolic process,83,0,1.84,1.00000,1,1,0,BP
GO:0030204,chondroitin sulfate metabolic process,22,0,0.49,1.00000,1,1,0,BP
GO:0030212,hyaluronan metabolic process,27,0,0.6,1.00000,1,1,0,BP
GO:0030224,monocyte differentiation,29,0,0.64,1.00000,1,1,0,BP
GO:0030261,chromosome condensation,45,0,1,1.00000,1,1,0,BP
GO:0030262,apoptotic nuclear changes,29,0,0.64,1.00000,1,1,0,BP
GO:0030325,adrenal gland development,24,0,0.53,1.00000,1,1,0,BP
GO:0030431,sleep,39,0,0.87,1.00000,1,1,0,BP
GO:0030488,tRNA methylation,29,0,0.64,1.00000,1,1,0,BP
GO:0030510,regulation of BMP signaling pathway,97,0,2.16,1.00000,1,1,0,BP
GO:0030511,positive regulation of transforming grow...,29,0,0.64,1.00000,1,1,0,BP
GO:0030513,positive regulation of BMP signaling pat...,38,0,0.84,1.00000,1,1,0,BP
GO:0030514,negative regulation of BMP signaling pat...,53,0,1.18,1.00000,1,1,0,BP
GO:0030593,neutrophil chemotaxis,101,0,2.24,1.00000,1,1,0,BP
GO:0030641,regulation of cellular pH,76,0,1.69,1.00000,1,1,0,BP
GO:0030728,ovulation,23,0,0.51,1.00000,1,1,0,BP
GO:0030851,granulocyte differentiation,38,0,0.84,1.00000,1,1,0,BP
GO:0030878,thyroid gland development,28,0,0.62,1.00000,1,1,0,BP
GO:0030888,regulation of B cell proliferation,69,0,1.53,1.00000,1,1,0,BP
GO:0030889,negative regulation of B cell proliferat...,20,0,0.44,1.00000,1,1,0,BP
GO:0030890,positive regulation of B cell proliferat...,44,0,0.98,1.00000,1,1,0,BP
GO:0030947,regulation of vascular endothelial growt...,33,0,0.73,1.00000,1,1,0,BP
GO:0031018,endocrine pancreas development,52,0,1.16,1.00000,1,1,0,BP
GO:0031294,lymphocyte costimulation,32,0,0.71,1.00000,1,1,0,BP
GO:0031295,T cell costimulation,30,0,0.67,1.00000,1,1,0,BP
GO:0031341,regulation of cell killing,125,0,2.78,1.00000,1,1,0,BP
GO:0031342,negative regulation of cell killing,27,0,0.6,1.00000,1,1,0,BP
GO:0031343,positive regulation of cell killing,94,0,2.09,1.00000,1,1,0,BP
GO:0031424,keratinization,35,0,0.78,1.00000,1,1,0,BP
GO:0031629,synaptic vesicle fusion to presynaptic a...,25,0,0.56,1.00000,1,1,0,BP
GO:0031638,zymogen activation,64,0,1.42,1.00000,1,1,0,BP
GO:0031639,plasminogen activation,25,0,0.56,1.00000,1,1,0,BP
GO:0031640,killing of cells of other organism,40,0,0.89,1.00000,1,1,0,BP
GO:0031645,negative regulation of neurological syst...,30,0,0.67,1.00000,1,1,0,BP
GO:0031648,protein destabilization,48,0,1.07,1.00000,1,1,0,BP
GO:0031649,heat generation,22,0,0.49,1.00000,1,1,0,BP
GO:0031663,lipopolysaccharide-mediated signaling pa...,51,0,1.13,1.00000,1,1,0,BP
GO:0031935,regulation of chromatin silencing,38,0,0.84,1.00000,1,1,0,BP
GO:0032042,mitochondrial DNA metabolic process,22,0,0.49,1.00000,1,1,0,BP
GO:0032069,regulation of nuclease activity,27,0,0.6,1.00000,1,1,0,BP
GO:0032196,transposition,22,0,0.49,1.00000,1,1,0,BP
GO:0032211,negative regulation of telomere maintena...,20,0,0.44,1.00000,1,1,0,BP
GO:0032288,myelin assembly,20,0,0.44,1.00000,1,1,0,BP
GO:0032303,regulation of icosanoid secretion,22,0,0.49,1.00000,1,1,0,BP
GO:0032309,icosanoid secretion,47,0,1.04,1.00000,1,1,0,BP
GO:0032332,positive regulation of chondrocyte diffe...,21,0,0.47,1.00000,1,1,0,BP
GO:0032350,regulation of hormone metabolic process,54,0,1.2,1.00000,1,1,0,BP
GO:0032352,positive regulation of hormone metabolic...,24,0,0.53,1.00000,1,1,0,BP
GO:0032366,intracellular sterol transport,22,0,0.49,1.00000,1,1,0,BP
GO:0032367,intracellular cholesterol transport,22,0,0.49,1.00000,1,1,0,BP
GO:0032400,melanosome localization,22,0,0.49,1.00000,1,1,0,BP
GO:0032461,positive regulation of protein oligomeri...,24,0,0.53,1.00000,1,1,0,BP
GO:0032543,mitochondrial translation,76,0,1.69,1.00000,1,1,0,BP
GO:0032616,interleukin-13 production,22,0,0.49,1.00000,1,1,0,BP
GO:0032633,interleukin-4 production,38,0,0.84,1.00000,1,1,0,BP
GO:0032673,regulation of interleukin-4 production,31,0,0.69,1.00000,1,1,0,BP
GO:0032682,negative regulation of chemokine product...,22,0,0.49,1.00000,1,1,0,BP
GO:0032689,negative regulation of interferon-gamma ...,32,0,0.71,1.00000,1,1,0,BP
GO:0032691,negative regulation of interleukin-1 bet...,24,0,0.53,1.00000,1,1,0,BP
GO:0032692,negative regulation of interleukin-1 pro...,33,0,0.73,1.00000,1,1,0,BP
GO:0032693,negative regulation of interleukin-10 pr...,21,0,0.47,1.00000,1,1,0,BP
GO:0032703,negative regulation of interleukin-2 pro...,25,0,0.56,1.00000,1,1,0,BP
GO:0032715,negative regulation of interleukin-6 pro...,51,0,1.13,1.00000,1,1,0,BP
GO:0032753,positive regulation of interleukin-4 pro...,25,0,0.56,1.00000,1,1,0,BP
GO:0032757,positive regulation of interleukin-8 pro...,46,0,1.02,1.00000,1,1,0,BP
GO:0032800,receptor biosynthetic process,25,0,0.56,1.00000,1,1,0,BP
GO:0032814,regulation of natural killer cell activa...,44,0,0.98,1.00000,1,1,0,BP
GO:0032816,positive regulation of natural killer ce...,31,0,0.69,1.00000,1,1,0,BP
GO:0032892,positive regulation of organic acid tran...,48,0,1.07,1.00000,1,1,0,BP
GO:0032897,negative regulation of viral transcripti...,22,0,0.49,1.00000,1,1,0,BP
GO:0032925,regulation of activin receptor signaling...,28,0,0.62,1.00000,1,1,0,BP
GO:0032946,positive regulation of mononuclear cell ...,139,0,3.09,1.00000,1,1,0,BP
GO:0032957,inositol trisphosphate metabolic process,27,0,0.6,1.00000,1,1,0,BP
GO:0032959,inositol trisphosphate biosynthetic proc...,23,0,0.51,1.00000,1,1,0,BP
GO:0032981,mitochondrial respiratory chain complex ...,45,0,1,1.00000,1,1,0,BP
GO:0033014,tetrapyrrole biosynthetic process,27,0,0.6,1.00000,1,1,0,BP
GO:0033028,myeloid cell apoptotic process,37,0,0.82,1.00000,1,1,0,BP
GO:0033032,regulation of myeloid cell apoptotic pro...,34,0,0.76,1.00000,1,1,0,BP
GO:0033033,negative regulation of myeloid cell apop...,20,0,0.44,1.00000,1,1,0,BP
GO:0033108,mitochondrial respiratory chain complex ...,78,0,1.73,1.00000,1,1,0,BP
GO:0033119,negative regulation of RNA splicing,29,0,0.64,1.00000,1,1,0,BP
GO:0033120,positive regulation of RNA splicing,47,0,1.04,1.00000,1,1,0,BP
GO:0033139,regulation of peptidyl-serine phosphoryl...,31,0,0.69,1.00000,1,1,0,BP
GO:0033141,positive regulation of peptidyl-serine p...,29,0,0.64,1.00000,1,1,0,BP
GO:0033198,response to ATP,28,0,0.62,1.00000,1,1,0,BP
GO:0033617,mitochondrial respiratory chain complex ...,20,0,0.44,1.00000,1,1,0,BP
GO:0033622,integrin activation,24,0,0.53,1.00000,1,1,0,BP
GO:0033687,osteoblast proliferation,30,0,0.67,1.00000,1,1,0,BP
GO:0033688,regulation of osteoblast proliferation,27,0,0.6,1.00000,1,1,0,BP
GO:0033866,nucleoside bisphosphate biosynthetic pro...,35,0,0.78,1.00000,1,1,0,BP
GO:0034030,ribonucleoside bisphosphate biosynthetic...,35,0,0.78,1.00000,1,1,0,BP
GO:0034033,purine nucleoside bisphosphate biosynthe...,35,0,0.78,1.00000,1,1,0,BP
GO:0034067,protein localization to Golgi apparatus,27,0,0.6,1.00000,1,1,0,BP
GO:0034104,negative regulation of tissue remodeling,24,0,0.53,1.00000,1,1,0,BP
GO:0034109,homotypic cell-cell adhesion,68,0,1.51,1.00000,1,1,0,BP
GO:0034110,regulation of homotypic cell-cell adhesi...,31,0,0.69,1.00000,1,1,0,BP
GO:0034121,regulation of toll-like receptor signali...,64,0,1.42,1.00000,1,1,0,BP
GO:0034122,negative regulation of toll-like recepto...,35,0,0.78,1.00000,1,1,0,BP
GO:0034123,positive regulation of toll-like recepto...,26,0,0.58,1.00000,1,1,0,BP
GO:0034142,toll-like receptor 4 signaling pathway,33,0,0.73,1.00000,1,1,0,BP
GO:0034143,regulation of toll-like receptor 4 signa...,20,0,0.44,1.00000,1,1,0,BP
GO:0034204,lipid translocation,29,0,0.64,1.00000,1,1,0,BP
GO:0034308,primary alcohol metabolic process,62,0,1.38,1.00000,1,1,0,BP
GO:0034311,diol metabolic process,23,0,0.51,1.00000,1,1,0,BP
GO:0034340,response to type I interferon,44,0,0.98,1.00000,1,1,0,BP
GO:0034367,protein-containing complex remodeling,21,0,0.47,1.00000,1,1,0,BP
GO:0034368,protein-lipid complex remodeling,20,0,0.44,1.00000,1,1,0,BP
GO:0034369,plasma lipoprotein particle remodeling,20,0,0.44,1.00000,1,1,0,BP
GO:0034377,plasma lipoprotein particle assembly,20,0,0.44,1.00000,1,1,0,BP
GO:0034381,plasma lipoprotein particle clearance,36,0,0.8,1.00000,1,1,0,BP
GO:0034383,low-density lipoprotein particle clearan...,24,0,0.53,1.00000,1,1,0,BP
GO:0034405,response to fluid shear stress,22,0,0.49,1.00000,1,1,0,BP
GO:0034453,microtubule anchoring,27,0,0.6,1.00000,1,1,0,BP
GO:0034505,tooth mineralization,24,0,0.53,1.00000,1,1,0,BP
GO:0034661,ncRNA catabolic process,37,0,0.82,1.00000,1,1,0,BP
GO:0034754,cellular hormone metabolic process,106,0,2.36,1.00000,1,1,0,BP
GO:0035036,sperm-egg recognition,46,0,1.02,1.00000,1,1,0,BP
GO:0035066,positive regulation of histone acetylati...,30,0,0.67,1.00000,1,1,0,BP
GO:0035094,response to nicotine,33,0,0.73,1.00000,1,1,0,BP
GO:0035162,embryonic hemopoiesis,28,0,0.62,1.00000,1,1,0,BP
GO:0035249,"synaptic transmission, glutamatergic",106,0,2.36,1.00000,1,1,0,BP
GO:0035268,protein mannosylation,22,0,0.49,1.00000,1,1,0,BP
GO:0035270,endocrine system development,137,0,3.04,1.00000,1,1,0,BP
GO:0035357,peroxisome proliferator activated recept...,21,0,0.47,1.00000,1,1,0,BP
GO:0035384,thioester biosynthetic process,25,0,0.56,1.00000,1,1,0,BP
GO:0035456,response to interferon-beta,66,0,1.47,1.00000,1,1,0,BP
GO:0035458,cellular response to interferon-beta,56,0,1.24,1.00000,1,1,0,BP
GO:0035493,SNARE complex assembly,23,0,0.51,1.00000,1,1,0,BP
GO:0035510,DNA dealkylation,23,0,0.51,1.00000,1,1,0,BP
GO:0035584,calcium-mediated signaling using intrace...,20,0,0.44,1.00000,1,1,0,BP
GO:0035634,response to stilbenoid,22,0,0.49,1.00000,1,1,0,BP
GO:0035640,exploration behavior,30,0,0.67,1.00000,1,1,0,BP
GO:0035710,"CD4-positive, alpha-beta T cell activati...",100,0,2.22,1.00000,1,1,0,BP
GO:0035743,"CD4-positive, alpha-beta T cell cytokine...",23,0,0.51,1.00000,1,1,0,BP
GO:0035813,regulation of renal sodium excretion,25,0,0.56,1.00000,1,1,0,BP
GO:0035825,homologous recombination,49,0,1.09,1.00000,1,1,0,BP
GO:0035883,enteroendocrine cell differentiation,34,0,0.76,1.00000,1,1,0,BP
GO:0036003,positive regulation of transcription fro...,27,0,0.6,1.00000,1,1,0,BP
GO:0036037,"CD8-positive, alpha-beta T cell activati...",27,0,0.6,1.00000,1,1,0,BP
GO:0036075,replacement ossification,30,0,0.67,1.00000,1,1,0,BP
GO:0036230,granulocyte activation,35,0,0.78,1.00000,1,1,0,BP
GO:0036303,lymph vessel morphogenesis,22,0,0.49,1.00000,1,1,0,BP
GO:0036342,post-anal tail morphogenesis,26,0,0.58,1.00000,1,1,0,BP
GO:0039528,cytoplasmic pattern recognition receptor...,24,0,0.53,1.00000,1,1,0,BP
GO:0040001,establishment of mitotic spindle localiz...,33,0,0.73,1.00000,1,1,0,BP
GO:0042036,negative regulation of cytokine biosynth...,32,0,0.71,1.00000,1,1,0,BP
GO:0042059,negative regulation of epidermal growth ...,25,0,0.56,1.00000,1,1,0,BP
GO:0042088,T-helper 1 type immune response,49,0,1.09,1.00000,1,1,0,BP
GO:0042092,type 2 immune response,38,0,0.84,1.00000,1,1,0,BP
GO:0042093,T-helper cell differentiation,63,0,1.4,1.00000,1,1,0,BP
GO:0042094,interleukin-2 biosynthetic process,22,0,0.49,1.00000,1,1,0,BP
GO:0042102,positive regulation of T cell proliferat...,100,0,2.22,1.00000,1,1,0,BP
GO:0042104,positive regulation of activated T cell ...,27,0,0.6,1.00000,1,1,0,BP
GO:0042119,neutrophil activation,29,0,0.64,1.00000,1,1,0,BP
GO:0042178,xenobiotic catabolic process,22,0,0.49,1.00000,1,1,0,BP
GO:0042181,ketone biosynthetic process,44,0,0.98,1.00000,1,1,0,BP
GO:0042267,natural killer cell mediated cytotoxicit...,61,0,1.36,1.00000,1,1,0,BP
GO:0042269,regulation of natural killer cell mediat...,50,0,1.11,1.00000,1,1,0,BP
GO:0042304,regulation of fatty acid biosynthetic pr...,41,0,0.91,1.00000,1,1,0,BP
GO:0042310,vasoconstriction,101,0,2.24,1.00000,1,1,0,BP
GO:0042398,cellular modified amino acid biosyntheti...,42,0,0.93,1.00000,1,1,0,BP
GO:0042403,thyroid hormone metabolic process,25,0,0.56,1.00000,1,1,0,BP
GO:0042430,indole-containing compound metabolic pro...,25,0,0.56,1.00000,1,1,0,BP
GO:0042446,hormone biosynthetic process,75,0,1.67,1.00000,1,1,0,BP
GO:0042462,eye photoreceptor cell development,44,0,0.98,1.00000,1,1,0,BP
GO:0042474,middle ear morphogenesis,24,0,0.53,1.00000,1,1,0,BP
GO:0042501,serine phosphorylation of STAT protein,36,0,0.8,1.00000,1,1,0,BP
GO:0042531,positive regulation of tyrosine phosphor...,56,0,1.24,1.00000,1,1,0,BP
GO:0042537,benzene-containing compound metabolic pr...,22,0,0.49,1.00000,1,1,0,BP
GO:0042558,pteridine-containing compound metabolic ...,31,0,0.69,1.00000,1,1,0,BP
GO:0042572,retinol metabolic process,24,0,0.53,1.00000,1,1,0,BP
GO:0042573,retinoic acid metabolic process,25,0,0.56,1.00000,1,1,0,BP
GO:0042698,ovulation cycle,61,0,1.36,1.00000,1,1,0,BP
GO:0042730,fibrinolysis,20,0,0.44,1.00000,1,1,0,BP
GO:0042737,drug catabolic process,150,0,3.33,1.00000,1,1,0,BP
GO:0042738,exogenous drug catabolic process,53,0,1.18,1.00000,1,1,0,BP
GO:0042744,hydrogen peroxide catabolic process,27,0,0.6,1.00000,1,1,0,BP
GO:0042745,circadian sleep/wake cycle,35,0,0.78,1.00000,1,1,0,BP
GO:0042749,regulation of circadian sleep/wake cycle,31,0,0.69,1.00000,1,1,0,BP
GO:0042753,positive regulation of circadian rhythm,27,0,0.6,1.00000,1,1,0,BP
GO:0042755,eating behavior,48,0,1.07,1.00000,1,1,0,BP
GO:0042832,defense response to protozoan,34,0,0.76,1.00000,1,1,0,BP
GO:0043011,myeloid dendritic cell differentiation,20,0,0.44,1.00000,1,1,0,BP
GO:0043029,T cell homeostasis,46,0,1.02,1.00000,1,1,0,BP
GO:0043038,amino acid activation,45,0,1,1.00000,1,1,0,BP
GO:0043039,tRNA aminoacylation,44,0,0.98,1.00000,1,1,0,BP
GO:0043090,amino acid import,31,0,0.69,1.00000,1,1,0,BP
GO:0043153,entrainment of circadian clock by photop...,23,0,0.51,1.00000,1,1,0,BP
GO:0043171,peptide catabolic process,26,0,0.58,1.00000,1,1,0,BP
GO:0043367,"CD4-positive, alpha-beta T cell differen...",81,0,1.8,1.00000,1,1,0,BP
GO:0043370,"regulation of CD4-positive, alpha-beta T...",50,0,1.11,1.00000,1,1,0,BP
GO:0043371,"negative regulation of CD4-positive, alp...",23,0,0.51,1.00000,1,1,0,BP
GO:0043372,"positive regulation of CD4-positive, alp...",30,0,0.67,1.00000,1,1,0,BP
GO:0043496,regulation of protein homodimerization a...,24,0,0.53,1.00000,1,1,0,BP
GO:0043537,negative regulation of blood vessel endo...,32,0,0.71,1.00000,1,1,0,BP
GO:0043551,regulation of phosphatidylinositol 3-kin...,41,0,0.91,1.00000,1,1,0,BP
GO:0043552,positive regulation of phosphatidylinosi...,29,0,0.64,1.00000,1,1,0,BP
GO:0043574,peroxisomal transport,20,0,0.44,1.00000,1,1,0,BP
GO:0043576,regulation of respiratory gaseous exchan...,23,0,0.51,1.00000,1,1,0,BP
GO:0043921,modulation by host of viral transcriptio...,24,0,0.53,1.00000,1,1,0,BP
GO:0043950,positive regulation of cAMP-mediated sig...,33,0,0.73,1.00000,1,1,0,BP
GO:0043966,histone H3 acetylation,63,0,1.4,1.00000,1,1,0,BP
GO:0043967,histone H4 acetylation,63,0,1.4,1.00000,1,1,0,BP
GO:0043984,histone H4-K16 acetylation,21,0,0.47,1.00000,1,1,0,BP
GO:0044062,regulation of excretion,31,0,0.69,1.00000,1,1,0,BP
GO:0044247,cellular polysaccharide catabolic proces...,22,0,0.49,1.00000,1,1,0,BP
GO:0044272,sulfur compound biosynthetic process,80,0,1.78,1.00000,1,1,0,BP
GO:0044273,sulfur compound catabolic process,21,0,0.47,1.00000,1,1,0,BP
GO:0044275,cellular carbohydrate catabolic process,36,0,0.8,1.00000,1,1,0,BP
GO:0044319,"wound healing, spreading of cells",31,0,0.69,1.00000,1,1,0,BP
GO:0044331,cell-cell adhesion mediated by cadherin,40,0,0.89,1.00000,1,1,0,BP
GO:0044364,disruption of cells of other organism,40,0,0.89,1.00000,1,1,0,BP
GO:0044458,motile cilium assembly,30,0,0.67,1.00000,1,1,0,BP
GO:0044788,modulation by host of viral process,28,0,0.62,1.00000,1,1,0,BP
GO:0045017,glycerolipid biosynthetic process,142,0,3.16,1.00000,1,1,0,BP
GO:0045047,protein targeting to ER,32,0,0.71,1.00000,1,1,0,BP
GO:0045061,thymic T cell selection,28,0,0.62,1.00000,1,1,0,BP
GO:0045063,T-helper 1 cell differentiation,22,0,0.49,1.00000,1,1,0,BP
GO:0045066,regulatory T cell differentiation,33,0,0.73,1.00000,1,1,0,BP
GO:0045071,negative regulation of viral genome repl...,57,0,1.27,1.00000,1,1,0,BP
GO:0045076,regulation of interleukin-2 biosynthetic...,20,0,0.44,1.00000,1,1,0,BP
GO:0045117,azole transport,26,0,0.58,1.00000,1,1,0,BP
GO:0045124,regulation of bone resorption,52,0,1.16,1.00000,1,1,0,BP
GO:0045187,regulation of circadian sleep/wake cycle...,28,0,0.62,1.00000,1,1,0,BP
GO:0045292,"mRNA cis splicing, via spliceosome",29,0,0.64,1.00000,1,1,0,BP
GO:0045332,phospholipid translocation,28,0,0.62,1.00000,1,1,0,BP
GO:0045454,cell redox homeostasis,63,0,1.4,1.00000,1,1,0,BP
GO:0045475,locomotor rhythm,21,0,0.47,1.00000,1,1,0,BP
GO:0045589,regulation of regulatory T cell differen...,30,0,0.67,1.00000,1,1,0,BP
GO:0045600,positive regulation of fat cell differen...,62,0,1.38,1.00000,1,1,0,BP
GO:0045606,positive regulation of epidermal cell di...,22,0,0.49,1.00000,1,1,0,BP
GO:0045622,regulation of T-helper cell differentiat...,38,0,0.84,1.00000,1,1,0,BP
GO:0045623,negative regulation of T-helper cell dif...,20,0,0.44,1.00000,1,1,0,BP
GO:0045624,positive regulation of T-helper cell dif...,22,0,0.49,1.00000,1,1,0,BP
GO:0045649,regulation of macrophage differentiation,20,0,0.44,1.00000,1,1,0,BP
GO:0045652,regulation of megakaryocyte differentiat...,31,0,0.69,1.00000,1,1,0,BP
GO:0045662,negative regulation of myoblast differen...,31,0,0.69,1.00000,1,1,0,BP
GO:0045663,positive regulation of myoblast differen...,28,0,0.62,1.00000,1,1,0,BP
GO:0045672,positive regulation of osteoclast differ...,33,0,0.73,1.00000,1,1,0,BP
GO:0045683,negative regulation of epidermis develop...,22,0,0.49,1.00000,1,1,0,BP
GO:0045684,positive regulation of epidermis develop...,37,0,0.82,1.00000,1,1,0,BP
GO:0045723,positive regulation of fatty acid biosyn...,24,0,0.53,1.00000,1,1,0,BP
GO:0045730,respiratory burst,27,0,0.6,1.00000,1,1,0,BP
GO:0045742,positive regulation of epidermal growth ...,26,0,0.58,1.00000,1,1,0,BP
GO:0045744,negative regulation of G protein-coupled...,59,0,1.31,1.00000,1,1,0,BP
GO:0045745,positive regulation of G protein-coupled...,36,0,0.8,1.00000,1,1,0,BP
GO:0045746,negative regulation of Notch signaling p...,38,0,0.84,1.00000,1,1,0,BP
GO:0045747,positive regulation of Notch signaling p...,40,0,0.89,1.00000,1,1,0,BP
GO:0045776,negative regulation of blood pressure,60,0,1.33,1.00000,1,1,0,BP
GO:0045780,positive regulation of bone resorption,28,0,0.62,1.00000,1,1,0,BP
GO:0045822,negative regulation of heart contraction,28,0,0.62,1.00000,1,1,0,BP
GO:0045823,positive regulation of heart contraction,43,0,0.96,1.00000,1,1,0,BP
GO:0045824,negative regulation of innate immune res...,60,0,1.33,1.00000,1,1,0,BP
GO:0045830,positive regulation of isotype switching,30,0,0.67,1.00000,1,1,0,BP
GO:0045838,positive regulation of membrane potentia...,20,0,0.44,1.00000,1,1,0,BP
GO:0045851,pH reduction,40,0,0.89,1.00000,1,1,0,BP
GO:0045880,positive regulation of smoothened signal...,38,0,0.84,1.00000,1,1,0,BP
GO:0045907,positive regulation of vasoconstriction,47,0,1.04,1.00000,1,1,0,BP
GO:0045910,negative regulation of DNA recombination,48,0,1.07,1.00000,1,1,0,BP
GO:0045911,positive regulation of DNA recombination,43,0,0.96,1.00000,1,1,0,BP
GO:0045912,negative regulation of carbohydrate meta...,52,0,1.16,1.00000,1,1,0,BP
GO:0045920,negative regulation of exocytosis,31,0,0.69,1.00000,1,1,0,BP
GO:0045922,negative regulation of fatty acid metabo...,24,0,0.53,1.00000,1,1,0,BP
GO:0045933,positive regulation of muscle contractio...,53,0,1.18,1.00000,1,1,0,BP
GO:0045948,positive regulation of translational ini...,21,0,0.47,1.00000,1,1,0,BP
GO:0045954,positive regulation of natural killer ce...,34,0,0.76,1.00000,1,1,0,BP
GO:0045956,positive regulation of calcium ion-depen...,28,0,0.62,1.00000,1,1,0,BP
GO:0045980,negative regulation of nucleotide metabo...,31,0,0.69,1.00000,1,1,0,BP
GO:0045987,positive regulation of smooth muscle con...,36,0,0.8,1.00000,1,1,0,BP
GO:0046006,regulation of activated T cell prolifera...,39,0,0.87,1.00000,1,1,0,BP
GO:0046039,GTP metabolic process,29,0,0.64,1.00000,1,1,0,BP
GO:0046131,pyrimidine ribonucleoside metabolic proc...,20,0,0.44,1.00000,1,1,0,BP
GO:0046325,negative regulation of glucose import,21,0,0.47,1.00000,1,1,0,BP
GO:0046339,diacylglycerol metabolic process,22,0,0.49,1.00000,1,1,0,BP
GO:0046364,monosaccharide biosynthetic process,82,0,1.82,1.00000,1,1,0,BP
GO:0046365,monosaccharide catabolic process,30,0,0.67,1.00000,1,1,0,BP
GO:0046427,positive regulation of JAK-STAT cascade,103,0,2.29,1.00000,1,1,0,BP
GO:0046456,icosanoid biosynthetic process,39,0,0.87,1.00000,1,1,0,BP
GO:0046457,prostanoid biosynthetic process,25,0,0.56,1.00000,1,1,0,BP
GO:0046460,neutral lipid biosynthetic process,38,0,0.84,1.00000,1,1,0,BP
GO:0046461,neutral lipid catabolic process,35,0,0.78,1.00000,1,1,0,BP
GO:0046463,acylglycerol biosynthetic process,38,0,0.84,1.00000,1,1,0,BP
GO:0046464,acylglycerol catabolic process,35,0,0.78,1.00000,1,1,0,BP
GO:0046466,membrane lipid catabolic process,32,0,0.71,1.00000,1,1,0,BP
GO:0046470,phosphatidylcholine metabolic process,37,0,0.82,1.00000,1,1,0,BP
GO:0046474,glycerophospholipid biosynthetic process,107,0,2.38,1.00000,1,1,0,BP
GO:0046475,glycerophospholipid catabolic process,23,0,0.51,1.00000,1,1,0,BP
GO:0046503,glycerolipid catabolic process,54,0,1.2,1.00000,1,1,0,BP
GO:0046514,ceramide catabolic process,20,0,0.44,1.00000,1,1,0,BP
GO:0046599,regulation of centriole replication,23,0,0.51,1.00000,1,1,0,BP
GO:0046633,alpha-beta T cell proliferation,41,0,0.91,1.00000,1,1,0,BP
GO:0046634,regulation of alpha-beta T cell activati...,104,0,2.31,1.00000,1,1,0,BP
GO:0046635,positive regulation of alpha-beta T cell...,70,0,1.56,1.00000,1,1,0,BP
GO:0046636,negative regulation of alpha-beta T cell...,42,0,0.93,1.00000,1,1,0,BP
GO:0046637,regulation of alpha-beta T cell differen...,67,0,1.49,1.00000,1,1,0,BP
GO:0046638,positive regulation of alpha-beta T cell...,49,0,1.09,1.00000,1,1,0,BP
GO:0046639,negative regulation of alpha-beta T cell...,27,0,0.6,1.00000,1,1,0,BP
GO:0046640,regulation of alpha-beta T cell prolifer...,38,0,0.84,1.00000,1,1,0,BP
GO:0046641,positive regulation of alpha-beta T cell...,23,0,0.51,1.00000,1,1,0,BP
GO:0046653,tetrahydrofolate metabolic process,20,0,0.44,1.00000,1,1,0,BP
GO:0046697,decidualization,21,0,0.47,1.00000,1,1,0,BP
GO:0046839,phospholipid dephosphorylation,36,0,0.8,1.00000,1,1,0,BP
GO:0046850,regulation of bone remodeling,62,0,1.38,1.00000,1,1,0,BP
GO:0046852,positive regulation of bone remodeling,28,0,0.62,1.00000,1,1,0,BP
GO:0046856,phosphatidylinositol dephosphorylation,24,0,0.53,1.00000,1,1,0,BP
GO:0046885,regulation of hormone biosynthetic proce...,39,0,0.87,1.00000,1,1,0,BP
GO:0046931,pore complex assembly,23,0,0.51,1.00000,1,1,0,BP
GO:0048025,"negative regulation of mRNA splicing, vi...",24,0,0.53,1.00000,1,1,0,BP
GO:0048026,"positive regulation of mRNA splicing, vi...",30,0,0.67,1.00000,1,1,0,BP
GO:0048103,somatic stem cell division,28,0,0.62,1.00000,1,1,0,BP
GO:0048199,"vesicle targeting, to, from or within Go...",20,0,0.44,1.00000,1,1,0,BP
GO:0048240,sperm capacitation,34,0,0.76,1.00000,1,1,0,BP
GO:0048245,eosinophil chemotaxis,20,0,0.44,1.00000,1,1,0,BP
GO:0048246,macrophage chemotaxis,43,0,0.96,1.00000,1,1,0,BP
GO:0048260,positive regulation of receptor-mediated...,57,0,1.27,1.00000,1,1,0,BP
GO:0048261,negative regulation of receptor-mediated...,20,0,0.44,1.00000,1,1,0,BP
GO:0048265,response to pain,40,0,0.89,1.00000,1,1,0,BP
GO:0048266,behavioral response to pain,25,0,0.56,1.00000,1,1,0,BP
GO:0048305,immunoglobulin secretion,27,0,0.6,1.00000,1,1,0,BP
GO:0048333,mesodermal cell differentiation,23,0,0.51,1.00000,1,1,0,BP
GO:0048490,anterograde synaptic vesicle transport,20,0,0.44,1.00000,1,1,0,BP
GO:0048512,circadian behavior,61,0,1.36,1.00000,1,1,0,BP
GO:0048520,positive regulation of behavior,40,0,0.89,1.00000,1,1,0,BP
GO:0048535,lymph node development,31,0,0.69,1.00000,1,1,0,BP
GO:0048536,spleen development,45,0,1,1.00000,1,1,0,BP
GO:0048557,embryonic digestive tract morphogenesis,20,0,0.44,1.00000,1,1,0,BP
GO:0048566,embryonic digestive tract development,33,0,0.73,1.00000,1,1,0,BP
GO:0048569,post-embryonic animal organ development,21,0,0.47,1.00000,1,1,0,BP
GO:0048714,positive regulation of oligodendrocyte d...,30,0,0.67,1.00000,1,1,0,BP
GO:0048741,skeletal muscle fiber development,39,0,0.87,1.00000,1,1,0,BP
GO:0048747,muscle fiber development,81,0,1.8,1.00000,1,1,0,BP
GO:0048821,erythrocyte development,39,0,0.87,1.00000,1,1,0,BP
GO:0048857,neural nucleus development,22,0,0.49,1.00000,1,1,0,BP
GO:0050482,arachidonic acid secretion,31,0,0.69,1.00000,1,1,0,BP
GO:0050654,chondroitin sulfate proteoglycan metabol...,30,0,0.67,1.00000,1,1,0,BP
GO:0050671,positive regulation of lymphocyte prolif...,137,0,3.04,1.00000,1,1,0,BP
GO:0050701,interleukin-1 secretion,62,0,1.38,1.00000,1,1,0,BP
GO:0050702,interleukin-1 beta secretion,53,0,1.18,1.00000,1,1,0,BP
GO:0050704,regulation of interleukin-1 secretion,54,0,1.2,1.00000,1,1,0,BP
GO:0050706,regulation of interleukin-1 beta secreti...,46,0,1.02,1.00000,1,1,0,BP
GO:0050716,positive regulation of interleukin-1 sec...,40,0,0.89,1.00000,1,1,0,BP
GO:0050718,positive regulation of interleukin-1 bet...,37,0,0.82,1.00000,1,1,0,BP
GO:0050798,activated T cell proliferation,47,0,1.04,1.00000,1,1,0,BP
GO:0050802,"circadian sleep/wake cycle, sleep",29,0,0.64,1.00000,1,1,0,BP
GO:0050805,negative regulation of synaptic transmis...,81,0,1.8,1.00000,1,1,0,BP
GO:0050817,coagulation,161,0,3.58,1.00000,1,1,0,BP
GO:0050818,regulation of coagulation,82,0,1.82,1.00000,1,1,0,BP
GO:0050819,negative regulation of coagulation,51,0,1.13,1.00000,1,1,0,BP
GO:0050820,positive regulation of coagulation,29,0,0.64,1.00000,1,1,0,BP
GO:0050832,defense response to fungus,25,0,0.56,1.00000,1,1,0,BP
GO:0050853,B cell receptor signaling pathway,48,0,1.07,1.00000,1,1,0,BP
GO:0050858,negative regulation of antigen receptor-...,26,0,0.58,1.00000,1,1,0,BP
GO:0050869,negative regulation of B cell activation,36,0,0.8,1.00000,1,1,0,BP
GO:0050871,positive regulation of B cell activation,85,0,1.89,1.00000,1,1,0,BP
GO:0050892,intestinal absorption,38,0,0.84,1.00000,1,1,0,BP
GO:0050907,detection of chemical stimulus involved ...,59,0,1.31,1.00000,1,1,0,BP
GO:0050909,sensory perception of taste,70,0,1.56,1.00000,1,1,0,BP
GO:0050910,detection of mechanical stimulus involve...,20,0,0.44,1.00000,1,1,0,BP
GO:0050912,detection of chemical stimulus involved ...,52,0,1.16,1.00000,1,1,0,BP
GO:0050913,sensory perception of bitter taste,51,0,1.13,1.00000,1,1,0,BP
GO:0050926,regulation of positive chemotaxis,27,0,0.6,1.00000,1,1,0,BP
GO:0050927,positive regulation of positive chemotax...,26,0,0.58,1.00000,1,1,0,BP
GO:0050966,detection of mechanical stimulus involve...,20,0,0.44,1.00000,1,1,0,BP
GO:0050974,detection of mechanical stimulus involve...,45,0,1,1.00000,1,1,0,BP
GO:0050982,detection of mechanical stimulus,60,0,1.33,1.00000,1,1,0,BP
GO:0050994,regulation of lipid catabolic process,57,0,1.27,1.00000,1,1,0,BP
GO:0050995,negative regulation of lipid catabolic p...,24,0,0.53,1.00000,1,1,0,BP
GO:0050996,positive regulation of lipid catabolic p...,27,0,0.6,1.00000,1,1,0,BP
GO:0051016,barbed-end actin filament capping,21,0,0.47,1.00000,1,1,0,BP
GO:0051023,regulation of immunoglobulin secretion,21,0,0.47,1.00000,1,1,0,BP
GO:0051123,RNA polymerase II preinitiation complex ...,26,0,0.58,1.00000,1,1,0,BP
GO:0051180,vitamin transport,32,0,0.71,1.00000,1,1,0,BP
GO:0051181,cofactor transport,36,0,0.8,1.00000,1,1,0,BP
GO:0051187,cofactor catabolic process,55,0,1.22,1.00000,1,1,0,BP
GO:0051195,negative regulation of cofactor metaboli...,21,0,0.47,1.00000,1,1,0,BP
GO:0051205,protein insertion into membrane,25,0,0.56,1.00000,1,1,0,BP
GO:0051290,protein heterotetramerization,54,0,1.2,1.00000,1,1,0,BP
GO:0051294,establishment of spindle orientation,36,0,0.8,1.00000,1,1,0,BP
GO:0051307,meiotic chromosome separation,28,0,0.62,1.00000,1,1,0,BP
GO:0051349,positive regulation of lyase activity,20,0,0.44,1.00000,1,1,0,BP
GO:0051354,negative regulation of oxidoreductase ac...,28,0,0.62,1.00000,1,1,0,BP
GO:0051446,positive regulation of meiotic cell cycl...,28,0,0.62,1.00000,1,1,0,BP
GO:0051447,negative regulation of meiotic cell cycl...,20,0,0.44,1.00000,1,1,0,BP
GO:0051450,myoblast proliferation,21,0,0.47,1.00000,1,1,0,BP
GO:0051452,intracellular pH reduction,35,0,0.78,1.00000,1,1,0,BP
GO:0051453,regulation of intracellular pH,69,0,1.53,1.00000,1,1,0,BP
GO:0051457,maintenance of protein location in nucle...,24,0,0.53,1.00000,1,1,0,BP
GO:0051590,positive regulation of neurotransmitter ...,51,0,1.13,1.00000,1,1,0,BP
GO:0051673,membrane disruption in other organism,28,0,0.62,1.00000,1,1,0,BP
GO:0051788,response to misfolded protein,25,0,0.56,1.00000,1,1,0,BP
GO:0051818,disruption of cells of other organism in...,21,0,0.47,1.00000,1,1,0,BP
GO:0051851,modification by host of symbiont morphol...,75,0,1.67,1.00000,1,1,0,BP
GO:0051875,pigment granule localization,23,0,0.51,1.00000,1,1,0,BP
GO:0051882,mitochondrial depolarization,24,0,0.53,1.00000,1,1,0,BP
GO:0051883,killing of cells in other organism invol...,21,0,0.47,1.00000,1,1,0,BP
GO:0051899,membrane depolarization,82,0,1.82,1.00000,1,1,0,BP
GO:0051900,regulation of mitochondrial depolarizati...,21,0,0.47,1.00000,1,1,0,BP
GO:0051905,establishment of pigment granule localiz...,20,0,0.44,1.00000,1,1,0,BP
GO:0051930,regulation of sensory perception of pain,54,0,1.2,1.00000,1,1,0,BP
GO:0051931,regulation of sensory perception,55,0,1.22,1.00000,1,1,0,BP
GO:0051957,positive regulation of amino acid transp...,28,0,0.62,1.00000,1,1,0,BP
GO:0051966,"regulation of synaptic transmission, glu...",78,0,1.73,1.00000,1,1,0,BP
GO:0051968,positive regulation of synaptic transmis...,40,0,0.89,1.00000,1,1,0,BP
GO:0051969,regulation of transmission of nerve impu...,23,0,0.51,1.00000,1,1,0,BP
GO:0052312,modulation of transcription in other org...,24,0,0.53,1.00000,1,1,0,BP
GO:0052472,modulation by host of symbiont transcrip...,24,0,0.53,1.00000,1,1,0,BP
GO:0052652,cyclic purine nucleotide metabolic proce...,24,0,0.53,1.00000,1,1,0,BP
GO:0055003,cardiac myofibril assembly,26,0,0.58,1.00000,1,1,0,BP
GO:0055064,chloride ion homeostasis,20,0,0.44,1.00000,1,1,0,BP
GO:0055069,zinc ion homeostasis,27,0,0.6,1.00000,1,1,0,BP
GO:0055075,potassium ion homeostasis,31,0,0.69,1.00000,1,1,0,BP
GO:0055081,anion homeostasis,68,0,1.51,1.00000,1,1,0,BP
GO:0055083,monovalent inorganic anion homeostasis,35,0,0.78,1.00000,1,1,0,BP
GO:0055090,acylglycerol homeostasis,35,0,0.78,1.00000,1,1,0,BP
GO:0060037,pharyngeal system development,28,0,0.62,1.00000,1,1,0,BP
GO:0060039,pericardium development,29,0,0.64,1.00000,1,1,0,BP
GO:0060065,uterus development,26,0,0.58,1.00000,1,1,0,BP
GO:0060071,"Wnt signaling pathway, planar cell polar...",40,0,0.89,1.00000,1,1,0,BP
GO:0060074,synapse maturation,31,0,0.69,1.00000,1,1,0,BP
GO:0060099,"regulation of phagocytosis, engulfment",20,0,0.44,1.00000,1,1,0,BP
GO:0060135,maternal process involved in female preg...,47,0,1.04,1.00000,1,1,0,BP
GO:0060216,definitive hemopoiesis,24,0,0.53,1.00000,1,1,0,BP
GO:0060218,hematopoietic stem cell differentiation,30,0,0.67,1.00000,1,1,0,BP
GO:0060219,camera-type eye photoreceptor cell diffe...,28,0,0.62,1.00000,1,1,0,BP
GO:0060259,regulation of feeding behavior,38,0,0.84,1.00000,1,1,0,BP
GO:0060260,regulation of transcription initiation f...,29,0,0.64,1.00000,1,1,0,BP
GO:0060261,positive regulation of transcription ini...,23,0,0.51,1.00000,1,1,0,BP
GO:0060292,long-term synaptic depression,35,0,0.78,1.00000,1,1,0,BP
GO:0060294,cilium movement involved in cell motilit...,20,0,0.44,1.00000,1,1,0,BP
GO:0060333,interferon-gamma-mediated signaling path...,23,0,0.51,1.00000,1,1,0,BP
GO:0060337,type I interferon signaling pathway,39,0,0.87,1.00000,1,1,0,BP
GO:0060338,regulation of type I interferon-mediated...,25,0,0.56,1.00000,1,1,0,BP
GO:0060343,trabecula formation,27,0,0.6,1.00000,1,1,0,BP
GO:0060350,endochondral bone morphogenesis,75,0,1.67,1.00000,1,1,0,BP
GO:0060351,cartilage development involved in endoch...,52,0,1.16,1.00000,1,1,0,BP
GO:0060384,innervation,29,0,0.64,1.00000,1,1,0,BP
GO:0060412,ventricular septum morphogenesis,51,0,1.13,1.00000,1,1,0,BP
GO:0060444,branching involved in mammary gland duct...,28,0,0.62,1.00000,1,1,0,BP
GO:0060456,positive regulation of digestive system ...,20,0,0.44,1.00000,1,1,0,BP
GO:0060512,prostate gland morphogenesis,34,0,0.76,1.00000,1,1,0,BP
GO:0060536,cartilage morphogenesis,27,0,0.6,1.00000,1,1,0,BP
GO:0060575,intestinal epithelial cell differentiati...,22,0,0.49,1.00000,1,1,0,BP
GO:0060603,mammary gland duct morphogenesis,40,0,0.89,1.00000,1,1,0,BP
GO:0060612,adipose tissue development,50,0,1.11,1.00000,1,1,0,BP
GO:0060632,regulation of microtubule-based movement,31,0,0.69,1.00000,1,1,0,BP
GO:0060669,embryonic placenta morphogenesis,32,0,0.71,1.00000,1,1,0,BP
GO:0060674,placenta blood vessel development,37,0,0.82,1.00000,1,1,0,BP
GO:0060706,cell differentiation involved in embryon...,33,0,0.73,1.00000,1,1,0,BP
GO:0060711,labyrinthine layer development,59,0,1.31,1.00000,1,1,0,BP
GO:0060713,labyrinthine layer morphogenesis,27,0,0.6,1.00000,1,1,0,BP
GO:0060716,labyrinthine layer blood vessel developm...,26,0,0.58,1.00000,1,1,0,BP
GO:0060740,prostate gland epithelium morphogenesis,33,0,0.73,1.00000,1,1,0,BP
GO:0060765,regulation of androgen receptor signalin...,28,0,0.62,1.00000,1,1,0,BP
GO:0060969,negative regulation of gene silencing,36,0,0.8,1.00000,1,1,0,BP
GO:0061036,positive regulation of cartilage develop...,31,0,0.69,1.00000,1,1,0,BP
GO:0061045,negative regulation of wound healing,71,0,1.58,1.00000,1,1,0,BP
GO:0061098,positive regulation of protein tyrosine ...,44,0,0.98,1.00000,1,1,0,BP
GO:0061099,negative regulation of protein tyrosine ...,27,0,0.6,1.00000,1,1,0,BP
GO:0061213,positive regulation of mesonephros devel...,25,0,0.56,1.00000,1,1,0,BP
GO:0061217,regulation of mesonephros development,28,0,0.62,1.00000,1,1,0,BP
GO:0061298,retina vasculature development in camera...,27,0,0.6,1.00000,1,1,0,BP
GO:0061337,cardiac conduction,58,0,1.29,1.00000,1,1,0,BP
GO:0061383,trabecula morphogenesis,53,0,1.18,1.00000,1,1,0,BP
GO:0061384,heart trabecula morphogenesis,36,0,0.8,1.00000,1,1,0,BP
GO:0061436,establishment of skin barrier,26,0,0.58,1.00000,1,1,0,BP
GO:0061478,response to platelet aggregation inhibit...,66,0,1.47,1.00000,1,1,0,BP
GO:0065005,protein-lipid complex assembly,24,0,0.53,1.00000,1,1,0,BP
GO:0070076,histone lysine demethylation,28,0,0.62,1.00000,1,1,0,BP
GO:0070129,regulation of mitochondrial translation,27,0,0.6,1.00000,1,1,0,BP
GO:0070199,establishment of protein localization to...,24,0,0.53,1.00000,1,1,0,BP
GO:0070206,protein trimerization,62,0,1.38,1.00000,1,1,0,BP
GO:0070207,protein homotrimerization,40,0,0.89,1.00000,1,1,0,BP
GO:0070227,lymphocyte apoptotic process,98,0,2.18,1.00000,1,1,0,BP
GO:0070228,regulation of lymphocyte apoptotic proce...,76,0,1.69,1.00000,1,1,0,BP
GO:0070229,negative regulation of lymphocyte apopto...,49,0,1.09,1.00000,1,1,0,BP
GO:0070230,positive regulation of lymphocyte apopto...,21,0,0.47,1.00000,1,1,0,BP
GO:0070231,T cell apoptotic process,58,0,1.29,1.00000,1,1,0,BP
GO:0070232,regulation of T cell apoptotic process,43,0,0.96,1.00000,1,1,0,BP
GO:0070233,negative regulation of T cell apoptotic ...,26,0,0.58,1.00000,1,1,0,BP
GO:0070242,thymocyte apoptotic process,22,0,0.49,1.00000,1,1,0,BP
GO:0070296,sarcoplasmic reticulum calcium ion trans...,29,0,0.64,1.00000,1,1,0,BP
GO:0070328,triglyceride homeostasis,35,0,0.78,1.00000,1,1,0,BP
GO:0070498,interleukin-1-mediated signaling pathway,20,0,0.44,1.00000,1,1,0,BP
GO:0070527,platelet aggregation,45,0,1,1.00000,1,1,0,BP
GO:0070665,positive regulation of leukocyte prolife...,146,0,3.24,1.00000,1,1,0,BP
GO:0070741,response to interleukin-6,32,0,0.71,1.00000,1,1,0,BP
GO:0070841,inclusion body assembly,22,0,0.49,1.00000,1,1,0,BP
GO:0070920,regulation of production of small RNA in...,21,0,0.47,1.00000,1,1,0,BP
GO:0070988,demethylation,64,0,1.42,1.00000,1,1,0,BP
GO:0071218,cellular response to misfolded protein,23,0,0.51,1.00000,1,1,0,BP
GO:0071234,cellular response to phenylalanine,25,0,0.56,1.00000,1,1,0,BP
GO:0071347,cellular response to interleukin-1,76,0,1.69,1.00000,1,1,0,BP
GO:0071354,cellular response to interleukin-6,30,0,0.67,1.00000,1,1,0,BP
GO:0071357,cellular response to type I interferon,39,0,0.87,1.00000,1,1,0,BP
GO:0071361,cellular response to ethanol,27,0,0.6,1.00000,1,1,0,BP
GO:0071392,cellular response to estradiol stimulus,24,0,0.53,1.00000,1,1,0,BP
GO:0071425,hematopoietic stem cell proliferation,26,0,0.58,1.00000,1,1,0,BP
GO:0071467,cellular response to pH,23,0,0.51,1.00000,1,1,0,BP
GO:0071514,genetic imprinting,38,0,0.84,1.00000,1,1,0,BP
GO:0071548,response to dexamethasone,31,0,0.69,1.00000,1,1,0,BP
GO:0071549,cellular response to dexamethasone stimu...,28,0,0.62,1.00000,1,1,0,BP
GO:0071577,zinc ion transmembrane transport,23,0,0.51,1.00000,1,1,0,BP
GO:0071604,transforming growth factor beta producti...,36,0,0.8,1.00000,1,1,0,BP
GO:0071605,monocyte chemotactic protein-1 productio...,20,0,0.44,1.00000,1,1,0,BP
GO:0071616,acyl-CoA biosynthetic process,25,0,0.56,1.00000,1,1,0,BP
GO:0071621,granulocyte chemotaxis,124,0,2.76,1.00000,1,1,0,BP
GO:0071622,regulation of granulocyte chemotaxis,50,0,1.11,1.00000,1,1,0,BP
GO:0071624,positive regulation of granulocyte chemo...,27,0,0.6,1.00000,1,1,0,BP
GO:0071634,regulation of transforming growth factor...,34,0,0.76,1.00000,1,1,0,BP
GO:0071637,regulation of monocyte chemotactic prote...,20,0,0.44,1.00000,1,1,0,BP
GO:0071674,mononuclear cell migration,82,0,1.82,1.00000,1,1,0,BP
GO:0071675,regulation of mononuclear cell migration,50,0,1.11,1.00000,1,1,0,BP
GO:0071677,positive regulation of mononuclear cell ...,25,0,0.56,1.00000,1,1,0,BP
GO:0071715,icosanoid transport,53,0,1.18,1.00000,1,1,0,BP
GO:0071825,protein-lipid complex subunit organizati...,37,0,0.82,1.00000,1,1,0,BP
GO:0071827,plasma lipoprotein particle organization,33,0,0.73,1.00000,1,1,0,BP
GO:0071887,leukocyte apoptotic process,132,0,2.93,1.00000,1,1,0,BP
GO:0072329,monocarboxylic acid catabolic process,112,0,2.49,1.00000,1,1,0,BP
GO:0072337,modified amino acid transport,23,0,0.51,1.00000,1,1,0,BP
GO:0072376,protein activation cascade,64,0,1.42,1.00000,1,1,0,BP
GO:0072395,signal transduction involved in cell cyc...,29,0,0.64,1.00000,1,1,0,BP
GO:0072401,signal transduction involved in DNA inte...,29,0,0.64,1.00000,1,1,0,BP
GO:0072422,signal transduction involved in DNA dama...,29,0,0.64,1.00000,1,1,0,BP
GO:0072527,pyrimidine-containing compound metabolic...,51,0,1.13,1.00000,1,1,0,BP
GO:0072528,pyrimidine-containing compound biosynthe...,27,0,0.6,1.00000,1,1,0,BP
GO:0072538,T-helper 17 type immune response,32,0,0.71,1.00000,1,1,0,BP
GO:0072539,T-helper 17 cell differentiation,28,0,0.62,1.00000,1,1,0,BP
GO:0072599,establishment of protein localization to...,36,0,0.8,1.00000,1,1,0,BP
GO:0072643,interferon-gamma secretion,24,0,0.53,1.00000,1,1,0,BP
GO:0072662,protein localization to peroxisome,20,0,0.44,1.00000,1,1,0,BP
GO:0072663,establishment of protein localization to...,20,0,0.44,1.00000,1,1,0,BP
GO:0072677,eosinophil migration,24,0,0.53,1.00000,1,1,0,BP
GO:0080053,response to phenylalanine,25,0,0.56,1.00000,1,1,0,BP
GO:0080111,DNA demethylation,21,0,0.47,1.00000,1,1,0,BP
GO:0080154,regulation of fertilization,28,0,0.62,1.00000,1,1,0,BP
GO:0086010,membrane depolarization during action po...,31,0,0.69,1.00000,1,1,0,BP
GO:0086019,cell-cell signaling involved in cardiac ...,25,0,0.56,1.00000,1,1,0,BP
GO:0086065,cell communication involved in cardiac c...,37,0,0.82,1.00000,1,1,0,BP
GO:0086091,regulation of heart rate by cardiac cond...,33,0,0.73,1.00000,1,1,0,BP
GO:0089718,amino acid import across plasma membrane,28,0,0.62,1.00000,1,1,0,BP
GO:0090022,regulation of neutrophil chemotaxis,31,0,0.69,1.00000,1,1,0,BP
GO:0090023,positive regulation of neutrophil chemot...,25,0,0.56,1.00000,1,1,0,BP
GO:0090025,regulation of monocyte chemotaxis,26,0,0.58,1.00000,1,1,0,BP
GO:0090077,foam cell differentiation,26,0,0.58,1.00000,1,1,0,BP
GO:0090114,COPII-coated vesicle budding,25,0,0.56,1.00000,1,1,0,BP
GO:0090175,regulation of establishment of planar po...,42,0,0.93,1.00000,1,1,0,BP
GO:0090189,regulation of branching involved in uret...,26,0,0.58,1.00000,1,1,0,BP
GO:0090190,positive regulation of branching involve...,23,0,0.51,1.00000,1,1,0,BP
GO:0090207,regulation of triglyceride metabolic pro...,45,0,1,1.00000,1,1,0,BP
GO:0090208,positive regulation of triglyceride meta...,26,0,0.58,1.00000,1,1,0,BP
GO:0090218,positive regulation of lipid kinase acti...,33,0,0.73,1.00000,1,1,0,BP
GO:0090280,positive regulation of calcium ion impor...,25,0,0.56,1.00000,1,1,0,BP
GO:0090303,positive regulation of wound healing,57,0,1.27,1.00000,1,1,0,BP
GO:0090313,regulation of protein targeting to membr...,34,0,0.76,1.00000,1,1,0,BP
GO:0090314,positive regulation of protein targeting...,28,0,0.62,1.00000,1,1,0,BP
GO:0090330,regulation of platelet aggregation,22,0,0.49,1.00000,1,1,0,BP
GO:0090382,phagosome maturation,22,0,0.49,1.00000,1,1,0,BP
GO:0090505,epiboly involved in wound healing,31,0,0.69,1.00000,1,1,0,BP
GO:0097006,regulation of plasma lipoprotein particl...,62,0,1.38,1.00000,1,1,0,BP
GO:0097009,energy homeostasis,39,0,0.87,1.00000,1,1,0,BP
GO:0097028,dendritic cell differentiation,38,0,0.84,1.00000,1,1,0,BP
GO:0097035,regulation of membrane lipid distributio...,53,0,1.18,1.00000,1,1,0,BP
GO:0097107,postsynaptic density assembly,22,0,0.49,1.00000,1,1,0,BP
GO:0097150,neuronal stem cell population maintenanc...,24,0,0.53,1.00000,1,1,0,BP
GO:0097186,amelogenesis,24,0,0.53,1.00000,1,1,0,BP
GO:0097194,execution phase of apoptosis,67,0,1.49,1.00000,1,1,0,BP
GO:0097320,plasma membrane tubulation,20,0,0.44,1.00000,1,1,0,BP
GO:0097345,mitochondrial outer membrane permeabiliz...,29,0,0.64,1.00000,1,1,0,BP
GO:0097484,dendrite extension,43,0,0.96,1.00000,1,1,0,BP
GO:0097502,mannosylation,23,0,0.51,1.00000,1,1,0,BP
GO:0097529,myeloid leukocyte migration,208,0,4.62,1.00000,1,1,0,BP
GO:0097530,granulocyte migration,146,0,3.24,1.00000,1,1,0,BP
GO:0097734,extracellular exosome biogenesis,21,0,0.47,1.00000,1,1,0,BP
GO:0097756,negative regulation of blood vessel diam...,107,0,2.38,1.00000,1,1,0,BP
GO:0098581,detection of external biotic stimulus,23,0,0.51,1.00000,1,1,0,BP
GO:0098586,cellular response to virus,50,0,1.11,1.00000,1,1,0,BP
GO:0098659,inorganic cation import across plasma me...,86,0,1.91,1.00000,1,1,0,BP
GO:0098661,inorganic anion transmembrane transport,59,0,1.31,1.00000,1,1,0,BP
GO:0098698,postsynaptic specialization assembly,29,0,0.64,1.00000,1,1,0,BP
GO:0098739,import across plasma membrane,119,0,2.64,1.00000,1,1,0,BP
GO:0098743,cell aggregation,20,0,0.44,1.00000,1,1,0,BP
GO:0098877,neurotransmitter receptor transport to p...,22,0,0.49,1.00000,1,1,0,BP
GO:0098969,neurotransmitter receptor transport to p...,21,0,0.47,1.00000,1,1,0,BP
GO:0099068,postsynapse assembly,34,0,0.76,1.00000,1,1,0,BP
GO:0099170,postsynaptic modulation of chemical syna...,22,0,0.49,1.00000,1,1,0,BP
GO:0099500,vesicle fusion to plasma membrane,26,0,0.58,1.00000,1,1,0,BP
GO:0099514,synaptic vesicle cytoskeletal transport,20,0,0.44,1.00000,1,1,0,BP
GO:0099517,synaptic vesicle transport along microtu...,20,0,0.44,1.00000,1,1,0,BP
GO:0099560,synaptic membrane adhesion,31,0,0.69,1.00000,1,1,0,BP
GO:0099587,inorganic ion import across plasma membr...,86,0,1.91,1.00000,1,1,0,BP
GO:0099632,protein transport within plasma membrane,31,0,0.69,1.00000,1,1,0,BP
GO:0099637,neurotransmitter receptor transport,31,0,0.69,1.00000,1,1,0,BP
GO:0120033,negative regulation of plasma membrane b...,25,0,0.56,1.00000,1,1,0,BP
GO:0140053,mitochondrial gene expression,103,0,2.29,1.00000,1,1,0,BP
GO:0140112,extracellular vesicle biogenesis,23,0,0.51,1.00000,1,1,0,BP
GO:0150077,regulation of neuroinflammatory response,25,0,0.56,1.00000,1,1,0,BP
GO:1900017,positive regulation of cytokine producti...,21,0,0.47,1.00000,1,1,0,BP
GO:1900027,regulation of ruffle assembly,29,0,0.64,1.00000,1,1,0,BP
GO:1900046,regulation of hemostasis,79,0,1.76,1.00000,1,1,0,BP
GO:1900047,negative regulation of hemostasis,50,0,1.11,1.00000,1,1,0,BP
GO:1900048,positive regulation of hemostasis,26,0,0.58,1.00000,1,1,0,BP
GO:1900117,regulation of execution phase of apoptos...,30,0,0.67,1.00000,1,1,0,BP
GO:1900120,regulation of receptor binding,24,0,0.53,1.00000,1,1,0,BP
GO:1900543,negative regulation of purine nucleotide...,30,0,0.67,1.00000,1,1,0,BP
GO:1900745,positive regulation of p38MAPK cascade,28,0,0.62,1.00000,1,1,0,BP
GO:1901020,negative regulation of calcium ion trans...,31,0,0.69,1.00000,1,1,0,BP
GO:1901028,regulation of mitochondrial outer membra...,20,0,0.44,1.00000,1,1,0,BP
GO:1901099,negative regulation of signal transducti...,33,0,0.73,1.00000,1,1,0,BP
GO:1901185,negative regulation of ERBB signaling pa...,27,0,0.6,1.00000,1,1,0,BP
GO:1901186,positive regulation of ERBB signaling pa...,28,0,0.62,1.00000,1,1,0,BP
GO:1901522,positive regulation of transcription fro...,21,0,0.47,1.00000,1,1,0,BP
GO:1901532,regulation of hematopoietic progenitor c...,27,0,0.6,1.00000,1,1,0,BP
GO:1901570,fatty acid derivative biosynthetic proce...,51,0,1.13,1.00000,1,1,0,BP
GO:1901571,fatty acid derivative transport,53,0,1.18,1.00000,1,1,0,BP
GO:1901607,alpha-amino acid biosynthetic process,61,0,1.36,1.00000,1,1,0,BP
GO:1901658,glycosyl compound catabolic process,25,0,0.56,1.00000,1,1,0,BP
GO:1901661,quinone metabolic process,31,0,0.69,1.00000,1,1,0,BP
GO:1901741,positive regulation of myoblast fusion,23,0,0.51,1.00000,1,1,0,BP
GO:1901797,negative regulation of signal transducti...,32,0,0.71,1.00000,1,1,0,BP
GO:1901984,negative regulation of protein acetylati...,24,0,0.53,1.00000,1,1,0,BP
GO:1901985,positive regulation of protein acetylati...,43,0,0.96,1.00000,1,1,0,BP
GO:1902108,regulation of mitochondrial membrane per...,40,0,0.89,1.00000,1,1,0,BP
GO:1902110,positive regulation of mitochondrial mem...,32,0,0.71,1.00000,1,1,0,BP
GO:1902253,regulation of intrinsic apoptotic signal...,30,0,0.67,1.00000,1,1,0,BP
GO:1902254,negative regulation of intrinsic apoptot...,20,0,0.44,1.00000,1,1,0,BP
GO:1902475,L-alpha-amino acid transmembrane transpo...,39,0,0.87,1.00000,1,1,0,BP
GO:1902476,chloride transmembrane transport,39,0,0.87,1.00000,1,1,0,BP
GO:1902600,proton transmembrane transport,90,0,2,1.00000,1,1,0,BP
GO:1902622,regulation of neutrophil migration,41,0,0.91,1.00000,1,1,0,BP
GO:1902624,positive regulation of neutrophil migrat...,33,0,0.73,1.00000,1,1,0,BP
GO:1902743,regulation of lamellipodium organization,44,0,0.98,1.00000,1,1,0,BP
GO:1902745,positive regulation of lamellipodium org...,31,0,0.69,1.00000,1,1,0,BP
GO:1902893,regulation of pri-miRNA transcription by...,45,0,1,1.00000,1,1,0,BP
GO:1902895,positive regulation of pri-miRNA transcr...,35,0,0.78,1.00000,1,1,0,BP
GO:1903035,negative regulation of response to wound...,89,0,1.98,1.00000,1,1,0,BP
GO:1903131,mononuclear cell differentiation,29,0,0.64,1.00000,1,1,0,BP
GO:1903306,negative regulation of regulated secreto...,23,0,0.51,1.00000,1,1,0,BP
GO:1903318,negative regulation of protein maturatio...,37,0,0.82,1.00000,1,1,0,BP
GO:1903429,regulation of cell maturation,33,0,0.73,1.00000,1,1,0,BP
GO:1903487,regulation of lactation,29,0,0.64,1.00000,1,1,0,BP
GO:1903489,positive regulation of lactation,27,0,0.6,1.00000,1,1,0,BP
GO:1903510,mucopolysaccharide metabolic process,58,0,1.29,1.00000,1,1,0,BP
GO:1903514,release of sequestered calcium ion into ...,22,0,0.49,1.00000,1,1,0,BP
GO:1903523,negative regulation of blood circulation,42,0,0.93,1.00000,1,1,0,BP
GO:1903524,positive regulation of blood circulation,90,0,2,1.00000,1,1,0,BP
GO:1903540,establishment of protein localization to...,23,0,0.51,1.00000,1,1,0,BP
GO:1903579,negative regulation of ATP metabolic pro...,29,0,0.64,1.00000,1,1,0,BP
GO:1903725,regulation of phospholipid metabolic pro...,72,0,1.6,1.00000,1,1,0,BP
GO:1903727,positive regulation of phospholipid meta...,46,0,1.02,1.00000,1,1,0,BP
GO:1903793,positive regulation of anion transport,65,0,1.44,1.00000,1,1,0,BP
GO:1903798,regulation of production of miRNAs invol...,20,0,0.44,1.00000,1,1,0,BP
GO:1903846,positive regulation of cellular response...,29,0,0.64,1.00000,1,1,0,BP
GO:1903859,regulation of dendrite extension,32,0,0.71,1.00000,1,1,0,BP
GO:1903861,positive regulation of dendrite extensio...,29,0,0.64,1.00000,1,1,0,BP
GO:1903963,arachidonate transport,31,0,0.69,1.00000,1,1,0,BP
GO:1904321,response to forskolin,65,0,1.44,1.00000,1,1,0,BP
GO:1904322,cellular response to forskolin,65,0,1.44,1.00000,1,1,0,BP
GO:1904357,negative regulation of telomere maintena...,26,0,0.58,1.00000,1,1,0,BP
GO:1904861,excitatory synapse assembly,29,0,0.64,1.00000,1,1,0,BP
GO:1904894,positive regulation of STAT cascade,107,0,2.38,1.00000,1,1,0,BP
GO:1905153,regulation of membrane invagination,21,0,0.47,1.00000,1,1,0,BP
GO:1905208,negative regulation of cardiocyte differ...,24,0,0.53,1.00000,1,1,0,BP
GO:1905314,semi-lunar valve development,31,0,0.69,1.00000,1,1,0,BP
GO:1905517,macrophage migration,57,0,1.27,1.00000,1,1,0,BP
GO:1905521,regulation of macrophage migration,42,0,0.93,1.00000,1,1,0,BP
GO:1905523,positive regulation of macrophage migrat...,27,0,0.6,1.00000,1,1,0,BP
GO:1905809,negative regulation of synapse organizat...,25,0,0.56,1.00000,1,1,0,BP
GO:1905939,regulation of gonad development,25,0,0.56,1.00000,1,1,0,BP
GO:1990126,"retrograde transport, endosome to plasma...",29,0,0.64,1.00000,1,1,0,BP
GO:1990182,exosomal secretion,20,0,0.44,1.00000,1,1,0,BP
GO:1990266,neutrophil migration,119,0,2.64,1.00000,1,1,0,BP
GO:1990573,potassium ion import across plasma membr...,43,0,0.96,1.00000,1,1,0,BP
GO:2000106,regulation of leukocyte apoptotic proces...,108,0,2.4,1.00000,1,1,0,BP
GO:2000107,negative regulation of leukocyte apoptot...,69,0,1.53,1.00000,1,1,0,BP
GO:2000108,positive regulation of leukocyte apoptot...,33,0,0.73,1.00000,1,1,0,BP
GO:2000178,negative regulation of neural precursor ...,28,0,0.62,1.00000,1,1,0,BP
GO:2000191,regulation of fatty acid transport,32,0,0.71,1.00000,1,1,0,BP
GO:2000193,positive regulation of fatty acid transp...,21,0,0.47,1.00000,1,1,0,BP
GO:2000249,regulation of actin cytoskeleton reorgan...,35,0,0.78,1.00000,1,1,0,BP
GO:2000272,negative regulation of signaling recepto...,27,0,0.6,1.00000,1,1,0,BP
GO:2000311,regulation of AMPA receptor activity,28,0,0.62,1.00000,1,1,0,BP
GO:2000316,regulation of T-helper 17 type immune re...,23,0,0.51,1.00000,1,1,0,BP
GO:2000352,negative regulation of endothelial cell ...,31,0,0.69,1.00000,1,1,0,BP
GO:2000514,"regulation of CD4-positive, alpha-beta T...",64,0,1.42,1.00000,1,1,0,BP
GO:2000515,"negative regulation of CD4-positive, alp...",31,0,0.69,1.00000,1,1,0,BP
GO:2000516,"positive regulation of CD4-positive, alp...",36,0,0.8,1.00000,1,1,0,BP
GO:2000678,negative regulation of transcription reg...,20,0,0.44,1.00000,1,1,0,BP
GO:2000726,negative regulation of cardiac muscle ce...,20,0,0.44,1.00000,1,1,0,BP
GO:2000757,negative regulation of peptidyl-lysine a...,22,0,0.49,1.00000,1,1,0,BP
GO:2000758,positive regulation of peptidyl-lysine a...,34,0,0.76,1.00000,1,1,0,BP
GO:2001032,regulation of double-strand break repair...,21,0,0.47,1.00000,1,1,0,BP
GO:2001224,positive regulation of neuron migration,21,0,0.47,1.00000,1,1,0,BP
GO:2001239,regulation of extrinsic apoptotic signal...,48,0,1.07,1.00000,1,1,0,BP
GO:2001240,negative regulation of extrinsic apoptot...,33,0,0.73,1.00000,1,1,0,BP
GO:2001258,negative regulation of cation channel ac...,41,0,0.91,1.00000,1,1,0,BP
GO:0005488,binding,13259,401,297.8,4.9e-27,4.0620999999999996e-24,4.0620999999999996e-24,1.35,MF
GO:0005515,protein binding,8941,310,200.82,7.4e-25,6.1346e-22,3.0673e-22,1.54,MF
GO:0019899,enzyme binding,2351,111,52.8,1.3e-14,1.0777e-11,3.592333333333333e-12,2.1,MF
GO:0008092,cytoskeletal protein binding,976,60,21.92,1.4e-12,1.1606000000000001e-9,2.9015000000000003e-10,2.74,MF
GO:1901363,heterocyclic compound binding,5061,181,113.67,2.1e-12,1.7408999999999999e-9,3.4818000000000003e-10,1.59,MF
GO:0097159,organic cyclic compound binding,5162,183,115.94,3.2e-12,2.6528e-9,4.421333333333333e-10,1.58,MF
GO:0003774,motor activity,133,20,2.99,1.9e-11,1.5751e-8,2.250142857142857e-9,6.69,MF
GO:0003676,nucleic acid binding,3105,121,69.74,3.2e-10,2.6528e-7,3.316e-8,1.74,MF
GO:0044877,protein-containing complex binding,1256,64,28.21,6.7e-10,5.5543e-7,6.171444444444445e-8,2.27,MF
GO:0003723,RNA binding,1068,56,23.99,3.2e-09,2.6528000000000002e-6,2.5623636363636364e-7,2.33,MF
GO:0003779,actin binding,429,32,9.64,3.4e-09,2.8186e-6,2.5623636363636364e-7,3.32,MF
GO:0003777,microtubule motor activity,84,14,1.89,5.2e-09,4.3108e-6,3.5923333333333334e-7,7.41,MF
GO:0003735,structural constituent of ribosome,151,17,3.39,5.4e-08,4.4766e-5,3.4435384615384616e-6,5.01,MF
GO:0043167,ion binding,5533,173,124.27,3.8e-07,3.1502e-4,2.2501428571428573e-5,1.39,MF
GO:0005198,structural molecule activity,610,35,13.7,4.4e-07,3.6476e-4,2.4317333333333335e-5,2.55,MF
GO:0015631,tubulin binding,339,24,7.61,8.2e-07,6.7978e-4,4.248625e-5,3.15,MF
GO:0003729,mRNA binding,270,21,6.06,8.9e-07,7.3781e-4,4.340058823529412e-5,3.47,MF
GO:0016462,pyrophosphatase activity,883,43,19.83,1.8e-06,0.0014922,7.8755e-5,2.17,MF
GO:0016817,"hydrolase activity, acting on acid anhyd...",886,43,19.9,1.9e-06,0.0015751,7.8755e-5,2.16,MF
GO:0016818,"hydrolase activity, acting on acid anhyd...",886,43,19.9,1.9e-06,0.0015751,7.8755e-5,2.16,MF
GO:0017111,nucleoside-triphosphatase activity,830,41,18.64,2.2e-06,0.0018238,8.684761904761905e-5,2.2,MF
GO:0017076,purine nucleotide binding,1843,72,41.39,2.5e-06,0.0020725,9.371304347826087e-5,1.74,MF
GO:0008017,microtubule binding,242,19,5.44,2.6e-06,0.0021554,9.371304347826087e-5,3.49,MF
GO:0035639,purine ribonucleoside triphosphate bindi...,1756,69,39.44,3.4e-06,0.0028186,1.1744166666666666e-4,1.75,MF
GO:0032555,purine ribonucleotide binding,1831,71,41.12,3.8e-06,0.0031502,1.26008e-4,1.73,MF
GO:0019900,kinase binding,821,40,18.44,4.1e-06,0.0033989,1.3072692307692307e-4,2.17,MF
GO:0030554,adenyl nucleotide binding,1505,61,33.8,5.2e-06,0.0043108,1.5691785714285714e-4,1.8,MF
GO:0032553,ribonucleotide binding,1848,71,41.51,5.3e-06,0.0043937,1.5691785714285714e-4,1.71,MF
GO:0032559,adenyl ribonucleotide binding,1494,60,33.56,8.3e-06,0.0068807,2.372655172413793e-4,1.79,MF
GO:0005524,ATP binding,1429,58,32.1,8.7e-06,0.0072123,2.4040999999999998e-4,1.81,MF
GO:0016301,kinase activity,778,37,17.47,1.6e-05,0.013264,4.278709677419355e-4,2.12,MF
GO:0000166,nucleotide binding,2075,75,46.6,2.3e-05,0.019067,5.777878787878788e-4,1.61,MF
GO:1901265,nucleoside phosphate binding,2075,75,46.6,2.3e-05,0.019067,5.777878787878788e-4,1.61,MF
GO:0019843,rRNA binding,71,9,1.59,2.9e-05,0.024041,7.070882352941177e-4,5.66,MF
GO:0003682,chromatin binding,589,30,13.23,3.0e-05,0.02487,7.105714285714286e-4,2.27,MF
GO:0042393,histone binding,218,16,4.9,3.6e-05,0.029844000000000002,8.290000000000001e-4,3.27,MF
GO:0097367,carbohydrate derivative binding,2158,76,48.47,4.9e-05,0.040621,0.001068973684210526,1.57,MF
GO:0051015,actin filament binding,200,15,4.49,4.9e-05,0.040621,0.001068973684210526,3.34,MF
GO:0043168,anion binding,2733,91,61.38,6.5e-05,0.053884999999999995,0.00136785,1.48,MF
GO:0070064,proline-rich region binding,20,5,0.45,6.6e-05,0.054714000000000006,0.00136785,11.11,MF
GO:0003714,transcription corepressor activity,190,14,4.27,0.00011,0.09119000000000001,0.0022241463414634146,3.28,MF
GO:0016772,"transferase activity, transferring phosp...",921,39,20.69,0.00012,0.09948,0.0023134883720930233,1.88,MF
GO:0019902,phosphatase binding,217,15,4.87,0.00012,0.09948,0.0023134883720930233,3.08,MF
GO:0019901,protein kinase binding,740,33,16.62,0.00016,0.13264,0.0029475555555555557,1.99,MF
GO:0004672,protein kinase activity,616,29,13.84,0.00016,0.13264,0.0029475555555555557,2.1,MF
GO:0000993,RNA polymerase II complex binding,38,6,0.85,0.00019,0.15751,0.0032814583333333333,7.06,MF
GO:0016887,ATPase activity,386,21,8.67,0.00019,0.15751,0.0032814583333333333,2.42,MF
GO:0016773,"phosphotransferase activity, alcohol gro...",717,32,16.1,0.00019,0.15751,0.0032814583333333333,1.99,MF
GO:0008144,drug binding,1685,60,37.85,0.00025,0.20725000000000002,0.004229591836734694,1.59,MF
GO:0003712,transcription coregulator activity,460,23,10.33,0.00032,0.26528,0.0053056,2.23,MF
GO:0008574,ATP-dependent microtubule motor activity...,28,5,0.63,0.00036,0.29844000000000004,0.005630943396226416,7.94,MF
GO:0140096,"catalytic activity, acting on a protein",2187,73,49.12,0.00036,0.29844000000000004,0.005630943396226416,1.49,MF
GO:0046872,metal ion binding,3533,108,79.35,0.00036,0.29844000000000004,0.005630943396226416,1.36,MF
GO:0043175,RNA polymerase core enzyme binding,43,6,0.97,0.00037,0.30673,0.005680185185185185,6.19,MF
GO:0017048,Rho GTPase binding,166,12,3.73,0.00038,0.31502,0.005727636363636364,3.22,MF
GO:0036094,small molecule binding,2460,80,55.25,0.00041,0.33988999999999997,0.006069464285714286,1.45,MF
GO:0043169,cation binding,3631,110,81.55,0.00044,0.36476000000000003,0.0063992982456140355,1.35,MF
GO:0044389,ubiquitin-like protein ligase binding,326,18,7.32,0.00045,0.37305,0.006431896551724137,2.46,MF
GO:0050839,cell adhesion molecule binding,245,15,5.5,0.00046,0.38134,0.006463389830508475,2.73,MF
GO:0019903,protein phosphatase binding,170,12,3.82,0.00048,0.39792,0.006632,3.14,MF
GO:0031625,ubiquitin protein ligase binding,307,17,6.9,0.00062,0.51398,0.008425901639344263,2.46,MF
GO:0005178,integrin binding,128,10,2.87,0.00064,0.53056,0.00855741935483871,3.48,MF
GO:1990939,ATP-dependent microtubule motor activity,49,6,1.1,0.00077,0.63833,0.010132222222222221,5.45,MF
GO:0051020,GTPase binding,527,24,11.84,0.00091,0.75439,0.01178734375,2.03,MF
GO:0051018,protein kinase A binding,54,6,1.21,0.00129,1,0.016452461538461537,4.96,MF
GO:0001098,basal transcription machinery binding,58,6,1.3,0.00187,1,0.0227975,4.62,MF
GO:0001099,basal RNA polymerase II transcription ma...,58,6,1.3,0.00187,1,0.0227975,4.62,MF
GO:0070063,RNA polymerase binding,58,6,1.3,0.00187,1,0.0227975,4.62,MF
GO:0004386,helicase activity,156,10,3.5,0.00282,1,0.03388086956521739,2.86,MF
GO:0019904,protein domain specific binding,813,31,18.26,0.00305,1,0.03584549295774648,1.7,MF
GO:0042802,identical protein binding,1906,61,42.81,0.00307,1,0.03584549295774648,1.42,MF
GO:0035255,ionotropic glutamate receptor binding,45,5,1.01,0.00326,1,0.03753527777777778,4.95,MF
GO:0043325,"phosphatidylinositol-3,4-bisphosphate bi...",28,4,0.63,0.00335,1,0.03804315068493151,6.35,MF
GO:0008270,zinc ion binding,691,27,15.52,0.00400,1,0.044810810810810814,1.74,MF
GO:0046914,transition metal ion binding,971,35,21.81,0.00417,1,0.0460924,1.6,MF
GO:0019894,kinesin binding,49,5,1.1,0.00473,1,0.051594342105263154,4.55,MF
GO:0035254,glutamate receptor binding,70,6,1.57,0.00485,1,0.051971923076923075,3.82,MF
GO:0043236,laminin binding,31,4,0.7,0.00489,1,0.051971923076923075,5.71,MF
GO:0042623,"ATPase activity, coupled",286,14,6.42,0.00550,1,0.05710888888888889,2.18,MF
GO:0002039,p53 binding,72,6,1.62,0.00557,1,0.05710888888888889,3.7,MF
GO:0032182,ubiquitin-like protein binding,95,7,2.13,0.00558,1,0.05710888888888889,3.29,MF
GO:0051082,unfolded protein binding,97,7,2.18,0.00625,1,0.0631859756097561,3.21,MF
GO:0002020,protease binding,148,9,3.32,0.00634,1,0.06332361445783133,2.71,MF
GO:1990841,promoter-specific chromatin binding,53,5,1.19,0.00662,1,0.06533309523809523,4.2,MF
GO:0003755,peptidyl-prolyl cis-trans isomerase acti...,34,4,0.76,0.00684,1,0.06593441860465116,5.26,MF
GO:0016776,"phosphotransferase activity, phosphate g...",34,4,0.76,0.00684,1,0.06593441860465116,5.26,MF
GO:0008022,protein C-terminus binding,238,12,5.35,0.00782,1,0.07451471264367816,2.24,MF
GO:0008135,"translation factor activity, RNA binding",78,6,1.75,0.00818,1,0.07705931818181817,3.43,MF
GO:0042162,telomeric DNA binding,36,4,0.81,0.00838,1,0.07805640449438202,4.94,MF
GO:0004674,protein serine/threonine kinase activity,463,19,10.4,0.00894,1,0.08234733333333333,1.83,MF
GO:0047485,protein N-terminus binding,130,8,2.92,0.00916,1,0.0834465934065934,2.74,MF
GO:0031267,small GTPase binding,432,18,9.7,0.00930,1,0.08380108695652172,1.86,MF
GO:0016859,cis-trans isomerase activity,38,4,0.85,0.01014,1,0.09038774193548386,4.71,MF
GO:0050840,extracellular matrix binding,59,5,1.33,0.01036,1,0.09119,3.76,MF
GO:0003677,DNA binding,2059,62,46.25,0.01049,1,0.09119,1.34,MF
GO:0019787,ubiquitin-like protein transferase activ...,405,17,9.1,0.01056,1,0.09119,1.87,MF
GO:0035091,phosphatidylinositol binding,251,12,5.64,0.01162,1,0.09930907216494846,2.13,MF
GO:0004003,ATP-dependent DNA helicase activity,22,3,0.49,0.01262,1,0.10461979999999999,6.12,MF
GO:0008026,ATP-dependent helicase activity,22,3,0.49,0.01262,1,0.10461979999999999,6.12,MF
GO:0070035,purine NTP-dependent helicase activity,22,3,0.49,0.01262,1,0.10461979999999999,6.12,MF
GO:1901981,phosphatidylinositol phosphate binding,166,9,3.73,0.01291,1,0.10596425742574256,2.41,MF
GO:0005547,"phosphatidylinositol-3,4,5-trisphosphate...",41,4,0.92,0.01320,1,0.10603304761904762,4.35,MF
GO:0044325,ion channel binding,139,8,3.12,0.01336,1,0.10603304761904762,2.56,MF
GO:0004842,ubiquitin-protein transferase activity,383,16,8.6,0.01341,1,0.10603304761904762,1.86,MF
GO:0019207,kinase regulator activity,196,10,4.4,0.01343,1,0.10603304761904762,2.27,MF
GO:0060090,molecular adaptor activity,200,10,4.49,0.01528,1,0.11950113207547171,2.23,MF
GO:0019212,phosphatase inhibitor activity,43,4,0.97,0.01554,1,0.12039869158878505,4.12,MF
GO:0016740,transferase activity,2276,66,51.12,0.01805,1,0.13855046296296294,1.29,MF
GO:0005518,collagen binding,68,5,1.53,0.01833,1,0.13940889908256882,3.27,MF
GO:0030234,enzyme regulator activity,973,32,21.85,0.02051,1,0.15457081818181817,1.46,MF
GO:0003743,translation initiation factor activity,47,4,1.06,0.02095,1,0.1550674107142857,3.77,MF
GO:0016538,cyclin-dependent protein serine/threonin...,47,4,1.06,0.02095,1,0.1550674107142857,3.77,MF
GO:0008094,DNA-dependent ATPase activity,72,5,1.62,0.02290,1,0.16800088495575222,3.09,MF
GO:0005509,calcium ion binding,621,22,13.95,0.02451,1,0.178235,1.58,MF
GO:0043130,ubiquitin binding,74,5,1.66,0.02543,1,0.18331713043478262,3.01,MF
GO:0017016,Ras GTPase binding,417,16,9.37,0.02716,1,0.1941003448275862,1.71,MF
GO:0051219,phosphoprotein binding,106,6,2.38,0.03240,1,0.22956923076923075,2.52,MF
GO:0003713,transcription coactivator activity,261,11,5.86,0.03448,1,0.2403403361344538,1.88,MF
GO:0030507,spectrin binding,32,3,0.72,0.03450,1,0.2403403361344538,4.17,MF
GO:0035591,signaling adaptor activity,55,4,1.24,0.03487,1,0.24089358333333333,3.23,MF
GO:0035035,histone acetyltransferase binding,33,3,0.74,0.03733,1,0.2536604098360656,4.05,MF
GO:0051959,dynein light intermediate chain binding,33,3,0.74,0.03733,1,0.2536604098360656,4.05,MF
GO:0045182,translation regulator activity,57,4,1.28,0.03902,1,0.2581742857142857,3.12,MF
GO:0045309,protein phosphorylated amino acid bindin...,57,4,1.28,0.03902,1,0.2581742857142857,3.12,MF
GO:0008134,transcription factor binding,726,24,16.31,0.03907,1,0.2581742857142857,1.47,MF
GO:1902936,phosphatidylinositol bisphosphate bindin...,111,6,2.49,0.03924,1,0.2581742857142857,2.41,MF
GO:0003824,catalytic activity,5780,147,129.82,0.04199,1,0.27344046875,1.13,MF
GO:0003697,single-stranded DNA binding,113,6,2.54,0.04222,1,0.27344046875,2.36,MF
GO:0008200,ion channel inhibitor activity,35,3,0.79,0.04335,1,0.27858255813953486,3.8,MF
GO:0019208,phosphatase regulator activity,86,5,1.93,0.04436,1,0.2828803076923077,2.59,MF
GO:0070273,phosphatidylinositol-4-phosphate binding,36,3,0.81,0.04653,1,0.29445320610687026,3.7,MF
GO:0003678,DNA helicase activity,61,4,1.37,0.04813,1,0.30227098484848486,2.92,MF
GO:0016248,channel inhibitor activity,37,3,0.83,0.04982,1,0.31053218045112785,3.61,MF
GO:0005200,structural constituent of cytoskeleton,63,4,1.41,0.05309,1,0.3268102222222222,2.84,MF
GO:0019205,nucleobase-containing compound kinase ac...,38,3,0.85,0.05322,1,0.3268102222222222,3.53,MF
GO:0005543,phospholipid binding,422,15,9.48,0.05508,1,0.33574499999999996,1.58,MF
GO:0004864,protein phosphatase inhibitor activity,39,3,0.88,0.05673,1,0.34327861313868613,3.41,MF
GO:0046983,protein dimerization activity,1422,41,31.94,0.06010,1,0.3610355072463768,1.28,MF
GO:0051117,ATPase binding,94,5,2.11,0.06067,1,0.3618376258992806,2.37,MF
GO:0032266,phosphatidylinositol-3-phosphate binding,41,3,0.92,0.06407,1,0.3766952482269504,3.26,MF
GO:0043531,ADP binding,41,3,0.92,0.06407,1,0.3766952482269504,3.26,MF
GO:0046982,protein heterodimerization activity,579,19,13,0.06500,1,0.3794718309859155,1.46,MF
GO:0048365,Rac GTPase binding,68,4,1.53,0.06664,1,0.38632559440559444,2.61,MF
GO:0005516,calmodulin binding,191,8,4.29,0.06716,1,0.3866363888888889,1.86,MF
GO:0004713,protein tyrosine kinase activity,129,6,2.9,0.07107,1,0.40632434482758617,2.07,MF
GO:0005089,Rho guanyl-nucleotide exchange factor ac...,70,4,1.57,0.07251,1,0.4078234899328859,2.55,MF
GO:0017049,GTP-Rho binding,20,2,0.45,0.07330,1,0.4078234899328859,4.44,MF
GO:0017116,single-stranded DNA-dependent ATP-depend...,20,2,0.45,0.07330,1,0.4078234899328859,4.44,MF
GO:0043142,single-stranded DNA-dependent ATPase act...,20,2,0.45,0.07330,1,0.4078234899328859,4.44,MF
GO:0070491,repressing transcription factor binding,71,4,1.59,0.07555,1,0.4175396666666667,2.52,MF
GO:0019887,protein kinase regulator activity,164,7,3.68,0.07727,1,0.42262638157894733,1.9,MF
GO:0030674,"protein binding, bridging",132,6,2.96,0.07749,1,0.42262638157894733,2.03,MF
GO:0043138,3'-5' DNA helicase activity,21,2,0.47,0.07985,1,0.43048785714285714,4.26,MF
GO:0004715,non-membrane spanning protein tyrosine k...,45,3,1.01,0.07997,1,0.43048785714285714,2.97,MF
GO:0008289,lipid binding,748,23,16.8,0.08065,1,0.4313474193548387,1.37,MF
GO:0019888,protein phosphatase regulator activity,73,4,1.64,0.08181,1,0.4347467307692307,2.44,MF
GO:0032813,tumor necrosis factor receptor superfami...,46,3,1.03,0.08419,1,0.441993417721519,2.91,MF
GO:0061630,ubiquitin protein ligase activity,235,9,5.28,0.08424,1,0.441993417721519,1.7,MF
GO:0008157,protein phosphatase 1 binding,22,2,0.49,0.08658,1,0.4430544444444445,4.08,MF
GO:0032947,protein-containing complex scaffold acti...,22,2,0.49,0.08658,1,0.4430544444444445,4.08,MF
GO:0034237,protein kinase A regulatory subunit bind...,22,2,0.49,0.08658,1,0.4430544444444445,4.08,MF
GO:0050998,nitric-oxide synthase binding,22,2,0.49,0.08658,1,0.4430544444444445,4.08,MF
GO:0003688,DNA replication origin binding,23,2,0.52,0.09346,1,0.46805898876404495,3.85,MF
GO:0030506,ankyrin binding,23,2,0.52,0.09346,1,0.46805898876404495,3.85,MF
GO:0019003,GDP binding,77,4,1.73,0.09505,1,0.46805898876404495,2.31,MF
GO:0001085,RNA polymerase II transcription factor b...,173,7,3.89,0.09586,1,0.46805898876404495,1.8,MF
GO:0031072,heat shock protein binding,140,6,3.14,0.09614,1,0.46805898876404495,1.91,MF
GO:0005102,signaling receptor binding,1644,45,36.92,0.09692,1,0.46805898876404495,1.22,MF
GO:0030544,Hsp70 protein binding,49,3,1.1,0.09740,1,0.46805898876404495,2.73,MF
GO:0019783,ubiquitin-like protein-specific protease...,109,5,2.45,0.09918,1,0.46805898876404495,2.04,MF
GO:0061659,ubiquitin-like protein ligase activity,244,9,5.48,0.10031,1,0.46805898876404495,1.64,MF
GO:0004129,cytochrome-c oxidase activity,24,2,0.54,0.10050,1,0.46805898876404495,3.7,MF
GO:0015002,heme-copper terminal oxidase activity,24,2,0.54,0.10050,1,0.46805898876404495,3.7,MF
GO:0016676,"oxidoreductase activity, acting on a hem...",24,2,0.54,0.10050,1,0.46805898876404495,3.7,MF
GO:0031683,G-protein beta/gamma-subunit complex bin...,24,2,0.54,0.10050,1,0.46805898876404495,3.7,MF
GO:0048027,mRNA 5'-UTR binding,24,2,0.54,0.10050,1,0.46805898876404495,3.7,MF
GO:0050780,dopamine receptor binding,24,2,0.54,0.10050,1,0.46805898876404495,3.7,MF
GO:0070840,dynein complex binding,24,2,0.54,0.10050,1,0.46805898876404495,3.7,MF
GO:0005546,"phosphatidylinositol-4,5-bisphosphate bi...",80,4,1.8,0.10561,1,0.48911,2.22,MF
GO:0016675,"oxidoreductase activity, acting on a hem...",25,2,0.56,0.10768,1,0.4931862983425414,3.57,MF
GO:0030515,snoRNA binding,25,2,0.56,0.10768,1,0.4931862983425414,3.57,MF
GO:0005525,GTP binding,360,12,8.09,0.11383,1,0.5184893956043956,1.48,MF
GO:0005158,insulin receptor binding,26,2,0.58,0.11499,1,0.5207016216216216,3.45,MF
GO:0030276,clathrin binding,53,3,1.19,0.11620,1,0.5207016216216216,2.52,MF
GO:0031491,nucleosome binding,53,3,1.19,0.11620,1,0.5207016216216216,2.52,MF
GO:0080025,"phosphatidylinositol-3,5-bisphosphate bi...",27,2,0.61,0.12242,1,0.545624623655914,3.28,MF
GO:0099106,ion channel regulator activity,117,5,2.63,0.12373,1,0.5485142780748664,1.9,MF
GO:0140110,transcription regulator activity,1354,37,30.41,0.12549,1,0.5519210052910053,1.22,MF
GO:0032550,purine ribonucleoside binding,367,12,8.24,0.12583,1,0.5519210052910053,1.46,MF
GO:0016853,isomerase activity,152,6,3.41,0.12817,1,0.5565150785340314,1.76,MF
GO:0003725,double-stranded RNA binding,86,4,1.93,0.12822,1,0.5565150785340314,2.07,MF
GO:0004407,histone deacetylase activity,28,2,0.63,0.12997,1,0.5582649222797927,3.17,MF
GO:0005070,SH3/SH2 adaptor activity,28,2,0.63,0.12997,1,0.5582649222797927,3.17,MF
GO:0001883,purine nucleoside binding,372,12,8.36,0.13483,1,0.573200358974359,1.44,MF
GO:0032549,ribonucleoside binding,372,12,8.36,0.13483,1,0.573200358974359,1.44,MF
GO:0033558,protein deacetylase activity,29,2,0.65,0.13762,1,0.5820764285714286,3.08,MF
GO:0004843,thiol-dependent ubiquitin-specific prote...,90,4,2.02,0.14432,1,0.5965516831683167,1.98,MF
GO:0004693,cyclin-dependent protein serine/threonin...,30,2,0.67,0.14536,1,0.5965516831683167,2.99,MF
GO:0042287,MHC protein binding,30,2,0.67,0.14536,1,0.5965516831683167,2.99,MF
GO:0045503,dynein light chain binding,30,2,0.67,0.14536,1,0.5965516831683167,2.99,MF
GO:0050681,androgen receptor binding,30,2,0.67,0.14536,1,0.5965516831683167,2.99,MF
GO:0098918,structural constituent of synapse,30,2,0.67,0.14536,1,0.5965516831683167,2.99,MF
GO:0008047,enzyme activator activity,457,14,10.26,0.15069,1,0.6153793596059113,1.36,MF
GO:0033613,activating transcription factor binding,92,4,2.07,0.15265,1,0.6165184466019418,1.93,MF
GO:0001968,fibronectin binding,31,2,0.7,0.15320,1,0.6165184466019418,2.86,MF
GO:0097472,cyclin-dependent protein kinase activity,31,2,0.7,0.15320,1,0.6165184466019418,2.86,MF
GO:0001882,nucleoside binding,383,12,8.6,0.15580,1,0.6239526570048309,1.4,MF
GO:0019001,guanyl nucleotide binding,384,12,8.62,0.15779,1,0.6258751674641149,1.39,MF
GO:0032561,guanyl ribonucleotide binding,384,12,8.62,0.15779,1,0.6258751674641149,1.39,MF
GO:0016504,peptidase activator activity,32,2,0.72,0.16111,1,0.6346368246445497,2.78,MF
GO:0005088,Ras guanyl-nucleotide exchange factor ac...,128,5,2.87,0.16153,1,0.6346368246445497,1.74,MF
GO:0045505,dynein intermediate chain binding,33,2,0.74,0.16909,1,0.6610204694835681,2.7,MF
GO:0004197,cysteine-type endopeptidase activity,96,4,2.16,0.16984,1,0.6610204694835681,1.85,MF
GO:0016787,hydrolase activity,2534,64,56.91,0.17248,1,0.6681585046728972,1.12,MF
GO:0042803,protein homodimerization activity,950,26,21.34,0.17403,1,0.6710273023255814,1.22,MF
GO:0005096,GTPase activator activity,241,8,5.41,0.17657,1,0.6736575688073395,1.48,MF
GO:0005164,tumor necrosis factor receptor binding,34,2,0.76,0.17715,1,0.6736575688073395,2.63,MF
GO:0051019,mitogen-activated protein kinase binding,34,2,0.76,0.17715,1,0.6736575688073395,2.63,MF
GO:0003724,RNA helicase activity,65,3,1.46,0.17940,1,0.6790986301369863,2.05,MF
GO:0036459,thiol-dependent ubiquitinyl hydrolase ac...,99,4,2.22,0.18315,1,0.688664798206278,1.8,MF
GO:0043022,ribosome binding,66,3,1.48,0.18503,1,0.688664798206278,2.03,MF
GO:0001103,RNA polymerase II repressing transcripti...,35,2,0.79,0.18525,1,0.688664798206278,2.53,MF
GO:0097718,disordered domain specific binding,35,2,0.79,0.18525,1,0.688664798206278,2.53,MF
GO:0140030,modification-dependent protein binding,171,6,3.84,0.18777,1,0.6949166517857143,1.56,MF
GO:0008234,cysteine-type peptidase activity,172,6,3.86,0.19117,1,0.7032319736842105,1.55,MF
GO:0101005,ubiquitinyl hydrolase activity,101,4,2.27,0.19221,1,0.7032319736842105,1.76,MF
GO:0005154,epidermal growth factor receptor binding,36,2,0.81,0.19341,1,0.7032319736842105,2.47,MF
GO:0061980,regulatory RNA binding,36,2,0.81,0.19341,1,0.7032319736842105,2.47,MF
GO:0003899,DNA-directed 5'-3' RNA polymerase activi...,37,2,0.83,0.20162,1,0.7298820087336244,2.41,MF
GO:0045296,cadherin binding,70,3,1.57,0.20802,1,0.7497764347826087,1.91,MF
GO:0051721,protein phosphatase 2A binding,38,2,0.85,0.20986,1,0.7531339393939394,2.35,MF
GO:0048306,calcium-dependent protein binding,71,3,1.59,0.21386,1,0.7641807758620689,1.89,MF
GO:0004712,protein serine/threonine/tyrosine kinase...,39,2,0.88,0.21814,1,0.7695236595744681,2.27,MF
GO:0034062,5'-3' RNA polymerase activity,39,2,0.88,0.21814,1,0.7695236595744681,2.27,MF
GO:0097747,RNA polymerase activity,39,2,0.88,0.21814,1,0.7695236595744681,2.27,MF
GO:0031369,translation initiation factor binding,40,2,0.9,0.22645,1,0.7920972573839663,2.22,MF
GO:0098631,cell adhesion mediator activity,40,2,0.9,0.22645,1,0.7920972573839663,2.22,MF
GO:0030695,GTPase regulator activity,259,8,5.82,0.22844,1,0.7957006722689076,1.37,MF
GO:0060589,nucleoside-triphosphatase regulator acti...,299,9,6.72,0.23163,1,0.8001231666666667,1.34,MF
GO:0016247,channel regulator activity,146,5,3.28,0.23164,1,0.8001231666666667,1.52,MF
GO:0030971,receptor tyrosine kinase binding,75,3,1.68,0.23757,1,0.8172013692946059,1.79,MF
GO:0003924,GTPase activity,303,9,6.81,0.24304,1,0.8294093827160494,1.32,MF
GO:0019213,deacetylase activity,42,2,0.94,0.24312,1,0.8294093827160494,2.13,MF
GO:0098772,molecular function regulator,1760,44,39.53,0.24830,1,0.8436094262295082,1.11,MF
GO:0043548,phosphatidylinositol 3-kinase binding,43,2,0.97,0.25147,1,0.850892367346939,2.06,MF
GO:0043021,ribonucleoprotein complex binding,152,5,3.41,0.25673,1,0.8651592276422765,1.47,MF
GO:0018024,histone-lysine N-methyltransferase activ...,44,2,0.99,0.25984,1,0.8720945748987854,2.02,MF
GO:0001784,phosphotyrosine residue binding,45,2,1.01,0.26820,1,0.8965233870967741,1.98,MF
GO:0030165,PDZ domain binding,118,4,2.65,0.27386,1,0.911766827309237,1.51,MF
GO:0015485,cholesterol binding,47,2,1.06,0.28493,1,0.941063625498008,1.89,MF
GO:0016879,"ligase activity, forming carbon-nitrogen...",47,2,1.06,0.28493,1,0.941063625498008,1.89,MF
GO:0005085,guanyl-nucleotide exchange factor activi...,198,6,4.45,0.28651,1,0.9425269444444444,1.35,MF
GO:0005246,calcium channel regulator activity,48,2,1.08,0.29327,1,0.9555281568627452,1.85,MF
GO:0015459,potassium channel regulator activity,48,2,1.08,0.29327,1,0.9555281568627452,1.85,MF
GO:0042826,histone deacetylase binding,122,4,2.74,0.29392,1,0.9555281568627452,1.46,MF
GO:0019209,kinase activator activity,85,3,1.91,0.29838,1,0.9624786770428015,1.57,MF
GO:0043178,alcohol binding,85,3,1.91,0.29838,1,0.9624786770428015,1.57,MF
GO:0000287,magnesium ion binding,202,6,4.54,0.30206,1,0.9672619540229886,1.32,MF
GO:0033218,amide binding,364,10,8.18,0.30321,1,0.9672619540229886,1.22,MF
GO:0008013,beta-catenin binding,86,3,1.93,0.30453,1,0.9672619540229886,1.55,MF
GO:0008276,protein methyltransferase activity,86,3,1.93,0.30453,1,0.9672619540229886,1.55,MF
GO:0001221,transcription cofactor binding,51,2,1.15,0.31823,1,1,1.74,MF
GO:0035258,steroid hormone receptor binding,89,3,2,0.32301,1,1,1.5,MF
GO:0008235,metalloexopeptidase activity,53,2,1.19,0.33475,1,1,1.68,MF
GO:0032934,sterol binding,53,2,1.19,0.33475,1,1,1.68,MF
GO:0043565,sequence-specific DNA binding,1145,28,25.72,0.34794,1,1,1.09,MF
GO:0001102,RNA polymerase II activating transcripti...,55,2,1.24,0.35115,1,1,1.61,MF
GO:0031593,polyubiquitin modification-dependent pro...,55,2,1.24,0.35115,1,1,1.61,MF
GO:0016278,lysine N-methyltransferase activity,56,2,1.26,0.35930,1,1,1.59,MF
GO:0016279,protein-lysine N-methyltransferase activ...,56,2,1.26,0.35930,1,1,1.59,MF
GO:0003727,single-stranded RNA binding,95,3,2.13,0.35993,1,1,1.41,MF
GO:0003730,mRNA 3'-UTR binding,95,3,2.13,0.35993,1,1,1.41,MF
GO:0015278,calcium-release channel activity,20,1,0.45,0.36526,1,1,2.22,MF
GO:0035014,phosphatidylinositol 3-kinase regulator ...,20,1,0.45,0.36526,1,1,2.22,MF
GO:0043274,phospholipase binding,20,1,0.45,0.36526,1,1,2.22,MF
GO:0070300,phosphatidic acid binding,20,1,0.45,0.36526,1,1,2.22,MF
GO:0008237,metallopeptidase activity,177,5,3.98,0.36626,1,1,1.26,MF
GO:0042054,histone methyltransferase activity,57,2,1.28,0.36741,1,1,1.56,MF
GO:0008327,methyl-CpG binding,21,1,0.47,0.37953,1,1,2.13,MF
GO:0008569,ATP-dependent microtubule motor activity...,21,1,0.47,0.37953,1,1,2.13,MF
GO:0050431,transforming growth factor beta binding,21,1,0.47,0.37953,1,1,2.13,MF
GO:0051428,peptide hormone receptor binding,21,1,0.47,0.37953,1,1,2.13,MF
GO:0004714,transmembrane receptor protein tyrosine ...,59,2,1.33,0.38351,1,1,1.5,MF
GO:0051087,chaperone binding,100,3,2.25,0.39048,1,1,1.33,MF
GO:0001223,transcription coactivator binding,22,1,0.49,0.39348,1,1,2.04,MF
GO:0030215,semaphorin receptor binding,22,1,0.49,0.39348,1,1,2.04,MF
GO:0044183,protein binding involved in protein fold...,22,1,0.49,0.39348,1,1,2.04,MF
GO:0004222,metalloendopeptidase activity,101,3,2.27,0.39655,1,1,1.32,MF
GO:0001540,amyloid-beta binding,61,2,1.37,0.39943,1,1,1.46,MF
GO:0017025,TBP-class protein binding,23,1,0.52,0.40711,1,1,1.92,MF
GO:0017056,structural constituent of nuclear pore,23,1,0.52,0.40711,1,1,1.92,MF
GO:0031492,nucleosomal DNA binding,23,1,0.52,0.40711,1,1,1.92,MF
GO:0090079,"translation regulator activity, nucleic ...",23,1,0.52,0.40711,1,1,1.92,MF
GO:0005080,protein kinase C binding,62,2,1.39,0.40732,1,1,1.44,MF
GO:1990782,protein tyrosine kinase binding,103,3,2.31,0.40864,1,1,1.3,MF
GO:0051287,NAD binding,63,2,1.41,0.41515,1,1,1.42,MF
GO:0015026,coreceptor activity,24,1,0.54,0.42044,1,1,1.85,MF
GO:0015491,cation:cation antiporter activity,24,1,0.54,0.42044,1,1,1.85,MF
GO:0070851,growth factor receptor binding,148,4,3.32,0.42602,1,1,1.2,MF
GO:0140097,"catalytic activity, acting on DNA",191,5,4.29,0.42848,1,1,1.17,MF
GO:0005496,steroid binding,107,3,2.4,0.43259,1,1,1.25,MF
GO:0004181,metallocarboxypeptidase activity,25,1,0.56,0.43347,1,1,1.79,MF
GO:0005212,structural constituent of eye lens,25,1,0.56,0.43347,1,1,1.79,MF
GO:0008307,structural constituent of muscle,25,1,0.56,0.43347,1,1,1.79,MF
GO:0016722,"oxidoreductase activity, oxidizing metal...",25,1,0.56,0.43347,1,1,1.79,MF
GO:0030371,translation repressor activity,25,1,0.56,0.43347,1,1,1.79,MF
GO:0030742,GTP-dependent protein binding,25,1,0.56,0.43347,1,1,1.79,MF
GO:0031210,phosphatidylcholine binding,25,1,0.56,0.43347,1,1,1.79,MF
GO:0050997,quaternary ammonium group binding,25,1,0.56,0.43347,1,1,1.79,MF
GO:0070412,R-SMAD binding,25,1,0.56,0.43347,1,1,1.79,MF
GO:0000062,fatty-acyl-CoA binding,26,1,0.58,0.44621,1,1,1.72,MF
GO:0004709,MAP kinase kinase kinase activity,26,1,0.58,0.44621,1,1,1.72,MF
GO:0005104,fibroblast growth factor receptor bindin...,26,1,0.58,0.44621,1,1,1.72,MF
GO:0016878,acid-thiol ligase activity,26,1,0.58,0.44621,1,1,1.72,MF
GO:0017134,fibroblast growth factor binding,26,1,0.58,0.44621,1,1,1.72,MF
GO:0046625,sphingolipid binding,26,1,0.58,0.44621,1,1,1.72,MF
GO:0099604,ligand-gated calcium channel activity,26,1,0.58,0.44621,1,1,1.72,MF
GO:0003785,actin monomer binding,27,1,0.61,0.45867,1,1,1.64,MF
GO:0008143,poly(A) binding,27,1,0.61,0.45867,1,1,1.64,MF
GO:0017075,syntaxin-1 binding,27,1,0.61,0.45867,1,1,1.64,MF
GO:0019239,deaminase activity,27,1,0.61,0.45867,1,1,1.64,MF
GO:0031435,mitogen-activated protein kinase kinase ...,27,1,0.61,0.45867,1,1,1.64,MF
GO:0033293,monocarboxylic acid binding,69,2,1.55,0.46103,1,1,1.29,MF
GO:0001530,lipopolysaccharide binding,28,1,0.63,0.47084,1,1,1.59,MF
GO:0005520,insulin-like growth factor binding,28,1,0.63,0.47084,1,1,1.59,MF
GO:0045499,chemorepellent activity,28,1,0.63,0.47084,1,1,1.59,MF
GO:0008266,poly(U) RNA binding,29,1,0.65,0.48274,1,1,1.54,MF
GO:0015298,solute:cation antiporter activity,29,1,0.65,0.48274,1,1,1.54,MF
GO:0019706,protein-cysteine S-palmitoyltransferase ...,29,1,0.65,0.48274,1,1,1.54,MF
GO:0019707,protein-cysteine S-acyltransferase activ...,29,1,0.65,0.48274,1,1,1.54,MF
GO:0030291,protein serine/threonine kinase inhibito...,29,1,0.65,0.48274,1,1,1.54,MF
GO:0035198,miRNA binding,29,1,0.65,0.48274,1,1,1.54,MF
GO:0071813,lipoprotein particle binding,29,1,0.65,0.48274,1,1,1.54,MF
GO:0071814,protein-lipid complex binding,29,1,0.65,0.48274,1,1,1.54,MF
GO:0071889,14-3-3 protein binding,29,1,0.65,0.48274,1,1,1.54,MF
GO:0120013,intermembrane lipid transfer activity,29,1,0.65,0.48274,1,1,1.54,MF
GO:0009055,electron transfer activity,72,2,1.62,0.48317,1,1,1.23,MF
GO:0004857,enzyme inhibitor activity,381,9,8.56,0.48631,1,1,1.05,MF
GO:0017022,myosin binding,75,2,1.68,0.50473,1,1,1.19,MF
GO:0042277,peptide binding,298,7,6.69,0.50561,1,1,1.05,MF
GO:0050699,WW domain binding,31,1,0.7,0.50575,1,1,1.43,MF
GO:0019199,transmembrane receptor protein kinase ac...,76,2,1.71,0.51179,1,1,1.17,MF
GO:0015078,proton transmembrane transporter activit...,121,3,2.72,0.51318,1,1,1.1,MF
GO:0005217,intracellular ligand-gated ion channel a...,32,1,0.72,0.51687,1,1,1.39,MF
GO:0008198,ferrous iron binding,32,1,0.72,0.51687,1,1,1.39,MF
GO:0005506,iron ion binding,167,4,3.75,0.51878,1,1,1.07,MF
GO:0005484,SNAP receptor activity,33,1,0.74,0.52773,1,1,1.35,MF
GO:0016417,S-acyltransferase activity,33,1,0.74,0.52773,1,1,1.35,MF
GO:0019956,chemokine binding,33,1,0.74,0.52773,1,1,1.35,MF
GO:0030295,protein kinase activator activity,79,2,1.77,0.53257,1,1,1.13,MF
GO:0017137,Rab GTPase binding,170,4,3.82,0.53280,1,1,1.05,MF
GO:0008187,poly-pyrimidine tract binding,34,1,0.76,0.53836,1,1,1.32,MF
GO:0016831,carboxy-lyase activity,34,1,0.76,0.53836,1,1,1.32,MF
GO:0001965,G-protein alpha-subunit binding,35,1,0.79,0.54874,1,1,1.27,MF
GO:0070717,poly-purine tract binding,35,1,0.79,0.54874,1,1,1.27,MF
GO:1901567,fatty acid derivative binding,35,1,0.79,0.54874,1,1,1.27,MF
GO:0016811,"hydrolase activity, acting on carbon-nit...",82,2,1.84,0.55273,1,1,1.09,MF
GO:0004721,phosphoprotein phosphatase activity,175,4,3.93,0.55571,1,1,1.02,MF
GO:0030246,carbohydrate binding,269,6,6.04,0.56396,1,1,0.99,MF
GO:0016651,"oxidoreductase activity, acting on NAD(P...",84,2,1.89,0.56583,1,1,1.06,MF
GO:0038024,cargo receptor activity,84,2,1.89,0.56583,1,1,1.06,MF
GO:0017124,SH3 domain binding,131,3,2.94,0.56687,1,1,1.02,MF
GO:0016877,"ligase activity, forming carbon-sulfur b...",37,1,0.83,0.56882,1,1,1.2,MF
GO:0051393,alpha-actinin binding,37,1,0.83,0.56882,1,1,1.2,MF
GO:0071949,FAD binding,37,1,0.83,0.56882,1,1,1.2,MF
GO:0016209,antioxidant activity,85,2,1.91,0.57227,1,1,1.05,MF
GO:0050660,flavin adenine dinucleotide binding,85,2,1.91,0.57227,1,1,1.05,MF
GO:0016810,"hydrolase activity, acting on carbon-nit...",133,3,2.99,0.57716,1,1,1,MF
GO:0000979,RNA polymerase II core promoter sequence...,38,1,0.85,0.57852,1,1,1.18,MF
GO:0017112,Rab guanyl-nucleotide exchange factor ac...,38,1,0.85,0.57852,1,1,1.18,MF
GO:0043014,alpha-tubulin binding,38,1,0.85,0.57852,1,1,1.18,MF
GO:0046332,SMAD binding,86,2,1.93,0.57865,1,1,1.04,MF
GO:0016409,palmitoyltransferase activity,39,1,0.88,0.58801,1,1,1.14,MF
GO:0042169,SH2 domain binding,39,1,0.88,0.58801,1,1,1.14,MF
GO:0051427,hormone receptor binding,183,4,4.11,0.59107,1,1,0.97,MF
GO:0008170,N-methyltransferase activity,88,2,1.98,0.59119,1,1,1.01,MF
GO:0035064,methylated histone binding,88,2,1.98,0.59119,1,1,1.01,MF
GO:0140034,methylation-dependent protein binding,88,2,1.98,0.59119,1,1,1.01,MF
GO:0004520,endodeoxyribonuclease activity,40,1,0.9,0.59728,1,1,1.11,MF
GO:0060590,ATPase regulator activity,40,1,0.9,0.59728,1,1,1.11,MF
GO:0015085,calcium ion transmembrane transporter ac...,140,3,3.14,0.61196,1,1,0.96,MF
GO:0004180,carboxypeptidase activity,42,1,0.94,0.61520,1,1,1.06,MF
GO:0016620,"oxidoreductase activity, acting on the a...",42,1,0.94,0.61520,1,1,1.06,MF
GO:0004177,aminopeptidase activity,44,1,0.99,0.63232,1,1,1.01,MF
GO:0015932,nucleobase-containing compound transmemb...,44,1,0.99,0.63232,1,1,1.01,MF
GO:0001227,DNA-binding transcription repressor acti...,241,5,5.41,0.63261,1,1,0.92,MF
GO:0031490,chromatin DNA binding,96,2,2.16,0.63855,1,1,0.93,MF
GO:0019838,growth factor binding,146,3,3.28,0.64022,1,1,0.91,MF
GO:0005504,fatty acid binding,45,1,1.01,0.64060,1,1,0.99,MF
GO:0008083,growth factor activity,147,3,3.3,0.64479,1,1,0.91,MF
GO:0016874,ligase activity,147,3,3.3,0.64479,1,1,0.91,MF
GO:0048020,CCR chemokine receptor binding,46,1,1.03,0.64869,1,1,0.97,MF
GO:0051879,Hsp90 protein binding,46,1,1.03,0.64869,1,1,0.97,MF
GO:0004725,protein tyrosine phosphatase activity,98,2,2.2,0.64970,1,1,0.91,MF
GO:0001664,G protein-coupled receptor binding,296,6,6.65,0.65640,1,1,0.9,MF
GO:0070888,E-box binding,47,1,1.06,0.65660,1,1,0.94,MF
GO:0000980,RNA polymerase II distal enhancer sequen...,100,2,2.25,0.66057,1,1,0.89,MF
GO:0008168,methyltransferase activity,201,4,4.51,0.66425,1,1,0.89,MF
GO:0042805,actinin binding,48,1,1.08,0.66433,1,1,0.93,MF
GO:0050661,NADP binding,48,1,1.08,0.66433,1,1,0.93,MF
GO:0008238,exopeptidase activity,101,2,2.27,0.66591,1,1,0.88,MF
GO:0001046,core promoter sequence-specific DNA bind...,49,1,1.1,0.67188,1,1,0.91,MF
GO:1901681,sulfur compound binding,253,5,5.68,0.67453,1,1,0.88,MF
GO:0035257,nuclear hormone receptor binding,154,3,3.46,0.67560,1,1,0.87,MF
GO:0008408,3'-5' exonuclease activity,50,1,1.12,0.67927,1,1,0.89,MF
GO:0016763,"transferase activity, transferring pento...",50,1,1.12,0.67927,1,1,0.89,MF
GO:0030331,estrogen receptor binding,50,1,1.12,0.67927,1,1,0.89,MF
GO:0003690,double-stranded DNA binding,1014,21,22.77,0.68088,1,1,0.92,MF
GO:0008201,heparin binding,156,3,3.5,0.68404,1,1,0.86,MF
GO:0016830,carbon-carbon lyase activity,51,1,1.15,0.68649,1,1,0.87,MF
GO:1990837,sequence-specific double-stranded DNA bi...,925,19,20.78,0.68860,1,1,0.91,MF
GO:0005245,voltage-gated calcium channel activity,52,1,1.17,0.69355,1,1,0.85,MF
GO:0005548,phospholipid transporter activity,52,1,1.17,0.69355,1,1,0.85,MF
GO:0016903,"oxidoreductase activity, acting on the a...",52,1,1.17,0.69355,1,1,0.85,MF
GO:0017046,peptide hormone binding,52,1,1.17,0.69355,1,1,0.85,MF
GO:0042562,hormone binding,107,2,2.4,0.69650,1,1,0.83,MF
GO:0004860,protein kinase inhibitor activity,53,1,1.19,0.70045,1,1,0.84,MF
GO:0005160,transforming growth factor beta receptor...,54,1,1.21,0.70720,1,1,0.83,MF
GO:0099516,ion antiporter activity,54,1,1.21,0.70720,1,1,0.83,MF
GO:0140098,"catalytic activity, acting on RNA",362,7,8.13,0.70737,1,1,0.86,MF
GO:0016741,"transferase activity, transferring one-c...",213,4,4.78,0.70782,1,1,0.84,MF
GO:0001012,RNA polymerase II regulatory region DNA ...,845,17,18.98,0.71374,1,1,0.9,MF
GO:0003707,steroid hormone receptor activity,55,1,1.24,0.71379,1,1,0.81,MF
GO:0003684,damaged DNA binding,56,1,1.26,0.72023,1,1,0.79,MF
GO:0008146,sulfotransferase activity,56,1,1.26,0.72023,1,1,0.79,MF
GO:0044212,transcription regulatory region DNA bind...,995,20,22.35,0.72734,1,1,0.89,MF
GO:0019210,kinase inhibitor activity,58,1,1.3,0.73269,1,1,0.77,MF
GO:0001067,regulatory region nucleic acid binding,999,20,22.44,0.73372,1,1,0.89,MF
GO:0004536,deoxyribonuclease activity,59,1,1.33,0.73871,1,1,0.75,MF
GO:0030145,manganese ion binding,59,1,1.33,0.73871,1,1,0.75,MF
GO:0000978,RNA polymerase II proximal promoter sequ...,573,11,12.87,0.74337,1,1,0.85,MF
GO:0005507,copper ion binding,60,1,1.35,0.74460,1,1,0.74,MF
GO:0000149,SNARE binding,118,2,2.65,0.74655,1,1,0.75,MF
GO:0001047,core promoter binding,62,1,1.39,0.75598,1,1,0.72,MF
GO:0000049,tRNA binding,63,1,1.41,0.76147,1,1,0.71,MF
GO:0000987,proximal promoter sequence-specific DNA ...,585,11,13.14,0.76674,1,1,0.84,MF
GO:0030374,nuclear receptor transcription coactivat...,64,1,1.44,0.76685,1,1,0.69,MF
GO:0005262,calcium channel activity,123,2,2.76,0.76686,1,1,0.72,MF
GO:0016779,nucleotidyltransferase activity,123,2,2.76,0.76686,1,1,0.72,MF
GO:0004521,endoribonuclease activity,65,1,1.46,0.77210,1,1,0.68,MF
GO:0043621,protein self-association,65,1,1.46,0.77210,1,1,0.68,MF
GO:0000976,transcription regulatory region sequence...,882,17,19.81,0.77483,1,1,0.86,MF
GO:0042379,chemokine receptor binding,66,1,1.48,0.77723,1,1,0.68,MF
GO:0000977,RNA polymerase II regulatory region sequ...,837,16,18.8,0.78006,1,1,0.85,MF
GO:0001158,enhancer sequence-specific DNA binding,127,2,2.85,0.78208,1,1,0.7,MF
GO:0004519,endonuclease activity,129,2,2.9,0.78935,1,1,0.69,MF
GO:0050662,coenzyme binding,295,5,6.63,0.79520,1,1,0.75,MF
GO:0019955,cytokine binding,131,2,2.94,0.79642,1,1,0.68,MF
GO:0004722,protein serine/threonine phosphatase act...,70,1,1.57,0.79664,1,1,0.64,MF
GO:0016597,amino acid binding,72,1,1.62,0.80571,1,1,0.62,MF
GO:0016782,"transferase activity, transferring sulfu...",74,1,1.66,0.81437,1,1,0.6,MF
GO:0070011,"peptidase activity, acting on L-amino ac...",613,11,13.77,0.81541,1,1,0.8,MF
GO:0004527,exonuclease activity,75,1,1.68,0.81855,1,1,0.6,MF
GO:0035326,enhancer binding,138,2,3.1,0.81951,1,1,0.65,MF
GO:0097110,scaffold protein binding,76,1,1.71,0.82264,1,1,0.58,MF
GO:0015297,antiporter activity,78,1,1.75,0.83055,1,1,0.57,MF
GO:0019905,syntaxin binding,79,1,1.77,0.83437,1,1,0.56,MF
GO:0016705,"oxidoreductase activity, acting on paire...",203,3,4.56,0.83749,1,1,0.66,MF
GO:0070405,ammonium ion binding,80,1,1.8,0.83810,1,1,0.56,MF
GO:0008757,S-adenosylmethionine-dependent methyltra...,148,2,3.32,0.84843,1,1,0.6,MF
GO:0016791,phosphatase activity,266,4,5.97,0.85124,1,1,0.67,MF
GO:0005539,glycosaminoglycan binding,210,3,4.72,0.85377,1,1,0.64,MF
GO:0008233,peptidase activity,640,11,14.37,0.85478,1,1,0.77,MF
GO:0031406,carboxylic acid binding,211,3,4.74,0.85598,1,1,0.63,MF
GO:0005126,cytokine receptor binding,330,5,7.41,0.86635,1,1,0.67,MF
GO:0004175,endopeptidase activity,440,7,9.88,0.86787,1,1,0.71,MF
GO:0008081,phosphoric diester hydrolase activity,90,1,2.02,0.87112,1,1,0.5,MF
GO:0043177,organic acid binding,224,3,5.03,0.88210,1,1,0.6,MF
GO:0099094,ligand-gated cation channel activity,99,1,2.22,0.89505,1,1,0.45,MF
GO:0003700,DNA-binding transcription factor activit...,999,17,22.44,0.90758,1,1,0.76,MF
GO:0042578,phosphoric ester hydrolase activity,359,5,8.06,0.90839,1,1,0.62,MF
GO:0140101,"catalytic activity, acting on a tRNA",113,1,2.54,0.92376,1,1,0.39,MF
GO:0004540,ribonuclease activity,116,1,2.61,0.92881,1,1,0.38,MF
GO:0004867,serine-type endopeptidase inhibitor acti...,118,1,2.65,0.93199,1,1,0.38,MF
GO:0004518,nuclease activity,200,2,4.49,0.94130,1,1,0.45,MF
GO:0005179,hormone activity,129,1,2.9,0.94711,1,1,0.34,MF
GO:0015276,ligand-gated ion channel activity,133,1,2.99,0.95173,1,1,0.33,MF
GO:0016616,"oxidoreductase activity, acting on the C...",134,1,3.01,0.95282,1,1,0.33,MF
GO:0030545,receptor regulator activity,527,7,11.84,0.95364,1,1,0.59,MF
GO:0019842,vitamin binding,135,1,3.03,0.95389,1,1,0.33,MF
GO:0005319,lipid transporter activity,136,1,3.05,0.95493,1,1,0.33,MF
GO:0022834,ligand-gated channel activity,136,1,3.05,0.95493,1,1,0.33,MF
GO:0005201,extracellular matrix structural constitu...,141,1,3.17,0.95980,1,1,0.32,MF
GO:0000981,DNA-binding transcription factor activit...,767,11,17.23,0.96027,1,1,0.64,MF
GO:0016614,"oxidoreductase activity, acting on CH-OH...",143,1,3.21,0.96160,1,1,0.31,MF
GO:0052689,carboxylic ester hydrolase activity,143,1,3.21,0.96160,1,1,0.31,MF
GO:0022843,voltage-gated cation channel activity,146,1,3.28,0.96415,1,1,0.3,MF
GO:0048018,receptor ligand activity,492,6,11.05,0.96659,1,1,0.54,MF
GO:0008194,UDP-glycosyltransferase activity,151,1,3.39,0.96802,1,1,0.29,MF
GO:0020037,heme binding,155,1,3.48,0.97082,1,1,0.29,MF
GO:0016491,oxidoreductase activity,796,11,17.88,0.97145,1,1,0.62,MF
GO:0061134,peptidase regulator activity,239,2,5.37,0.97213,1,1,0.37,MF
GO:0001228,DNA-binding transcription activator acti...,443,5,9.95,0.97228,1,1,0.5,MF
GO:0046906,tetrapyrrole binding,164,1,3.68,0.97625,1,1,0.27,MF
GO:0016746,"transferase activity, transferring acyl ...",270,2,6.06,0.98482,1,1,0.33,MF
GO:0016829,lyase activity,185,1,4.16,0.98532,1,1,0.24,MF
GO:0005244,voltage-gated ion channel activity,195,1,4.38,0.98833,1,1,0.23,MF
GO:0022832,voltage-gated channel activity,195,1,4.38,0.98833,1,1,0.23,MF
GO:0004866,endopeptidase inhibitor activity,197,1,4.42,0.98885,1,1,0.23,MF
GO:0015077,monovalent inorganic cation transmembran...,363,3,8.15,0.98894,1,1,0.37,MF
GO:0061135,endopeptidase regulator activity,204,1,4.58,0.99051,1,1,0.22,MF
GO:0030414,peptidase inhibitor activity,208,1,4.67,0.99134,1,1,0.21,MF
GO:0005125,cytokine activity,217,1,4.87,0.99295,1,1,0.21,MF
GO:0005261,cation channel activity,317,2,7.12,0.99408,1,1,0.28,MF
GO:0048037,cofactor binding,542,5,12.17,0.99417,1,1,0.41,MF
GO:0016788,"hydrolase activity, acting on ester bond...",741,8,16.64,0.99433,1,1,0.48,MF
GO:0022839,ion gated channel activity,323,2,7.25,0.99475,1,1,0.28,MF
GO:0015291,secondary active transmembrane transport...,235,1,5.28,0.99534,1,1,0.19,MF
GO:0016747,"transferase activity, transferring acyl ...",236,1,5.3,0.99545,1,1,0.19,MF
GO:0022836,gated channel activity,335,2,7.52,0.99589,1,1,0.27,MF
GO:0022890,inorganic cation transmembrane transport...,575,5,12.91,0.99663,1,1,0.39,MF
GO:0046873,metal ion transmembrane transporter acti...,433,3,9.73,0.99698,1,1,0.31,MF
GO:0016757,"transferase activity, transferring glyco...",278,1,6.24,0.99827,1,1,0.16,MF
GO:0008324,cation transmembrane transporter activit...,627,5,14.08,0.99861,1,1,0.36,MF
GO:0005216,ion channel activity,407,2,9.14,0.99907,1,1,0.22,MF
GO:0022838,substrate-specific channel activity,420,2,9.43,0.99929,1,1,0.21,MF
GO:0015267,channel activity,444,2,9.97,0.99957,1,1,0.2,MF
GO:0022803,passive transmembrane transporter activi...,444,2,9.97,0.99957,1,1,0.2,MF
GO:0022804,active transmembrane transporter activit...,355,1,7.97,0.99971,1,1,0.13,MF
GO:0015318,inorganic molecular entity transmembrane...,796,5,17.88,0.99993,1,1,0.28,MF
GO:0015075,ion transmembrane transporter activity,855,5,19.2,0.99998,1,1,0.26,MF
GO:0022857,transmembrane transporter activity,1013,6,22.75,0.99999,1,1,0.26,MF
GO:0005215,transporter activity,1099,7,24.68,1.00000,1,1,0.28,MF
GO:0004930,G protein-coupled receptor activity,750,1,16.85,1.00000,1,1,0.06,MF
GO:0060089,molecular transducer activity,2344,12,52.65,1.00000,1,1,0.23,MF
GO:0038023,signaling receptor activity,2295,9,51.55,1.00000,1,1,0.17,MF
GO:0003674,molecular_function,20837,468,468,1.00000,1,1,1,MF
GO:0004888,transmembrane signaling receptor activit...,2107,5,47.32,1.00000,1,1,0.11,MF
GO:0000030,mannosyltransferase activity,26,0,0.58,1.00000,1,1,0,MF
GO:0000175,3'-5'-exoribonuclease activity,29,0,0.65,1.00000,1,1,0,MF
GO:0000217,DNA secondary structure binding,25,0,0.56,1.00000,1,1,0,MF
GO:0001091,RNA polymerase II basal transcription fa...,22,0,0.49,1.00000,1,1,0,MF
GO:0001222,transcription corepressor binding,20,0,0.45,1.00000,1,1,0,MF
GO:0001614,purinergic nucleotide receptor activity,20,0,0.45,1.00000,1,1,0,MF
GO:0001618,virus receptor activity,20,0,0.45,1.00000,1,1,0,MF
GO:0001637,G protein-coupled chemoattractant recept...,25,0,0.56,1.00000,1,1,0,MF
GO:0001653,peptide receptor activity,149,0,3.35,1.00000,1,1,0,MF
GO:0001671,ATPase activator activity,26,0,0.58,1.00000,1,1,0,MF
GO:0001786,phosphatidylserine binding,63,0,1.41,1.00000,1,1,0,MF
GO:0001848,complement binding,22,0,0.49,1.00000,1,1,0,MF
GO:0001871,pattern binding,21,0,0.47,1.00000,1,1,0,MF
GO:0003823,antigen binding,57,0,1.28,1.00000,1,1,0,MF
GO:0003887,DNA-directed DNA polymerase activity,27,0,0.61,1.00000,1,1,0,MF
GO:0003950,NAD+ ADP-ribosyltransferase activity,23,0,0.52,1.00000,1,1,0,MF
GO:0003954,NADH dehydrogenase activity,29,0,0.65,1.00000,1,1,0,MF
GO:0004033,aldo-keto reductase (NADP) activity,28,0,0.63,1.00000,1,1,0,MF
GO:0004112,cyclic-nucleotide phosphodiesterase acti...,31,0,0.7,1.00000,1,1,0,MF
GO:0004114,"3',5'-cyclic-nucleotide phosphodiesteras...",30,0,0.67,1.00000,1,1,0,MF
GO:0004190,aspartic-type endopeptidase activity,29,0,0.65,1.00000,1,1,0,MF
GO:0004252,serine-type endopeptidase activity,181,0,4.07,1.00000,1,1,0,MF
GO:0004298,threonine-type endopeptidase activity,21,0,0.47,1.00000,1,1,0,MF
GO:0004364,glutathione transferase activity,34,0,0.76,1.00000,1,1,0,MF
GO:0004402,histone acetyltransferase activity,65,0,1.46,1.00000,1,1,0,MF
GO:0004497,monooxygenase activity,141,0,3.17,1.00000,1,1,0,MF
GO:0004529,exodeoxyribonuclease activity,25,0,0.56,1.00000,1,1,0,MF
GO:0004532,exoribonuclease activity,32,0,0.72,1.00000,1,1,0,MF
GO:0004553,"hydrolase activity, hydrolyzing O-glycos...",100,0,2.25,1.00000,1,1,0,MF
GO:0004601,peroxidase activity,52,0,1.17,1.00000,1,1,0,MF
GO:0004602,glutathione peroxidase activity,22,0,0.49,1.00000,1,1,0,MF
GO:0004620,phospholipase activity,89,0,2,1.00000,1,1,0,MF
GO:0004623,phospholipase A2 activity,31,0,0.7,1.00000,1,1,0,MF
GO:0004683,calmodulin-dependent protein kinase acti...,27,0,0.61,1.00000,1,1,0,MF
GO:0004745,retinol dehydrogenase activity,21,0,0.47,1.00000,1,1,0,MF
GO:0004806,triglyceride lipase activity,27,0,0.61,1.00000,1,1,0,MF
GO:0004812,aminoacyl-tRNA ligase activity,41,0,0.92,1.00000,1,1,0,MF
GO:0004869,cysteine-type endopeptidase inhibitor ac...,68,0,1.53,1.00000,1,1,0,MF
GO:0004879,nuclear receptor activity,40,0,0.9,1.00000,1,1,0,MF
GO:0004896,cytokine receptor activity,98,0,2.2,1.00000,1,1,0,MF
GO:0004950,chemokine receptor activity,25,0,0.56,1.00000,1,1,0,MF
GO:0004984,olfactory receptor activity,1110,0,24.93,1.00000,1,1,0,MF
GO:0004993,G protein-coupled serotonin receptor act...,39,0,0.88,1.00000,1,1,0,MF
GO:0005044,scavenger receptor activity,45,0,1.01,1.00000,1,1,0,MF
GO:0005048,signal sequence binding,39,0,0.88,1.00000,1,1,0,MF
GO:0005109,frizzled binding,43,0,0.97,1.00000,1,1,0,MF
GO:0005112,Notch binding,25,0,0.56,1.00000,1,1,0,MF
GO:0005132,type I interferon receptor binding,24,0,0.54,1.00000,1,1,0,MF
GO:0005148,prolactin receptor binding,27,0,0.61,1.00000,1,1,0,MF
GO:0005184,neuropeptide hormone activity,25,0,0.56,1.00000,1,1,0,MF
GO:0005227,calcium activated cation channel activit...,29,0,0.65,1.00000,1,1,0,MF
GO:0005230,extracellular ligand-gated ion channel a...,71,0,1.59,1.00000,1,1,0,MF
GO:0005231,excitatory extracellular ligand-gated io...,36,0,0.81,1.00000,1,1,0,MF
GO:0005242,inward rectifier potassium channel activ...,20,0,0.45,1.00000,1,1,0,MF
GO:0005248,voltage-gated sodium channel activity,21,0,0.47,1.00000,1,1,0,MF
GO:0005249,voltage-gated potassium channel activity,86,0,1.93,1.00000,1,1,0,MF
GO:0005251,delayed rectifier potassium channel acti...,30,0,0.67,1.00000,1,1,0,MF
GO:0005253,anion channel activity,80,0,1.8,1.00000,1,1,0,MF
GO:0005254,chloride channel activity,69,0,1.55,1.00000,1,1,0,MF
GO:0005267,potassium channel activity,123,0,2.76,1.00000,1,1,0,MF
GO:0005272,sodium channel activity,40,0,0.9,1.00000,1,1,0,MF
GO:0005310,dicarboxylic acid transmembrane transpor...,36,0,0.81,1.00000,1,1,0,MF
GO:0005326,neurotransmitter transporter activity,50,0,1.12,1.00000,1,1,0,MF
GO:0005328,neurotransmitter:sodium symporter activi...,26,0,0.58,1.00000,1,1,0,MF
GO:0005342,organic acid transmembrane transporter a...,150,0,3.37,1.00000,1,1,0,MF
GO:0005343,organic acid:sodium symporter activity,25,0,0.56,1.00000,1,1,0,MF
GO:0005355,glucose transmembrane transporter activi...,23,0,0.52,1.00000,1,1,0,MF
GO:0005385,zinc ion transmembrane transporter activ...,22,0,0.49,1.00000,1,1,0,MF
GO:0005402,carbohydrate:cation symporter activity,20,0,0.45,1.00000,1,1,0,MF
GO:0005501,retinoid binding,32,0,0.72,1.00000,1,1,0,MF
GO:0005537,mannose binding,26,0,0.58,1.00000,1,1,0,MF
GO:0005540,hyaluronic acid binding,21,0,0.47,1.00000,1,1,0,MF
GO:0005544,calcium-dependent phospholipid binding,54,0,1.21,1.00000,1,1,0,MF
GO:0005549,odorant binding,578,0,12.98,1.00000,1,1,0,MF
GO:0005550,pheromone binding,216,0,4.85,1.00000,1,1,0,MF
GO:0008009,chemokine activity,43,0,0.97,1.00000,1,1,0,MF
GO:0008028,monocarboxylic acid transmembrane transp...,52,0,1.17,1.00000,1,1,0,MF
GO:0008066,glutamate receptor activity,27,0,0.61,1.00000,1,1,0,MF
GO:0008080,N-acetyltransferase activity,94,0,2.11,1.00000,1,1,0,MF
GO:0008106,alcohol dehydrogenase (NADP+) activity,25,0,0.56,1.00000,1,1,0,MF
GO:0008137,NADH dehydrogenase (ubiquinone) activity,26,0,0.58,1.00000,1,1,0,MF
GO:0008138,protein tyrosine/serine/threonine phosph...,40,0,0.9,1.00000,1,1,0,MF
GO:0008171,O-methyltransferase activity,25,0,0.56,1.00000,1,1,0,MF
GO:0008173,RNA methyltransferase activity,63,0,1.41,1.00000,1,1,0,MF
GO:0008175,tRNA methyltransferase activity,32,0,0.72,1.00000,1,1,0,MF
GO:0008188,neuropeptide receptor activity,45,0,1.01,1.00000,1,1,0,MF
GO:0008227,G protein-coupled amine receptor activit...,72,0,1.62,1.00000,1,1,0,MF
GO:0008236,serine-type peptidase activity,203,0,4.56,1.00000,1,1,0,MF
GO:0008373,sialyltransferase activity,21,0,0.47,1.00000,1,1,0,MF
GO:0008374,O-acyltransferase activity,43,0,0.97,1.00000,1,1,0,MF
GO:0008375,acetylglucosaminyltransferase activity,56,0,1.26,1.00000,1,1,0,MF
GO:0008376,acetylgalactosaminyltransferase activity,44,0,0.99,1.00000,1,1,0,MF
GO:0008378,galactosyltransferase activity,36,0,0.81,1.00000,1,1,0,MF
GO:0008391,arachidonic acid monooxygenase activity,38,0,0.85,1.00000,1,1,0,MF
GO:0008392,arachidonic acid epoxygenase activity,34,0,0.76,1.00000,1,1,0,MF
GO:0008395,steroid hydroxylase activity,73,0,1.64,1.00000,1,1,0,MF
GO:0008483,transaminase activity,22,0,0.49,1.00000,1,1,0,MF
GO:0008509,anion transmembrane transporter activity,313,0,7.03,1.00000,1,1,0,MF
GO:0008514,organic anion transmembrane transporter ...,210,0,4.72,1.00000,1,1,0,MF
GO:0008519,ammonium transmembrane transporter activ...,32,0,0.72,1.00000,1,1,0,MF
GO:0008527,taste receptor activity,36,0,0.81,1.00000,1,1,0,MF
GO:0008528,G protein-coupled peptide receptor activ...,140,0,3.14,1.00000,1,1,0,MF
GO:0008536,Ran GTPase binding,38,0,0.85,1.00000,1,1,0,MF
GO:0008553,"proton-exporting ATPase activity, phosph...",20,0,0.45,1.00000,1,1,0,MF
GO:0009975,cyclase activity,25,0,0.56,1.00000,1,1,0,MF
GO:0010485,H4 histone acetyltransferase activity,23,0,0.52,1.00000,1,1,0,MF
GO:0015020,glucuronosyltransferase activity,33,0,0.74,1.00000,1,1,0,MF
GO:0015036,disulfide oxidoreductase activity,42,0,0.94,1.00000,1,1,0,MF
GO:0015079,potassium ion transmembrane transporter ...,159,0,3.57,1.00000,1,1,0,MF
GO:0015081,sodium ion transmembrane transporter act...,143,0,3.21,1.00000,1,1,0,MF
GO:0015101,organic cation transmembrane transporter...,23,0,0.52,1.00000,1,1,0,MF
GO:0015103,inorganic anion transmembrane transporte...,132,0,2.96,1.00000,1,1,0,MF
GO:0015106,bicarbonate transmembrane transporter ac...,20,0,0.45,1.00000,1,1,0,MF
GO:0015108,chloride transmembrane transporter activ...,96,0,2.16,1.00000,1,1,0,MF
GO:0015125,bile acid transmembrane transporter acti...,20,0,0.45,1.00000,1,1,0,MF
GO:0015144,carbohydrate transmembrane transporter a...,38,0,0.85,1.00000,1,1,0,MF
GO:0015145,monosaccharide transmembrane transporter...,25,0,0.56,1.00000,1,1,0,MF
GO:0015149,hexose transmembrane transporter activit...,23,0,0.52,1.00000,1,1,0,MF
GO:0015171,amino acid transmembrane transporter act...,75,0,1.68,1.00000,1,1,0,MF
GO:0015175,neutral amino acid transmembrane transpo...,32,0,0.72,1.00000,1,1,0,MF
GO:0015179,L-amino acid transmembrane transporter a...,57,0,1.28,1.00000,1,1,0,MF
GO:0015238,drug transmembrane transporter activity,89,0,2,1.00000,1,1,0,MF
GO:0015248,sterol transporter activity,31,0,0.7,1.00000,1,1,0,MF
GO:0015293,symporter activity,145,0,3.26,1.00000,1,1,0,MF
GO:0015294,solute:cation symporter activity,99,0,2.22,1.00000,1,1,0,MF
GO:0015295,solute:proton symporter activity,22,0,0.49,1.00000,1,1,0,MF
GO:0015301,anion:anion antiporter activity,29,0,0.65,1.00000,1,1,0,MF
GO:0015370,solute:sodium symporter activity,70,0,1.57,1.00000,1,1,0,MF
GO:0015399,primary active transmembrane transporter...,119,0,2.67,1.00000,1,1,0,MF
GO:0015405,P-P-bond-hydrolysis-driven transmembrane...,118,0,2.65,1.00000,1,1,0,MF
GO:0015464,acetylcholine receptor activity,22,0,0.49,1.00000,1,1,0,MF
GO:0015605,organophosphate ester transmembrane tran...,27,0,0.61,1.00000,1,1,0,MF
GO:0015662,"ATPase activity, coupled to transmembran...",39,0,0.88,1.00000,1,1,0,MF
GO:0016229,steroid dehydrogenase activity,45,0,1.01,1.00000,1,1,0,MF
GO:0016289,CoA hydrolase activity,27,0,0.61,1.00000,1,1,0,MF
GO:0016298,lipase activity,122,0,2.74,1.00000,1,1,0,MF
GO:0016405,CoA-ligase activity,23,0,0.52,1.00000,1,1,0,MF
GO:0016407,acetyltransferase activity,117,0,2.63,1.00000,1,1,0,MF
GO:0016408,C-acyltransferase activity,22,0,0.49,1.00000,1,1,0,MF
GO:0016410,N-acyltransferase activity,115,0,2.58,1.00000,1,1,0,MF
GO:0016493,C-C chemokine receptor activity,24,0,0.54,1.00000,1,1,0,MF
GO:0016502,nucleotide receptor activity,20,0,0.45,1.00000,1,1,0,MF
GO:0016503,pheromone receptor activity,99,0,2.22,1.00000,1,1,0,MF
GO:0016627,"oxidoreductase activity, acting on the C...",56,0,1.26,1.00000,1,1,0,MF
GO:0016628,"oxidoreductase activity, acting on the C...",24,0,0.54,1.00000,1,1,0,MF
GO:0016638,"oxidoreductase activity, acting on the C...",24,0,0.54,1.00000,1,1,0,MF
GO:0016641,"oxidoreductase activity, acting on the C...",21,0,0.47,1.00000,1,1,0,MF
GO:0016645,"oxidoreductase activity, acting on the C...",28,0,0.63,1.00000,1,1,0,MF
GO:0016655,"oxidoreductase activity, acting on NAD(P...",37,0,0.83,1.00000,1,1,0,MF
GO:0016667,"oxidoreductase activity, acting on a sul...",57,0,1.28,1.00000,1,1,0,MF
GO:0016684,"oxidoreductase activity, acting on perox...",56,0,1.26,1.00000,1,1,0,MF
GO:0016701,"oxidoreductase activity, acting on singl...",31,0,0.7,1.00000,1,1,0,MF
GO:0016702,"oxidoreductase activity, acting on singl...",30,0,0.67,1.00000,1,1,0,MF
GO:0016706,"oxidoreductase activity, acting on paire...",45,0,1.01,1.00000,1,1,0,MF
GO:0016709,"oxidoreductase activity, acting on paire...",45,0,1.01,1.00000,1,1,0,MF
GO:0016712,"oxidoreductase activity, acting on paire...",61,0,1.37,1.00000,1,1,0,MF
GO:0016725,"oxidoreductase activity, acting on CH or...",23,0,0.52,1.00000,1,1,0,MF
GO:0016758,"transferase activity, transferring hexos...",209,0,4.69,1.00000,1,1,0,MF
GO:0016765,"transferase activity, transferring alkyl...",64,0,1.44,1.00000,1,1,0,MF
GO:0016769,"transferase activity, transferring nitro...",25,0,0.56,1.00000,1,1,0,MF
GO:0016790,thiolester hydrolase activity,46,0,1.03,1.00000,1,1,0,MF
GO:0016796,"exonuclease activity, active with either...",52,0,1.17,1.00000,1,1,0,MF
GO:0016798,"hydrolase activity, acting on glycosyl b...",125,0,2.81,1.00000,1,1,0,MF
GO:0016799,"hydrolase activity, hydrolyzing N-glycos...",22,0,0.49,1.00000,1,1,0,MF
GO:0016814,"hydrolase activity, acting on carbon-nit...",29,0,0.65,1.00000,1,1,0,MF
GO:0016835,carbon-oxygen lyase activity,67,0,1.5,1.00000,1,1,0,MF
GO:0016836,hydro-lyase activity,55,0,1.24,1.00000,1,1,0,MF
GO:0016849,phosphorus-oxygen lyase activity,25,0,0.56,1.00000,1,1,0,MF
GO:0016860,intramolecular oxidoreductase activity,46,0,1.03,1.00000,1,1,0,MF
GO:0016866,intramolecular transferase activity,27,0,0.61,1.00000,1,1,0,MF
GO:0016875,"ligase activity, forming carbon-oxygen b...",41,0,0.92,1.00000,1,1,0,MF
GO:0016891,"endoribonuclease activity, producing 5'-...",28,0,0.63,1.00000,1,1,0,MF
GO:0016893,"endonuclease activity, active with eithe...",40,0,0.9,1.00000,1,1,0,MF
GO:0016895,"exodeoxyribonuclease activity, producing...",23,0,0.52,1.00000,1,1,0,MF
GO:0016896,"exoribonuclease activity, producing 5'-p...",31,0,0.7,1.00000,1,1,0,MF
GO:0016917,GABA receptor activity,22,0,0.49,1.00000,1,1,0,MF
GO:0016922,nuclear receptor binding,26,0,0.58,1.00000,1,1,0,MF
GO:0017069,snRNA binding,39,0,0.88,1.00000,1,1,0,MF
GO:0017080,sodium channel regulator activity,33,0,0.74,1.00000,1,1,0,MF
GO:0017091,AU-rich element binding,31,0,0.7,1.00000,1,1,0,MF
GO:0017127,cholesterol transporter activity,20,0,0.45,1.00000,1,1,0,MF
GO:0017147,Wnt-protein binding,38,0,0.85,1.00000,1,1,0,MF
GO:0017171,serine hydrolase activity,208,0,4.67,1.00000,1,1,0,MF
GO:0019200,carbohydrate kinase activity,21,0,0.47,1.00000,1,1,0,MF
GO:0019789,SUMO transferase activity,22,0,0.49,1.00000,1,1,0,MF
GO:0019825,oxygen binding,23,0,0.52,1.00000,1,1,0,MF
GO:0019829,cation-transporting ATPase activity,61,0,1.37,1.00000,1,1,0,MF
GO:0019840,isoprenoid binding,38,0,0.85,1.00000,1,1,0,MF
GO:0019865,immunoglobulin binding,22,0,0.49,1.00000,1,1,0,MF
GO:0019957,C-C chemokine binding,25,0,0.56,1.00000,1,1,0,MF
GO:0022824,transmitter-gated ion channel activity,58,0,1.3,1.00000,1,1,0,MF
GO:0022829,wide pore channel activity,22,0,0.49,1.00000,1,1,0,MF
GO:0022835,transmitter-gated channel activity,58,0,1.3,1.00000,1,1,0,MF
GO:0022853,active ion transmembrane transporter act...,61,0,1.37,1.00000,1,1,0,MF
GO:0030020,extracellular matrix structural constitu...,39,0,0.88,1.00000,1,1,0,MF
GO:0030170,pyridoxal phosphate binding,53,0,1.19,1.00000,1,1,0,MF
GO:0030247,polysaccharide binding,21,0,0.47,1.00000,1,1,0,MF
GO:0030332,cyclin binding,32,0,0.72,1.00000,1,1,0,MF
GO:0030547,receptor inhibitor activity,26,0,0.58,1.00000,1,1,0,MF
GO:0030551,cyclic nucleotide binding,36,0,0.81,1.00000,1,1,0,MF
GO:0030552,cAMP binding,22,0,0.49,1.00000,1,1,0,MF
GO:0030594,neurotransmitter receptor activity,117,0,2.63,1.00000,1,1,0,MF
GO:0031420,alkali metal ion binding,22,0,0.49,1.00000,1,1,0,MF
GO:0031489,myosin V binding,21,0,0.47,1.00000,1,1,0,MF
GO:0031624,ubiquitin conjugating enzyme binding,34,0,0.76,1.00000,1,1,0,MF
GO:0031681,G-protein beta-subunit binding,23,0,0.52,1.00000,1,1,0,MF
GO:0031690,adrenergic receptor binding,21,0,0.47,1.00000,1,1,0,MF
GO:0032451,demethylase activity,42,0,0.94,1.00000,1,1,0,MF
GO:0032452,histone demethylase activity,27,0,0.61,1.00000,1,1,0,MF
GO:0032794,GTPase activating protein binding,20,0,0.45,1.00000,1,1,0,MF
GO:0033038,bitter taste receptor activity,29,0,0.65,1.00000,1,1,0,MF
GO:0033612,receptor serine/threonine kinase binding,28,0,0.63,1.00000,1,1,0,MF
GO:0033764,"steroid dehydrogenase activity, acting o...",37,0,0.83,1.00000,1,1,0,MF
GO:0034061,DNA polymerase activity,33,0,0.74,1.00000,1,1,0,MF
GO:0034212,peptide N-acetyltransferase activity,76,0,1.71,1.00000,1,1,0,MF
GO:0034593,phosphatidylinositol bisphosphate phosph...,21,0,0.47,1.00000,1,1,0,MF
GO:0035250,UDP-galactosyltransferase activity,25,0,0.56,1.00000,1,1,0,MF
GO:0035259,glucocorticoid receptor binding,21,0,0.47,1.00000,1,1,0,MF
GO:0035586,purinergic receptor activity,25,0,0.56,1.00000,1,1,0,MF
GO:0035925,mRNA 3'-UTR AU-rich region binding,29,0,0.65,1.00000,1,1,0,MF
GO:0036002,pre-mRNA binding,35,0,0.79,1.00000,1,1,0,MF
GO:0036442,proton-exporting ATPase activity,31,0,0.7,1.00000,1,1,0,MF
GO:0042056,chemoattractant activity,40,0,0.9,1.00000,1,1,0,MF
GO:0042165,neurotransmitter binding,61,0,1.37,1.00000,1,1,0,MF
GO:0042605,peptide antigen binding,35,0,0.79,1.00000,1,1,0,MF
GO:0042625,ATPase coupled ion transmembrane transpo...,61,0,1.37,1.00000,1,1,0,MF
GO:0042626,"ATPase activity, coupled to transmembran...",113,0,2.54,1.00000,1,1,0,MF
GO:0042887,amide transmembrane transporter activity,43,0,0.97,1.00000,1,1,0,MF
GO:0042923,neuropeptide binding,25,0,0.56,1.00000,1,1,0,MF
GO:0042974,retinoic acid receptor binding,33,0,0.74,1.00000,1,1,0,MF
GO:0042975,peroxisome proliferator activated recept...,21,0,0.47,1.00000,1,1,0,MF
GO:0043015,gamma-tubulin binding,29,0,0.65,1.00000,1,1,0,MF
GO:0043027,cysteine-type endopeptidase inhibitor ac...,28,0,0.63,1.00000,1,1,0,MF
GO:0043028,cysteine-type endopeptidase regulator ac...,39,0,0.88,1.00000,1,1,0,MF
GO:0043394,proteoglycan binding,37,0,0.83,1.00000,1,1,0,MF
GO:0043425,bHLH transcription factor binding,32,0,0.72,1.00000,1,1,0,MF
GO:0043492,"ATPase activity, coupled to movement of ...",114,0,2.56,1.00000,1,1,0,MF
GO:0043539,protein serine/threonine kinase activato...,29,0,0.65,1.00000,1,1,0,MF
GO:0044390,ubiquitin-like protein conjugating enzym...,39,0,0.88,1.00000,1,1,0,MF
GO:0044769,"ATPase activity, coupled to transmembran...",34,0,0.76,1.00000,1,1,0,MF
GO:0046875,ephrin receptor binding,31,0,0.7,1.00000,1,1,0,MF
GO:0046915,transition metal ion transmembrane trans...,37,0,0.83,1.00000,1,1,0,MF
GO:0046943,carboxylic acid transmembrane transporte...,150,0,3.37,1.00000,1,1,0,MF
GO:0046961,"proton-transporting ATPase activity, rot...",21,0,0.47,1.00000,1,1,0,MF
GO:0046965,retinoid X receptor binding,23,0,0.52,1.00000,1,1,0,MF
GO:0046966,thyroid hormone receptor binding,26,0,0.58,1.00000,1,1,0,MF
GO:0047555,"3',5'-cyclic-GMP phosphodiesterase activ...",20,0,0.45,1.00000,1,1,0,MF
GO:0047617,acyl-CoA hydrolase activity,25,0,0.56,1.00000,1,1,0,MF
GO:0048029,monosaccharide binding,85,0,1.91,1.00000,1,1,0,MF
GO:0048156,tau protein binding,21,0,0.47,1.00000,1,1,0,MF
GO:0048487,beta-tubulin binding,43,0,0.97,1.00000,1,1,0,MF
GO:0050136,NADH dehydrogenase (quinone) activity,26,0,0.58,1.00000,1,1,0,MF
GO:0050321,tau-protein kinase activity,20,0,0.45,1.00000,1,1,0,MF
GO:0050750,low-density lipoprotein particle recepto...,26,0,0.58,1.00000,1,1,0,MF
GO:0051059,NF-kappaB binding,32,0,0.72,1.00000,1,1,0,MF
GO:0051119,sugar transmembrane transporter activity,26,0,0.58,1.00000,1,1,0,MF
GO:0051213,dioxygenase activity,94,0,2.11,1.00000,1,1,0,MF
GO:0051371,muscle alpha-actinin binding,21,0,0.47,1.00000,1,1,0,MF
GO:0051536,iron-sulfur cluster binding,63,0,1.41,1.00000,1,1,0,MF
GO:0051537,"2 iron, 2 sulfur cluster binding",25,0,0.56,1.00000,1,1,0,MF
GO:0051539,"4 iron, 4 sulfur cluster binding",39,0,0.88,1.00000,1,1,0,MF
GO:0051540,metal cluster binding,63,0,1.41,1.00000,1,1,0,MF
GO:0051787,misfolded protein binding,24,0,0.54,1.00000,1,1,0,MF
GO:0051861,glycolipid binding,21,0,0.47,1.00000,1,1,0,MF
GO:0052745,inositol phosphate phosphatase activity,20,0,0.45,1.00000,1,1,0,MF
GO:0052866,phosphatidylinositol phosphate phosphata...,25,0,0.56,1.00000,1,1,0,MF
GO:0061631,ubiquitin conjugating enzyme activity,39,0,0.88,1.00000,1,1,0,MF
GO:0061650,ubiquitin-like protein conjugating enzym...,41,0,0.92,1.00000,1,1,0,MF
GO:0061733,peptide-lysine-N-acetyltransferase activ...,67,0,1.5,1.00000,1,1,0,MF
GO:0070001,aspartic-type peptidase activity,30,0,0.67,1.00000,1,1,0,MF
GO:0070003,threonine-type peptidase activity,21,0,0.47,1.00000,1,1,0,MF
GO:0070279,vitamin B6 binding,54,0,1.21,1.00000,1,1,0,MF
GO:0070325,lipoprotein particle receptor binding,30,0,0.67,1.00000,1,1,0,MF
GO:0070330,aromatase activity,35,0,0.79,1.00000,1,1,0,MF
GO:0070530,K63-linked polyubiquitin modification-de...,22,0,0.49,1.00000,1,1,0,MF
GO:0070566,adenylyltransferase activity,30,0,0.67,1.00000,1,1,0,MF
GO:0070696,transmembrane receptor protein serine/th...,20,0,0.45,1.00000,1,1,0,MF
GO:0071837,HMG box domain binding,25,0,0.56,1.00000,1,1,0,MF
GO:0071855,neuropeptide receptor binding,32,0,0.72,1.00000,1,1,0,MF
GO:0072341,modified amino acid binding,104,0,2.34,1.00000,1,1,0,MF
GO:0072509,divalent inorganic cation transmembrane ...,27,0,0.61,1.00000,1,1,0,MF
GO:0090482,vitamin transmembrane transporter activi...,22,0,0.49,1.00000,1,1,0,MF
GO:0098531,"transcription factor activity, direct li...",40,0,0.9,1.00000,1,1,0,MF
GO:0098632,cell-cell adhesion mediator activity,31,0,0.7,1.00000,1,1,0,MF
GO:0098960,postsynaptic neurotransmitter receptor a...,57,0,1.28,1.00000,1,1,0,MF
GO:0099095,ligand-gated anion channel activity,21,0,0.47,1.00000,1,1,0,MF
GO:0099528,G protein-coupled neurotransmitter recep...,45,0,1.01,1.00000,1,1,0,MF
GO:0099529,neurotransmitter receptor activity invol...,55,0,1.24,1.00000,1,1,0,MF
GO:0099589,serotonin receptor activity,39,0,0.88,1.00000,1,1,0,MF
GO:0104005,hijacked molecular function,20,0,0.45,1.00000,1,1,0,MF
GO:0120015,intermembrane sterol transfer activity,21,0,0.47,1.00000,1,1,0,MF
GO:0120020,intermembrane cholesterol transfer activ...,20,0,0.45,1.00000,1,1,0,MF
GO:0140103,"catalytic activity, acting on a glycopro...",22,0,0.49,1.00000,1,1,0,MF
GO:0140104,molecular carrier activity,50,0,1.12,1.00000,1,1,0,MF
GO:0140142,nucleocytoplasmic carrier activity,29,0,0.65,1.00000,1,1,0,MF
GO:1901338,catecholamine binding,21,0,0.47,1.00000,1,1,0,MF
GO:1901505,carbohydrate derivative transmembrane tr...,46,0,1.03,1.00000,1,1,0,MF
GO:1901618,organic hydroxy compound transmembrane t...,43,0,0.97,1.00000,1,1,0,MF
GO:1901682,sulfur compound transmembrane transporte...,31,0,0.7,1.00000,1,1,0,MF
GO:1904315,transmitter-gated ion channel activity i...,52,0,1.17,1.00000,1,1,0,MF
GO:1904680,peptide transmembrane transporter activi...,27,0,0.61,1.00000,1,1,0,MF
GO:0043229,intracellular organelle,11997,408,268.29, 1e-30,6.300000000000001e-28,7.000000000000001e-29,1.52,CC
GO:0044424,intracellular part,13717,435,306.76, 1e-30,6.300000000000001e-28,7.000000000000001e-29,1.42,CC
GO:0005622,intracellular,13747,435,307.43, 1e-30,6.300000000000001e-28,7.000000000000001e-29,1.41,CC
GO:0043226,organelle,12314,409,275.38, 1e-30,6.300000000000001e-28,7.000000000000001e-29,1.49,CC
GO:0044446,intracellular organelle part,7228,299,161.64, 1e-30,6.300000000000001e-28,7.000000000000001e-29,1.85,CC
GO:0044422,organelle part,7595,307,169.85, 1e-30,6.300000000000001e-28,7.000000000000001e-29,1.81,CC
GO:0043228,non-membrane-bounded organelle,4161,206,93.05, 1e-30,6.300000000000001e-28,7.000000000000001e-29,2.21,CC
GO:0043232,intracellular non-membrane-bounded organ...,4141,205,92.61, 1e-30,6.300000000000001e-28,7.000000000000001e-29,2.21,CC
GO:0005634,nucleus,6846,276,153.1, 1e-30,6.300000000000001e-28,7.000000000000001e-29,1.8,CC
GO:0043227,membrane-bounded organelle,11062,368,247.38,1.5e-30,9.45e-28,9.449999999999999e-29,1.49,CC
GO:0005737,cytoplasm,10993,365,245.84,9.8e-30,6.174e-27,5.612727272727272e-28,1.48,CC
GO:0043231,intracellular membrane-bounded organelle,10334,351,231.1,1.7e-29,1.0709999999999999e-26,8.925e-28,1.52,CC
GO:0044464,cell part,16127,452,360.65,3.4e-29,2.1419999999999997e-26,1.6476923076923077e-27,1.25,CC
GO:0005623,cell,16132,452,360.77,3.8e-29,2.394e-26,1.7099999999999998e-27,1.25,CC
GO:0044444,cytoplasmic part,8386,298,187.54,5.9e-25,3.7169999999999997e-22,2.478e-23,1.59,CC
GO:0005856,cytoskeleton,2118,124,47.37,2.5e-24,1.575e-21,9.84375e-23,2.62,CC
GO:0032991,protein-containing complex,5422,222,121.25,6.7e-24,4.220999999999999e-21,2.415e-22,1.83,CC
GO:0044428,nuclear part,3985,182,89.12,6.9e-24,4.3470000000000005e-21,2.415e-22,2.04,CC
GO:0005829,cytosol,3292,154,73.62,1.3e-20,8.19e-18,4.3105263157894735e-19,2.09,CC
GO:0044430,cytoskeletal part,1561,97,34.91,1.4e-20,8.820000000000001e-18,4.41e-19,2.78,CC
GO:0031981,nuclear lumen,3506,150,78.41,2.1e-16,1.323e-13,6.300000000000001e-15,1.91,CC
GO:0070013,intracellular organelle lumen,3883,159,86.84,9.3e-16,5.859e-13,2.49375e-14,1.83,CC
GO:0031974,membrane-enclosed lumen,3884,159,86.86,9.5e-16,5.985e-13,2.49375e-14,1.83,CC
GO:0043233,organelle lumen,3884,159,86.86,9.5e-16,5.985e-13,2.49375e-14,1.83,CC
GO:0015630,microtubule cytoskeleton,1156,69,25.85,8.1e-14,5.103e-11,2.0412e-12,2.67,CC
GO:0015629,actin cytoskeleton,494,40,11.05,2.4e-12,1.512e-9,5.815384615384615e-11,3.62,CC
GO:0005654,nucleoplasm,2607,111,58.3,9.4e-12,5.922e-9,2.193333333333333e-10,1.9,CC
GO:0099513,polymeric cytoskeletal fiber,679,46,15.18,2.6e-11,1.6380000000000002e-8,5.85e-10,3.03,CC
GO:0022626,cytosolic ribosome,109,18,2.44,3.7e-11,2.331e-8,8.037931034482759e-10,7.38,CC
GO:0099512,supramolecular fiber,899,53,20.1,1.3e-10,8.19e-8,2.73e-9,2.64,CC
GO:0099081,supramolecular polymer,905,53,20.24,1.7e-10,1.071e-7,3.346875e-9,2.62,CC
GO:0099080,supramolecular complex,906,53,20.26,1.7e-10,1.071e-7,3.346875e-9,2.62,CC
GO:0097458,neuron part,1982,88,44.32,2.9e-10,1.827e-7,5.536363636363636e-9,1.99,CC
GO:0042995,cell projection,2473,102,55.3,5.1e-10,3.213e-7,9.45e-9,1.84,CC
GO:0005874,microtubule,429,33,9.59,8.0e-10,5.040000000000001e-7,1.44e-8,3.44,CC
GO:0120025,plasma membrane bounded cell projection,2273,94,50.83,2.6e-09,1.638e-6,4.5500000000000004e-8,1.85,CC
GO:0005875,microtubule associated complex,150,18,3.35,7.5e-09,4.725e-6,1.277027027027027e-7,5.37,CC
GO:0044463,cell projection part,1567,71,35.04,9.1e-09,5.733e-6,1.47e-7,2.03,CC
GO:0120038,plasma membrane bounded cell projection ...,1567,71,35.04,9.1e-09,5.733e-6,1.47e-7,2.03,CC
GO:1990904,ribonucleoprotein complex,967,51,21.63,1.3e-08,8.190000000000001e-6,2.0475e-7,2.36,CC
GO:0012505,endomembrane system,3805,133,85.09,3.0e-08,1.89e-5,4.609756097560975e-7,1.56,CC
GO:0005730,nucleolus,821,45,18.36,3.2e-08,2.016e-5,4.800000000000001e-7,2.45,CC
GO:0048471,perinuclear region of cytoplasm,656,39,14.67,3.3e-08,2.079e-5,4.834883720930232e-7,2.66,CC
GO:0044445,cytosolic part,265,23,5.93,3.4e-08,2.142e-5,4.868181818181819e-7,3.88,CC
GO:0005840,ribosome,227,21,5.08,4.6e-08,2.898e-5,6.44e-7,4.13,CC
GO:0005938,cell cortex,316,25,7.07,5.5e-08,3.465e-5,7.532608695652174e-7,3.54,CC
GO:0045202,synapse,1417,64,31.69,6.1e-08,3.843e-5,8.176595744680851e-7,2.02,CC
GO:0022625,cytosolic large ribosomal subunit,61,11,1.36,9.5e-08,5.9850000000000005e-5,1.246875e-6,8.09,CC
GO:0043005,neuron projection,1523,66,34.06,1.7e-07,1.0709999999999999e-4,2.1857142857142857e-6,1.94,CC
GO:0005813,centrosome,517,32,11.56,2.4e-07,1.512e-4,2.9076923076923074e-6,2.77,CC
GO:0030027,lamellipodium,168,17,3.76,2.4e-07,1.512e-4,2.9076923076923074e-6,4.52,CC
GO:0005815,microtubule organizing center,680,38,15.21,2.4e-07,1.512e-4,2.9076923076923074e-6,2.5,CC
GO:0044391,ribosomal subunit,192,18,4.29,3.4e-07,2.1419999999999998e-4,4.041509433962264e-6,4.2,CC
GO:0014069,postsynaptic density,397,27,8.88,3.5e-07,2.205e-4,4.083333333333333e-6,3.04,CC
GO:0032279,asymmetric synapse,400,27,8.95,4.0e-07,2.52e-4,4.581818181818182e-6,3.02,CC
GO:0005871,kinesin complex,57,10,1.27,4.8e-07,3.024e-4,5.399999999999999e-6,7.87,CC
GO:0099568,cytoplasmic region,481,30,10.76,5.0e-07,3.1499999999999996e-4,5.526315789473684e-6,2.79,CC
GO:0099572,postsynaptic specialization,436,28,9.75,6.7e-07,4.221e-4,7.277586206896553e-6,2.87,CC
GO:0031252,cell leading edge,387,26,8.65,7.3e-07,4.599e-4,7.794915254237288e-6,3.01,CC
GO:1902494,catalytic complex,1365,59,30.53,9.1e-07,5.733e-4,9.554999999999999e-6,1.93,CC
GO:0098984,neuron to neuron synapse,425,27,9.5,1.3e-06,8.190000000000001e-4,1.3426229508196722e-5,2.84,CC
GO:0032432,actin filament bundle,96,12,2.15,1.6e-06,0.001008,1.6258064516129034e-5,5.58,CC
GO:0098794,postsynapse,740,38,16.55,1.9e-06,0.001197,1.9e-5,2.3,CC
GO:0044441,ciliary part,464,28,10.38,2.3e-06,0.001449,2.2640625e-5,2.7,CC
GO:0022627,cytosolic small ribosomal subunit,44,8,0.98,5.2e-06,0.0032760000000000003,5.04e-5,8.16,CC
GO:0044448,cell cortex part,212,17,4.74,6.2e-06,0.0039059999999999997,5.9181818181818176e-5,3.59,CC
GO:0030175,filopodium,93,11,2.08,7.3e-06,0.004599000000000001,6.864179104477612e-5,5.29,CC
GO:0070161,anchoring junction,316,21,7.07,1.0e-05,0.006300000000000001,9.130434782608696e-5,2.97,CC
GO:0000785,chromatin,588,31,13.15,1.0e-05,0.006300000000000001,9.130434782608696e-5,2.36,CC
GO:0042641,actomyosin,98,11,2.19,1.2e-05,0.00756,1.08e-4,5.02,CC
GO:0030424,axon,717,35,16.03,1.5e-05,0.00945,1.3309859154929577e-4,2.18,CC
GO:0044297,cell body,811,38,18.14,1.6e-05,0.010079999999999999,1.3808219178082192e-4,2.09,CC
GO:0005912,adherens junction,301,20,6.73,1.6e-05,0.010079999999999999,1.3808219178082192e-4,2.97,CC
GO:0030426,growth cone,206,16,4.61,1.7e-05,0.01071,1.4472972972972973e-4,3.47,CC
GO:0030427,site of polarized growth,211,16,4.72,2.3e-05,0.01449,1.932e-4,3.39,CC
GO:0001725,stress fiber,87,10,1.95,2.4e-05,0.01512,1.9636363636363636e-4,5.13,CC
GO:0097517,contractile actin filament bundle,87,10,1.95,2.4e-05,0.01512,1.9636363636363636e-4,5.13,CC
GO:0005681,spliceosomal complex,194,15,4.34,3.3e-05,0.020790000000000003,2.6653846153846156e-4,3.46,CC
GO:0000775,"chromosome, centromeric region",195,15,4.36,3.5e-05,0.022049999999999997,2.791139240506329e-4,3.44,CC
GO:0030054,cell junction,1144,47,25.58,4.5e-05,0.02835,0.00035437500000000004,1.84,CC
GO:0005635,nuclear envelope,414,23,9.26,6.6e-05,0.041580000000000006,5.133333333333334e-4,2.48,CC
GO:0035145,exon-exon junction complex,21,5,0.47,8.3e-05,0.052289999999999996,6.376829268292683e-4,10.64,CC
GO:0005905,clathrin-coated pit,64,8,1.43,8.7e-05,0.05481,6.603614457831326e-4,5.59,CC
GO:0030864,cortical actin cytoskeleton,101,10,2.26,8.9e-05,0.056069999999999995,6.674999999999999e-4,4.42,CC
GO:0005694,chromosome,1111,45,24.85,9.2e-05,0.05796,6.73953488372093e-4,1.81,CC
GO:0043025,neuronal cell body,722,33,16.15,9.2e-05,0.05796,6.73953488372093e-4,2.04,CC
GO:0015934,large ribosomal subunit,122,11,2.73,9.4e-05,0.059219999999999995,6.806896551724138e-4,4.03,CC
GO:0033267,axon part,454,24,10.15,9.9e-05,0.062369999999999995,7.007865168539325e-4,2.36,CC
GO:0005929,cilium,632,30,14.13,9.9e-05,0.062369999999999995,7.007865168539325e-4,2.12,CC
GO:0030425,dendrite,728,33,16.28,0.00011,0.0693,7.700000000000001e-4,2.03,CC
GO:0097447,dendritic tree,731,33,16.35,0.00012,0.0756,8.129032258064517e-4,2.02,CC
GO:0001726,ruffle,147,12,3.29,0.00012,0.0756,8.129032258064517e-4,3.65,CC
GO:0044427,chromosomal part,991,41,22.16,0.00012,0.0756,8.129032258064517e-4,1.85,CC
GO:0044456,synapse part,1098,44,24.55,0.00014,0.08819999999999999,9.284210526315789e-4,1.79,CC
GO:1990234,transferase complex,770,34,17.22,0.00014,0.08819999999999999,9.284210526315789e-4,1.97,CC
GO:0030863,cortical cytoskeleton,134,11,3,0.00022,0.1386,0.0014437500000000002,3.67,CC
GO:0031410,cytoplasmic vesicle,1830,64,40.92,0.00023,0.1449,0.0014785714285714287,1.56,CC
GO:0036477,somatodendritic compartment,1056,42,23.62,0.00023,0.1449,0.0014785714285714287,1.78,CC
GO:0005868,cytoplasmic dynein complex,26,5,0.58,0.00024,0.1512,0.0015272727272727272,8.62,CC
GO:0097708,intracellular vesicle,1835,64,41.04,0.00025,0.1575,0.001575,1.56,CC
GO:0015935,small ribosomal subunit,76,8,1.7,0.00029,0.1827,0.001808910891089109,4.71,CC
GO:0098858,actin-based cell projection,211,14,4.72,0.00030,0.18899999999999997,0.0018529411764705882,2.97,CC
GO:0150034,distal axon,374,20,8.36,0.00032,0.20160000000000003,0.0019572815533980582,2.39,CC
GO:0097525,spliceosomal snRNP complex,59,7,1.32,0.00033,0.2079,0.0019990384615384614,5.3,CC
GO:0044451,nucleoplasm part,1017,40,22.74,0.00041,0.2583,0.00246,1.76,CC
GO:0043209,myelin sheath,219,14,4.9,0.00044,0.2772,0.0026150943396226417,2.86,CC
GO:0044295,axonal growth cone,45,6,1.01,0.00047,0.2961,0.002767289719626168,5.94,CC
GO:0036064,ciliary basal body,148,11,3.31,0.00051,0.32130000000000003,0.002975,3.32,CC
GO:0061695,"transferase complex, transferring phosph...",249,15,5.57,0.00052,0.32759999999999995,0.003005504587155963,2.69,CC
GO:0030532,small nuclear ribonucleoprotein complex,64,7,1.43,0.00055,0.34650000000000003,0.0031500000000000005,4.9,CC
GO:0031982,vesicle,1969,66,44.03,0.00058,0.3654,0.003291891891891892,1.5,CC
GO:0005819,spindle,280,16,6.26,0.00061,0.3843,0.00343125,2.56,CC
GO:0005911,cell-cell junction,484,23,10.82,0.00062,0.3906,0.003456637168141593,2.13,CC
GO:0005768,endosome,840,34,18.79,0.00067,0.42210000000000003,0.003670434782608696,1.81,CC
GO:0005925,focal adhesion,153,11,3.42,0.00067,0.42210000000000003,0.003670434782608696,3.22,CC
GO:0045121,membrane raft,370,19,8.27,0.00073,0.4599,0.003930769230769231,2.3,CC
GO:0030139,endocytic vesicle,179,12,4,0.00073,0.4599,0.003930769230769231,3,CC
GO:0098857,membrane microdomain,371,19,8.3,0.00075,0.47250000000000003,0.004004237288135593,2.29,CC
GO:0098562,cytoplasmic side of membrane,182,12,4.07,0.00084,0.5292,0.004447058823529412,2.95,CC
GO:0000922,spindle pole,134,10,3,0.00088,0.5544,0.00462,3.33,CC
GO:0005924,cell-substrate adherens junction,159,11,3.56,0.00093,0.5859000000000001,0.004842148760330579,3.09,CC
GO:0000776,kinetochore,137,10,3.06,0.00104,0.6551999999999999,0.005326829268292682,3.27,CC
GO:0016607,nuclear speck,323,17,7.22,0.00104,0.6551999999999999,0.005326829268292682,2.35,CC
GO:0098589,membrane region,383,19,8.57,0.00109,0.6867,0.005537903225806452,2.22,CC
GO:0005814,centriole,115,9,2.57,0.00113,0.7119,0.0056952,3.5,CC
GO:0008180,COP9 signalosome,36,5,0.81,0.00117,0.7371,0.00585,6.17,CC
GO:0005794,Golgi apparatus,1398,49,31.26,0.00123,0.7749,0.00605390625,1.57,CC
GO:0016604,nuclear body,670,28,14.98,0.00123,0.7749,0.00605390625,1.87,CC
GO:0009898,cytoplasmic side of plasma membrane,165,11,3.69,0.00125,0.7875,0.006057692307692307,2.98,CC
GO:0044450,microtubule organizing center part,165,11,3.69,0.00125,0.7875,0.006057692307692307,2.98,CC
GO:0030055,cell-substrate junction,166,11,3.71,0.00132,0.8316,0.0063480916030534355,2.96,CC
GO:0098978,glutamatergic synapse,514,23,11.49,0.00138,0.8694,0.006586363636363636,2,CC
GO:0120114,Sm-like protein family complex,75,7,1.68,0.00143,0.9009,0.0067736842105263154,4.17,CC
GO:0099091,"postsynaptic specialization, intracellul...",38,5,0.85,0.00150,0.9450000000000001,0.00705223880597015,5.88,CC
GO:0098687,chromosomal region,308,16,6.89,0.00166,1,0.007746666666666667,2.32,CC
GO:0070603,SWI/SNF superfamily-type complex,78,7,1.74,0.00180,1,0.008338235294117648,4.02,CC
GO:0030286,dynein complex,58,6,1.3,0.00184,1,0.0084,4.62,CC
GO:0005721,pericentric heterochromatin,24,4,0.54,0.00184,1,0.0084,7.41,CC
GO:0031672,A band,40,5,0.89,0.00189,1,0.008566187050359712,5.62,CC
GO:0005884,actin filament,125,9,2.8,0.00201,1,0.009045000000000001,3.21,CC
GO:0000790,nuclear chromatin,406,19,9.08,0.00213,1,0.009517021276595743,2.09,CC
GO:0016459,myosin complex,60,6,1.34,0.00219,1,0.009716197183098591,4.48,CC
GO:0019898,extrinsic component of membrane,320,16,7.16,0.00243,1,0.010705594405594406,2.23,CC
GO:0044291,cell-cell contact zone,84,7,1.88,0.00276,1,0.012074999999999999,3.72,CC
GO:0035770,ribonucleoprotein granule,214,12,4.79,0.00330,1,0.01423972602739726,2.51,CC
GO:0097386,glial cell projection,28,4,0.63,0.00330,1,0.01423972602739726,6.35,CC
GO:0019897,extrinsic component of plasma membrane,187,11,4.18,0.00335,1,0.014357142857142857,2.63,CC
GO:0005684,U2-type spliceosomal complex,89,7,1.99,0.00381,1,0.016218243243243245,3.52,CC
GO:0016363,nuclear matrix,90,7,2.01,0.00406,1,0.017166442953020136,3.48,CC
GO:0098590,plasma membrane region,1226,42,27.42,0.00409,1,0.017178,1.53,CC
GO:0097733,photoreceptor cell cilium,114,8,2.55,0.00412,1,0.017189403973509938,3.14,CC
GO:0005913,cell-cell adherens junction,115,8,2.57,0.00434,1,0.017870588235294117,3.11,CC
GO:0034399,nuclear periphery,115,8,2.57,0.00434,1,0.017870588235294117,3.11,CC
GO:0042383,sarcolemma,167,10,3.73,0.00445,1,0.018204545454545452,2.68,CC
GO:0097731,9+0 non-motile cilium,116,8,2.59,0.00457,1,0.01845576923076923,3.09,CC
GO:0098685,Schaffer collateral - CA1 synapse,116,8,2.59,0.00457,1,0.01845576923076923,3.09,CC
GO:0042788,polysomal ribosome,31,4,0.69,0.00482,1,0.01934140127388535,5.8,CC
GO:0032587,ruffle membrane,71,6,1.59,0.00510,1,0.020335443037974684,3.77,CC
GO:0048786,presynaptic active zone,94,7,2.1,0.00515,1,0.02040566037735849,3.33,CC
GO:0031967,organelle envelope,1063,37,23.77,0.00536,1,0.020974390243902435,1.56,CC
GO:0034451,centriolar satellite,32,4,0.72,0.00541,1,0.020974390243902435,5.56,CC
GO:0099092,"postsynaptic density, intracellular comp...",32,4,0.72,0.00541,1,0.020974390243902435,5.56,CC
GO:0031975,envelope,1064,37,23.79,0.00544,1,0.020974390243902435,1.56,CC
GO:0000792,heterochromatin,95,7,2.12,0.00546,1,0.020974390243902435,3.3,CC
GO:1904949,ATPase complex,96,7,2.15,0.00578,1,0.022069090909090913,3.26,CC
GO:0005776,autophagosome,73,6,1.63,0.00583,1,0.022125903614457834,3.68,CC
GO:0044309,neuron spine,202,11,4.52,0.00596,1,0.022483832335329343,2.43,CC
GO:0036464,cytoplasmic ribonucleoprotein granule,203,11,4.54,0.00618,1,0.023037869822485207,2.42,CC
GO:0005923,bicellular tight junction,122,8,2.73,0.00618,1,0.023037869822485207,2.93,CC
GO:0098805,whole membrane,1114,38,24.91,0.00661,1,0.02449588235294118,1.53,CC
GO:0005844,polysome,75,6,1.68,0.00665,1,0.024499999999999997,3.57,CC
GO:0005783,endoplasmic reticulum,1715,54,38.35,0.00676,1,0.02476046511627907,1.41,CC
GO:0097730,non-motile cilium,152,9,3.4,0.00731,1,0.02662023121387283,2.65,CC
GO:0099738,cell cortex region,55,5,1.23,0.00761,1,0.027553448275862067,4.07,CC
GO:0070160,tight junction,129,8,2.88,0.00855,1,0.030780000000000002,2.78,CC
GO:0030880,RNA polymerase complex,104,7,2.33,0.00885,1,0.031678977272727275,3,CC
GO:0032153,cell division site,58,5,1.3,0.00949,1,0.033777966101694916,3.85,CC
GO:0031616,spindle pole centrosome,20,3,0.45,0.00955,1,0.03380056179775281,6.67,CC
GO:0031461,cullin-RING ubiquitin ligase complex,160,9,3.58,0.01006,1,0.035406703910614526,2.51,CC
GO:0071013,catalytic step 2 spliceosome,83,6,1.86,0.01075,1,0.037625,3.23,CC
GO:0000151,ubiquitin ligase complex,282,13,6.31,0.01136,1,0.03954033149171271,2.06,CC
GO:0016528,sarcoplasm,85,6,1.9,0.01200,1,0.04153846153846154,3.16,CC
GO:0031430,M band,22,3,0.49,0.01248,1,0.042963934426229505,6.12,CC
GO:0000228,nuclear chromosome,655,24,14.65,0.01288,1,0.0441,1.64,CC
GO:0044454,nuclear chromosome part,621,23,13.89,0.01311,1,0.04464486486486487,1.66,CC
GO:0098831,presynaptic active zone cytoplasmic comp...,23,3,0.51,0.01412,1,0.047233333333333336,5.88,CC
GO:0099243,extrinsic component of synaptic membrane,23,3,0.51,0.01412,1,0.047233333333333336,5.88,CC
GO:0032154,cleavage furrow,42,4,0.94,0.01414,1,0.047233333333333336,4.26,CC
GO:0030660,Golgi-associated vesicle membrane,64,5,1.43,0.01417,1,0.047233333333333336,3.5,CC
GO:0031984,organelle subcompartment,913,31,20.42,0.01429,1,0.04738263157894737,1.52,CC
GO:0043296,apical junction complex,142,8,3.18,0.01469,1,0.04845392670157068,2.52,CC
GO:0042734,presynaptic membrane,200,10,4.47,0.01488,1,0.048825,2.24,CC
GO:0000307,cyclin-dependent protein kinase holoenzy...,43,4,0.96,0.01532,1,0.050008290155440414,4.17,CC
GO:0035327,transcriptionally active chromatin,25,3,0.56,0.01774,1,0.05760927835051546,5.36,CC
GO:0005901,caveola,94,6,2.1,0.01893,1,0.06115846153846154,2.86,CC
GO:0012506,vesicle membrane,336,14,7.51,0.01968,1,0.06325714285714286,1.86,CC
GO:0030135,coated vesicle,181,9,4.05,0.02094,1,0.06696548223350254,2.22,CC
GO:0030659,cytoplasmic vesicle membrane,309,13,6.91,0.02243,1,0.07136818181818182,1.88,CC
GO:0031594,neuromuscular junction,98,6,2.19,0.02274,1,0.07199095477386935,2.74,CC
GO:0035869,ciliary transition zone,73,5,1.63,0.02376,1,0.074844,3.07,CC
GO:0097060,synaptic membrane,516,19,11.54,0.02400,1,0.07522388059701493,1.65,CC
GO:0055029,nuclear DNA-directed RNA polymerase comp...,100,6,2.24,0.02482,1,0.0774089108910891,2.68,CC
GO:0030315,T-tubule,74,5,1.65,0.02503,1,0.07767931034482758,3.03,CC
GO:0000428,DNA-directed RNA polymerase complex,101,6,2.26,0.02591,1,0.08001617647058823,2.65,CC
GO:0000780,"condensed nuclear chromosome, centromeri...",29,3,0.65,0.02640,1,0.0807378640776699,4.62,CC
GO:0090568,nuclear transcriptional repressor comple...,29,3,0.65,0.02640,1,0.0807378640776699,4.62,CC
GO:0000779,"condensed chromosome, centromeric region",51,4,1.14,0.02701,1,0.08186971153846154,3.51,CC
GO:1902911,protein kinase complex,102,6,2.28,0.02703,1,0.08186971153846154,2.63,CC
GO:0016529,sarcoplasmic reticulum,76,5,1.7,0.02770,1,0.08349760765550239,2.94,CC
GO:0098793,presynapse,564,20,12.61,0.02962,1,0.08886,1.59,CC
GO:0005881,cytoplasmic microtubule,78,5,1.74,0.03054,1,0.09044788732394367,2.87,CC
GO:0008023,transcription elongation factor complex,53,4,1.19,0.03058,1,0.09044788732394367,3.36,CC
GO:0032155,cell division site part,53,4,1.19,0.03058,1,0.09044788732394367,3.36,CC
GO:1990752,microtubule end,31,3,0.69,0.03143,1,0.09252757009345795,4.35,CC
GO:0045111,intermediate filament cytoskeleton,166,8,3.71,0.03349,1,0.09715871559633027,2.16,CC
GO:0001750,photoreceptor outer segment,80,5,1.79,0.03356,1,0.09715871559633027,2.79,CC
GO:0000793,condensed chromosome,197,9,4.41,0.03362,1,0.09715871559633027,2.04,CC
GO:0043197,dendritic spine,197,9,4.41,0.03362,1,0.09715871559633027,2.04,CC
GO:0046540,U4/U6 x U5 tri-snRNP complex,33,3,0.74,0.03693,1,0.10575409090909091,4.05,CC
GO:0097526,spliceosomal tri-snRNP complex,33,3,0.74,0.03693,1,0.10575409090909091,4.05,CC
GO:0005769,early endosome,266,11,5.95,0.03774,1,0.10758461538461539,1.85,CC
GO:1902554,serine/threonine protein kinase complex,83,5,1.86,0.03842,1,0.10902972972972973,2.69,CC
GO:0030667,secretory granule membrane,84,5,1.88,0.04014,1,0.11340000000000001,2.66,CC
GO:0016328,lateral plasma membrane,58,4,1.3,0.04066,1,0.11384601769911505,3.08,CC
GO:0045171,intercellular bridge,58,4,1.3,0.04066,1,0.11384601769911505,3.08,CC
GO:0099503,secretory vesicle,585,20,13.08,0.04084,1,0.11384601769911505,1.53,CC
GO:0031965,nuclear membrane,237,10,5.3,0.04126,1,0.1145101321585903,1.89,CC
GO:0030176,integral component of endoplasmic reticu...,143,7,3.2,0.04202,1,0.1161078947368421,2.19,CC
GO:0031253,cell projection membrane,305,12,6.82,0.04257,1,0.11697272727272726,1.76,CC
GO:0000118,histone deacetylase complex,59,4,1.32,0.04288,1,0.11697272727272726,3.03,CC
GO:0097546,ciliary base,35,3,0.78,0.04289,1,0.11697272727272726,3.85,CC
GO:0030496,midbody,144,7,3.22,0.04336,1,0.11774482758620691,2.17,CC
GO:0044304,main axon,86,5,1.92,0.04370,1,0.11815879828326181,2.6,CC
GO:0042175,nuclear outer membrane-endoplasmic retic...,554,19,12.39,0.04422,1,0.11905384615384616,1.53,CC
GO:0005790,smooth endoplasmic reticulum,36,3,0.81,0.04604,1,0.12342638297872341,3.7,CC
GO:0044433,cytoplasmic vesicle part,527,18,11.79,0.05084,1,0.13571694915254237,1.53,CC
GO:0031970,organelle envelope lumen,90,5,2.01,0.05137,1,0.136553164556962,2.49,CC
GO:0005789,endoplasmic reticulum membrane,529,18,11.83,0.05236,1,0.13815188284518828,1.52,CC
GO:0014704,intercalated disc,63,4,1.41,0.05241,1,0.13815188284518828,2.84,CC
GO:0031227,intrinsic component of endoplasmic retic...,151,7,3.38,0.05348,1,0.140385,2.07,CC
GO:0031256,leading edge membrane,152,7,3.4,0.05504,1,0.14386296296296294,2.06,CC
GO:0005791,rough endoplasmic reticulum,92,5,2.06,0.05549,1,0.14386296296296294,2.43,CC
GO:0005902,microvillus,92,5,2.06,0.05549,1,0.14386296296296294,2.43,CC
GO:0044431,Golgi apparatus part,497,17,11.11,0.05594,1,0.14443524590163934,1.53,CC
GO:0010494,cytoplasmic stress granule,65,4,1.45,0.05758,1,0.14806285714285716,2.76,CC
GO:0044853,plasma membrane raft,123,6,2.75,0.05822,1,0.1491,2.18,CC
GO:0098827,endoplasmic reticulum subcompartment,543,18,12.14,0.06390,1,0.16298380566801618,1.48,CC
GO:0043198,dendritic shaft,68,4,1.52,0.06581,1,0.16717862903225805,2.63,CC
GO:0005793,endoplasmic reticulum-Golgi intermediate...,69,4,1.54,0.06869,1,0.173754,2.6,CC
GO:0031234,extrinsic component of cytoplasmic side ...,98,5,2.19,0.06895,1,0.173754,2.28,CC
GO:0005680,anaphase-promoting complex,20,2,0.45,0.07276,1,0.18020470588235296,4.44,CC
GO:0016010,dystrophin-associated glycoprotein compl...,20,2,0.45,0.07276,1,0.18020470588235296,4.44,CC
GO:0045277,respiratory chain complex IV,20,2,0.45,0.07276,1,0.18020470588235296,4.44,CC
GO:0090665,glycoprotein complex,20,2,0.45,0.07276,1,0.18020470588235296,4.44,CC
GO:0043292,contractile fiber,229,9,5.12,0.07294,1,0.18020470588235296,1.76,CC
GO:0001650,fibrillar center,131,6,2.93,0.07413,1,0.18218521400778212,2.05,CC
GO:0098796,membrane protein complex,1134,33,25.36,0.07432,1,0.18218521400778212,1.3,CC
GO:0005798,Golgi-associated vesicle,135,6,3.02,0.08292,1,0.20247906976744184,1.99,CC
GO:0032391,photoreceptor connecting cilium,46,3,1.03,0.08336,1,0.20276756756756759,2.91,CC
GO:0016323,basolateral plasma membrane,236,9,5.28,0.08425,1,0.20414423076923077,1.7,CC
GO:0001741,XY body,22,2,0.49,0.08594,1,0.20744137931034481,4.08,CC
GO:0044449,contractile fiber part,206,8,4.61,0.09227,1,0.22140681818181818,1.74,CC
GO:0002080,acrosomal membrane,23,2,0.51,0.09278,1,0.22140681818181818,3.92,CC
GO:0035371,microtubule plus-end,23,2,0.51,0.09278,1,0.22140681818181818,3.92,CC
GO:0030141,secretory granule,385,13,8.61,0.09335,1,0.2219264150943396,1.51,CC
GO:0016591,"RNA polymerase II, holoenzyme",77,4,1.72,0.09394,1,0.2224894736842105,2.33,CC
GO:0005604,basement membrane,108,5,2.42,0.09500,1,0.22415730337078651,2.07,CC
GO:0071005,U2-type precatalytic spliceosome,49,3,1.1,0.09645,1,0.2267294776119403,2.73,CC
GO:0030684,preribosome,78,4,1.74,0.09736,1,0.22801784386617102,2.3,CC
GO:0030662,coated vesicle membrane,79,4,1.77,0.10085,1,0.23477380073800738,2.26,CC
GO:0071011,precatalytic spliceosome,50,3,1.12,0.10099,1,0.23477380073800738,2.68,CC
GO:0000794,condensed nuclear chromosome,144,6,3.22,0.10471,1,0.24252683823529414,1.86,CC
GO:0030057,desmosome,25,2,0.56,0.10691,1,0.24581496350364965,3.57,CC
GO:0030687,"preribosome, large subunit precursor",25,2,0.56,0.10691,1,0.24581496350364965,3.57,CC
GO:0030016,myofibril,215,8,4.81,0.11065,1,0.25348909090909094,1.66,CC
GO:0005689,U12-type spliceosomal complex,26,2,0.58,0.11417,1,0.26060543478260867,3.45,CC
GO:0017053,transcriptional repressor complex,83,4,1.86,0.11535,1,0.2623483754512635,2.15,CC
GO:0044452,nucleolar part,184,7,4.11,0.11972,1,0.27130791366906476,1.7,CC
GO:0002102,podosome,27,2,0.6,0.12156,1,0.2725366548042705,3.33,CC
GO:0032839,dendrite cytoplasm,27,2,0.6,0.12156,1,0.2725366548042705,3.33,CC
GO:0097440,apical dendrite,27,2,0.6,0.12156,1,0.2725366548042705,3.33,CC
GO:0030137,COPI-coated vesicle,28,2,0.63,0.12906,1,0.28832553191489363,3.17,CC
GO:0044432,endoplasmic reticulum part,641,19,14.33,0.13089,1,0.29138056537102475,1.33,CC
GO:0005802,trans-Golgi network,225,8,5.03,0.13323,1,0.2955454225352112,1.59,CC
GO:0016342,catenin complex,29,2,0.65,0.13666,1,0.30209052631578953,3.08,CC
GO:0045211,postsynaptic membrane,376,12,8.41,0.13928,1,0.3068055944055944,1.43,CC
GO:0030120,vesicle coat,58,3,1.3,0.14014,1,0.3076243902439024,2.31,CC
GO:0005942,phosphatidylinositol 3-kinase complex,30,2,0.67,0.14436,1,0.31253195876288653,2.99,CC
GO:0044665,MLL1/2 complex,30,2,0.67,0.14436,1,0.31253195876288653,2.99,CC
GO:0071339,MLL1 complex,30,2,0.67,0.14436,1,0.31253195876288653,2.99,CC
GO:0097431,mitotic spindle pole,30,2,0.67,0.14436,1,0.31253195876288653,2.99,CC
GO:0005882,intermediate filament,125,5,2.8,0.14892,1,0.3213,1.79,CC
GO:0000407,phagophore assembly site,31,2,0.69,0.15215,1,0.3260357142857143,2.9,CC
GO:0098945,intrinsic component of presynaptic activ...,31,2,0.69,0.15215,1,0.3260357142857143,2.9,CC
GO:0045335,phagocytic vesicle,93,4,2.08,0.15520,1,0.3314440677966102,1.92,CC
GO:0008305,integrin complex,32,2,0.72,0.16002,1,0.3382973154362416,2.78,CC
GO:0070069,cytochrome complex,32,2,0.72,0.16002,1,0.3382973154362416,2.78,CC
GO:0080008,Cul4-RING E3 ubiquitin ligase complex,32,2,0.72,0.16002,1,0.3382973154362416,2.78,CC
GO:0005667,transcription factor complex,426,13,9.53,0.16131,1,0.33988394648829434,1.36,CC
GO:0001669,acrosomal vesicle,129,5,2.88,0.16317,1,0.34265700000000004,1.74,CC
GO:0034704,calcium channel complex,64,3,1.43,0.17229,1,0.36060697674418607,2.1,CC
GO:0030136,clathrin-coated vesicle,99,4,2.21,0.18125,1,0.3781043046357616,1.81,CC
GO:0097223,sperm part,244,8,5.46,0.18195,1,0.3783118811881188,1.47,CC
GO:0000777,condensed chromosome kinetochore,35,2,0.78,0.18403,1,0.38007941176470583,2.56,CC
GO:0051233,spindle midzone,35,2,0.78,0.18403,1,0.38007941176470583,2.56,CC
GO:0031090,organelle membrane,1753,45,39.2,0.18461,1,0.38007941176470583,1.15,CC
GO:0005903,brush border,137,5,3.06,0.19320,1,0.39646905537459287,1.63,CC
GO:0019005,SCF ubiquitin ligase complex,68,3,1.52,0.19477,1,0.3983931818181818,1.97,CC
GO:0032838,plasma membrane bounded cell projection ...,174,6,3.89,0.19548,1,0.39855145631067956,1.54,CC
GO:0098791,Golgi subcompartment,444,13,9.93,0.19752,1,0.4014116129032258,1.31,CC
GO:0031463,Cul3-RING ubiquitin ligase complex,37,2,0.83,0.20031,1,0.4031798722044729,2.41,CC
GO:0031941,filamentous actin,37,2,0.83,0.20031,1,0.4031798722044729,2.41,CC
GO:0098636,protein complex involved in cell adhesio...,37,2,0.83,0.20031,1,0.4031798722044729,2.41,CC
GO:0001772,immunological synapse,38,2,0.85,0.20852,1,0.41704,2.35,CC
GO:1990391,DNA repair complex,38,2,0.85,0.20852,1,0.41704,2.35,CC
GO:0005643,nuclear pore,72,3,1.61,0.21793,1,0.43448069620253166,1.86,CC
GO:0016605,PML body,73,3,1.63,0.22380,1,0.4447760252365931,1.84,CC
GO:0055037,recycling endosome,145,5,3.24,0.22499,1,0.4457349056603773,1.54,CC
GO:0005777,peroxisome,146,5,3.27,0.22907,1,0.4509815625,1.53,CC
GO:0042579,microbody,146,5,3.27,0.22907,1,0.4509815625,1.53,CC
GO:0072686,mitotic spindle,110,4,2.46,0.23228,1,0.4536388888888889,1.63,CC
GO:0000152,nuclear ubiquitin ligase complex,41,2,0.92,0.23330,1,0.4536388888888889,2.17,CC
GO:0000803,sex chromosome,41,2,0.92,0.23330,1,0.4536388888888889,2.17,CC
GO:0043596,nuclear replication fork,41,2,0.92,0.23330,1,0.4536388888888889,2.17,CC
GO:0060076,excitatory synapse,76,3,1.7,0.24161,1,0.46548715596330276,1.76,CC
GO:0005771,multivesicular body,42,2,0.94,0.24161,1,0.46548715596330276,2.13,CC
GO:0120111,neuron projection cytoplasm,42,2,0.94,0.24161,1,0.46548715596330276,2.13,CC
GO:0008021,synaptic vesicle,227,7,5.08,0.24676,1,0.4726718181818182,1.38,CC
GO:0005739,mitochondrion,1809,45,40.46,0.24691,1,0.4726718181818182,1.11,CC
GO:0005758,mitochondrial intermembrane space,77,3,1.72,0.24759,1,0.4726718181818182,1.74,CC
GO:0005720,nuclear heterochromatin,43,2,0.96,0.24993,1,0.4742647590361446,2.08,CC
GO:0009925,basal plasma membrane,43,2,0.96,0.24993,1,0.4742647590361446,2.08,CC
GO:0030017,sarcomere,192,6,4.29,0.26041,1,0.4926675675675675,1.4,CC
GO:0055038,recycling endosome membrane,45,2,1.01,0.26658,1,0.5028305389221557,1.98,CC
GO:0098588,bounding membrane of organelle,1060,27,23.71,0.26921,1,0.5062755223880597,1.14,CC
GO:0034708,methyltransferase complex,118,4,2.64,0.27134,1,0.5087625,1.52,CC
GO:0043235,receptor complex,396,11,8.86,0.27426,1,0.5124062130177515,1.24,CC
GO:0048787,presynaptic active zone membrane,46,2,1.03,0.27491,1,0.5124062130177515,1.94,CC
GO:0005801,cis-Golgi network,49,2,1.1,0.29985,1,0.5572433628318584,1.82,CC
GO:0098552,side of membrane,615,16,13.75,0.30328,1,0.56196,1.16,CC
GO:0031514,motile cilium,204,6,4.56,0.30647,1,0.5662055718475073,1.32,CC
GO:0070382,exocytic vesicle,247,7,5.52,0.31638,1,0.5811428571428572,1.27,CC
GO:0031901,early endosome membrane,51,2,1.14,0.31640,1,0.5811428571428572,1.75,CC
GO:0005930,axoneme,130,4,2.91,0.33167,1,0.6027,1.37,CC
GO:0071944,cell periphery,5388,125,120.49,0.33232,1,0.6027,1.04,CC
GO:0030134,COPII-coated ER to Golgi transport vesic...,53,2,1.19,0.33286,1,0.6027,1.68,CC
GO:0070062,extracellular exosome,91,3,2.04,0.33292,1,0.6027,1.47,CC
GO:0070469,respiratory chain,91,3,2.04,0.33292,1,0.6027,1.47,CC
GO:0098797,plasma membrane protein complex,545,14,12.19,0.33629,1,0.606132,1.15,CC
GO:0097014,ciliary plasm,131,4,2.93,0.33674,1,0.606132,1.37,CC
GO:0045177,apical part of cell,422,11,9.44,0.34542,1,0.6199846153846155,1.17,CC
GO:0030018,Z disc,133,4,2.97,0.34691,1,0.6208900568181818,1.35,CC
GO:0035097,histone methyltransferase complex,94,3,2.1,0.35130,1,0.6269660056657224,1.43,CC
GO:0000930,gamma-tubulin complex,20,1,0.45,0.36399,1,0.6352180055401662,2.22,CC
GO:0005686,U2 snRNP,20,1,0.45,0.36399,1,0.6352180055401662,2.22,CC
GO:0030904,retromer complex,20,1,0.45,0.36399,1,0.6352180055401662,2.22,CC
GO:0031091,platelet alpha granule,20,1,0.45,0.36399,1,0.6352180055401662,2.22,CC
GO:0033646,host intracellular part,20,1,0.45,0.36399,1,0.6352180055401662,2.22,CC
GO:0043656,intracellular region of host,20,1,0.45,0.36399,1,0.6352180055401662,2.22,CC
GO:0044232,organelle membrane contact site,20,1,0.45,0.36399,1,0.6352180055401662,2.22,CC
GO:0090723,growth cone part,20,1,0.45,0.36399,1,0.6352180055401662,2.22,CC
GO:0044455,mitochondrial membrane part,219,6,4.9,0.36574,1,0.6365088397790056,1.22,CC
GO:0000242,pericentriolar material,21,1,0.47,0.37823,1,0.6528353424657535,2.13,CC
GO:0012507,ER to Golgi transport vesicle membrane,21,1,0.47,0.37823,1,0.6528353424657535,2.13,CC
GO:0030673,axolemma,21,1,0.47,0.37823,1,0.6528353424657535,2.13,CC
GO:1903561,extracellular vesicle,99,3,2.21,0.38179,1,0.6571795081967213,1.36,CC
GO:0098802,plasma membrane receptor complex,182,5,4.07,0.38505,1,0.6605735294117647,1.23,CC
GO:0030117,membrane coat,100,3,2.24,0.38785,1,0.6605735294117647,1.34,CC
GO:0048475,coated membrane,100,3,2.24,0.38785,1,0.6605735294117647,1.34,CC
GO:0005788,endoplasmic reticulum lumen,60,2,1.34,0.38942,1,0.6605735294117647,1.49,CC
GO:0030132,clathrin coat of coated pit,22,1,0.49,0.39215,1,0.6605735294117647,2.04,CC
GO:0031307,integral component of mitochondrial oute...,22,1,0.49,0.39215,1,0.6605735294117647,2.04,CC
GO:0033643,host cell part,22,1,0.49,0.39215,1,0.6605735294117647,2.04,CC
GO:0043194,axon initial segment,22,1,0.49,0.39215,1,0.6605735294117647,2.04,CC
GO:0030658,transport vesicle membrane,144,4,3.22,0.40270,1,0.6709417322834645,1.24,CC
GO:0000421,autophagosome membrane,23,1,0.51,0.40576,1,0.6709417322834645,1.96,CC
GO:0005797,Golgi medial cisterna,23,1,0.51,0.40576,1,0.6709417322834645,1.96,CC
GO:0031306,intrinsic component of mitochondrial out...,23,1,0.51,0.40576,1,0.6709417322834645,1.96,CC
GO:0045120,pronucleus,23,1,0.51,0.40576,1,0.6709417322834645,1.96,CC
GO:0046930,pore complex,23,1,0.51,0.40576,1,0.6709417322834645,1.96,CC
GO:0097470,ribbon synapse,23,1,0.51,0.40576,1,0.6709417322834645,1.96,CC
GO:0031674,I band,145,4,3.24,0.40774,1,0.6724507853403141,1.23,CC
GO:0019866,organelle inner membrane,489,12,10.94,0.41283,1,0.6734892857142857,1.1,CC
GO:0099023,tethering complex,63,2,1.41,0.41302,1,0.6734892857142857,1.42,CC
GO:0005743,mitochondrial inner membrane,446,11,9.97,0.41360,1,0.6734892857142857,1.1,CC
GO:0062023,collagen-containing extracellular matrix,360,9,8.05,0.41465,1,0.6734892857142857,1.12,CC
GO:0005858,axonemal dynein complex,24,1,0.54,0.41906,1,0.6734892857142857,1.85,CC
GO:0018995,host,24,1,0.54,0.41906,1,0.6734892857142857,1.85,CC
GO:0033017,sarcoplasmic reticulum membrane,24,1,0.54,0.41906,1,0.6734892857142857,1.85,CC
GO:0036452,ESCRT complex,24,1,0.54,0.41906,1,0.6734892857142857,1.85,CC
GO:0043601,nuclear replisome,24,1,0.54,0.41906,1,0.6734892857142857,1.85,CC
GO:0043657,host cell,24,1,0.54,0.41906,1,0.6734892857142857,1.85,CC
GO:0005773,vacuole,536,13,11.99,0.42244,1,0.677193893129771,1.08,CC
GO:0030894,replisome,25,1,0.56,0.43207,1,0.6856526448362721,1.79,CC
GO:0031233,intrinsic component of external side of ...,25,1,0.56,0.43207,1,0.6856526448362721,1.79,CC
GO:0042588,zymogen granule,25,1,0.56,0.43207,1,0.6856526448362721,1.79,CC
GO:0060077,inhibitory synapse,25,1,0.56,0.43207,1,0.6856526448362721,1.79,CC
GO:0045178,basal part of cell,66,2,1.48,0.43616,1,0.6904040201005025,1.35,CC
GO:0098862,cluster of actin-based cell projections,194,5,4.34,0.43800,1,0.6915789473684211,1.15,CC
GO:0097038,perinuclear endoplasmic reticulum,26,1,0.58,0.44478,1,0.6987815461346634,1.72,CC
GO:0099059,integral component of presynaptic active...,26,1,0.58,0.44478,1,0.6987815461346634,1.72,CC
GO:0000139,Golgi membrane,242,6,5.41,0.45712,1,0.7125206896551723,1.11,CC
GO:0099524,postsynaptic cytosol,27,1,0.6,0.45721,1,0.7125206896551723,1.67,CC
GO:0032589,neuron projection membrane,69,2,1.54,0.45879,1,0.7125206896551723,1.3,CC
GO:0030672,synaptic vesicle membrane,112,3,2.5,0.45918,1,0.7125206896551723,1.2,CC
GO:0099501,exocytic vesicle membrane,112,3,2.5,0.45918,1,0.7125206896551723,1.2,CC
GO:0031045,dense core granule,28,1,0.63,0.46937,1,0.7247625000000001,1.59,CC
GO:0071007,U2-type catalytic step 2 spliceosome,28,1,0.63,0.46937,1,0.7247625000000001,1.59,CC
GO:0043230,extracellular organelle,114,3,2.55,0.47074,1,0.7251007334963325,1.18,CC
GO:0005770,late endosome,203,5,4.54,0.47705,1,0.7323369565217392,1.1,CC
GO:0005657,replication fork,72,2,1.61,0.48089,1,0.7323369565217392,1.24,CC
GO:0032592,integral component of mitochondrial memb...,72,2,1.61,0.48089,1,0.7323369565217392,1.24,CC
GO:0030125,clathrin vesicle coat,29,1,0.65,0.48125,1,0.7323369565217392,1.54,CC
GO:0030140,trans-Golgi network transport vesicle,29,1,0.65,0.48125,1,0.7323369565217392,1.54,CC
GO:0005886,plasma membrane,5243,118,117.25,0.48584,1,0.7359234042553191,1.01,CC
GO:0046658,anchored component of plasma membrane,73,2,1.63,0.48813,1,0.7359234042553191,1.23,CC
GO:0030686,90S preribosome,30,1,0.67,0.49287,1,0.7359234042553191,1.49,CC
GO:0044215,other organism,30,1,0.67,0.49287,1,0.7359234042553191,1.49,CC
GO:0044216,other organism cell,30,1,0.67,0.49287,1,0.7359234042553191,1.49,CC
GO:0044217,other organism part,30,1,0.67,0.49287,1,0.7359234042553191,1.49,CC
GO:0044305,calyx of Held,30,1,0.67,0.49287,1,0.7359234042553191,1.49,CC
GO:0044306,neuron projection terminus,207,5,4.63,0.49412,1,0.7359234042553191,1.08,CC
GO:0044798,nuclear transcription factor complex,207,5,4.63,0.49412,1,0.7359234042553191,1.08,CC
GO:0098573,intrinsic component of mitochondrial mem...,74,2,1.65,0.49531,1,0.7359558962264151,1.21,CC
GO:0042470,melanosome,31,1,0.69,0.50422,1,0.7421929906542056,1.45,CC
GO:0045334,clathrin-coated endocytic vesicle,31,1,0.69,0.50422,1,0.7421929906542056,1.45,CC
GO:0048770,pigment granule,31,1,0.69,0.50422,1,0.7421929906542056,1.45,CC
GO:1902555,endoribonuclease complex,31,1,0.69,0.50422,1,0.7421929906542056,1.45,CC
GO:0010008,endosome membrane,210,5,4.7,0.50679,1,0.7442370629370629,1.06,CC
GO:0016234,inclusion body,76,2,1.7,0.50947,1,0.7458703016241299,1.18,CC
GO:0036126,sperm flagellum,121,3,2.71,0.51027,1,0.7458703016241299,1.11,CC
GO:1905348,endonuclease complex,32,1,0.72,0.51533,1,0.7515229166666666,1.39,CC
GO:0005921,gap junction,33,1,0.74,0.52618,1,0.7638096774193548,1.35,CC
GO:0098688,parallel fiber to Purkinje cell synapse,33,1,0.74,0.52618,1,0.7638096774193548,1.35,CC
GO:0000784,"nuclear chromosome, telomeric region",79,2,1.77,0.53022,1,0.7661435779816514,1.13,CC
GO:0005746,mitochondrial respiratory chain,79,2,1.77,0.53022,1,0.7661435779816514,1.13,CC
GO:0032588,trans-Golgi network membrane,34,1,0.76,0.53679,1,0.7738620137299771,1.32,CC
GO:0044459,plasma membrane part,2879,64,64.38,0.54147,1,0.7788267123287671,0.99,CC
GO:0005719,nuclear euchromatin,35,1,0.78,0.54717,1,0.7831285714285714,1.28,CC
GO:0097729,9+2 motile cilium,128,3,2.86,0.54819,1,0.7831285714285714,1.05,CC
GO:0098889,intrinsic component of presynaptic membr...,128,3,2.86,0.54819,1,0.7831285714285714,1.05,CC
GO:0098803,respiratory chain complex,83,2,1.86,0.55695,1,0.7925627539503385,1.08,CC
GO:0016592,mediator complex,36,1,0.81,0.55731,1,0.7925627539503385,1.23,CC
GO:0098800,inner mitochondrial membrane protein com...,130,3,2.91,0.55871,1,0.7927641891891892,1.03,CC
GO:0030665,clathrin-coated vesicle membrane,37,1,0.83,0.56723,1,0.8030447191011235,1.2,CC
GO:0005669,transcription factor TFIID complex,38,1,0.85,0.57692,1,0.8149318385650225,1.18,CC
GO:0030133,transport vesicle,324,7,7.25,0.58960,1,0.830979865771812,0.97,CC
GO:0044447,axoneme part,40,1,0.89,0.59567,1,0.8365530066815144,1.12,CC
GO:0043679,axon terminus,185,4,4.14,0.59621,1,0.8365530066815144,0.97,CC
GO:0044440,endosomal part,234,5,5.23,0.60285,1,0.8428758849557523,0.96,CC
GO:0043204,perikaryon,139,3,3.11,0.60415,1,0.8428758849557523,0.96,CC
GO:0099522,region of cytosol,41,1,0.92,0.60473,1,0.8428758849557523,1.09,CC
GO:0019867,outer membrane,189,4,4.23,0.61306,1,0.8495723076923077,0.95,CC
GO:0031968,organelle outer membrane,189,4,4.23,0.61306,1,0.8495723076923077,0.95,CC
GO:0005637,nuclear inner membrane,42,1,0.94,0.61358,1,0.8495723076923077,1.06,CC
GO:0031305,integral component of mitochondrial inne...,43,1,0.96,0.62224,1,0.8596736842105264,1.04,CC
GO:0005740,mitochondrial envelope,663,14,14.83,0.62488,1,0.8600941176470588,0.94,CC
GO:0031225,anchored component of membrane,192,4,4.29,0.62540,1,0.8600941176470588,0.93,CC
GO:0031012,extracellular matrix,477,10,10.67,0.62664,1,0.8600941176470588,0.94,CC
GO:0031304,intrinsic component of mitochondrial inn...,44,1,0.98,0.63071,1,0.8619520607375271,1.02,CC
GO:0031966,mitochondrial membrane,619,13,13.84,0.63073,1,0.8619520607375271,0.94,CC
GO:0000791,euchromatin,45,1,1.01,0.63898,1,0.8694544276457883,0.99,CC
GO:0030285,integral component of synaptic vesicle m...,45,1,1.01,0.63898,1,0.8694544276457883,0.99,CC
GO:0016020,membrane,9366,206,209.45,0.64310,1,0.8731745689655173,0.98,CC
GO:0008287,protein serine/threonine phosphatase com...,46,1,1.03,0.64707,1,0.8732852248394004,0.97,CC
GO:1903293,phosphatase complex,46,1,1.03,0.64707,1,0.8732852248394004,0.97,CC
GO:0098839,postsynaptic density membrane,98,2,2.19,0.64734,1,0.8732852248394004,0.91,CC
GO:0032590,dendrite membrane,48,1,1.07,0.66272,1,0.8921230769230769,0.93,CC
GO:0030118,clathrin coat,49,1,1.1,0.67028,1,0.8984604255319149,0.91,CC
GO:0031201,SNARE complex,49,1,1.1,0.67028,1,0.8984604255319149,0.91,CC
GO:0035861,site of double-strand break,50,1,1.12,0.67767,1,0.9045171610169491,0.89,CC
GO:0098686,hippocampal mossy fiber to CA3 synapse,50,1,1.12,0.67767,1,0.9045171610169491,0.89,CC
GO:0098982,GABA-ergic synapse,104,2,2.33,0.67918,1,0.904616067653277,0.86,CC
GO:0031902,late endosome membrane,54,1,1.21,0.70561,1,0.937836075949367,0.83,CC
GO:0005765,lysosomal membrane,110,2,2.46,0.70864,1,0.9398804210526316,0.81,CC
GO:0098852,lytic vacuole membrane,111,2,2.48,0.71332,1,0.9440999999999999,0.81,CC
GO:0031312,extrinsic component of organelle membran...,56,1,1.25,0.71867,1,0.9491867924528302,0.8,CC
GO:0090575,RNA polymerase II transcription factor c...,166,3,3.71,0.72101,1,0.9495449064449064,0.81,CC
GO:0016324,apical plasma membrane,320,6,7.16,0.72375,1,0.9495449064449064,0.84,CC
GO:0005876,spindle microtubule,57,1,1.27,0.72497,1,0.9495449064449064,0.79,CC
GO:0008328,ionotropic glutamate receptor complex,57,1,1.27,0.72497,1,0.9495449064449064,0.79,CC
GO:0000781,"chromosome, telomeric region",114,2,2.55,0.72700,1,0.9502282157676348,0.78,CC
GO:0001917,photoreceptor inner segment,58,1,1.3,0.73114,1,0.9530442148760331,0.77,CC
GO:0005774,vacuolar membrane,169,3,3.78,0.73218,1,0.9530442148760331,0.79,CC
GO:0098878,neurotransmitter receptor complex,59,1,1.32,0.73717,1,0.9575610309278351,0.76,CC
GO:0005741,mitochondrial outer membrane,171,3,3.82,0.73943,1,0.9584926078028747,0.79,CC
GO:0034703,cation channel complex,224,4,5.01,0.74093,1,0.9584926078028747,0.8,CC
GO:0044438,microbody part,61,1,1.36,0.74883,1,0.9647503067484662,0.74,CC
GO:0044439,peroxisomal part,61,1,1.36,0.74883,1,0.9647503067484662,0.74,CC
GO:0031301,integral component of organelle membrane,228,4,5.1,0.75328,1,0.968044399185336,0.78,CC
GO:0031985,Golgi cisterna,62,1,1.39,0.75446,1,0.968044399185336,0.72,CC
GO:0044437,vacuolar part,180,3,4.03,0.77013,1,0.9790530241935484,0.74,CC
GO:0098936,intrinsic component of postsynaptic memb...,180,3,4.03,0.77013,1,0.9790530241935484,0.74,CC
GO:0090734,site of DNA damage,65,1,1.45,0.77061,1,0.9790530241935484,0.69,CC
GO:0098563,intrinsic component of synaptic vesicle ...,65,1,1.45,0.77061,1,0.9790530241935484,0.69,CC
GO:0005764,lysosome,440,8,9.84,0.77081,1,0.9790530241935484,0.81,CC
GO:0000323,lytic vacuole,441,8,9.86,0.77293,1,0.9797704225352113,0.81,CC
GO:0044429,mitochondrial part,851,16,19.03,0.79544,1,1,0.84,CC
GO:0034702,ion channel complex,299,5,6.69,0.80156,1,1,0.75,CC
GO:0099240,intrinsic component of synaptic membrane,246,4,5.5,0.80328,1,1,0.73,CC
GO:0032993,protein-DNA complex,191,3,4.27,0.80358,1,1,0.7,CC
GO:0000932,P-body,73,1,1.63,0.80869,1,1,0.61,CC
GO:0099634,postsynaptic specialization membrane,137,2,3.06,0.81444,1,1,0.65,CC
GO:0031300,intrinsic component of organelle membran...,256,4,5.73,0.82731,1,1,0.7,CC
GO:0008076,voltage-gated potassium channel complex,78,1,1.74,0.82922,1,1,0.57,CC
GO:1902495,transmembrane transporter complex,314,5,7.02,0.83409,1,1,0.71,CC
GO:0000795,synaptonemal complex,81,1,1.81,0.84046,1,1,0.55,CC
GO:0099086,synaptonemal structure,81,1,1.81,0.84046,1,1,0.55,CC
GO:0005811,lipid droplet,83,1,1.86,0.84754,1,1,0.54,CC
GO:0098798,mitochondrial protein complex,266,4,5.95,0.84886,1,1,0.67,CC
GO:1990351,transporter complex,325,5,7.27,0.85508,1,1,0.69,CC
GO:0005795,Golgi stack,86,1,1.92,0.85758,1,1,0.52,CC
GO:0043195,terminal bouton,87,1,1.95,0.86078,1,1,0.51,CC
GO:0034705,potassium channel complex,89,1,1.99,0.86696,1,1,0.5,CC
GO:1905368,peptidase complex,93,1,2.08,0.87852,1,1,0.48,CC
GO:0099055,integral component of postsynaptic membr...,171,2,3.82,0.89823,1,1,0.52,CC
GO:0009986,cell surface,955,16,21.36,0.90991,1,1,0.75,CC
GO:0099056,integral component of presynaptic membra...,116,1,2.59,0.92797,1,1,0.39,CC
GO:0016442,RISC complex,123,1,2.75,0.93858,1,1,0.36,CC
GO:0031332,RNAi effector complex,123,1,2.75,0.93858,1,1,0.36,CC
GO:0005759,mitochondrial matrix,266,3,5.95,0.93885,1,1,0.5,CC
GO:0099699,integral component of synaptic membrane,228,2,5.1,0.96486,1,1,0.39,CC
GO:0009897,external side of plasma membrane,434,4,9.71,0.98848,1,1,0.41,CC
GO:0044421,extracellular region part,1855,27,41.48,0.99527,1,1,0.65,CC
GO:0044425,membrane part,7301,136,163.27,0.99696,1,1,0.83,CC
GO:0005615,extracellular space,1621,19,36.25,0.99962,1,1,0.52,CC
GO:0005576,extracellular region,2399,32,53.65,0.99973,1,1,0.6,CC
GO:0031226,intrinsic component of plasma membrane,1604,17,35.87,0.99991,1,1,0.47,CC
GO:0005887,integral component of plasma membrane,1526,14,34.13,0.99998,1,1,0.41,CC
GO:0031224,intrinsic component of membrane,6068,79,135.7,1.00000,1,1,0.58,CC
GO:0016021,integral component of membrane,5896,75,131.85,1.00000,1,1,0.57,CC
GO:0005575,cellular_component,21419,479,479,1.00000,1,1,1,CC
GO:0000123,histone acetyltransferase complex,83,0,1.86,1.00000,1,1,0,CC
GO:0000159,protein phosphatase type 2A complex,20,0,0.45,1.00000,1,1,0,CC
GO:0000178,exosome (RNase complex),23,0,0.51,1.00000,1,1,0,CC
GO:0000313,organellar ribosome,93,0,2.08,1.00000,1,1,0,CC
GO:0000314,organellar small ribosomal subunit,31,0,0.69,1.00000,1,1,0,CC
GO:0000315,organellar large ribosomal subunit,60,0,1.34,1.00000,1,1,0,CC
GO:0000502,proteasome complex,66,0,1.48,1.00000,1,1,0,CC
GO:0000786,nucleosome,88,0,1.97,1.00000,1,1,0,CC
GO:0000788,nuclear nucleosome,38,0,0.85,1.00000,1,1,0,CC
GO:0001533,cornified envelope,56,0,1.25,1.00000,1,1,0,CC
GO:0001673,male germ cell nucleus,23,0,0.51,1.00000,1,1,0,CC
GO:0001891,phagocytic cup,22,0,0.49,1.00000,1,1,0,CC
GO:0005581,collagen trimer,83,0,1.86,1.00000,1,1,0,CC
GO:0005732,small nucleolar ribonucleoprotein comple...,26,0,0.58,1.00000,1,1,0,CC
GO:0005747,mitochondrial respiratory chain complex ...,50,0,1.12,1.00000,1,1,0,CC
GO:0005753,mitochondrial proton-transporting ATP sy...,20,0,0.45,1.00000,1,1,0,CC
GO:0005761,mitochondrial ribosome,93,0,2.08,1.00000,1,1,0,CC
GO:0005762,mitochondrial large ribosomal subunit,60,0,1.34,1.00000,1,1,0,CC
GO:0005763,mitochondrial small ribosomal subunit,31,0,0.69,1.00000,1,1,0,CC
GO:0005778,peroxisomal membrane,45,0,1.01,1.00000,1,1,0,CC
GO:0005834,heterotrimeric G-protein complex,33,0,0.74,1.00000,1,1,0,CC
GO:0005838,proteasome regulatory particle,23,0,0.51,1.00000,1,1,0,CC
GO:0005849,mRNA cleavage factor complex,20,0,0.45,1.00000,1,1,0,CC
GO:0005865,striated muscle thin filament,30,0,0.67,1.00000,1,1,0,CC
GO:0005891,voltage-gated calcium channel complex,45,0,1.01,1.00000,1,1,0,CC
GO:0005922,connexin complex,20,0,0.45,1.00000,1,1,0,CC
GO:0009295,nucleoid,47,0,1.05,1.00000,1,1,0,CC
GO:0015030,Cajal body,35,0,0.78,1.00000,1,1,0,CC
GO:0016235,aggresome,40,0,0.89,1.00000,1,1,0,CC
GO:0016327,apicolateral plasma membrane,22,0,0.49,1.00000,1,1,0,CC
GO:0016469,proton-transporting two-sector ATPase co...,49,0,1.1,1.00000,1,1,0,CC
GO:0022624,proteasome accessory complex,25,0,0.56,1.00000,1,1,0,CC
GO:0030119,AP-type membrane coat adaptor complex,48,0,1.07,1.00000,1,1,0,CC
GO:0030131,clathrin adaptor complex,30,0,0.67,1.00000,1,1,0,CC
GO:0030173,integral component of Golgi membrane,53,0,1.19,1.00000,1,1,0,CC
GO:0030666,endocytic vesicle membrane,32,0,0.72,1.00000,1,1,0,CC
GO:0030964,NADH dehydrogenase complex,50,0,1.12,1.00000,1,1,0,CC
GO:0030990,intraciliary transport particle,29,0,0.65,1.00000,1,1,0,CC
GO:0030992,intraciliary transport particle B,21,0,0.47,1.00000,1,1,0,CC
GO:0031082,BLOC complex,20,0,0.45,1.00000,1,1,0,CC
GO:0031228,intrinsic component of Golgi membrane,55,0,1.23,1.00000,1,1,0,CC
GO:0031231,intrinsic component of peroxisomal membr...,20,0,0.45,1.00000,1,1,0,CC
GO:0031248,protein acetyltransferase complex,93,0,2.08,1.00000,1,1,0,CC
GO:0031362,anchored component of external side of p...,22,0,0.49,1.00000,1,1,0,CC
GO:0031519,PcG protein complex,47,0,1.05,1.00000,1,1,0,CC
GO:0031526,brush border membrane,77,0,1.72,1.00000,1,1,0,CC
GO:0031903,microbody membrane,45,0,1.01,1.00000,1,1,0,CC
GO:0032040,small-subunit processome,37,0,0.83,1.00000,1,1,0,CC
GO:0032281,AMPA glutamate receptor complex,32,0,0.72,1.00000,1,1,0,CC
GO:0032420,stereocilium,54,0,1.21,1.00000,1,1,0,CC
GO:0032421,stereocilium bundle,64,0,1.43,1.00000,1,1,0,CC
GO:0032426,stereocilium tip,20,0,0.45,1.00000,1,1,0,CC
GO:0032806,carboxy-terminal domain protein kinase c...,21,0,0.47,1.00000,1,1,0,CC
GO:0032809,neuronal cell body membrane,36,0,0.81,1.00000,1,1,0,CC
GO:0032994,protein-lipid complex,36,0,0.81,1.00000,1,1,0,CC
GO:0033176,proton-transporting V-type ATPase comple...,26,0,0.58,1.00000,1,1,0,CC
GO:0033177,proton-transporting two-sector ATPase co...,22,0,0.49,1.00000,1,1,0,CC
GO:0034358,plasma lipoprotein particle,34,0,0.76,1.00000,1,1,0,CC
GO:0034364,high-density lipoprotein particle,23,0,0.51,1.00000,1,1,0,CC
GO:0034706,sodium channel complex,24,0,0.54,1.00000,1,1,0,CC
GO:0034707,chloride channel complex,46,0,1.03,1.00000,1,1,0,CC
GO:0035267,NuA4 histone acetyltransferase complex,21,0,0.47,1.00000,1,1,0,CC
GO:0036379,myofilament,32,0,0.72,1.00000,1,1,0,CC
GO:0042611,MHC protein complex,21,0,0.47,1.00000,1,1,0,CC
GO:0042645,mitochondrial nucleoid,47,0,1.05,1.00000,1,1,0,CC
GO:0043073,germ cell nucleus,30,0,0.67,1.00000,1,1,0,CC
GO:0043083,synaptic cleft,20,0,0.45,1.00000,1,1,0,CC
GO:0043189,H4/H2A histone acetyltransferase complex,21,0,0.47,1.00000,1,1,0,CC
GO:0044292,dendrite terminus,20,0,0.45,1.00000,1,1,0,CC
GO:0044298,cell body membrane,38,0,0.85,1.00000,1,1,0,CC
GO:0044420,extracellular matrix component,52,0,1.16,1.00000,1,1,0,CC
GO:0044815,DNA packaging complex,96,0,2.15,1.00000,1,1,0,CC
GO:0045095,keratin filament,40,0,0.89,1.00000,1,1,0,CC
GO:0045259,proton-transporting ATP synthase complex,21,0,0.47,1.00000,1,1,0,CC
GO:0045271,respiratory chain complex I,50,0,1.12,1.00000,1,1,0,CC
GO:0060170,ciliary membrane,53,0,1.19,1.00000,1,1,0,CC
GO:0061702,inflammasome complex,21,0,0.47,1.00000,1,1,0,CC
GO:0070461,SAGA-type complex,26,0,0.58,1.00000,1,1,0,CC
GO:0070971,endoplasmic reticulum exit site,27,0,0.6,1.00000,1,1,0,CC
GO:0071782,endoplasmic reticulum tubular network,23,0,0.51,1.00000,1,1,0,CC
GO:0097225,sperm midpiece,28,0,0.63,1.00000,1,1,0,CC
GO:0097228,sperm principal piece,32,0,0.72,1.00000,1,1,0,CC
GO:0097346,INO80-type complex,24,0,0.54,1.00000,1,1,0,CC
GO:0098948,intrinsic component of postsynaptic spec...,113,0,2.53,1.00000,1,1,0,CC
GO:0098993,anchored component of synaptic vesicle m...,20,0,0.45,1.00000,1,1,0,CC
GO:0099060,integral component of postsynaptic speci...,107,0,2.39,1.00000,1,1,0,CC
GO:0099061,integral component of postsynaptic densi...,74,0,1.65,1.00000,1,1,0,CC
GO:0099146,intrinsic component of postsynaptic dens...,80,0,1.79,1.00000,1,1,0,CC
GO:0099523,presynaptic cytosol,25,0,0.56,1.00000,1,1,0,CC
GO:0101031,chaperone complex,21,0,0.47,1.00000,1,1,0,CC
GO:1902493,acetyltransferase complex,93,0,2.08,1.00000,1,1,0,CC
GO:1902562,H4 histone acetyltransferase complex,43,0,0.96,1.00000,1,1,0,CC
GO:1902710,GABA receptor complex,21,0,0.47,1.00000,1,1,0,CC
GO:1905354,exoribonuclease complex,23,0,0.51,1.00000,1,1,0,CC
GO:1905360,GTPase complex,33,0,0.74,1.00000,1,1,0,CC
GO:1905369,endopeptidase complex,67,0,1.5,1.00000,1,1,0,CC
GO:1990204,oxidoreductase complex,109,0,2.44,1.00000,1,1,0,CC
GO:1990777,lipoprotein particle,34,0,0.76,1.00000,1,1,0,CC
